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ABSTRACT 
 
Embryonic stem cells (ESC) have unlimited potential in the field of biological sciences 
and regenerative medicine due to their pluripotency and ability to self-renew 
indefinitely. With the goal to establish, isolate and culture murine (mESC) as well as 
caprine (gESC) embryonic stem cells, in vivo- and in vitro-derived blastocysts were 
used as a source in producing mESC and gESC lines. Both mESC and gESC were 
cultured in vitro using mouse embryonic fibroblast (MEF) as feeder cell layer in this 
study. The aims of this study were: a) to compare the effects of murine strain, blastocyst 
stage and inner cell mass (ICM) isolation techniques on the efficiency of deriving 
murine embryonic stem cell (mESC) lines in murine species and b) to compare the 
effects of in vivo- and in vitro-derived blastocyst sources as well as to establish effective 
technologies to isolate and culture ESC in caprine species. Mouse embryonic fibroblasts 
(MEF) were derived from murine foetuses (13.5 to 14.0 d.p.c.), cultured up to Passage 2 
(P2), cryopreserved and thawed at each passage to be used as feeder cell layer for 
mESC and gESC cultures. In order to obtain the blastocyst sources for production of 
mESC and gESC lines, somatic cell nuclear transfer (in vitro) and in vivo flushing were 
carried out in this study. For isolation of the inner cell mass (ICM) from blastocyst, 
whole blastocyst culture, manual cut and laser dissection were compared among 
respective treatment groups to derive mESC and gESC lines. In murine, a total of 71 
(ICR), 38 (CBA/ca), 22 (C57BL/6J) mESC lines were produced from 971, 758 and 709 
murine blastocysts, respectively. Five blastocyst stages were cultured on the MEF with 
3 ICM isolation techniques. ICM outgrowths were disaggregated by trypsin/EDTA 
(0.05%) and manual dissociation, cultured on new inactivated MEF in CO2 (5%) 
incubator at 37ºC. The attachment, primary ICM outgrowth and successful consecutive 
passages rates up to P3 were compared among the murine strains, blastocyst stages and 
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ICM isolation techniques. There were significant differences (P<0.05) in successful 
passage rate at P3 between CBA/ca with ICR and C57BL/6J (19.81% vs. 9.00% and 
8.50%), respectively, also mESC at Passage 1 (P1) for mid-, expanded- and hatching 
blastocyst stages versus early- and hatched blastocyst (45.35%, 52.79% and 43.01% vs. 
27.88% and 24.53%), respectively. Manual cut ICM isolation technique consistently 
gave the highest attachment, primary ICM outgrowth and successful mESC P2 and P3 
rates compared with whole blastocyst culture and laser dissection techniques (78.03% 
vs. 66.52% and 71.06%; 78.35% vs. 75.32% and 75.67%; 52.06% vs. 41.62% and 
45.06%; 36.52% vs. 25.77% and 30.49%), respectively. In summary, the CBA/ca strain, 
expanded blastocyst stage and manual cut for ICM isolation techniques showed the 
optimal outcomes obtained in production of mESC lines. A total of 156 and 13 caprine 
blastocysts were obtained from in vitro- and in vivo-derived blastocyst, respectively. 
The in vivo-derived blastocsyts gave significant difference in production gESC lines at 
P3 compared with in vitro-derived blastocysts (91.67% vs. 20.83%). The caprine ICM 
outgrowths for gESC production were then disaggregated by trypsin/EDTA (0.05%) 
and manual dissociation and cultured on new inactivated MEF feeder cell layer in CO2 
(5%) incubator at 37ºC. Manual cut for ICM isolation technique consistently gave the 
highest successful rates of gESC in P1 and P3 compared with whole blastocyst culture 
and laser dissection technique (71.28% vs. 39.58% and 43.89%; 35.04% vs. 12.50% 
and 23.33%), respectively. The mESC and gESC were stained to evaluate the 
expression of alkaline phosphates (AP) and positive results confirming the pluripotency 
of mESC and gESC were obtained. The ICM outgrowths for mESC were also 
characterised for Oct 4 and SSEA 1, whereas ICM outgrowths for gESC were 
characterised using Oct 4 and SSEA 3 and positive results were detected. It is 
concluded that ICM cells could be isolated from in vivo- and in vitro-derived murine 
and caprine blastocysts using whole blastocysts culture, manual cut and laser dissection 
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techniques and subsequently cultured to produce mESC and gESC lines as confirmed 
by positive expression of AP, Oct 4, SSEA 1 and SSEA 3. It is hoped that the findings 
obtained from this research will provide the fundamental information for future studies 
regarding establishment of ESC and MEF cell lines that can be potentially applied to 
overcome issues in livestock production, wildlife conservation and human regenerative 
medicine. 
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ABSTRAK 
 
Sel batang embrionik (ESC) mempunyai potensi yang tidak terbatas dalam bidang sains 
biologi dan perubatan regeneratif oleh kerana pluripotensi dan keupayaannya untuk 
memperbaharui selnya sendiri tanpa batasan. Dengan sasaran untuk membangun, 
mengasing dan mengkultur sel batang embrionik mencit (mESC) dan kambing (gESC), 
blastosis yang diperolehi secara in vivo dan in vitro digunakan sebagai suatu sumber 
dalam menghasilkan titisan-titisan mESC dan gESC. Kedua-dua mESC dan gESC 
dikultur in vitro dengan menggunakan fibroblas embrionik mencit (MEF) sebagai 
lapisan sel pembantu dalam kajian ini. Tujuan kajian ini adalah: a) untuk membanding 
kesan strain mencit, peringkat blastosis dan teknik mengasingkan jisim sel dalaman 
(ICM) terhadap kecekapan dalam memperolehi titisan sel batang embrionik mencit 
(mESC) dalam spesies mencit dan b) untuk membanding kesan sumber blastosis 
diperolehi secara in vivo dan in vitro serta membangunkan teknologi yang berkesan 
untuk mengasing dan mengkultur ESC dalam spesis kambing. Fibroblast embronik 
mencit (MEF) telah diperolehi daripada janin mencit (13.5  hingga 14.0 d.p.c.), dikultur 
sehingga Pasaj 2 (P2), dikrioawet dan dinyahsejukbeku pada setiap pasaj untuk 
digunakan sebagai lapisan sel pembantu bagi pengkulturan mESC dan gESC. Untuk 
mendapatkan sumber blastosis bagi menghasilkan titisan-titisan mESC dan gESC, 
pemindahan nuklear sel somatik (in vitro) dan pengepaman keluar in vivo telah 
dijalankan dalam kajian ini. Untuk mengasingkan jisim sel dalaman (ICM) daripada 
blastosis, kultur seluruh blastosis, pemotongan secara manual dan pembedahan laser 
telah dibandingkan antara kumpulan perlakuan masing-masing untuk memperolehi 
titisan-titisan mESC dan gESC. Dalam mencit, sejumlah 71 (ICR), 38 (CBA/ca), 22 
(C57BL/6J) titisan-titisan mESC telah dihasilkan daripada 971, 758 dan 709 blastosis 
mencit, masing-masing. Lima peringkat blastosis telah dikultur atas MEF dengan 3 
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teknik pengasingan ICM. Pertumbuhan ICM telah dipisahkan dengan cara 
trypsin/EDTA (0.05%) dan penceraian secara manual, dikultur di atas MEF baru yang 
telah teraktif di dalam inkubator CO2 (5%) pada 37ºC. Pelekapan, pertumbuhan ICM 
primer dan kadar pasaj turutan yang berjaya sehingga ke P3 telah dibanding antara 
strain mencit, peringkat blastosis dan teknik pengasingan ICM. Terdapat perbezaan 
signifikan (P<0.05) dalam kadar pasaj yang berjaya pada P3 antara CBA/ca dengan ICR 
dan C57BL/6J (19.81% vs. 9.00% dan 8.50%), masing-masing juga mESC pada P1 
bagi peringkat blastosis pertengahan-, pengembangan dan penetasan berlawan dengan 
peringkat blastosis awal- dan menetas (45.35%, 52.79% dan 43.01% vs. 27.88% dan 
24.53%), masing-masing. Teknik penceraian ICM secara pemotongan manual dengan 
konsisten memberi kadar paling tinggi pelekapan, pertumbuhan ICM primer serta P2 
dan P3 bagi mESC yang berjaya berbanding dengan kultur seluruh blastosis dan teknik 
pembedahan laser (78.03% vs. 66.52% dan 71.06%; 78.35% vs. 75.32% dan 75.67%; 
52.06% vs. 41.62% dan 45.06%; 36.52% vs. 25.77% dan 30.49%), masing-masing. 
Secara ringkasnya, strain CBA/ca, peringkat pengembagan blastosis dan pemotongan 
secara manual bagi teknik pengasingan ICM menunjukkan hasilan optimal diperolehi 
dalam menghasilkan titisan-titisan mESC. Sejumlah 156 dan 13 blastosis kambing telah 
diperolehi daripada blastosis berasal in vitro dan in vivo, masing-masing. Blastosis 
berasal in vivo telah memberi perbezaan yang signifikan dalam menghasilkan titisan 
gESC pada P3 berbanding dengan blastosis berasal in vitro (91.67% vs. 20.83%). 
Pertumbuhan ICM kambing untuk penghasilan gESC kemudian dipisahkan dengan 
trypsin/EDTA (0.05%) dan penceraian secara manual serta dikultur di atas lapisan sel 
pembantu MEF yang telah teraktif baru dalam inkubator CO2 (5%) pada 37ºC. 
Pemotongan secara manual bagi teknik pengasingan ICM secara konsisten memberi 
kadar kejayaan yang tertinggi bagi gESC pada P1 dan P3 berbanding dengan kultur 
seluruh blastosis dan teknik pembedahan laser (71.28% vs. 39.58% dan 43.89%; 
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35.04% vs. 12.50% dan 23.33%), masing-masing. mESC dan gESC telah diwarnakan 
untuk menilai ekspresi fosfat alkali (AP) dan keputusan positif diperolehi yang 
mengesahkan pluripotensi mESC dan ESC. Pertumbuhan ICM bagi mESC  juga telah 
dicirikan dengan menguna Oct 4 dan SSEA 1, manakala pertumbuhan ICM bagi gESC 
telah dicirikan denagan mengguna Oct 4 dan SSEA 3 dan keputusan positif telah 
dikesan. Dirumuskan bahawa sel ICM boleh diasingkan daripada blastosis mencit dan 
kambing berasal dari in vivo dan in vitro dengan menggunakan kultur seluruh blastosis, 
teknik-teknik pemotongan secara manual dan pembedahan laser dan seterusnya 
dikulturkan bagi menghasilkan titisan-titisan mESC dan gESC sebagaimana disahkan 
oleh ekspresi positif AP, Oct 4, SSEA 1 dan SSEA 3. Adalah diharapkan semoga 
penemuan yang diperolehi daripada kajian ini akan menyediakan maklumat asas bagi 
kajian-kajian masa hadapan yang berhubung kait dengan pembangunan titisan-titsan sel 
ESC dan MEF yang mempunyai potensi untuk diaplikasi bagi menyelesaikan isu-isu 
dalam produksi haiwan ternakan, konservasi hidupan liar dan perubatan regeneratif 
manusia. 
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Chapter 1 
1.0 INTRODUCTION 
 
At the turn of the twentieth century, development of stem cells from a variety of sources 
has led to the rapid worldwide progression in stem cell research for basic biological 
information and therapeutic applications. Stem cells are cells that consist of prolonged 
or unlimited capacity for self-renewal in an undifferentiated state, which have the 
capacity to develop into at least one type of highly differentiated descendent. They are 
pluripotent and capable to differentiate to specialised cell types when induced by 
appropriate stimulants under suitable conditions (Bongso and Lee, 2005). In vitro 
studies have repeatedly shown that cells grown under the control of specific growth 
factors can differentiate into cardiomyocytes, epithelial cells, and neurons (Shamblott et 
al., 2001). According to Thomson et al. (1998), stem cells can be classified into 2 
groups, namely adult stem cells and embryonic stem cells (ESC). Conventionally, adult 
stem cells are isolated from various tissues and organs, such as the blood 
(heamatopoietic stem cell), cord blood (cord blood stem cell), bone marrow 
(mesenchymal stem cell), skin and hair (epidermal stem cell) and amniotic stem cell 
(Coppi et al., 2007). However, adult stem cells (multipotent) have limited 
differentiation capability compared to embryonic stem cells (pluripotent) where the 
deriving cell types of its own origins (Kondo and Raft, 2000). The former may develop 
into many different cells, but not all cell types. It has become increasingly clear that 
embryonic stem cells have distinct advantages over adult-derived stem cells. Embryonic 
stem cells are more potent than adult stem cell because it typically derived from the 
inner cell mass (ICM) of blastocyst stage embryos (Thomson et al., 1998). Similar to 
cells of the inner cell mass, embryonic stem cells are pluripotent diploid cells and 
capable to differentiate into all cell types of the 3 embryonic germ layers, namely 
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ectoderm, mesoderm and endoderm, including germ cells both in vivo and in vitro 
(Smith, 2001; Hoffman and Carpenter, 2005; Soto-Gutierrez et al., 2006). Embryonic 
stem cells are remarkable because they can be cultured and manipulated relatively 
easily in vitro without losing their developmental potential and behave like normal 
embryonic cells when they are injected into host blastocysts (Robertson, 1987) or 8-cell 
stage embryos (Tokunaga and Tsunoda, 1992).   
Sources of blastocyst are an important factor to obtain inner cell mass in 
producing the embryonic stem cells. There are two ways to obtain inner cell mass, 
namely in vivo flushing and somatic cell nuclear transfer (SCNT). Blastocysts also can 
be obtained by other methods such as in vitro fertilisation (IVF), intracytoplasmic 
sperm injection (ICSI) and parthenogenesis (pathenogenetic activation; PA). However, 
the focus of this project was in vivo flushing (in vivo fertilisation), cloning (SCNT) and 
parthenogenetic activation because it is routine in our laboratory to produce blastocyst 
through in vivo flushing, cloning (SCNT) and pathenogenetic activation (PA), although 
other researchers obtain blastocyst sources from in vitro fertilisation and 
intracytoplasmic sperm injection procedures.   
 Primary mouse embryonic fibroblast (MEF) is used as feeder cell layer to 
prevent embryonic stem cell differentiation. Mouse embryonic fibroblast continues to 
be the most commonly used feeder cell type for the culture and maintenance of murine 
and human derived embryonic stem cell lines. Mouse embryonic fibroblast provides a 
complex, but unknown mixture of nutrients and substrates for the long term growth and 
proliferation of undifferentiated pluripotent embryonic stem cells. Mouse embryonic 
fibroblast has been used as feeder cell layer for the culture of embryonic stem cells 
since the first murine embryonic stem cells were derived in 1981 (Evan and Kaufman, 
1981). Mouse embryonic fibroblast is currently giving encouraging results as feeder cell 
layer for culturing embryonic stem cells. The advantages of mouse embryonic fibroblast 
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are easier to prepare, cheaper comparing to STO cells, and it is available in our 
laboratory. However, the researchers in ABEL laboratory mostly used murine species to 
produce murine embryonic stem cells (mESC). Some results with other species such as 
ovine (Meinecke-Tillmann et al., 2011) and bovine (Roach et al., 2006) are just 
encouraging as well. In this study, the mouse embryonic fibroblast as feeder cell layer 
for caprine species to obtain caprine embryonic stem cell (gESC) line was tested. In 
relation to this, the effect of culture medium and protein source on the formation of 
pluripotent primary outgrowths from in vitro (SCNT) produced and in vivo (flushing) 
derived murine and caprine embryos as the first step towards the isolation of embryonic 
stem cells was examined. Dulbecco's Modified Eagle Medium (DMEM), which has 
been widely used for embryonic stem cells isolation was also compared with Alpha 
Modified Eagle Medium (αMEM), both supplemented with foetal bovine serum (FBS), 
which has shown promising results in previous studies by Ivan et al. (1995). 
 
1.1 BACKGROUND 
 
Since the past 2 decades, the concept of using embryonic stem cells as a source of 
multiple cell types for use in tissue repair has existed. Keller and Snodgrass (1999) 
reported that because many degenerative and chronic disease states involve the 
dysfunction or destruction of a single tissue, the derivation of embryonic stem cells, 
whose differentiation in vitro might be guided towards the affected cell types, raises the 
attractive prospect of cell replacement therapy. Although the concept of exploiting the 
pluripotency of embryonic stem cells to aid tissue repair was first conceived over 20 
years ago, it is only recently that various technological advances have begun to realise 
this vision, heralding the emerging field of regenerative medicine. Approximately 3000 
people estimated die every day in the United States from diseases that could have been 
treated with stem cell–derived tissues (Lanza et al., 2001). It is not surprising that 
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embryonic stem cell research has been rapidly expanding where it provide the therapeutic 
potential and growing public awareness of stem cells to treat degenerative diseases since 
mouse embryonic stem cells were first isolated in 1981 (Evans and Kaufman, 1981; 
Martin, 1981) followed by the isolation of human embryonic stem cells (hESC) in 1998 
(Shamblott et al., 1998; Thomson et al., 1998) from the inner cell mass of human 
blastocysts. Although adult stem cells such as bone marrow transplantation since the 
1960s have been used clinically and hold great therapeutic promise, embryonic stem cells 
represent an alternative source of cells, with benefits and advantages including ease of 
isolation, ability to propagate rapidly without differentiation, and potential to form all cell 
types in the body. Besides murine embryonic stem cells , embryonic stem cells had also 
been derived in different animal species such as rabbit (Graves and Moreadith, 1993), 
mink (Polejaeva et al., 1997), equine (Saito et al., 1992), porcine (Chen et al., 1999; Li et 
al., 2003a, 2004), bovine (Wang et al., 2005), primate (Thomson et al., 1995; Suemori et 
al., 2001; Vrana et al., 2003; Shoukhart, 2006), and human (Thomson et al., 1998; 
Cowan et al., 2004; Heins et al., 2004; Lee et al., 2005; Ludwig et al., 2006; Baharvand 
et al., 2006).  
Establishment of embryonic stem cells from domestic animals would be one of 
the most important milestones in the history of farm animal breeding. Recent 
breakthroughs in somatic nuclear transfer and human embryonic stem cells derivations 
have produced new and exciting avenues of research basic scientific information and 
applications in this area. For example, establishment of embryonic stem cell lines that are 
customised or tailored and genetically identical as well as immunologically compatible to 
the individual patients would be new innovative procedures to treat degenerative diseases 
that could not be treated before. Embryonic stem cells are promising sources of cells for 
regenerative therapy, hence an enhanced understanding of the molecular mechanisms that 
regulate their propagation and pluripotency will allow us to better utilise them for clinical 
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treatments. Preceding to this technology, the advent of somatic stem cell nuclear transfer 
has allowed us and others to produce cloned blastocsyt as a source for production of 
embryonic stem cells (Wilmut et al., 1997). However, somatic cell nuclear transfer 
suffers from the limitation that somatic cells have a limited lifespan in culture which 
makes it impossible to perform multiple rounds of gene targeting, which is required for 
producing expressing multiple transgenes for xenotransplantation research (Nottle et al., 
2001), highlighting the need for embryonic stem cells for this as well as other 
applications. Hundreds of cloned animals exist today, but the number of different species 
is limited. Somatic cell nuclear transfer technique of Dolly the sheep in 1997 can be used 
to produce an embryo from which cells called embryonic stem cell could be extracted to 
use in research into potential therapies for a wide variety of diseases such as Alzhemier, 
Leukaemia, Parkinson, Stroke and Huntington diseases. Some researchers compared the 
efficiency with which primary cell lines could be established from in vitro versus in vivo 
derived whole blastocyst cultured. The present study aimed to develop conditions for the 
isolation of homogenous pluripotent outgrowths from whole embryos, as the majority of 
methods that have been used so far result in heterogenous outgrowths which may inhibit 
isolation (Vackova et al., 2007). Separation of blastomeres into the trophoblast and the 
inner cell mass is the first visible stage of embryo differentiation. To prevent further 
differentiation, the cells must be disaggregated and seeded onto a feeder cell layer. The 
cells containing the smallest amount of cytoplasm and highest rate of proliferation should 
be the embryonic stem cells. This technique was introduced by Evans and Kaufman 
(1981) and Martin (Matsui et al., 1992) in order to isolate murine embryonic stem cells. 
Later, this method was used to isolate embryonic stem cells from other species: Syrian 
golden hamster (Doetchman et al., 1988), porcine (Notarianni et al., 1983) rabbit (Graves 
et al., 1993), bovine (Strelchenko et al,. 1991), mink (Sukoyan et al,. 1993), rodent 
(Iannaccone et al., 1994) and primate (Thomson, et al., 1995). However, there is no 
6 
 
report on caprine embryonic stem cells was found in the literature. The goal of this 
project was an attempt to establish caprine embryonic stem cell lines through in vitro 
propagation and expansion of inner cell mass obtained from blastocysts using mouse 
embryonic fibroblast as feeder cell layer. 
 
 
1.2 STATEMENT OF PROBLEMS 
 
Below are some of the pertinent issues regarding the performance of production of 
embryonic stem cells culture in caprine and murine species:   
a) How can caprine and murine embryonic stem cells be maintained through many 
passages in a truly stable state? 
b) Which passages of caprine and murine embryonic stem cells will obtain pure 
embryonic stem cells line? 
c) Can inner cell mass produce the embryonic stem cell lines in caprine species?   
d) Is there any difference between in vivo or in vitro caprine and murine produced 
embryos for blastocyst production as a source to produce optimum quality of 
embryonic stem cell lines?  
e) Which inner cell mass isolation techniques are more efficient in producing 
caprine and murine embryonic stem cell lines? 
f) Is it possible to produce totipotent tissues or organs from single embryonic stem 
cell through nuclear transfer of embryonic stem cells (ntES)? 
g) Which strains of murine would be suitable to produce mouse embryonic 
fibroblast as a feeder cell layer for caprine and murine embryonic stem cells 
culture? 
h) Which stage(s) of blastocyst would give optimum embryonic stem cell lines 
production? 
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i) Why is it difficult to derive and maintain embryonic stem cells from being 
differentiated? 
j) How many inner cell mass cells are needed to produce embryonic stem cell lines 
in caprine and murine species?  
k) Which developmental stages of embryos are suitable to do chimaera in caprine 
and murine species? 
l) Can fresh cumulus cell produce cloned caprine and murine embryos for 
blastocyst production through whole cell intracytoplasmic injection (WCICI) 
technique? 
m) Can caprine ear fibroblast cells produced cloned caprine embryos for blastocyst 
production through WCICI technique? 
n) How many passages of caprine ear fibroblast cells to stabilise cell lines for 
caprine cloning? 
o) Is there any difference in caprine breed to obtain suitable embryonic stem cell 
lines? 
p) How could the culture conditions be improved for sustaining embryonic stem 
cells development?   
q) How the embryonic stem cell lines could be expressed to their optimal 
pluripotency traits? 
r) How the embryonic stem cell lines can be applied in human degenerative 
diseases? 
 
s) Are embryonic stem cells true pluripotent stem cells?  
 
t) What are the similarities and differences between murine and caprine embryonic 
stem cells culture?  
u) How can embryonic stem cells be directed to differentiate reproducibly into 
given cell types? 
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v) How can we ensure that embryonic stem cells will not be tumorigenic in vivo?  
 
1.3 JUSTIFICATION 
The main purpose of this study was to produce caprine embryonic stem cells after 
culturing inner cell mass using mouse embryonic fibroblast as feeder cell. The inner cell 
mass cells were obtained from blastocysts using cloning (SCNT) and in vivo fertilised 
techniques. Currently, Malaysian government gives a high priority to agriculture 
including caprine commercialisation as third engine of economic growth. Caprine 
species has the comparative advantages to other livestock animals due to less fat content 
in the carcass, easy to manage, more economical in production and could be consumed 
by all the ethnic groups of Malaysia. In addition, caprine is a excellent animal model for 
the study and applications of embryos cloning and stem cell research in human 
therapeutic purposes. However, embryonic stem cells and embryo culture in caprine as 
any other mammalian species is dependent on breed, age and reproductive status of the 
animals as well as culture requirements and conditions. Several embryo biotechnology 
techniques already developed in caprine and other species could be utilised and 
complementary to caprine cloning and stem cells research. By producing the large 
number of embryonic stem cells that lead to cloning of embryonic stem cells (ntES), it 
will accelerate the rate of propagation of commercially desirable traits, overcome 
infertility problems and upgrading the quality of economically valuable caprine breed. 
The embryonic stem cells in caprine that are used in cloning could be applied not only 
to reproductive cloning but also to therapeutic cloning to produce pharmaceutical drugs, 
tissues for repair and organ for xenotransplant. However, we are constantly lacking of 
caprine samples in carrying out the experiments. We were using murine and bovine 
model as learning curve as well as subsequently applied in caprine species since they 
are more easily available in our laboratory. Murine was chosen as our animal model due 
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to easier to manage, handle and prolificacy. Also, a short gestation length, short 
oestrous cycle (5 days) and large litters make murine an ideal candidate. Also, murine 
can be backcrossed to achieve animal sizes that are more easily managed in animal care 
facilities and maintained under laboratory condition. Murine are the species of choice 
because of the wealth of biological information known about the murine genome, and a 
multiple homologous recombination strategy for disrupting genes has already been 
demonstrated in murine. Murine is inexpensive and non-seasonal breeders which can be 
carried out the experiment at anytime. Murine embryonic stem cells have been routinely 
used and preferred by many researchers to produce cloned murine including nuclear 
transfer of embryonic stem cells (ntES) technique. However, Stice et al. (1996) and 
Cibelli et al. (1998) have extensive experience in bovine and porcine embryonic stem-
like cells in both gene modification and cloning, and after extensive nuclear transfer 
studies, they were never able to produce a cloned offspring derived from their 
embryonic stem-like cell lines (Stice et al., 1996). In the present study, caprine species 
was chosen as a model species in an attempt to produce embryonic stem cell lines 
towards applications in human therapeutic cloning.  Related reproductive techniques in 
the caprine have already developed and therefore, they provide convenient and 
complementary way of obtaining a large number of oocytes and embryos for the stem 
cells research in caprine species.  
 
1.4 APPLICATIONS 
Embryonic stem cells provide with great characteristics potential for use in cell-based 
drug discovery and regenerative medicine (Fan et al., 2010). It is a need for derivation 
new embryonic stem cell lines to meet emerging requirements for their use in cell 
replacement therapies, disease modeling and basic research (Fan et al., 2010). 
Embryonic stem cells are isolated more easily in single cell type populations, multiply 
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more readily in the laboratory, and are more proficient in producing much specialised 
cell types including pancreatic islet and neurons cells. The current and potential 
applications of embryonic stem cells for use in biomedical and biotechnological 
applications are advancing rapidly. Yong and Yuqiang (1998) reported that the 
application of nuclear transfer technology using blastomeres of early caprine embryos. 
Six generations of cloned caprine embryos were produced by using serial nuclear 
transfer. With the embryonic stem cells in caprine, it increase production of caprine, 
improve the quality of caprine for commercialisation at the very rapid rate as well as its 
human applications to help cure diabetes, to cure burn patients, may provide a cure for 
Parkinson’s disease, help many other diseases, help cloned organs using therapeutic 
stem cells and create organs for xenotransplantation in human. There were more than 
62,000 people in United States of America are on waiting lists to receive donated 
organs, to mass-produce pharmaceuticals where a gene can be inserted into an animal to 
make that animal produce a particular protein in its milk, for example, insulin, to save 
endangered species, to cloned pets or animals, to repair damage tissues and to do organ 
for xenotransplant. Parkinson’s patients were treated by surgical implantation of foetal 
cells into their brain even though not completely effective, perhaps owing to lack of 
sufficient numbers of dopamine secreting cells, similar experiments using appropriately 
differentiated stem cells should overcome those obstacles. More complex experiments 
have already been successfully conducted in rodent models of Parkinson’s. Similar 
approaches could be developed to replace the dead or dysfunctional cells in cortical and 
hippocampal brain regions that are affected in patients with Alzheimer’s. Transplants of 
haematopoietic stem cells (the cells which eventually produce blood) following 
treatments for cancer, for example, have been done for years now in human beings. 
Further, somewhat cruder experiments (for example, the transplantation of foetal tissue 
into the brains of Parkinson’s patients) indicate that the expectation that stem cell 
11 
 
therapies could provide robust treatments for many human diseases is a reasonable one. 
The interplay between developmental biologists and stem cell biologists will be key to a 
fundamental understanding of stem cell development and its translation into therapeutic 
outcomes. Pluripotent stem cells, instructed to differentiate into a particular pancreatic 
cell called a beta cell (β-cell), could overcome the shortage of therapeutically effective 
material to transplant. Pluripotent stem cells could be used to create an unlimited supply 
of cells, tissues, or organs that could be used to restore function without the requirement 
for toxic immunosuppression and without regard to tissue matching compatibility. In 
gene therapy, genetic material that provides a missing or necessary protein, or causes a 
clinically-relevant biochemical process, is introduced into an organ for a therapeutic 
effect. For gene-based therapies (specifically, those using DNA sequences), it is critical 
that the desired gene be introduced into organ stem cells in order to achieve long-term 
expression and therapeutic effect. Although techniques for delivering the therapeutic 
DNA have been greatly improved since the first gene therapy protocol almost 10 years 
ago, there are as yet no bona fide successes. The science of stem cells dates to the mid-
1960s, and many papers have been published on the isolation and laboratory 
manipulation of stem cells from animal models. While these models are imperfect, they 
are accepted in the scientific community as good initial predictors of what occurs in 
human beings. Despite these and other advances in the prevention and treatment of 
human diseases, devastating illnesses such as heart disease, diabetes, cancer, and 
diseases of the nervous system such as Alzheimer’s disease present continuing 
challenges to the health and well-being of people everywhere. All this research on 
embryonic stem cells, both murine and human as well as caprine, will provide new 
insights into embryonic development and new clues as to how to isolate and 
characterise new stem cells from different embryonic or adult tissues. Much work 
remains to be done, to gain more insight into the basic mechanisms regulating 
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proliferation, differentiation and reprogramming of embryonic and somatic stem cells. 
We are looking forward to future developments in this field. 
 
1.5 OBJECTIVES 
a) To develop a protocol for production of murine embryonic stem cell (mESC) lines 
in murine. 
b) An attempt to develop a protocol for production of caprine embryonic stem cell 
(gESC) lines in caprine. 
c) To produce cleaved murine embryos through in vivo fertilisation and somatic cell 
nuclear transfer (SCNT) for blastocyst formation to be used in embryonic stem cell 
lines development. 
d) To produce cleaved bovine embryos through somatic cell nuclear transfer (SCNT) 
as a model to develop somatic cell nuclear transfer (SCNT) protocol in caprine. 
e) To produce caprine cleaved embryos through somatic cell nuclear transfer (SCNT), 
in vivo fertilisation and parthenogenesis as a source of blastocyst for embryonic 
stem cell lines production. 
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2.1 STEM CELL BACKGROUND 
 
Several types of stem cell have been discovered from embryo, germ cells, foetus and 
adult. Each of them promised to revolutionise the future of regenerative medicine 
through the provision of cell replacement therapies to treat a variety of debilitating and 
degenerative diseases. Stem cell research is raises many ethical and religious debates 
and generates a great deal of public interest. A capability of embryonic stem cells (ESC) 
versus the adult stem cell (somatic stem cells) has ignited debates as to the choice of 
one cell type over another for future application. However, the biology of these 
mysterious cells have yet to be more understood and a lot more basic research is needed 
to carry out before applied new therapies using stem cell differentiated derivatives. We 
always read and listen to news reports everyday about how stem cells change our lives 
with remedy for every imaginable disease, for example rhetoric that stem cell therapy 
will some day delay the process of aging. We hope someday many degenerative human 
diseases will be treated with stem cell therapy examples of whole organ and limb 
regeneration in animals, as well as the historical success of bone marrow transplants 
(xenotransplantation), which have improved the lives of many patients suffering from 
leukaemia, immunological and other blood disorders. However, there will be quite long 
road towards the development of an effective cell based therapy for widespread use and 
involves overcoming many technical, ethical and safety issues. According to Alison et 
al. (2002), stem cell is a cell with the ability to divide indefinitely in vitro culture and 
with the potential to give rise to mature specialised cell types.  
Stem cells can be isolated from many adult tissue types (Vogel, 2001), foetal 
and embryo sources. Usually, isolation of stem cell has been most successful in cells 
 14 
 
from tissues that undergo rapid senescence (aging), cell turnover, and replacement such 
as germ cells, epithelia, and hematopoietic system as well as in some tissues that have a 
more limited cellular regeneration, for example, hepatocytes (Vogel, 2001). Adult stem 
cells are mostly considered as multipotent, meaning that they may develop into many 
different cell types, but not all cell types whereas embryonic stem cells are pluripotent 
where it capable to develop into all cell type, except extraembryonic. By working with 
animal models has shown that transplantation of pluripotent stem cells can be 
successfully treat a variety of disorders such as Duchenne muscular dystrophy, spinal 
cord injuries, and heart failure and are recently being applied to clinical models (Van 
and Weiss, 2000; Watt and Hogan, 2000; Odorico et al., 2001). Both embryonic and 
adult stem cells have enormous potential to further our understanding of basic 
developmental processes. It is very important to identify the nature of the pluripotent 
state in embryonic stem cells. How it is acquired, maintained and propagated and which 
genes confer pluripotency. By understanding the fundamental mechanisms, cell fate is 
determined during embryonic development will prove informative for the in vitro 
manipulation of stem cells. 
An early stem cell research goal is to find out how to isolate and store stem cells 
from different types of tissues. Theoretically, stem cells could be collected, grown and 
stored to provide a plentiful supply of healthy replacement tissue for transplantation into 
anybody site using much less invasive surgery than conventional transplants. Scientists 
have already reported success with human brain tissue transplants to treat Parkinson’s 
disease and with stem cell-derived murine heart-muscle cell grafts. Stem cell has 
symmetrical dividing property that could generate 2 daughter cells which absolutely 
identical to mother cell. Besides that, stem cell also has capacity to self-renewal (Figure 
2.1). 
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 Figure 2.1: Stem cell has capacity to self-renew and asymmetric division. At each  
                    cell division, stem cells have to choose between self-renewal (stem  
                    cells) and differentiation (somatic or mature cells) (Cai et al., 1997; Lu  
                    et al., 2000). 
  
2.1.1 Totipotency, Pluripotency and Multipotency 
Stem cells can be classified as totipotent, pluripotent and multipotent. Totipotency stem 
cell have unlimited capability where they can basically form the whole organisms, 
including the entire foetus and placenta (for example, early mammalian preimplantation 
embryos are clusters of totipotent cells). Pluripotency has the ability to form several cell 
types of all 3 germ layers (ectoderm, mesoderm and endoderm) but not the whole 
organism. Theoretically, pluripotent stem cells have the ability to form all the 200 or so 
cell types in the body. There are divided into 4 classes of pluripotent stem cells, namely 
embryonic stem cells (ESC), embryonic germ cells (EGC), embryonic carcinoma cells 
(EC) and recently the discovery of a fourth class of pluripotent stem cell, the 
multipotent adult progenitor cell (MAPC) from bone marrow (Smith, 2001) (Figure 
2.2). It is generally assumed that the potential fates for embryonic germ cells will be 
relatively limited compared to embryonic stem cells because embryonic germ cells are 
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much further along in the schema of embryonic development. Embryonal carcinoma 
cell lines are derived from tumours of germ cell origin and have long served as the 
human counterpart of murine embryonic carcinoma cells for studying human 
development and differentiation in vitro (Andrews, 2000). Not all embryonic carcinoma 
cell lines are pluripotent and some feeder-independent embryonic carcinoma lines have 
been reported to be nullipotent. Jiang et al. (2002) isolated murine multipotent adult 
progenitor cells from murine bone marrow and demonstrated that these cells express 
telomerase and that a single multipotent adult progenitor cell could be expanded 
clonally into a large number of daughter cells. Additionally, under appropriate 
conditions, multipotent adult progenitor cell differentiate into ectoderm, endoderm and 
mesoderm and are capable of generating chimaeric murine when injected into murine 
blastocysts.  
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Figure 2.2: Origins of pluripotent stem cell (Brook and Garder, 1997). 
  
Multipotency stem cell has the ability of giving rise to a limited range of cells 
and tissues appropriate to their location, for example, blood stem cells give rise to red 
blood cells, white blood cells and platelets, whereas skin stem cells give rise to the 
various types of skin cells. Some current reports suggested that adult stem cells, such as 
haemopoietic stem cells, neuronal stem cells and mesenchymal stem cells, could cross 
boundaries and differentiate into cells of a different tissue (Bjornson et al., 1999; 
Jackson et al., 1999; Clarke et al., 2000; Krause et al., 2001).  
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2. 2 BACKGROUND HISTORY OF CLONING 
The idea of cloning came about in the early 1900s where a German scientist named 
Hans Spemann first thought of the cloning methods around 1938. Although nuclear 
transfer in cloning mammals began more than 20 years ago, the basic biology 
underlying this process still remains unclear. After the birth of Dolly the sheep (Wilmut 
et al., 1997), the first cloned mammal using somatic cell nucmear transfer, success in 
cloning using adult somatic cells has been reported in other mammalian species 
including murine (Wakayama and Yanagimachi 1999; Wakayama et al., 1998, 2000), 
bovine (Kato et al., 1998; Galli et al., 1999; Renard et al., 1999; Wells et al., 1999; 
Zakhartchenko et al., 1999; Hill et al., 2000; Kubota, 2000), caprine (Baguisi et al., 
1999), porcine (Polejaeva et al., 2000), and Bos gaurus (gaur) (Lanza et al., 2000). The 
efficiency of cloning has increased from around 1 out of 300 to 1 out of 10 to 30 
reconstructed embryos transferred depending on the study (Kato et al., 1998; Wells et 
al., 1999; Kubota, 2000). Smith (1989) reported that a clone can be defined as a set of 
genetically identical animals and very useful in animal selection for the determination 
of the genetic component of zootechnical traits or in research to reduce the number of 
experimental animals (Lamberson, 1994). Cloning technology has made several steps 
forward in recent years, most notably in somatic cell nuclear transfer (SCNT) and in 
combining cloning with transgenic technologies. The advantages of somatic cell nuclear 
transfer are cloning valuable research animals may alleviate a limited availability of 
highly informative genotypes while to obtain optimum results by reducing the number 
of animals used. Cloning and transgenics are now available for producing phenotypes in 
large animals to study devastating disease. Today, cloning plays a relatively small role 
in research and commercial endeavors. Cloning technology is used to produce 
therapeutics in milk and for cell replacement or cell therapy. In these areas, along with 
xenotransplantation and animal agriculture transgenics require approval in the form of 
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clinical trials or safety studies. Obviously, cloned animals can replace more genetically 
dissimilar animals in studies when the trait being investigated is highly heritable.  
The first attempt on cloning was by a scientist named Adolph Eduard D. 
Genzyme began a program to produce therapeutic proteins in the milk of transgenic 
goats in the early 1990s (Genzyme, 1990). They inserted a genetic construct into the 
nucleus of a one-cell embryo by using microinjection technique. Professor Zhang Yong 
from the Northwest University of Science and Technology for Agriculture and Forestry 
from China has successfully produced the first cloned caprine from ear fibroblast cells 
(Yong et al., 2002). Besides that, the first success in cloning Asian Yellow Goat by 
nuclear transfer had recently been achieved in east China's Shandong Province (Chen et 
al., 2007).  Asian Yellow Goat (Capra hircus) also named Nanjiang yellow goat which 
is a new breed developed after 40 years by efforts from Chinese scientists. The 
improvement of the cloning technique may provide new approaches for conserving and 
saving endangered and valuable animal species. Yong et al. (1991) reported that 
successfu1 nuclear transfer has also been reported in caprine; a number of attempts has 
been made to try intergeneric (interspecies) nuclear transfer, for example, bovine 
embryonic nuclei into bison, caprine or hamster oocyte recipient cytoplasms, or caprine 
nuclei into ovine or bovine oocytes, but very limited development to the blastocyst 
stage was obtained (l to 2%) (Wolfe and Kraemer,1992). Cloning by nuclear transfer 
has great potential application in pharmaceutical protein production, 
xenotransplanation, and most excitingly, therapeutic cloning. In therapeutic cloning a 
patient’s own skin cells can be used to generate cloned embryos from which embryonic 
stem cells are isolated. Through targeted differentiation, embryonic stem cells can be 
directed to develop into the desired tissues/organs for replacement. According to 
Wakayama et al. (1998), a piezo-electric nuclear transfer method has been used to 
generate cloned murine from cumulus cells and tail-tip cells of adult animals as well as 
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embryonic stem cells. Cloning live murine using Sertoli cells by the same piezo-electric 
injection method (Ogura et al., 2000a). Ogura et al. (2000b) reported that cell fusion or 
injections without a piezo-electric device were used successfully to produce live cloned 
murine. However the percentage of live offspring obtained in murine cloning is less 
than 3%. The success rate of cloning so low may be due to a few percent of any cell 
population are ‘cloning competent’ and technical problems. Many technical factors such 
as cell cycle, oocyte activation and chemical agents affect development of cloned 
embryos as well as reprogramming of donor nucleus and recipient cytoplast.  
The cloned ovine (Dolly) in 1997 began a biological revolution which showed 
us the way to physiologically differentiate already committed somatic cells, opening the 
gate to a whole new world of possibilities in the study of basic biological mechanisms 
that touch the origins of life as its core (Cibelli et al., 1998). After Dolly, nuclear 
transfer enabled the cloning of bovine, caprine and porcine. The era of livestock cloning 
had arrived. The debate about therapeutic cloning has led to a consensus in which 
embryonic stem cells are adjudged to offer the best short term prospects for tissue 
repair, while adult stem cells seem destined to predominate in the longer term (Robert et 
al., 1998). There were early reports of nuclear transfer in the rabbit during the late 
1970s where McGrath and Solter (1983) demonstrated that by using microsurgery, 
pronuclei could be exchanged between murine zygotes and development still be 
obtained. Subsequently, Willadsen (1986) produced live lambs after transferring nuclei 
from 8- to 16-cell ovine embryos into enucleated MII oocytes. Although a lot of 
attention has been paid on the possibility, cloning can be used as a great biochemical 
tool in providing invaluable advances in medicine and pharmacology. Cloning is in 
transition from a distinguished past to a new future. Robert et al. (1998) reported that if 
used in an imaginative manner, this move will ensure that nuclear transplantation 
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continues to serve as a beacon of scientific excellent and as an important contributor to 
human health. 
 
2.3 TIMELINE OF MURINE, BOVINE AND CAPRINE SOMATIC CELL  
      NUCLEAR TRANSFER (SCNT) 
 
Table 2.1 shows the timeline of significant findings in somatic cell nuclear transfer  
  (SCNT) in murine, bovine, gaur and caprine  
 
Table 2.1: Timeline of significant findings in somatic cell nuclear transfer (SCNT) in   
                  murine, bovine, gaur and caprine  
 
Year Author Species Significant finding 
1997 Wilmut et al. Ovine Successful somatic cell nuclear 
transfer (SCNT) responsible for 
cloning of the first mammalian 
species (Dolly). 
1998 Cibelli et al. Bovine Live cloned bovine offspring 
produced through somatic cell 
nuclear transfer (SCNT). 
1998 Kato et al. Bovine Produced 8 cloned calves (4 calves 
die after birth). 
1998 Wakayama et al. Murine Produce cloned murine using 
cumulus cells as donor karyoplasts 
through whole cell 
intracytoplasmic injection (WCICI) 
technique. 
1998 Zhang and Li Caprine Production of caprine by serially 
cloning embryos. 
1999 Baguisi et al. Caprine Caprine offspring produce through 
somatic cell nuclear transfer 
(SCNT) by using cumulus cells. 
2000 Lanza et al. Gaur Cloned gaur produce through 
somatic cell nuclear transfer 
(SCNT) cloning. 
(Continued) 
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2000 Wang et al. Caprine Production of cloned caprine 
(Gapra hircus) from foetal 
fibroblast cell lines. 
2001 Reggio et al. Caprine Production of transgenic caprine 
offspring from oocytes derived 
from follicle stimulating hormone 
stimulated and nonstimulated 
abattoir derived ovaries. 
2001 Ono et al. Murine Cloned murine from foetal 
fibroblast cells arrested at 
metaphase by a serial nuclear 
transfer. 
2002 Baldassare et al. Caprine Production of transgenic caprine 
using laparoscopic ovum pick-up 
and in embryo production 
technology. 
2002 Hitoshi et al. Bovine 86.00% of cleaved bovine embryos 
obtained by using cumulus cells as 
donor cell. 
2002 Keefer et al. Caprine Production of cloned caprine after 
nuclear transfer using caprine 
granulose cells and foetus 
fibroblast cells. 
2003 Gasparrini et al. Murine Cloned murine derived from 
embryonic stem cell karyoplasts 
and activated cytoplasts prepared 
by induced enucleation. 
2007 Chen et al. Caprine First success in cloning Asian 
Yellow Goat by whole cell 
intracytoplasmic injection (WCICI) 
technique. 
2009 Tao et al. Caprine Production of Boer goat (Gapra 
hircus) by nuclear transfer of 
cultured and cryopreerved ear 
fibroblast cells into slaughterhouse 
derived oocytes. 
2011 Tang et al. Caprine Production of 5 cloned caprine 
using foetus fibroblast cell lines as 
donor cell through somatic cell 
nuclear transfer (SCNT) technique. 
(Continued) 
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2.4 SOURCES OF OOCYTES 
Success of any in vitro produced system including somatic cell nuclear transfer is 
mostly dependant on the good quality oocytes supply. Caprine oocytes can be collected 
from either both live and dead or killed does. For live does, oocyte recovery may be 
obtained via laparoscopic ovum pick-up (LOPU), ovariectomy and laparotomy 
techniques. On the other hand, oocytes also can derived from dead does from abattoir 
(slaughterhouse) or during post-mortem. Since collecting ovaries from dead does in 
largely depended on the availability and uncertain, access to abattoir derived ovaries is 
easier, cheap and provides large sample source of oocytes. 
 
2.4.1 Recovery of Oocytes from Laparoscopic Ovum Pick-up (LOPU) Technique 
Although abattoir ovary source is easier and cheaper compared to laparoscopic ovum 
pick-up technique, ovary source from abattoir is very limited in some countries such as 
Malaysia. Therefore, laparoscopic ovum pick-up technique could be an alternative 
method for caprine oocyte recovery to carry out somatic cell nuclear transfer in present 
study. Snyder and Dukelow (1974) first described the recovery of 6 oocytes from an 
ovine by follicular aspiration of 21 follicles under laparoscopic observation. However, 
the technique was not fully developed until recent years, in conjunction with the 
development of in vitro embryo production technologies (Baldassarre et al., 1994, 1996, 
2001; Graff et al., 1995, 1999; Tervit 1995). Laparoscopic ovum pick-up is a 
convenient methodology by which oocytes can be recovered and used either for in vitro 
production of zygotes or as a source of cytoplasts in nuclear transfer procedures 
(Balsassare et al., 2002). The laparoscopic ovum pick-up is one of the best techniques 
for oocyte recovery from live does. The laparoscopic ovum pick-up is advantageous 
than standard laparotomy-based method which allows repetition of the laparoscopic 
procedure more frequently and more times during the reproductive life of a valuable 
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female (Baldassarre et al., 2007). The main advantages of the laparoscopic ovum pick-
up methodology over the utilisation of in vivo produced zygotes or in vivo matured 
oocytes are improved control over the stage of maturation/development of zygotes and 
oocytes and the less invasive means of recovery, thereby allowing for repeating the 
laparoscopic ovum pick-up procedure to the donor animals several times. The 
laparoscopic ovum pick-up can be repeated several times without ovarian damage or 
decrease in the donors’ fertility (McKelvey et al., 1986; Stangl et al., 1999; Alberio et 
al., 2002; Pierson et al., 2004). Additionally, compared with oocytes sourced from 
abattoir ovaries, laparoscopic ovum pick-up allows one to source the oocytes from live 
animals of known health status, which is very important for the production of 
therapeutic proteins for pharmaceutical applications. Laparoscopic ovum pick-up 
technique already allows field application in commercial programmes (Hasler et al., 
1995). In addition, this method can be applied to prepubertal animals and thereby could 
contribute to a considerable shortening of the generation interval.  Usually, oocytes used 
for cloning were obtained from the ovaries of slaughtered caprine so that genetic 
background of the oocytes was unknown. Such an approach would be unsuitable when 
oocytes with defined genomes or defined sources are required. A good method for 
obtaining oocytes from a defined source is to use the laparoscopic ovum pick-up 
technology which allows harvesting of oocytes from defined individual caprine (De 
Roover et al., 2008).  
 
2.4.2 Oocyte Recovery from Abattoir 
According to Rajikin (1995) and Amir (2007), abattoir source is easier and cheaper way 
of obtaining oocytes for various reproductive technologies. For example, in Malaysia, 
this source of oocyte is extremely limited due to less slaughtering activities as shortage 
of breeding stock, normally older or culled does are chosen. Generally, the quality of 
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the oocytes recovered from abattoir is quite low compared to laparoscopic ovum pick-
up technique. Caprine oocytes source from slaughterhouse are obtained via slicing or 
follicle aspiration technique. Simple aspiration of follicular contents performed by using 
a syringe and a needle 18 to 22 G (Keskintepe and Brachett, 1996; Keskintepe et al., 
1998 Yadav et al., 1998). Ovaries have been subjected to dissection and isolation of 
individual follicles followed by rupture of the latter (Le Gal, 1996; Crozet et al., 2000) 
or slicing of the ovaries followed by simple rinsing of the slices (Pawshe et al., 1994b, 
1996; Ongeri et al., 2001; Rho et al., 2001). Ovary slicing was a simpler and more 
efficient technique than follicle aspiration in that an average of 6 COC per ovary were 
obtained by slicing as opposed to between 1.5 to 2.0 oocytes per ovary by aspiration 
(Martino et al., 1994; Pawshe et al., 1994a).  
 
2.5 FACTORS AFFECTING DEVELOPMENT OF NUCLEAR TRANSFER  
        RECONSTRUCTED EMBRYOS 
Since the birth of Dolly in 1997 (Wilmut et al., 1997), this success revealed the 
extraordinary capacity of the oocyte to erase the process of genome cell differentiation 
and to reprogramme the genetic information to produce a new individual (Campbell et 
al., 2002). Li et al. (2004) reported that this process is attainable by nuclear transfer, 
which consists of the replacement of the maternal genetic material of the oocyte by the 
genetic information of donor cells after nuclear transfer. Unfortunately, although 
cloning is possible now, nuclear transfer is a very complex, poorly understood, time 
consuming and inefficient process. In fact, the efficiency of nuclear transfer has been 
estimated to be between 1 and 2% of all oocytes used (Polejaeva et al., 2000). Several 
reasons for this low efficiency can be attributed to the source and quality of oocytes, the 
preparation of the recipient cytoplasm, the donor cell type, the synchronisation of the 
cell cycle of both, recipient cytoplasm and donor cells, the failure to reprogramme the 
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transplanted nucleus and finally the failure of artificial activation methods. Embryo 
manipulations such as nuclear transfer or unusual embryo culture environments may 
also result in inappropriate epigenetic modification of imprinted genes during early 
embryogenesis. 
 
2.5.1 In Vitro Maturation (IVM) of Caprine Oocytes 
In vitro maturation of oocyte is a reproductive technology which enables the production 
of mature oocytes by culturing them in standard cell culture conditions until they reach 
metaphase II stage (Gilchrist and Thompson, 2007). Before oocyte able to mature in 
vitro, it must be visualised as being normal. Usually, normal oocyte should have 
cumulus cells surrounding the zona pellucida, absence of cracked zona pellucida and 
vesicles in the ooplasm. The more the cumulus cell layers presence is consider better. 
Rajikin et al. (1994) described good quality of caprine oocyte will appear golden, 
golden yellow or brownish in colour and have granulated appearance in the ooplasm. 
Size of an oocyte is also very important for the attainment of maturation. There are 86% 
of caprine oocytes from follicles 2 to 6 mm in diameter progressed to metaphase II, 
whereas only 24% of oocytes from follicles 1 to 1.8 mm reached metaphase II stage 
(Smedt et al., 1992). Maturation of oocytes was assessed by cumulus expansion and the 
extrusion of the first polar body. Cumulus cells were removed through use of finely 
drawn glass pipettes with 0.2% hyaluronidase (Sigma). Only oocytes that had extruded 
the first polar body with a complete perivitelline space separating the zona pellucida 
and cell membrane and with evenly granulated cytoplasm were used for enucleation 
experiments (Bavister et al., 1989).  
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2.5.2 Oocyte Enucleation 
Quality of the recipient oocyte is important factor in successful nuclear transfer. All 
critical maternal factors (such as proteins and messenger RNA required for synthesis of 
new proteins) required for early embryo development are stored and synthetised in the 
oocyte cytoplasm during oocyte maturation. Therefore, it would be logical to assume 
that the amount of these factors in cytoplasm would also play a role in successful 
cloning. One of the major steps involved in the nuclear transfer procedure is the 
removal of important cytoplasmic components (genetic material) from the recipient 
oocyte (enucleation), which may reduce cytoplast viability. Usually, one third or more 
of the ooplasm is removed that would result in a corresponding decrease in the total cell 
number of cloned blastocysts. This procedure and technique requires time and limits the 
number of oocytes available for cloning. Therefore, the oocyte enucleation procedure is 
crucially important to cloning efficiency by eliminating any genetic contribution of the 
recipient cytoplasm, and for excluding the possibility of parthenogenesis (Dominko et 
al., 2000). According to Wilmut et al. (1997), mammalian oocyte cytoplasts are 
prepared by physically removing nuclear chromatin by micromanipulation techniques in 
preparation to receive the donor genome. Enucleated oocytes arrested at MII are 
subsequently ‘‘reconstructed’’ by the combination of the donor karyoplast, typically 
using either electrofusion (Wilmut et al., 1997) or microinjection techniques 
(Wakayama et al., 1998). Generally, enucleation is preferably guided by the polar body 
which may be used to identify the position of the metaphase plate. Enucleated oocytes 
were stained with Hoechst 33342 and exposure to ultra-violet may cause damages of 
cytoplasmic organelles and mitochondrial DNA and these results in low cloning 
efficiency. In bovine and caprine, the position of the polar body can be used to identify 
the position of the metaphase plate because visual observation of chromatin in oocytes 
is impossible due to dark, opaque cytoplasm. Besides that, chemically assisted 
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enucleation is probably a better procedure for animal cloning. Recently, with colcemid 
assisted enucleation, cloned rabbit foetus (Yin et al., 2002a), porcine (Yin et al., 
2002b), and murine (Gasparrini et al., 2003) were produced. Most studies on nuclear 
transfer have relied on enucleation by aspiration where it depending on the skill of the 
micromanipulator and between 5 to 50% of the cytoplasm is removed with a metaphase 
plate (Westhusin et al. 1992; Westhusin and Azambujam, 1996).  Another method of 
enucleation is to bisect oocytes and discard the chromatin containing half, resulting in 
loss of 50% of the volume. Enucleation rate is very high (96%), which insures that the 
maternal genetic material is removed, and eliminates the possibility of the involvement 
of maternal genetic residual in nuclear transfer embryos. In addition, any oocyte derived 
chromatin left in to the reconstituted embryo could cause disturbances in the process of 
normal chromosome and cell division even without participating directly to embryonic 
development. Therefore, it prevents proper development of nuclear transfer embryos.  
 
2.5.2.1 Enucleation techniques 
Several enucleation methods have been published (Willadsen, 1986) and most rely on 
the removal of a karyoplast via micromanipulation in combination with a DNA 
fluorescent stain to confirm positive enucleation (Westhusin et al., 1992). This 
technique has improved enucleation and development as compared with enucleation by 
blind oocyte biopsy (Willadsen, 1986), but it has limitations associated with the time 
required for the production of large numbers of nuclear transfer embryos through 
micromanipulation. In the murine, the spindle is identifiable as a translucent region. The 
karyoplasts removed by micromanipulation were individually stained with Hoechst 
33342 and then checked for the presence of metaphase II chromosomes by 
epifluorescent microscopy to confirm whether the corresponding oocyte had been 
successfully enucleated (Brendan et al., 1995). According to Wakayama et al. (1998), 
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enucleation of oocytes was performed by removing the metaphase II spindle with a 
small amount of ooplasm, and the first polar body. However, enucleation is a major 
limiting step in the nuclear transfer procedure. The successful and efficient removal or 
the destruction of genetic material in the recipient oocyte is dependent upon the 
technique used. Staining by places the oocyte under stresses associated with exposure to 
Hoechst 33342 and ultra-violet irradiation (Smith, 1993), which may also affect 
development. In earlier reports, germinal vesicle enucleation was performed rather 
‘indirectly’ by increasing the pressure inside a holding pipette to expel a germinal 
vesicle karyoplast (nucleus) through a slit made in the zona (Sun et al., 1991). The zona 
pellucida was penetrated by pressing a glass microneedle tangentially into the 
perivitelline space against the holding pipette. The germinal vesicle nucleus surrounded 
by a small amount of cytoplasm (germinal vesicle karyoplast) was removed by a 
micropipette with a 20 µm inner diameter.  
 
2.5.3 Donor Cell Preparation 
Cloning of mammals by nuclear transfer of differentiated cells has become a tool to 
propagate valuable animals (Wilmut et al., 1997) and can be used as an avenue to 
produce genetically modified animals (Willadsen et al., 1991). The stage of donor cell 
cycle is a major factor in the success of nuclear transfer in mammalian cloning 
(Campbell et al., 1996). Quiescent donor cells arrested in G0/G1  phases of the cell cycle 
have been used to produce cloned murine (Wakayama et al., 1998), ovine (Well et al., 
1997), caprine (Baguisi et al., 1999), porcine (Polejaeva et al., 2000), rabbits (Chesne et 
al., 2002) and bovine (Kato et al.,1998). Quiescent cells arrested in the G0/G1 phases of 
the cell cycle by either serum starvation or growth arrest when cultured cells reach 
confluence have been used as donors to produce cloned animals. Recently, Sezen et al. 
(1997) developed a novel and effective method using roscovitine to synchronise adult 
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bovine granulose cells in the G0/G1 cell cycle stage. The sizes of donor cells varied with 
different confluence degrees even though in the same culture dish. According to the 
experimental results of Tao et al. (1999), it was shown that donor cell size could affect 
the reprogramming of nuclear transfer embryos. The percentage of chromosome 
condensation and nuclear formation were higher in reconstructed embryos derived from 
small donor cells (15 µm) compared to large donor cells (20 µm), respectively. Variety 
of donor cell types have been used to generate viable cloned offspring in ovine 
(Schnieke et al., 1997; Wilmut et al., 1997), bovine (Cibelli et al., 1998; Kato et al., 
1998; Wells et al., 1999), murine (Wakayama et al., 1998), caprine (Baguisi et al., 
1999), porcine (Onishi et al., 2000; Polejaeva et al., 2000 ; Lee et al., 2007), rabbits 
(Chesne et al., 2002), and feline (Shin et al., 2002). This study was to investigate the 
effects of donor cell passage, size and type on the development of nuclear transfer 
embryos. 
 
2.5.4 Whole Cell Intracytoplasmic Injection (WCICI) Technique  
In 2007, used simplified manipulation procedure to reconstruct Asian Yellow Goat 
cloning embryos by Professor D.Y. Chen and colleagues known as direct whole cell 
intracytoplasmic injection into in vitro matured oocytes enucleated at telophase II stage 
(Chen et al., 2007). High pregnancy rate (24%), high birth rate (20%), high natural 
delivery rate (100%), and high survival rate (83%) were achieved by this method. Jang 
et al. (2004) reported that the first time that directly injecting a whole cell into the 
cytoplasm of an enucleated porcine oocytes (WCICI, whole cell intracytoplasmic 
injection) is feasible for the production of cloned embryos and piglet. Whole cell 
injection for nuclear transfer had not been attempted previously because of concerns 
that the plasma membrane of the donor cell may persist in the oocytes resulting in 
failure to release the nucleus. Majority, the membrane of the donor cell dissolved 
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relatively rapidly, within an hour of injection. However, the exact mechanism for the 
donor cell’s plasma membrane dissolution in the oocyte is still unclear. There are 2 
possible mechanisms can potentially explain the dissolution process. First, the oocyte 
might have actively recognised the donor cell’s plasma membrane or its surface proteins 
as belonging to a cell surface, not to the cytoplasm of the oocyte. By this recognition, it 
would lead the oocyte to actively degrade the donor cell’s plasma membrane or 
transport it to the oocyte’s cell surface. This active dissolution would then release the 
nucleus for reprogramming (Lee et al., 2003). Thus, it actively dissolved the membrane 
of the whole cell and recycled it to the oocyte’s surface membrane. The second possible 
mechanism for donor cell membrane dissolution may be that the donor cell membrane 
was damaged during whole cell injection and the leaky plasma membrane then released 
the nucleus, which resulted in its reprogramming. In previous report, they found that 
different donor cell types require different amounts of conditioning time in the oocytes 
before activation. Fibroblast cells required longer exposure to the methaphase II (MII) 
cytoplasm than granulosa cells when whole cells were used for injection. These results 
are consistent with those in murine and porcine showing that delayed activation for 
fusion as well as nucleus injection methods was beneficial to embryo development (De 
et al., 2002). In vitro blastocyst development rate obtained as high as 37% by using in 
vitro matured porcine oocytes and the simple whole cell intracytoplasmic injection 
technique and conventional micromanipulation equipment. This attribute the high 
efficiency of our new cloning procedure to the following: 1) technique for the injection 
of whole cells reduced the manipulation time of donor cells and recipient oocytes as 
compared with the other 2 nuclear transfer methods and, therefore, is beneficial to 
embryo development; 2) the injection of a whole cell assured delivery of all cellular 
components to the enucleated oocytes; these components of the donor cells might be 
important for later development in caprine; the microtubule organising centre is needed 
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during natural fertilisation in most mammals except for the murine (Schatten et al., 
2005 ); and 3) whole cell injection assured delivery of DNA into each injected oocyte 
and thus avoided fusion failure and potential damage to the nucleus during isolation. 
Whole cell intracytoplasmic injection technique yet helped improve our nuclear transfer 
efficiency may be that we avoided ultra-violet exposure and the use of Hoechst staining 
during enucleation, which was a common practice for cloning (Betthauser et al., 2000) 
and was found to cause abnormal meiosis and poor development (Tsunoda et al., 1988).  
 
2.5.5 Tools and Skills for Micromanipulation 
Anyone who researched embryo micromanipulation in the 1970s and 1980s would 
remember the necessary emphasis on producing the appropriate micropipettes and 
micromanipulators, and learning how to handle embryos gently and deftly. One of the 
pioneers in this field, Lin (1971) described equipment used to inject murine oocyte and 
for intracytoplasmic sperm injection (ICSI) of murine sperm. Later, Yang et al. (1990) 
expanded this space in rabbit oocytes by using hypertonic media to facilitate nuclear 
transfer without mechanically disturbing the cytoplast. Gardner (1988) used 
microinjection techniques extensively to produce chimaeras. He emphasised the need 
for patience as much as manual dexterity and need to have spare needles because as he 
stated “trying to continue with broken needles or partly occluded pipettes leads to a 
vicious circle of abortive operations and increasing exasperation. Micromanipulation is 
comparatively a recent term of biological microdissection that known as “micrurgy” in 
the old term. The term “micrurgy” was first coined by Peterfi (1923) for biological 
micro-dissection which also known as “micrurgery” (cited by Timson and McDermott, 
1994). The first micromanipulatior with a joystick was designed that could directly 
transmit the movement required by the operator (El Badry, 1963). Nuclear transfer 
involves a manual manipulation process in vitro which requires exposure of oocytes and 
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cells to fluctuations in light, temperature, atmospheric conditions, and different media. 
Different systems have been used for enucleation (micromanipulation, chemical and 
zona free), transfer of the donor nucleus (electrofusion and direct injection) and 
activation stimulus (electrical, chemical and biological extracts). A minor alteration at 
any one step in the process can have significant effects on the success rates. 
Particularly, species specific requirements and sensitivities need to be identified to 
achieve successful nuclear transfer that adjustments in media components, temperatures 
or decreased exposure to detrimental conditions (Ribas et al., 2006; Hinrichs, 2010).  
 
2.5.6 Activation Oocytes 
After nuclear transfer, the recipient oocyte must be stimulated to initiate development. 
In normal fetilisation, this stimulation is achieved by inducing changes in the oocyte 
cytoplasm that normally are triggered by the sperm. Changes will be occurred where a 
transient increase in the intracellular free calcium concentration induced by an electrical 
pulse or by chemical agents. Ca 
2+
 as the trigger of oocyte activation. Ca 
2+
 transient is 
registered in echinoderm, fish, and frog oocytes (Jaffe, 1983). Repetitive calcium 
oscillations that last several hours are observed in mammals (Miyazaki et al., 1993; Sun 
et al., 1994; Nakada and Mizuno, 1998). This has also been shown in murine, hamster, 
rat, rabbit, porcine, bovine, and human oocytes (reviewed by Jones, 1998). The first 
calcium wave originates from the penetration site (Miyazaki et al., 1986), whereas 
subsequent oscillations arise in the cortical region of the vegetal hemisphere with a non-
wave type uniform calcium rise in murine oocytes (Deguchi et al., 2000). Usually, 
calcium oscillations are of low frequency and appear at intervals of 6 to 31 minutes in 
murine (Deguchi et al., 2000) and 8 to 25 minutes in bovine oocytes (Fissore et al., 
1992). The interval of Ca
2+
  transients is prolonged with time and last for several hours, 
until pronuclear formation in murine oocytes (Kline and Kline, 1992; Deguchi et al., 
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2000) whereas these Ca 
2+
 oscillations last for 22 hours in bovine with a decline in the 
amplitude by 12 to15 hours (Nakada et al., 1995). Completion of meiosis is observed 
when a single Ca 
2+
 pulse is applied in a murine oocyte, but no pronuclear formation 
takes place. Kubiak et al. (1993) reported that a metaphase plate (or MII) forms after 
extrusion of the second polar body instead of a pronucleus. A donor nucleus is 
introduced into the cytoplasm of an “enucleated,” unfertilised oocyte during nuclear 
transfer. Thus, in the absence of fertilisation, the oocyte must be exposed to artificial 
stimuli that are expected (Verma et al., 1994). Susko-Parrish et al. (1994) described an 
activation procedure where the nuclear transfer oocytes were activated between 24 and 
28 hours after the start of maturation (6 to10 hours post-nuclear transfer). The nuclear 
transfer oocytes were washed through Ca
2+ 
and Mg
2+
 free TALP-Hepes and then 
exposed to 5 mM ionomycin for 4 minutes, washed in bovine serum albumin in TALP-
Hepes (30 mg/ml), and incubated in 1.9 mM 6-dimethylaminopurine (6-DMAP) 
(Susko-Parrish et al., 1994) in CR1aa (Rosenkrans et al., 1993) for 4 hours at 39.8˚C 
and  CO2 (5%) in air stained with aceto-orcein. According to Wakayama et al. (1998, 
2000), this activation protocol was used for the production of first cloned murine 
‘Cumulina’ and her clones. When the oocytes were activated in cytochalasin B, the 
chromosomes were transformed into 2 or more pseudo-pronuclei. The reconstructed 
embryos were activated with ionomycin (5 μM) in phosphate buffer saline for 5 
minutes, followed by exposure to bovine serum albumin (30 mg/ml) for 4 minutes in 
order to stop the activation. In order to maintain the low level of maturation or mitosis 
promoting factor (MPF), the reconstructed oocytes were further incubated in in vitro 
culture medium containing DMAP (2 μM) for 4 hours. Then, the reconstructed embryos 
were cultured in SOFaa (0.5 ml), supplemented with  foetal bovine serum (5%) in 4-
well dishes overlaid with mineral oil at 38.5°C in a humidified atmosphere with  CO2 
(5%). Cleaved embryos were further cultured in SOFaa medium supplemented with 
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bovine serum albumin (2 mg/ml) for 7 days (Xiang et al., 2007). For a frog oocyte 
initiates pronuclear formation within minutes after sperm penetration. In mammals, this 
is observed after 2 to 6 hours depending on the species (murine: 3 to 4 hours, Krishna 
and Generoso, 1977; bovine: 4 to 6 hours, Liu and Yang, 1999). A single Kubiak et al. 
(1993) reported that Ca
2+ 
transient is not sufficient to induce definitive maturation or 
mitosis promoting factor degradation in young matured murine oocytes.  
 
2.5.7 Efficiency of In Vitro Culture Methods 
Except rabbit, most embryos of domestic mammals especially ruminants often exhibit 
an in vitro arrest of development that coincides with the period of maternal zygotic 
transition (MZT). Co-culture system using different supporting cells (such as oviduct 
epithelial cells and granulosa cells) have been used for developing in vitro produced 
embryos to overcome this in vitro block stage (Goto et al., 1992; Rehman et al., 1994). 
Besides co-culture with somatic cells, proteins and other undefined substances 
contained in in vitro culture medium (Chung et al., 1998; Joo et al., 1998; Uhm et al., 
1998). It is also to achieve in vitro produced embryos as well as co-culture with somatic 
cells (Vansteenbrugge et al., 1994; Palma et al., 1997). Eckert and Niemann (1996) 
studied the importance of the supplementation of media with proteins with the final goal 
to develop a fully defined culture medium. The protein supplements are play important 
roles in culture medium which it reducing embryo toxicity of medium supplements or 
products from embryonic metabolism. Second, the proteins supplement serving as a 
source for basic nutritive requirements of early embryos and as a source of growth or 
proliferation. However, further studies are needed on the road towards a completely 
defined culture medium for the efficient in vitro production of caprine embryos 
(Keskintepe and Brachett, 1996). Embryos from farm animals can be routinely cultured 
up to the blastocyst stage with increased suitability of culture medium and culture 
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related techniques. According to Takano et al. (1997), the proportions of oocytes 
receiving somatic cells that developed into blastocysts were higher than those obtained 
in multiple-nuclear transfer of embryonic nuclei (27% to 37%). As compared with in 
vivo derived embryos, culture reduced total cell number and inner cell mass: 
trophectoderm cell ratio. In vitro culture system is one of the most useful strategies for 
understanding the mechanisms of early development and establishing optimum culture 
conditions. Usually, a medium including fractionated bovine serum albumin is defined 
as a chemically defined medium. In order to establish a simple and optimum culture 
system for the in vitro development of porcine embryos, parthenogenetic diploid 
embryos (Van Thuan et al., 2002) were used instead of fertilised embryos and their 
ability to develop to the blastocyst stage was examined under various culture 
conditions. With the presence of non-polar essential amino acids especially valine, 
leucine, isoleucine and methionine during the first 48 hours of culture after electrical 
stimulation causing severe delay of the first division of the parthenogenetic embryos 
(Van Thuan et al., 2002), hence, inhibiting their further development beyond the 4-cell 
stage. The presence of non-essential amino acids (NEAA) in the medium for embryos 
beyond the 4-cell stage produced favorable conditions for blastocyst expansion. 
Osmolarity changing in culture media after the 4-cell stage increased the rate of 
expanded blastocyst formation in porcine parthenogenetic diploids. By comparing with 
in vivo produced control embryos, level of messenger RNA (mRNA) expression in in 
vitro produced embryos can differ with stage of embryo development as well as with 
the base medium and supplements used for embryo culture (Wrenzycki et al., 2004). 
Several culture medium have been used for the culture of caprine embryos derived 
somatic cell nuclear transfer, including TCM 199 (Baguisi et al., 1999), Charles 
Rosenkrans medium (CR1) (Guo et al., 2002; Lan et al., 2006; Chen et al., 2007) and 
synthetic oviductal fluid (SOF) (Melican et al., 2005). Generally, in vitro culture media 
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generally require supplementation with additional compounds which can aid in vitro 
development but in the long term, can alter embryo quality. Serum is known to be 
detrimental to embryonic and foetal development. The effects of serum compared to 
bovine serum albumin supplementation during in vitro murine development results in 
lower preimplantation development and neonatal offspring, which demonstrated 
behavioral abnormalities in anxiety and deficiencies in implicit memories (Fernandez-
Gonzalez et al., 2004). The addition of foetal bovine serum or oestrus cow serum (OCS) 
to TCM 199 or synthetic oviductal fluid (SOF) media enhanced blastocyst yield 
compared to TCM 199 containing polyvinyl alcohol (PVA) (Wreanzycki et al., 1999, 
2000). Generally, a higher developmental rate to the blastocyts stage was obtained from 
media supplemented with serum (Pinyopummintr and Bavister, 1994; Van 
Langendonckt et al., 1997). Bovine embryos generated in the synthetic oviductal fluid 
system were suggested to be more similar to their in vivo counterparts with regard to 
gene expression patterns (Niemann and Wrenzycki, 2000; Sagirkaya et al., 2006), 
although Bhuiyan et al. (2004) observed greater development from (KSOM). Watson et 
al. (1994) reported that the use of low oxygen systems in the absence of co-culture has 
also been reported to improve development.  
 
2.5.8 Reprogramming 
Reprogramming usually occurs aberrantly in most cloned embryos. Incomplete 
reprogramming may contribute to the low efficiency of cloning. Global epigenetic 
reprogramming of somatic nuclei is mainly in most preimplantation cloned embryos 
(Dean et al., 2001). Therefore, correct epigenetic reprogramming is necessary for 
successful and normal developmental of clones (Dean et al., 2001). All animals derived 
from nuclear transfer, whether from somatic or embryonic stem cells, have some 
abnormal gene expression, after analysis of more than 10,000 genes. The low success 
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rate could be caused by an incomplete reprogramming of the epigenetic state of nuclei 
from differentiated donor cells. It is easy to understand that genes permanently switched 
off in the course of cell differentiation may be hard to reactivate efficiently. An example 
of such a gene is Oct 4, whose product is required for embryonic development and the 
maintenance of stem cell status (Nichols et al., 1998). The incomplete reactivation of 
Oct 4 may account for some failures of nuclear transfer embryo development (Boiani et 
al., 2002; Bortvin et al., 2003).  
 
2.5.8.1 Pre-zygotic reprogramming 
Most of cloning used an unfertilised and mature oocyte as recipient, reprogramming 
occurred within the brief interval between the transfer of the donor nucleus into the 
enucleated oocyte and here the start of zygotic transcription. Thus, pre-zygotic 
modifications (any modifications that have occurred before the mature oocyte stage) are 
expected to be less efficiently reprogrammed than post-zygotic modifications. The fact 
is that imprints in donor nuclei are usually not corrected in the clones. Epigenetic 
modification of DNA resulting in the mono-allelic and parent-of-origin–specific 
expression of certain genes are named as genomic imprinting. Young et al. (1998) 
reported that the dysregulation of imprinted genes is particularly pronounced in cloned 
animal derived from embryonic stem cells, because cultured embryonic stem cells are 
epigenetically very unstable and frequently gain or lose genomic imprints. According to 
Humpherys et al. (2002), cloned animal derived from uncultured cumulus cells with 
normal imprints also have aberrant expression of imprinted genes, proving that the 
dysregulation of imprinted genes is influenced by both the epigenetic state of the donor 
cell and the nuclear transfer procedure. Since imprinted genes are important for foetal 
growth and placental function, aberrant expression of these genes might account for the 
severely abnormal foetal and placental phenotypes in many clones. A sub-group of 
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these genes was found to be misexpressed exclusively in clones derived from cumulus 
cells, whereas another sub-group was aberrantly expressed only in clones derived from 
embryonic stem cells showed a result consistent with the finding that clones derived 
from different types of donor cells can have different abnormalities (Hochedlinger and 
Jaenisch, 2002; Ogonuki et al., 2002; Tamashiro et al., 2002). Therefore, pre-zygotic 
reprogramming, which affects the expression of imprinted and most non-imprinted 
genes, appears to be faulty in clones.  
 
2.5.8.2 Post-zygotic reprogramming 
Most cloned animals, the lengths of telomeres are normal or even longer than normal 
(Lanza et al., 2000; Tian et al., 2000; Wakayama et al., 2000; Betts et al., 2001). In 
normal fertilisation, telomeres undergo progressively shorten with each cell division, 
and this shortening has been correlated with organismal and cellular aging. The function 
of telomeres is structures that protect the ends of chromosomes. Pre-zygotic 
modifications that usually occur during gametogenesis are not corrected in the clones. 
Inactivation of one X chromosome in female cells is a mechanism that to ensure equal 
dosage of X linked genes in the 2 sexes. In early embryogenesis, it is accomplished by 
the random and stable silencing of one of the 2 X chromosomes. Inactive X was found 
to be reactivated properly, resulting in random X inactivation in cloned murine embryos 
from female somatic cells (Eggan et al., 2000). Thus, all available evidence indicates 
that reproductive cloning, in contrast to normal development or in vitro fertilisation, is 
limited by the fundamental biologic problem of epigenetic reprogramming of the donor 
nucleus. This incomplete reprogramming may result in abnormal phenotypes, aberrant 
gene expression, and the death of most clones.  
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2.5.8.3 Maternal zygotic transcription (MZT) 
The onset of maternal zygotic transition is species dependent such as murine 1 to 2-cell 
stage (Bolton et al., 1984); bovine, caprine and ovine 8- to 16-cell stage (Calarco and 
McClaren, 1976; Camous et al., 1986) and Xenopus approximately 4000 (Newport and 
Kirschner, 1982). With improvements in nuclear transfer techniques, development from 
later developmental stages has been achieved and live offspring have been reported 
following direct transfer of karyoplasts to enucleated metaphase II oocytes in the 
murine from morula stage embryos and in ovine and bovine from inner cell mass cells 
(Smith and Wilmut, 1989; Collas and Barnes, 1994). In murine (Howlett et al., 1987) 
and rabbit (Kanka et al., 1996), inhibition of transcription and establishment of zygotic 
gene expression profiles have been reported when transferring transcriptionally active 
blastomere nuclei, suggesting ‘reprogramming’.  
 
2.5.9 Effects of Cytoplast Cell Cycle Stage 
When using different donor cell cycle phases a direct comparison of all cytoplast 
recipients is not possible. Consider the fate of the chromatin from a diploid donor 
nucleus on transfer to an metaphase II or a pre-activated cytoplast recipient is very 
important. The chromatin transferred to the methaphase II cytoplast will undergo an 
additional round of chromosome condensation in comparison to the pre-activated 
oocyte. The period of exposure of the chromatin to the cytoplasm of the oocyte can be 
increased by utilising an unactivated metaphase II oocyte as cytoplast (Campbell, 
1999). Nuclear structure and function are intimately related. In addition, precise nuclear 
structure is required for some of the physical events required for embryo development. 
Alternatively nuclear remodeling may occur not as a single event but during successive 
mitosis and therefore, the effects of an extra round of nuclear envelope break down 
(NEBD) is additive. The ideas suggest that nuclear remodeling is essential for some 
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processes during early development. However, whether nuclear envelope break down is 
necessary is presently unclear and what changes are essential in different species are 
also unclear.  
 
2.5.10 Cell Cycle Stage of Donor Nucleus 
The donor cells in late G2, M or early G1 phases of the cell cycle are more able to 
promote development (Kwon and Kono, 1996). Recently, live offspring have been 
reported from embryonic foetal and adult derived cell populations that were in the G0 
phase of the cell cycle at the time of transfer (Campbell et al., 1996; Wilmut et al., 
1997; Wells et al., 1997; Schnieke et al., 1997; Wakayama et al., 1998). During the late 
G2 phase of the cell cycle, nelcaer envelope break down and chromosome condensation 
occur as the cell enters mitosis. During mitosis, the chromosomes remain condensed 
and are segregated to the 2 new daughter cells. Then, during the G1 period, chromosome 
decondensation occurs and the nuclear envelope reforms. Martinez-Balbas et al. (1995) 
described during mitosis transcription is dramatically reduced and transcription factors 
become displaced from the chromatin. Cell cycle coordination between donor cells and 
recipient oocytes has been stressed importantly (Campbell et al., 1996, 1999). 
Although, it was once thought that donor cells must be at the G0 stage of a cell cycle 
during nuclear transfer for successful cloning (Wilmut et al., 1997), subsequent studies 
revealed that this is not necessarily the case. However, the donor cells at the G1 or G2 
stage and even those at the M stage can be used as long as the cloned embryos are 
diploid (Campbell et al., 1996; Tani et al., 2001; Ono et al., 2001). When we injected 
cumulus cell nuclei (which were mostly at the G0 and G1 stage) into murine oocytes and 
then activated it, part of cumulus chromosomes (2n) were shed into pseudo-second 
polar bodies which resulting in the production of hypoploidy embryos which were 
doomed to die. To avoid this problem, culturing nucleus-injected oocytes in a medium 
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which activated oocytes and inhibited their cytokinesis simultaneously should be carried 
out. The medium used was a Ca
2+
 free medium containing strontium (Sr
2+
) and 
cytochalasin B (CB). Strontium activated the oocytes and cytochalasin B inhibited 
cytokinesis of the activated oocytes (Wakayama et al., 1998). The first production of 
live murine was obtained by transferring nuclei from 2-cell embryos at the G2 phase to 
ooplasts (Kono et al., 1991, 1992).  
 
2.5.11 Genomic Imprinting 
Genomic imprinting is an epigenetic chromosomal modification in the germ line that 
leads to preferential expression of one of the 2 parental alleles in a parent-of origin-
specific manner. The study of imprinting is provides new insights into epigenetic gene 
modification during development. Genomic imprinting in mammals was discovered in 
the early 1980s. In early 1990s, the discovery of the first imprinted genes, which were 
expressed differently on maternal and paternal chromosomes (Barlow et al., 1991; 
Bartolomei et al., 1991; DeChiara et al., 1991). According to Barlow (1995), imprinting 
genes are particularly implicated in the regulation of foetal growth, development, and 
function of placenta in mammals. DNA methylation by the enzyme Dnmt1 plays a 
central role in genomic imprinting, and may be the main epigenetic mechanism. The 
most common phenotypes observed in animals cloned from either somatic cell nuclei or 
embryonic stem cell nuclei are foetal growth abnormalities for example increased 
placental and birth weight. Jaenish (1997) reported that similar phenotypes have been 
observed in human patients and in murine as a consequence of both naturally occurring 
and targeted mutagenesis of imprinted genes, these apparent similarities suggested that 
aberrant expression of imprinted genes might cause some of the abnormalities in clones. 
Humpherys et al. (2001) have examined imprinted gene expression in both murine 
cloned by nuclear transfer and embryonic stem cell donor populations from which they 
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were derived in an effort to correlate gene expression with foetal and survival 
overgrowth. Epigenetic state of the embryonic stem cell genome was found to be 
extremely unstable. Imprinting is an important genetic mechanism in mammals, and is 
thought to influence the transfer of nutrients to the foetus and the newborn from the 
mother. DNA methylation was a key molecular mechanism of imprinting, the 
methylation marks the imprinted genes differently in egg and sperm, and inheritance of 
these epigenetic marks leads to differential gene expression (Reik et al., 1987; Sapienze 
et al., 1987; Swain et al., 1987; Chaillet et al., 1991; Sasaki et al., 1991). The 
evolutionary understanding of imprinting and its likely biological purposes is increasing 
(Moor and Haig, 1991; Hurst and Mc Vean, 1997) and the study of imprinting is 
providing general insights into the importance of epigenetic mechanisms in 
development. Genomic imprinting, the preferential expression of one parental allele, is 
regulated primarily by DNA methylation of CpG islands. Wilkins and Haig (2003) 
reported that the majority of imprinted genes have roles in foetal growth and 
development, and both the maternal and paternal genomes are required for normal 
development. The phenomenon of genomic imprinting is mainly observed in eutherian 
mammals, suggesting that it evolved when placental mammals developed direct 
maternal-foetal interactions throughout pregnancy (Wilkins and Haig, 2003; Wagschai 
and Feil, 2006). The time course of imprinting has been best studied in the murine 
where distinct allelic expression patterns of imprinted genes can be established as early 
as the 2-cell stage, and by the blastocyst stage (Latham, 1999; Monk and Salpekar, 
2001).  Monoallelic expression of many imprinted genes is observed, which closely 
follows the reestablishment of genome-wide DNA methylation in early development 
(Latham, 1999; Monk and Salpekar, 2001). 
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2.5.12 DNA Methylation 
DNA methylation is a major epigenetic modification of the genome that regulates 
crucial aspects of its function. In mammals there are at least 2 developmental periods: in 
germ cells and in preimplantation embryos, in which methylation patterns are 
reprogrammed genome wide, generating cells with a broad developmental potential 
(Reik et al., 2001). Therefore, during cell division, the methylation pattern should also 
pass over to the daughter cell. Genomic methylation patterns in somatic differentiated 
cells are generally stable and heritable. According to Bird and Wolffe (1999), 
methylation of cytosine residues is implicated in several genomic functions, such as 
imprinting, X chromosome inactivation, genomic stability, immobilisation of 
mammalian transposons, and tissue-specific gene expression. The somatic donor nuclei 
that have been used include foetal and adult fibroblasts, embryonic stem cells, and other 
somatic cells that were presumably differentiated. All these cells have a highly 
methylated genome, which is the characteristic of somatic cells (Kang et al., 2001). 
Aberrant DNA methylation patterns have been reported in genomic repetitive elements 
in cloned bovine blastocysts (Bourc’hi et al., 2001; Dean et al., 2001; Kang et at., 
2001). In cloned bovine morulae and blastocysts, the methylation levels of several 
repeat and unique sequences were found by bisulfite analysis to be much higher than 
that in normal embryos, and thus resembled methylation levels in the donor cell genome 
(Kang et al., 2001). Dean et al. (2001) reported that reorganisation of the nuclear 
pattern of methylation to resemble that of differentiated nuclei occurred prematurely in 
cloned embryos. Chung et al. (2003) found cloned preimplantation murine embryos 
aberrantly expressing the somatic form of the Dnmt1 DNA (cytosine-5) 
methyltransferas, this confirmed the front speculation. Kang et al. (2003) studied a 
unique DNA methylation change occurring at bovine neuropeptide galanin gene 
sequence in cloned preimplantation bovine embryos. Recently, epigenetic alterations in 
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DNA methylation and imprinted gene expression arising from derivation or culture 
murine embryonic stem cells do not become corrected during post-implantation 
development and are associsted with aberrant gene expression in the embryonic stem 
cell derived foetus (Dean et al., 1998). In all embryonic stem cell lines studied, the 
maternal Igf2 allele was unusually methylated, in addition to the paternal allele. In 
several foetuses this resulted in expression of Igf2 from both alleles, but particularly 
from the maternal allele. Finally the Igf2 allele gene was maternally methylated in all 
embryonic stem cell lines and in most embryonic stem cell foetuses. In all embryonic 
stem cell lines the pattern of Igf2r expression was biallelic but in the majority of 
embryonic stem cell foetuses was only from the maternal allele. This is consistent with 
the patterns of Igf2r methylation and expression found in normal murine blastocyst 
stage embryos (from which embryonic stem cells are derived) and foetuses. As in the 
age effect suggested for donor somatic nuclei from older animals (Jaenisch, 1997), 
imprinting errors may also be expected to increase with age and passage number in 
embryonic stem cells. There have been recent reports of the isolation of both bovine and 
human (Thomson et al., 1998) embryonic stem-like cells from blastocyst inner cell 
mass cells. During normal early embryonic development in mammals, the global pattern 
of genomic DNA methylation undergoes marked changes. The level of methylation is 
high in male and female gametes. De novo methylation in murine occurs at the 
blastocyst stage, preferentially in the inner cell mass. De novo methylation in bovine 
embryos happens at the 8- to 16-cell stage, concurrent with zygotic genome activation. 
It has been proposed that chromatin configuration has a significant role in establishing 
the ‘histone code’, a cellular memory that is responsible for maintaining the identity of 
differentiated cells (Bird, 2002). Histones are the proteins that make up chromatin, and 
their N-terminal tails can be modified in several ways, including methylation, 
acetylation, phosphorylation and ubiquitinylation.  
 46 
 
2.6 HISTORICAL BACKGROUND OF EMBRYONIC STEM CELL  
In 1998, researchers at the University of Wisconsin building on earlier stem cell 
research, isolated cells from the inner cell mass (ICM) of the early human embryo, 
called the blastocyst.  This is the first human embryonic stem cell lines development 
(Thomsom et al., 1998). During that exact same year, Gearhart, from Johns Hopkins 
University, derived germ cells from cells in foetal gonad tissue; pluripotent stem cell 
lines were developed from both sources. Since then, it has made a lot of progress, with 
2,000 research papers on embryonic and adult stem cells being published in reputed 
scientific journals every year. Now, adult stem cells are being used to treat over 100 
conditions, including leukaemia, Hunter’s syndrome and heart disease. However, 
embryonic stem cell research is still in its infancy, especially when it is yet to yield any 
clinical trials.  In 1988, embryonic stem cell lines were created from a hamster. The first 
development of 1990s, in context of stem cell research, comprised of the derivation of 
the first embryonic stem cell line from a primate, in 1995. Two years later, the world 
witnessed its first case of cloning, where cloned lamb were created from stem cells. The 
same year, haematopoietic stem cell was found as the origin of leukaemia, indicating 
possible proof of cancer stem cells. Today, it is believed that embryonic stem cells can 
become almost any of the specialised cells in the body and thus, have the ability to 
generate replacement cells for a wide range of tissues and organs in the body, like heart, 
liver, pancreas and nervous system. Smith and Wilmut (1989) reported that nuclei 
isolated from the inner cel1 mass of ovine blastocysts are totipotent as one full-term 
lamb was obtained after fusing such cells to enucleated recipient oocytes. According to 
Campbell et al. (1995), more recent experiments in the same laboratory demonstrated 
that even after several passages in culture such cells derived from ovine inner cell mass 
can be transferred and result in the birth of lambs. High developmental rate to the 
morula stage, up to 70% can be obtained in sheep using 16-cel1 stage donor morula and 
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in vivo enucleated and preactivated oocytes (Loi et al., 1995). Embryonic stem cell lines 
have been established from murine blastocysts generated by nuclear transfer of murine 
somatic cell nuclei. The somatic cell types were ovarian cumulus cells (Munsie et al., 
2000; Wakayama et al., 2001), tail-tip fibroblasts (Wakayama et al., 2001), and fetal 
neuronal cells (Kawase et al., 2000a). The 3 primary embryonic lineages were all 
represented in teratomas (Kawase et al., 2000b; Munsie et al., 2000) and normal 
chimaeric progeny were obtained when the embryonic stem cells were injected into host 
blastocysts (Munsie, 2000; Wakayama et al., 2001). The embryonic stem cells 
contributed to all tissues of the chimaeric murine, including germ line transmission. The 
primary difficulty for nuclear transfer in murine is the efficiency of insertion of somatic 
cell nuclei into oocytes (Munsie, 2000). It is difficult to electrofuse cells that are very 
different sizes, and attempts to vary the techniques of electrofusion, reduced size 
differences. Therefore, other parameters such as nuclear injection has remained the 
method of choice (Trounson et al., 1998). The use of piezo-electronic impact 
micromanipulation (Prime Tech Ltd or Burleigh Instruments) enables very improved 
efficiencies of nuclear transfer to produce viable embryos (Wakayama et al., 1998). 
This method was used to produce nuclear transfer embryos for embryonic stem cells 
production in all the studies reported to date. There were no obvious differences 
between strains of murine as donor cells and between cumulus cells or fibroblasts, in 
the development to blastocysts. Wakayama et al. (2001) have been established 
embryonic stem cell lines and number of chimaeric offspring produced by combining 
nuclear transfer of embryonic stem cells (ntES) with wild-type blastocysts. He 
suggested that the donor cell origin or tissue type has no effect on the ability to generate 
embryonic stem cells, and this would be an attractive strategy to explore for generation 
of embryonic stem cells for human cell therapies. Embryonic stem cells therapies have 
been proposed for regenerative medicine and tissue replacement after injury or disease 
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because of their plasticity and potentially unlimited capacity for self-renewal. 
Embryonic stem cells also known as “master cells” which able to develop into almost 
any cell in the human body. Most of research has focused on the potential that 
embryonic stem cells where they can offer to treat diseases and conditions as well as to 
generate replacement tissues for disfunctioning cells, tissues or organs (Judith et al., 
2001).  Research efforts also have focused on spinal cord injury, multiple sclerosis, 
Parkinson’s disease, Alzheimer’s disease, diabetes, and other degenerative diseases. 
The embryo is destroyed in the removal process in order to extract the stem cells found 
within the embryo. In 1981, embryonic stem cells were first derived from murine 
embryos by Martin Evans and Matthew Kaufman at the Department of Genetics, 
University of Cambridge. Martin is credited with coining the term "Embryonic Stem 
Cell" (Martin, 1981). A breakthrough occurred when researchers, led by James 
Thomson at the University of Wisconsin-Madison, first developed a technique to isolate 
and grow in cell culture human embryonic stem cells (Thomson et al., 1998). It was 
discovered that there was a way to extract embryonic stem cells without destroying the 
actual embryo (Klimanskaya et al., 2005). This technical achievement enable scientists 
to work with new lines of embryonic stem cells derived using public funding in the 
United State, where federal funding was at the time limited to research using embryonic 
stem cell lines derived prior to August 2001. Zangani et al. (2007) reported that 
Professor Shinya Yamanaka had a recent breakthrough in which the skin cells of 
laboratory murine were genetically manipulated back to their embryonic state. This was 
confirmed by 2 other groups, demonstrating that the addition of just 4 genes (Oct 3/4, 
Sox 2, Klf4, and c-Myc) could reprogram murine skin cells into embryonic stem like 
cells. This finding is important in science and stem cell field where after Hwang Woo-
Suk from Korea fabricated data, claiming to have generated human embryonic stem 
cells from cloned embryos. Yamanaka as well as the other laboratories demonstrated all 
 49 
 
the hallmarks of embryonic stem cells including the ability to form chimaeric murine 
and contribute to the germ line. In 2008, these embryos can be harvested for patient 
matching embryonic stem cells. First isolated in 1997 by researchers at the Johns 
Hopkins Medical Institutions the embryonic stem cell is a fairly recent addition to the 
list stem cell types.  
 Over past 15 years, many reports have been published on bovine, porcine, 
caprine, ovine and equine embryonic stem cell lines are often called as “embryonic 
stem-like” cell lines. This is similar to a few embryonic stem-like cell lines from 
rodents other than the murine (hamster, Doetschman et al., 1988; rat, Iannaccone et al., 
1994; Vassilieva et al., 2000) and from rabbit (Schoonjans et al., 1996) have also 
reported. None of these cell lines has been definitively proven to be embryonic stem 
cells. With our knowledge, none has been successfully used as a biological reagent in a 
manner similar to the use of human, monkey or murine embryo such as directed 
pluripotent in vitro differentiation (Perrier et al., 2004; Takagi et al., 2005) or 
embryonic chimaera formation as a means of genetically engineering (Bradley, 1987). 
Embryonic stem cell lines were first isolated from explant cultures of in vivo derived 
murine blastocyst stage embryos (Evans and Kaufman, 1981; Martin, 1981; Robertson, 
1987). Embryonic stem cell lines have also been derived from 8-cell and morula stage 
embryos prior to the first embryonic differentiation events, such as formation of the 
inner cell mass and trophectoderm (TE) of the blastocyst (Eistetter, 1989; Delhaise et 
al., 1996; Strelchenko et al., 2004). In general, primate embryonic stem cell lines have 
been established from in vivo derived blastocysts of monkeys (Thomson et al., 1995) 
and in vitro fertilised (IVF) as well as in vitro cultured (IVC) blastocysts of humans 
(Thomson et al., 1998; Reubinoff et al., 2000; Lee et al., 2005).  
An attempt to create embryonic stem cell lines of the porcine, caprine, ovine and 
equine have most often used in vivo blastocysts acquired from the reproductive tract at 
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various stages, but generally from the early blastocyst stage to the later elongated or 
filamentous stage. Efficient and cost effective in vitro produced (IVP) embryo culture 
systems are commonly used for bovine which early blastocyst stage embryos are the 
most frequent starting material for attempts at making embryonic stem cell lines. 
Production of these in vitro produced embryos usually involves in vitro maturation 
(IVM), in vitro fertilisation and culture to morula or blastocyst stages. In vitro produced 
blastocysts may be altered in terms of cell metabolism, epigenetic status and constituent 
cell numbers, but it is probably that some will prove competent for the establishment of 
bovine embryonic stem cell lines. This seems reasonable since human embryonic stem 
cell lines have been derived from in vitro fertilisation or in vitro culture embryos, and 
because culture of in vitro produced derived bovine epiblast tissue displays normal 
differentiation and pluripotency in vitro (Talbot et al., 1995). Besides that, peer-
reviewed reports of porcine embryonic stem cells, embryonic stem-like or inner cell 
mass cell lines have been published by at least 6 groups, all of which used in vivo 
derived blastocysts as their primary culture material (Notarianni et al., 1990, 1991; 
Piedrahita et al., 1990; Hochereau-de Reviers and Perreau, 1993; Wheeler, 1994; Chen 
et al., 1999; Li et al., 2003a, 2004a, 2004b). Li et al. (2004b) reported that putative 
porcine embryonic stem cell lines also isolated from in vitro produced porcine embryos, 
as were several bovine embryonic stem cells or embryonic stem-like cell lines from in 
vitro produced early blastocyst stage embryos (Evans et al., 1990; Cibelli et al., 1998; 
Iwasaki et al., 2000; Mitalipova et al., 2001; Saito et al., 2002, 2003; Wang et al., 
2005). Production of ovine, equine and caprine embryonic stem-like cell lines has also 
been reported (Notarianni et al., 1991; Keefer et al., 1996; Saito et al., 2002). There are 
also several reports of similar embryonic stem-like cell lines of the porcine, caprine and 
bovine that was derived from primordial germ cells found in the early genital ridge 
tissue, sometimes referred to as embryonic germ cell lines (Piedrahita et al., 1997; Shim 
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et al., 1997; Mueller et al., 1999; Tsung et al., 2003; Rui, 2004). Both murine and 
human embryonic germ cell lines have been proven or are assumed to be functionally 
equivalent to embryonic stem cell lines (Matsui et al., 1992; Resnick et al., 1992; 
Shamblott et al., 1998). Through the above mentioned studies have provided us 
valuable information on ungulate embryonic cell culture, future studies need to focus 
more intensely on the critical characteristics to define true embryonic stem cell lines. 
Embryonic stem cells can be derived from numerous techniques through in vitro 
produced embryos [such as in vitro fertilisation (IVF), intracytoplasmic sperm injection 
(ICSI), parthenogenesis (PA) and somatic cell nuclear transfer] and in vivo produced 
embryos (oviductal and uterine flushing). Based on above sources, only 
parthenogenesis, somatic cell nuclear transfer and flushing techniques have been 
utilised to obtain embryonic stem cells in caprine in our study. Since inner cell mass 
could develop to be a foetus, so it is a valuable source for embryonic stem cells 
establishment. There are several techniques to isolate a clump of inner cell mass cells 
such as blastocyst outgrowth (Tabar, 2005; Genbacev et al., 2005), mechanical 
dissection (Wang et al., 2005), laser assisted blastocyst dissection (Tanaka et al., 2006) 
and immunosurgery (Solter and Knowles, 1975; Reubinoff et al., 2000; Mateizel et al., 
2006; Tanaka et al., 2006). Immunosurgery technique is one of the most efficient 
techniques used for isolating inner cell mass cells. Once isolated and cultured in vitro 
under appropriate conditions, the inner cell mass cells could propagated as an 
embryonic stem cell line.  
 
2.7 EMBRYONIC STEM CELLS PROPERTIES  
The embryonic stem cells are pluripotent where they can differentiate into almost all 
tissues of the 3 embryonic germ layers (ectoderm, mesoderm and endoderm) after in 
vitro induced differentiation. Besides that, embryonic stem cells are capable to form 
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teratocarcinomas after subcutaneous injection into severe compromised immune 
deficient (SCID) murine, except embryonic stem cells could not differentiated to any 
cell types of the trophoblast lineage (Cavaleri and Scholer, 2004). The general 
characteristics of embryonic stem cells were: a) embryonic stem cells derived from 
preimplantation embryo, b) pluripotent (capable of differentiating into specialised cells 
from all three embryonic germ layers), c) immortal (the cell cultures can be maintained 
indefinitely by long term cultures or continuous passages (Suda et al., 1987; Amit et al., 
2000), d) maintaining normal karyotype after prolonged culture, e) ability to contribute 
to all embryonic germ layers including the germ line after injection into blastocyst, f) 
expressing unique pattern of embryonic stem cells markers such as Oct 4, Sox 2, Nanog 
and cell surface markers such as stage specific embryonic antigen SSEA 1, SSEA 2, 
SSEA 3, SSEA 4, tumor resistant antigen TRA-1-60 and TRA-1-81 and g) clonogenic 
(each individual cell processing the above characteristics).  
The term “cell line” indicated the maintenance of the cell culture’s original 
phenotype during continuous culture or passage, such as hundreds of population 
doublings and also implies homogeneity of phenotype within the population of cells. In 
1981, the derivations of pluripotent cell lines from murine blastocyst by 2 different 
groups (Evan and Kaufman, 1981; Martin, 1981). Therefore, murine embryonic stem 
cells establishment has been used for establish embryonic stem cell lines from different 
species including rabbit, hamster, pig, monkey and human (Gardner, 2004). Althoguh 
embryonic stem cell lines were considered as pluripotent, they exhibit different 
properties from murine embryonic stem cells such as morphology of undifferentiated 
colonies and the expression profile of stem cell markers. According to Thomson et al., 
(1995), the morphologically appearance of embryonic stem cell colonies vary in 
different animal species such as murine embryonic stem cells undifferentiated colonies 
which showed colonies with dome shape, clear edge and high nuclear-cytoplasmic ratio 
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while the undifferentiated primate embryonic stem cells as appeared as flat colonies 
with high nuclear–cytoplasmic ratio. The primate embryonic stem cells are differed 
from the murine embryonic stem cells in the expression of stem cell markers pattern and 
cytokine factors that are important for maintaining at undifferentiated stage.  
Stem cell markers can be proved where samples tested should be free of feeder 
cells. This is because feeder cells may contain a mixture of cell types or have undefined 
gene expression profiles which can complicate interpretation of results (Talbot et al., 
2004). Moreover, embryoid body formation demonstrations by ungulate embryonic 
stem-like cells must differentiate embryoid-like bodies from similar multicellular 
vesicle-like bodies that are commonly produced by the anchorage-independent growth 
of ungulate trophectoderm and visceral endoderm cells or by other polarised, dome-
forming epithelial cell lines (Robertson, 1987) for a clear description of murine 
embryonic stem cells embryoid bodies. By proving the pluripotency of primate and 
murine embryonic stem cells is that of teratoma formation in immune-compromised 
murine. In recent research, embryonic stem cells have been successfully established 
from early embryos, 2-cells to morula stage, instead of using the inner cell mass of a 
blastocyst (Bradley et al., 1984; Eistetter, 1989; Strelchenko et al., 2004; Tesar, 2005). 
Furthermore, embryonic stem cells have been successfully established from a single 
biopsied blastomere of early preimplantation stage murine and human embryo (Chung 
et al., 2006; Klimanskaya et al., 2006, Wakayama et al., 2007). These breakthroughs 
have demonstrated the feasibility of deriving personal embryonic stem cells. Some 
embryonic stem-like cell lines were used as nuclear donor cells to create cloned animals 
by nuclear transfer (Chen et al., 1999; Saito et al., 2003). The use of the cells in nuclear 
cloning in no way proves their embryonic stem cells character since many types of fully 
differentiated somatic cell nuclei have proven competent for the creation of cloned 
animals (Kato et al., 2000; Wakayama and Yanagimachi, 2001) and nuclear cloned 
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animals have also been created from trophectoderm cells (Tsunoda and Kato, 1998). 
The latter demonstration is very significant because trophectoderm cells are easily 
confused with epiblast cells and a common cell contaminant in attempts to establish 
embryonic stem cell lines. 
Embryonic stem cell colonies usually grow quickly to contain hundreds if not 
thousands of cells per colony. Thus, the colonies will fuse with one another to form 
monolayers if there are sufficient colonies in close proximity.  Murine embryonic stem 
cells will begin to spontaneously differentiate at the periphery of the colony with the 
formation of flatter, larger and irregularly cuboidal visceral endoderm cells. On the 
same time, other somatic cell types may appear in or around the differentiating colony. 
Primate embryonic stem cells colony morphology is different from murine embryonic 
stem cells in that the monkey or human embryonic stem cells are generally flatter in 
appearance and spontaneous differentiation tends to begin in the center of colonies if 
they are left undisturbed for a week or more without passage (Thomson et al., 1995, 
1998; Thomson and Marshall, 1998). Some researchers reported that cell morphology 
of embryonic stem cells and primary cultures of epiblast cells are very similar across 
species (Robertson, 1987; Talbot et al., 1993; Thomson et al., 1995, 1998; Thomson 
and Marshall, 1998). The general size of embryonic stem cells is 10 to 15 µm in 
diameter with a round to oval shape. Their most distinctive morphological feature when 
viewed by phase contrast microscopy is their large nucleus surrounded by a narrow 
band of non-granular cytoplasm. Most nuclei are observed to contain 1 or 2 very large 
and distinct nucleoli. An ultrastructural study of the inner cell mass of in vivo porcine 
blastocysts and of primary cultures of porcine epiblast cells showed contrast to primate 
and murine embryonic stem cells where the porcine epiblast cells develop relatively 
robust complex junctions or tight junctions shortly after blastocyst formation (Talbot 
and Garrett, 2001).  Another important property of embryonic stem cells is that of 
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asymmetric division, yielding one differentiated progeny and one stem cell daughter 
(Cai et al., 1997; Lu et al., 2000). Table 2.2 shows the comparision between murine and 
human embryonic stem cells. 
 
Table 2.2: Comparision between murine and human embryonic stem cells 
 Pluripotent markers  Murine 
embryonic stem cells 
 Human 
embryonic stem cells 
AP  +  + 
SSEA-1  +  - 
SSEA-3  -  + 
SSEA-4  -  + 
TRA-1-60  -  + 
TRA-1-81  -  + 
Oct-4  +  + 
Feeder cell  Need  Need 
Cytokine factor control 
self-renew  
LIF and some growth factors that 
work through GP130 receptor 
 Feeder cell and bFGF 
Morphology of 
undifferentiated colony  
Multi layers clump, dome shape, 
clear edge 
 Mono layer clump, 
loose, flat colony 
Embryoid body 
formation  
Yes  Yes 
Teratoma formation  Yes  Yes 
Chimaera formation  Yes  Yes 
 
 
2.8 MAINTAINING OF EMBRYONIC STEM CELLS IN THEIR   
      UNDIFFERENTIATED STATE  
Embryonic stem cells are derived from totipotent cells of the early mammalian  embryo 
and are capable of unlimited, undifferentiated proliferation in vitro (Evans and Kaufman 
1981; Martin, 1981; Morrison et al., 1981). Undifferentiated murine embryonic stem 
cells can be maintained for extended periods in media containing the cytokine, 
leukaemia inhibitory factor or Millipore’s proprietary embryonic stem cell culture 
reagent ESGRO (Smith et al., 1988; Williams, 1988). Upon removal of leukaemia 
inhibitory factor from the culture medium, in vitro, the murine embryonic stem cells 
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differentiate into cells derived from all 3 germ layers. In contrast, human embryonic 
stem cells cultures required mouse fibroblasts as feeder cells and cannot be maintained 
with leukaemia inhibitory factor for self-renewal (Shamblott et al., 1998; Thomson and 
Marshall, 1998). 
Embryonic stem cells can be maintained in a proliferative, undifferentiated state 
in vitro by growing them on feeder layers of mouse embryonic fibroblast cells. Smith 
(2001) and Williams et al. (1988) have been reported that an alternative to culture on 
feeder layers is the addition of leukaemia inhibitory factor to the culture medium. 
Leukaemia inhibitory factor is produced by feeder cells and it allows embryonic stem 
cells in vitro to continue proliferating without differentiating (Rathjen et al., 1990).  
 
2.8.1 Leukaemia Inhibitory Factor (LIF) 
Gearing et al. (1987) had identified the role of leukaemia inhibitory factor in 
maintaining stem cell functions. This approach was applied by Williams et al. (1988) 
who used it to maintain stem cell properties in cultures of murine embryos. The 
leukaemia inhibitory factor receptor consists of the luekaemia inhibitory factor-specific 
receptor subunit (LIFRh) and the common signal transducer gp130 (Davis et al., 1993). 
Added leukaemia inhibitory factor enhances embryonic stem cell self-renewal 
suggesting a combinational effect of these pathways on self-renewal (Chambers et al., 
2003; Mitsui et al., 2003). Yoshida et al. (1994) reported that the effect of leukaemia 
inhibitory factor on self-renewal is not exclusive but is also seen by a small group of 
related cytokines which act via the common gp130 receptor.  
 
2.8.2 Cytokine Control Pluripotent State  
Cytokine is a polypeptide protein that could maintain self-renewal of embryonic stem 
cell and control the undifferentiated state of embryonic stem cells. The important 
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cytokine for embryonic stem cell maintaining self-renewal state is leukaemia inhibitory 
factor which secreted from feeder cell and added into culture medium. In the past, 
culture conditions for the establishment of embryonic stem cells and embryonic stem-
like cells in murine, ungulates and other animals have relied on a system of co-culture 
with mouse embryonic fibroblasts (primary mouse embryonic fibroblasts or 
transformed STO cells) and supplementation of medium with foetal bovine serum 
(FBS), glutamine and beta-mercaptoethanol. Both foetal bovine serum and the medium 
conditioned by feeder cells comprise a poorly defined system of growth factors and 
cytokines. In murine embryonic stem cells, supplementation with leukaemia inhibitory 
factor obviates the need for any other additive in feeder and serum free conditions. 
Therefore, supplement the culture medium with a combination of growth factors and 
cytokines proven beneficial for murine embryonic stem cells. The most common 
supplements used to establish and maintain embryonic stem-like cells include 
leukaemia inhibitory factor (Strelchenko, 1996; Iwasaki et al., 2000; Saito et al., 2003; 
Li et al., 2004c; Yadav et al., 2005), basic fibroblast growth factors (bFGF) 
(Strelchenko, 1996; Li et al., 2004c; Yadav et al., 2005), stem cell factor (SCF) and 
epidermal growth factor (EGF) (Saito et al., 2003). It has been known for some time 
that leukaemia inhibitory factor and its related family members namely oncostatin M, 
interleukin-6 and ciliary neurotrophic factor are key cytokines for the maintenance of 
murine embryonic stem cell lines (Piquet-Pellorce et al., 1994; Yoshida et al., 1994), 
whereas they do not appear to function in human embryonic stem cell lines (Thomson 
and Marshall, 1998). Thus, some of the challenges in establishing embryonic stem cell 
lines may be reflected in the differences identified in cytokine requirements for the 
maintenance of undifferentiated murine and human embryonic stem cells. In previous 
report, they found that the bovine inner cell mass and its primary outgrowths do have 
the leukaemia inhibitory factor receptor and gp130 signal transducer (Pant and Keefer, 
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2006). The maintenance of pluripotency is probably the most critical problem to be 
solved in establishing embryonic stem cell lines and should be the major focus of 
current and future research. Identification of functional pathways in ruminant 
embryonic cells will help determine what cytokines are beneficial and which may be 
inhibiting the establishment of true embryonic stem cells.  
 
2.8.3 Mouse Embryonic Fibroblast (MEF) 
Mouse embryonic fibroblast have been used reliably as feeder cell layer for murine 
embryonic stem cells since the early 1980s when the first murine embryonic stem cell 
lines were being derived and cultivated (Puck et al., 1956). Feeder cell layer are usually 
used in culturing embryonic stem cells to maintain their undifferentiated and pluripotent 
status. Mouse embryonic fibroblast serve as feeder cell layer in embryonic stem cell 
culture (Evans and Kaufman, 1981; Thomson et al., 1998; Smith, 2001; Turksen, 2002). 
Williams et al. (1988) reported that one of the substances released by mouse embryonic 
fibroblast that inhibit the differentiation of embryonic stem cells is leukaemia inhibitory 
factor. The first published derivation of human embryonic stem cells used mouse 
embryonic fibroblast as feeder cell layer, and many laboratories continue to use them 
routinely for long-term human embryonic stem cell culture. Mouse embryonic 
fibroblast are primary cells derived from days 12.5–14.5 foetuses. It is primary cells that 
do not continue to proliferate indefinitely. Once the cells begin to senesce they seem to 
lose their capacity to support undifferentiated growth and proliferation of human 
embryonic stem cells. So, usually mouse embryonic fibroblast is used optimally 
between Passages 1 to 3. Process of preparation mouse embryonic fibroblast to be 
repeated only occasionally which usually large batches are made, tested, and 
cryopreserved. It is important that mouse embryonic fibroblast are mitotically 
inactivated before being co-cultured with murine or human embryonic stem cells, or the 
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mouse embryonic fibroblast will become a growing contaminant cell type that is 
difficult to remove. There are 2 common ways of inactivating mouse embryonic 
fibroblast: irradiation and mitomycin C (MTC) treatment. The cells can be 
cryopreserved either before or after mitotic inactivation. Embryonic stem cells are 
usually grown on a layer of mitotically inactivated primary mouse embryonic fibroblast 
to promote growth and prevent differentiation. These cells stop dividing after a couple 
of passages, so embryonic fibroblast need to be isolated freshly from time to time. To 
avoid isolation at time to time we need to be preserve them safely. Mouse embryonic 
fibroblast cells are isolated from murine embryos at day 14 of gestation as described by 
Robertson (1987). The specific role of mouse embryonic fibroblast in prolonging 
embryonic stem cell culture is less clear. It is generally known that mouse embryonic 
fibroblast provides a befitting environment for the interplay of signaling networks that 
regulate the fate of embryonic stem cells (Xu et al., 2001; Lim and Bodnar, 2002). 
However, the feeder cell layer of xenogeneic or allogeneic origin make it possible to 
introduce inter-and intra-species transfer of pathogens (Odorico et al., 2001; Richards et 
al., 2002). In addition, the use of mouse embryonic fibroblast as feeders has other 
disadvantages, including a limited performance window that is optimal only between 
the 4th and 6th passages, so it is necessary to repeatedly sacrifice murine foetuses 
(Odorico et al., 2001; Richards et al., 2002; Stojkovic et al., 2005). To avoid these 
issues, recently some investigators have successfully established novel feeder systems 
that were derived from human embryonic stem cells themselves (Stojkovic et al., 2005; 
Wang et al., 2005; Yoo et al., 2005). However, a correlative study about deriving 
feeders from murine embryonic stem cells has not been reported.  
Historically, embryonic stem cells have been cultured under a variety of 
conditions to prevent differentiation (Wurst and Joyner, 1993). The most common 
method utilises feeder layers prepared from mouse embryo fibroblast or from SIM 
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mouse embryo fibroblast (STO cells) resistant to thioguanine and oubain (Martin and 
Evans, 1975; Hogan et al., 1994). The advantage of mouse embryonic fibroblast is that 
they provide a more consistent source of feeder cells. Early passage cells with 
reproducible characteristics must be used because they rapidly lose their ability to 
divide. Long-term propagation of STO cells can lead to changes that result in 
characteristics that are less favorable for embryonic stem cell growth. Because of these 
potential problems, researchers who are new to embryonic stem cell culture and who 
wish to generate embryonic stem cell clones capable of germline transmission will 
probably have more success with primary mouse embryonic fibroblasts. Mouse 
embryonic fibroblast cells form intercellular junctions such as gap junctions, adherens 
junctions and tight junctions with the embryonic stem cell culture (Ehmann et al., 
1998). Therefore, Ehmann et al. (1998) reported that the mouse embryonic fibroblasts 
providing physical support to assist in the attachment of the embryonic stem cells. 
Furthermore, mouse embryonic fibroblasts also secrete factors such as fibroblast growth 
factors (FGF) (Shimoaka et al., 2002) and anti-apoptotic factors (Tseng et al., 1996) 
that support the clonal growth and expansion of the embryonic stem cell culture. Mouse 
emberyonic fibrolbast cells will provide certain nutrients which not found in the 
medium (Fisher and Puck, 1956). The mouse embryonic fibroblast as feeder cell layer 
as well as providing growth factors to support the embryonic stem cell culture. Mouse 
embryonic fibroblast cells also function in the removal of toxicants from the culture 
medium (Rajabalian et al., 2003). In 1972, Evans described the use of chick embryonic 
fibroblast as feeder cell layer for culture of embryonic carcinoma cells. Martin and 
Evans (1975) used a type of mouse embryonic fibroblast called STO cell lines to 
replace the use of chick fibroblast as feeder cell layer. Later, they were also used for 
murine embryonic stem cells culture (Evans and Kaufman, 1981; Martin, 1981).  
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2.8.4 Signaling Pathway in Embryonic Stem Cells 
There are numerous defined and undefined signaling pathways involved in proliferation 
and self-renewal embryonic stem cells such as leukaemia inhibitory factor receptor–
STAT3 (LIF-STAT), Wnt and bone morphogenetic proteins (BMP) signaling pathway. 
It is even more difficult to understand the cascade of control since the signal 
transductions are able to cross talk among other pathways. Therefore, the Wnt and bone 
morphogenetic proteins pathway is an ongoing effort. Only the leukaemia inhibitory 
factor receptor–STAT3 pathway has been defined in detail.  
 
2.8.4.1 Leukaemia inhibitory factor (LIF) receptor (LIFR) – STAT3 pathway  
Leukaemia inhibitory factor is also known as differentiation inhibitory factor (DIA). It 
secreted cytokine to inhibit the spontaneous differentiation of embryonic stem cells 
(Smith et al., 1988; Willium et al., 1988). Activation of the STAT3 pathway on 
engagement of the leukaemia inhibitory factor receptor is essential for embryonic stem 
cell self-renewal, and indeed under certain experimental systems STAT3 signalling 
seems to be sufficient for self-renewal (Matsuda et al., 1999). Recruitment and 
activation of STAT3 on engagement of the leukaemia inhibitory factor receptor is 
necessary for self-renewal of embryonic stem cells as interference in this process 
inhibits embryonic stem cell self-renewal (Niwa et al., 1998; Ernst et al., 1999). 
Leukaemia inhibitory factor bind with 2 part receptor complex, namely leukaemia 
inhibitory factor receptor and the glycoprotein-130 receptor. With this binding of 
leukaemia inhibitory factor will triggers the activation of the latent transcription factor 
STAT3 where in a necessary the continued proliferation of embryonic stem cells in 
vitro (Niwa et al., 1998; Burdon et al., 1999; Matsuda et al., 1999). The function of 
leukaemia inhibitory factor by binding to leukaemia inhibitory factor receptor at the cell 
surface, which causes it to heterodimerise with another transmembrane protein called 
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glycoprotein-130 (gp130). The dimerisation of STAT3 proteins will move into nucleus 
and activated the DNA for self-renewal. Besides that, the self-renewal of embryonic 
stem cells also influenced by SHP-2 and extracellular regulated kinase (ERK) activity. 
SHP-2 is a tyrosine phosphatase, an enzyme that removes phosphate groups to the 
tyrosine residues of various proteins and it interacts with the intracellular (amino 
terminus) domain of the gp130 receptor. The protein tyrosine phosphatase SHP-2 is 
recruited to the receptor where it associates with Gab1. This promotes the activation of 
Ras which initiates a cascade of transphosphorylations involving Raf and MAPK kinase 
(MEK) kinases resulting in the activation of extracellular regulated kinase (Takahashi-
Tezula et al., 1998; Kolch, 2000). SHP-2 modulates embryonic stem cell self-renewal 
and differentiation via bi-directional regulation of the extracellular regulated kinase and 
STAT3 pathways. Extracellular regulated kinase is one kind of enzymes that become 
activated when the glycoprotein-130 receptor and other cell-surface receptors are 
stimulated. Extracellular regulated kinase can phosphorylate cytoplasmic proteins and 
be translocated to the nucleus where they can modulate the activities of transcriptional 
regulators. In embryonic stem cells, activation of this pathway on stimulation of the 
leukaemia inhibitory factor receptor is a pro-differentiation signal rather than 
contributing to self-renewal (Cheng et al., 1998; Burdon et al., 1999). Therefore, the 
addition of MEK inhibitors to growth medium can promote self-renewal by preventing 
the activation of this pathway leading to enhanced STAT3 signaling. Both extracellular 
regulated kinase and SHP-2 are components of a signal-transduction pathway that 
counteracts the proliferative effects of STAT3 activation (Figure 2.3). Therefore, if 
extracellular regulated kinase and SHP-2 are active, they inhibit embryonic stem cell 
self-renewal (Burdon et al., 1999). The STAT3 pathway is active in many cell types 
other than embryonic stem cells; embryos deficient in the LIF/STAT3 pathway develop 
normal inner cell mass; some murine embryonic stem cell lines do not require 
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leukaemia inhibitory factor, yet can still self-renew (Berger and Strum, 1997; Dani et 
al., 1998). This suggests that there is an underlying feature of embryonic stem cells that 
determines the embryonic stem cell phenotype that is independent of the STAT3 
pathway (Figures 2.3 and 2.4). 
 
 
Figure 2.3: LIF–STAT3 signaling pathway control embryonic stem cells self renewal as  
                   well as in the mean time, it could inhibit extracellular regulated kinase  
                   (ERK) signaling which usually induce the differentiation of cell (Burdon et  
                   al., 1999).  
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Figure 2.4: LIF-STAT3 signaling pathway control embryonic stem cells self renewal  
                    whereas extracellular regulated kinase (ERK) signaling which induce the  
                    differentiation of cell (Burdon et al., 1999).  
 
 
2.8.4.2 Wnt signaling in embryonic stem cells  
Activation of Wnt signal transduction pathways upon ligand binding can regulate 
diverse processes including cell proliferation, migration, polarity, differentiation and 
axon outgrowth. According to Cadigan and Nusse (1997), Wnt proteins are very 
important regulators of cell proliferation and differentiation. Wnt molecules will secrete 
lipid modified signaling proteins that bind to Frizzed receptors in the cell surface 
(Figure 2.4). Wnt signaling pathways involves proteins that directly participate in both 
cell adhesion and gene transcription. Several cytoplasmic components transduce the 
signal to beta-catenin, which enter the nucleus and forms a complex with a high 
mobility group (HMG) box containing DNA binding protein such as TCF (T cell factor) 
and lymphoid enhancer factor (LEF). The beta-catenin is a central player of the 
canonical Wnt signaling pathway, which is degraded in the absence of Wnt in 
cytoplasm.  
In the presence of Wnt signaling, Dishevelled (Dsh) becomes activated which 
leads to the uncoupling of beta-catenin from the degradation pathway by inhibition of 
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GSK-3beta activity. This caused the accumulation of beta-catenin, which enters the 
nucleus and interacts with partners such as TCF or LEF. Therefore, stabilisation of beta-
catenin and its accumulation in the cytoplasm is a crucial step in canonical Wnt 
dependent target gene expression (Eisenmann, 2005; Paratore and Sommer, 2006). 
Currently, Miyabayashi et al. (2007) reported that Wnt/beta-catenin has been 
considered to maintain long-term pluripotency state of embryonic stem cells. The large-
scale gene expression profiling studies of undifferentiated murine and human 
embryonic stem cells found that the main components of the canonical Wnt signaling 
pathways are expressed (Aubert et al., 2002; Sato et al., 2003) and the activation of Wnt 
signaling pathway could inhibit embryonic stem cells from being differentiated. Recent 
studies have been showed that activation of Wnt signaling pathway using either a 
specific pharmacological inhibitor of glycogen synthase kinase 3 (GSK03), 6-
bromoindirubin-3-oxime (BIO), (Sato et al., 2005) or a small molecule, IQ 1, 
(Miyabayashi et al., 2007) or a purine derivative, QS11, (Zhang et al., 2007) is 
sufficient to maintain embryonic stem cell at undifferentiated state of by working 
through different down stream targets of Wnt signaling pathway (Figure 2.5).  
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Figure 2.5: A canonical Wnt signaling pathway. Eisenmann (2005) described the Wnt  
                   mechanism where without a signal, action of the destruction complex (CKIα,  
                   GSK3β, APC, Axin) creates a hyperphosphorylated β-catenin, which is a  
                   target for ubiqitination and degradation by the proteosome. Wnt ligand bind  
                   to a Frizzled receptor complex leads to stabilisation of hypophosphorylated  
                   β-catenin, which interacts with TCF or LEF proteins in the nucleus to  
                   activate transcription. 
 
2.8.4.3 Bone morphogenetic proteins (BMP) signaling in embryonic stem cells  
Leukaemia inhibitory factor alone is insufficient to prevent murine embryonic stem 
cells from differentiating into other cell types and also not sufficient to support self-
renewal of human embryonic stem cell. Bone morphogenetic proteins might support 
embryonic stem cell self-renewal especially in serum-free culture environment. Ying 
and colleagues (2003) and Qi and colleagues (2004) reported that the combination of 
bone morphogenetic proteins (BMP) and leukaemia inhibitory factor is sufficient to 
support the self-renewal of murine embryonic stem cells. The effects of bone 
morphogenetic proteins on embryonic stem cells involve induction of inhibitor of 
differentiation (Id) proteins, and inhibition of extracellular receptor kinase and p38 
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mitogen-activated protein kinases (MAPK). Bone morphogenetic proteins initiate 
signalling from the cell surface by interacting with heterodimers of type I and type II 
serine-threonine receptors (Canalis et al., 2003). In embryonic stem cells the 2 signaling 
pathways initiated by leukaemia inhibitory factor and bone morphogenetic proteins act 
in combination and are highly controlled in order to sustain self-renewal. Cytoplasmic 
proteins called Smads are activated by phosphorylation, form heterodimers with Smad 4 
and are translocated to the nucleus where they inhibit or activate target genes. 
According to Ying et al. (2003), bone morphogenetic proteins 4 has no direct effect on 
STAT3 signalling and it inhibit the extracellular regulated kinase pathway. The bone 
morphogenetic proteins signaling is parallel pathway to LIF/STAT3. According to Ying 
et al. (2003), bone morphogenetic proteins 4, transcripts for types I and II serine–
threonine and GDF6 are found are found in undifferentiated embryonic stem cells. 
Inhibitor of differentiation (Id) genes encode negative bHLH (basic helix–loop–helix) 
factors and these proteins bind to ubiquitous helix–loop–helix (HLH) factors, the E 
proteins (Norton, 2000). The inhibitor differentiation proteins were shown to be the 
factors that directly involved in self-renewal as expression of Id1, Id2 or Id3 in the 
absence of bone morphogenetic proteins caused the cells to grow as well as when 
cultured with leukaemia inhibitory factor and bone morphogenetic proteins. It was also 
seen that serum induces inhibitor differentiation gene expression in embryonic stem 
cells (Ying et al., 2003). Therefore, the inhibitor differentiation proteins may act in an 
antidifferentiation manner by sequestering E proteins which normally partner pro-neural 
basic helix–loop–helix factors, such as Mash-1 which is expressed in embryonic stem 
cells (Jen et al., 1992; Ying et al., 2003). Bone morphogenetic proteins were chosen as 
it is an anti-neural factor in embryos. As embryonic stem cells grown without serum 
develop spontaneously into neural phenotypes (Ying et al., 2003) it was thought that an 
anti-neurogenic factor may play a role in maintaining the self-renewal phenotype. When 
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embryonic stem cells are cultured in bone morphogenetic proteins containing media in 
the absence of leukaemia inhibitory factor, the embryonic stem cells differentiate into 
mesoderm and hematopoietic cells (Johansson and Wiles, 1995; Ying et al., 2003). 
However, in conjunction with leukaemia inhibitory factor, bone morphogenetic proteins 
4 or GDF6 acts to maintain pluripotency. The balance of those pathways to remain in a 
self-renewal state is needed since there are several signaling pathways which involved 
for maintaining embryonic stem cell in pluripotency state. Embryonic stem cells might 
begin to differentiate if the balance shifts (Figure 2.6). 
 
 
 
Figure 2.6: Bone morphogenetic proteins binds to bone morphogenetic proteins receptor  
                  type II (BMP-RII) that in turn activities bone morphogenetic proteins-RI  
                  (Ying et al., 2003; Qi et al., 2004). 
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2.8.4.4 Interaction between leukaemia inhibitory factor receptor (LIFR)-STAT3  
             and bone morphogenetic proteins signaling pathways 
 
Similar to the situation of activation of the leukaemia inhibitory factor receptor, bone 
morphogenetic proteins binding with bone morphogenetic proteins receptor (BMPR) 
can activate both pro-self-renewal pathways, for example, inhibitor of differentiation 
gene activity and inhibitory pathways for self-renewal (for example, mitogen-activated 
protein kinases pathway). Thus, a balance may exist between STAT3 activation, SMAD 
activation and mitogen-activated protein kinases activity on stimulation of the 
respective receptors. Bone morphogenetic proteins acting through the SMAD pathway 
inhibits neurectoderm differentiation of embryonic stem cells, whilst leukaemia 
inhibitory factor activation of the STAT3 pathway blocks the bone morphogenetic 
proteins-induced endoderm and mesoderm differentiation that would occur in the 
absence of leukaemia inhibitory factor. Concomitant leukaemia inhibitory factor and 
bone morphogenetic proteins signalling through STAT3 and SMAD activation, helps to 
maintain pluripotency within the embryonic stem cell population. Interacting pathway 
between SMAD and STAT3 via formation of a tertiary complex between SMAD, 
STAT3, and the transcription factor p300, has been identified in neuroepithelial cells 
which reported by Nakashima et al. (1999). Ying et al. (2003) published data which 
showed that embryonic stem cells could be derived and maintained, even from single 
cells, in a serum-free medium supplemented with leukaemia inhibitory factor and bone 
morphogenic protein such as bone morphogenic protein 4 (Figure 2.7).  
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Figure 2.7: Interaction between luekaemia inhibitory factor receptor-STAT3 and bone  
                    morphogenetic proteins signaling pathways in controlling the self-renewal  
                    and maintaining the undifferentiated of embryonic stem cells (Boiani and  
                    Scholer, 2005).  
 
 
2.8.4.5 The mitogen-activated protein kinase (MAPK)  
Binetruy et al. (2007) reported that the mitogen-activated protein kinase family consist 
of mitogen-activated protein kinase 2 (MAPK2); extracellular regulated kinase 
5(ERK5); c-Jun amino terminal kinases (JNK) 1, 2 and 3 as well as P38 mitogen-
activated protein kinase (P38 MAPK) α, β, δ and γ, where each isoform is encoded by 
its own gene. The extracellular regulated kinase 1 or 2 (ERK1/2), c-Jun amino terminal 
kinases and P38 mitogen-activated protein kinase pathway were the most studied in 
stem cell research among the mitogen-activated protein kinase family (Binetruy et al., 
2007). Besides involved in regulating apoptotic process, these kinases are important 
regulators of the proliferation and differentiation of the embryonic stem cells. Chung et 
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al. (2006) reported that the MEK-1 (I) has been used for deriving murine embryonic 
stem cells from embryonic blastomere, which was co-cultured with established murine 
embryonic stem cell. There are several mitogen-activated protein kinase inhibitors have 
been investigated for their roles in early embryo development, for example, MEK-1 (I) 
(Paliga et al., 2005; Chung et al., 2006) and P38 mitogen-activated protein kinase (I) 
(Natale et al., 2004; Maekawa et al., 2005; Paliga et al., 2005; Madan et al., 2006). 
Embryonic stem cell lines have been successfully established, but the role of MEK-1 (I) 
and embryonic stem cells co-culture on single blastomere development has not yet been 
determined. Maekawa et al. (2005) reported that P38 mitogen-activated protein kinase 
(I) has shown to have inhibiting effect on the development of trophectoderm cells in 
murine morula stage embryos, which may enhance the development toward the inner 
cell mass fate while trophectoderm is being suppressed.  
 
 
2.8.4.6 Adrenocorticotropic hormone (ACTH) on embryonic stem cell  
            establishment  
 
Adrenocorticotropic hormone also known as corticotropin is a polypeptide hormone 
secreted and produced by the pituitary gland. Adrenocorticotropic hormone is also 
generates several other hormones in the pituitary gland such as proopiomelanocortin 
(POMC) (Bowen, 1998). Adrenocorticotropic hormone could induce the adenylyl 
cyclase (AC) activity (Dhanasekaran and colleagues, 1998). When the adenylyl cyclase 
activity is high, the cAMP level will also high since adenylyl cyclase converse ATP to 
cAMP. Currently, Faherty and colleagues (2007) studied about the role of cAMP/PKA 
pathway on murine embryonic stem cell self renewal where they suggested that using 
the forskolin, the adenylate cyclase agonist, could increase cAMP level. Therefore, high 
cAMP level could induce the embryonic stem cell self renewal but only if the culture 
medium did not supplemented with leulaemia inhibitory factor and foetal bovine serum 
(FBS).  
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2.9 EXPRESSION OF MARKERS IN UNDIFFERENTIATED, PLURIPOTENT  
       CELLS OF EMBRYONIC STEM CELLS 
Recently, stem cells have become the subject of extensive investigation where partly 
due to their therapeutic potential and because stem cells raise several fundamental 
issues concerning the regulation of proliferation and differentiation. Five widely 
adopted antibody markers, anti-Oct 4, anti-Sox 2, anti-SSEA 3, anti-TRA-1-60 and anti-
TRA-1-81, are the protein marker that usually found on embryonic stem cells. Several 
transcription factors, including Oct 3/4 (Nichols et al., 1998; Niwa and Smith, 2000), 
Sox 2 (Avilion et al., 2003), and Nanog (Chambers et al., 2003; Mitsui et al., 2003), 
function in the maintenance of pluripotency in both early embryos and embryonic stem 
cells. Several genes that are frequently upregulated in tumors, such as STAT3 (Matsuda 
et al., 1999; Niwa et al., 1998), E-Ras (Takahashi et al., 2003), c-myc (Cartwright et 
al., 2005), Klf4 (Li et al., 2005), and beta-catenin (Kielman et al., 2002; Sato et al., 
2004), have been shown to contribute to the long term maintenance of the embrtonic 
stem cell phenotype and the rapid proliferation of embryonic stem cells in culture. In 
addition, it has been identified several other genes that are specifically expressed in 
embryonic stem cells (Maruyama et al., 2005; Mitsui et al., 2003). Oct 4 and Sox 2 are 
transcription factors highly expressed in undifferentiated embryonic stem cells and 
embryonic germ cells (Looijenga et al., 2003; Masui and Shinji, 2007; Zhao and Daley, 
2008). Embryonic stem cells are continuous proliferating stem cell lines of embryonic 
origin first isolated from the inner cell mass. Two distinguishing features of embryonic 
stem cells are their ability to be maintained indefinitely in an undifferentiated state and 
their potential to develop into any cell within the body. Based on previous methods 
developed for murine embryonic stem cells, human embryonic stem cell lines were first 
established by Thomson and Marshal (1981). Like murine embryonic stem cells, human 
embryonic stem cells express high levels of membrane alkaline phosphatase (AP) and 
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Oct 4, a transcriptional factor critical to inner cells mass and germline formation. 
However, unlike murine embryonic stem cells, human embryonic stem cells do not 
express stage-specific embryonic antigen (SSEA 1). In addition, prolonged propagation 
of human embryonic stem cells is typically achieved by co-culture with primary mouse 
embryonic fibroblasts serving as feeder cells. Human embryonic stem cell lines are not 
able to maintain their undifferentiated state in the absence of supporting feeder layer 
cells, even when exogenous cytokines such as leukemia inhibitory factor and gelatin-
coated plates are used.  
The undifferentiated state of embryonic stem cells can be characterised by high 
level of expression of alkaline phosphatase (AP) (Pease et al., 1990), the expression 
surface markers including SSEA and TRA antigens and the transcription factor Octamer 
4 (Oct 4). Undifferentiated state of the embryonic stem cells will express high level of 
the POU transcription factor Oct 4 (Pesce et al., 1998a). This relationship between Oct 
4 and plurioptency has seen this transcription factor emerge as a marker of pluripotent 
stem cells. Undifferentiated murine and human pluripotent embryonic stem cells and 
embryonic carcinoma cells express Oct 4. Additionally, murine embryonic germ cells 
also known to express Oct 4. Following stem cell differentiation, the level of Oct 4 
expression decreases. However, the Oct 4 protein itself is insufficient to maintain 
embryonic stem cells in the undifferentiated state. Few years later, Chamber and 
colleagues (2003) and Mitsui and colleagues (2003) identified another transcription 
factor, Nanog, that is essential for the maintenance of the undifferentiated state of 
mouse embryonic stem cells. The expression of Nanog decreased rapidly if murine 
embryonic stem cells differentiated. Cooperative interaction between Oct 4 and Sox 2 
forms a heterodimer. This synergistic interaction between the 2 drives transcription of 
target genes such as Nanog which is a transcription factor that functions in maintaining 
the pluripotent cells of the inner cell mass and in deriving embryonic stem cells from 
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these cells (Rodda et al., 2005). So, the set of Oct 4, Sox 2 and Nanog expression is 
considered as transcription factors involved in maintaining the pluripotent embryonic 
stem cell phenotype.  
Pluripotent embryonic stem cells can be characterised by high level expression 
of Oct 3/4, (also termed Oct 3 or Oct 4) a member of the POU transcription factors, and 
Nanog. A critical amount of Oct 3/4 and Nanog expression is required to sustain stem 
cell pluripotency. When embryonic stem cells are induced to differentiate, Oct 3/4 and 
Nanog are down-regulated, which has proven to be essential for a proper and divergent 
developmental program (Solter and Knowles, 1978; Smith et al., 1988; Pease et al., 
1990; Shamblott  et al., 1998; Thomson and Marshall, 1998). Pluripotent stem cells can 
also be characterised by the expression of a number of cell surface antigens. SSEA 1, a 
carbohydrate antigen, is a fucosylated derivative of type-2 polyactosamine and appears 
during late cleavage stages of murine embryos. It is strongly expressed by 
undifferentiated, murine embryonic stem cells (Solter et al., 1978; Gooi et al., 1981). 
Undifferentiated, human embryonic stem cells also express the keratin sulphate-
associated antigen, TRA-1-60 and TRA-1-81 (Andrews et al., 1984; Banting et al., 
1984).   
 
 
2.9.1 Octamer 4 (Oct 4) 
In embryonic stem cells, a critical level of expression of Oct 4 is essential and important 
in maintaining embryonic stem cell renewal (Niwa and Smith, 2000). Less than a 2 fold 
increase causes embryonic stem cells to differentiate into mesoderm or endoderm, while 
reduction to less than 50% expression levels causes differentiation into trophectoderm. 
A classical marker of undifferentiated embryonic stem cells is expression of the POU 
class transcription factor Oct 4 gene. Oct 4 is very essential for embryo development 
throughout blastocyst stage (Nichols et al., 1998). Its expression is restricted to 
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totipotent and pluripotent cells of the mouse (Pesce et al., 1998a) and is down-regulated 
in the majority of adult tissue excluding the germ line (Teom et al., 1996). Normally, 
Oct 4 is express in all blastomeres up to morula stage then Oct 4 expression is more 
restricted in inner cell mass cells and very low express in trophectoderm cells. The 
establishment of embryonic stem cells in domestic species is the capability to identify 
truly pluripotent cells are limited. Henderson et al. (2002) reported that stem cell 
marker gene expression is generally limited to the inner cell mass and is not observed in 
the trophectoderm in murine and human blastocyts. Hence, the best approach is to use a 
panel of markers because any one marker may not be truly definitive. In the past, 
researchers have depended on only a few markers, such as Oct 4 (POU5F1), a single 
stage-specific embryonic antigen (for example, SSEA 1) or alkaline phosphatase (AP), 
without a clear understanding of the expression of these gene markers in embryos of 
different species. By using alone of the marker may not be sufficient as they are not 
specific to the inner cell mass in ungulates. As an example, different laboratories have 
now shown that Oct 4 protein is expressed in both the inner cell mass and 
trophectoderm of ungulates, such as porcine, bovine and caprine (van Eijk et al., 1999; 
Kirchhof et al., 2000; He et al., 2004). He et al. (2006) found that SSEA 1 and SSEA 4 
genes are expressed by both inner cell mass and trophectoderm of caprine embryos. 
Similarly, the alkaline phosphatase gene appears to be expressed at different times by 
either epiblast or trophectoderm (Talbot et al., 1995; Vejlsted et al., 2005). Therefore, 
these markers should be considered characteristic of embryonic stem cells, but may not 
be used as definitive markers. Depending on the study, comparisons were made 
between either differentiated versus undifferentiated embryonic stem cells, murine 
versus human embryonic stem cells, or adult compared with embryonic stem cells 
(Bhattacharya et al., 2004; Ginis et al., 2004; Wei et al., 2005). By using microarrays, 
Sperger et al. (2003) showed the genes POU5F1 (Oct 4) and FLJ10713 (a homolog 
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highly expressed in murine embryonic stem cells) (Ramalho-Santos et al., 2002) are 
highly expressed in both the pluripotential human embryonic stem cell and embryonal 
carcinoma cells in seminomas. Apart from being a marker, Oct 4 is a key factor that 
regulates self-renewal of embryonic stem cells. Nichols et al. (1998) showed by 
targeted gene deletion the role of Oct 4 in vivo is to establish the pluripotent nature of 
cells within the inner cell mass. Oct 4 is not a direct target gene of STAT3 and therefore 
its expression is not directly regulated by leukaemia inhibitory factor. When Oct 4 is 
constitutively expressed within embryonic stem cells it does not prevent differentiation 
of embryonic stem cell induced by leukaemia inhibitory factor withdrawal (Niwa et al., 
2000). Therefore, expression of Oct 4 alone is not sufficient to maintain pluripotency, 
but rather also needs the cytokine-induced action of STAT3. Oct 4 is thought to 
function in several ways within embryonic stem cells. If Oct 4 expression is inhibited in 
cultured embryonic stem cells, the cells generate trophectoderm (Niwa and Smith, 2005) 
whereas Oct 4 expression level is artificially increased, embryonic stem cells would 
differentiate into primitive endoderm and mesoderm. Therefore, the level of Oct 4 
expression dictates a significant aspect of the developmental program of embryonic 
stem cell. Oct 4 can also repress or active other target genes by cooperating with various 
transcriptional co-factors. Sry-related factor Sox 2 (Avillion et al., 2003) and the 
Forkhead Box family member, FoxD3 are the 2 co-factors thought to play a key role in 
self-renewal (Hanna et al., 2002). Both co-factors cooperatively function with Oct 4 
(Guo et al., 2002; Yuan et al.,1995). Oct 4 transcription factor has been used as one of 
the pluripotency markers in embryonic stem cells (Hay et al., 2004). Recent knowledge 
about mechanism of Oct 4 to maintain pluripotent state is not yet been clearly identified 
but it is possible that some of the components of signaling pathways in cultured mouse 
embryonic stem cells such as adaptor protein, Gab1, may suppress interactions of 
specific receptors to the Ras-ERK signaling pathway. Furthermore, the expression of 
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this altered form of Gab1 may be promoted by the transcription factor Oct 4. In murine 
embryonic stem cells, Oct 4 expression and increased synthesis of Gab1 may help 
suppress induction of differentiation by suppress extracellular regulated kinase down 
stream signaling pathway result in the inhibition of differentiate. 
 
2.9.2 Nanog 
Nanog usually detected in the morula stage, inner cell mass and early germ cells and in 
the proximal epiblast in the region of the presumptive primitive streak (Mitsui et al., 
2003; Hart et al., 2004). It is expressed slightly later than Oct 4 during murine 
ontogeny. Nanog plays a role at the second stage when the primitive endoderm is 
formed. Nanog is specially expressed in embryonic stem cells, embryonic carcinoma 
cells and embryonic germ cells, but is not expressed in hematopoietic stem cells, adult 
tissues or differentiated cells (Chambers et al., 2003; Mitsui et al., 2003). During 
development in Nanog-deficient murine, the cells of the inner cell mass spontaneously 
differentiate into visceral and parietal endoderm (Mitsui et al., 2003). Oct 4 and Nanog 
act together during embryonic stem cell self-renewal with Nanog being downstream of 
Oct 4. Nanog does appear to be a specific marker of pluripotency for ruminants because 
Nanog mRNA and protein are found in the inner cell mass and strongly down-regulated 
in the trophectoderm of caprine blastocysts (He et al., 2005; 2006). Chambers et al. 
(2003) and Mitsui et al. (2003) described a divergent homeobox transcription factor; 
Nanog, which promotes embryonic stem cell self-renewal, pluripotency and epiblast 
formation. According to Chambers et al. (2003), Nanog and STAT3 signalling are not 
directly related. However, when leukaemia inhibitory factor was added to Nanog 
overexpressing cells it enhanced their proliferation. Thus self-renewal via the Nanog 
pathway acts in a STAT3 independent manner. 
 
 78 
 
2.9.3 Sox 2 
Sox 2 is a member of the Sox gene family that encode transcription factors with a single 
high mobility group (chromosomal proteins where known nuclear proteins
 
which 
specifically bind to the nucleosome core particle and are implicated
 
in the generation 
and/or maintenance of structural features specific to
 
active chromatin) DNA-binding 
domain. Several lines of evidence indicate that Sox 2 may act to maintain or preserve 
developmental potential. For example, Sox 2 expression is associated with uncommitted 
dividing stem and precursor cells of the developing central nervous system (CNS) and 
indeed can be used to isolate such cells (Li et al., 1998; Zappone et al., 2000). Avilion 
et al. (2003) reported that Sox 2 is highly expressed in embryonic stem cells and is 
essential in pluripotentiality. Sox 2 belongs to the Sox B1 subgroup, which also 
includes Sox 1 and Sox 3, based on homology within and outside the HMG box 
(Kamachi et al., 2000). Sox 2 also marks the pluripotent lineage of the early murine 
embryo, so that like Oct 4 it is expressed in the inner cell mass, epiblast, and germ cells. 
Sox 2 was found in the inner cell mass at blastocyst stages, in which the protein was 
primarily nuclear as shown by antibody staining on isolated inner cell mass. The intact 
blastocysts also revealed the presence of Sox 2 in trophectoderm, but here the protein 
was only cytoplasmic. Oct 4 was seen in the layer of cells adjacent to the blastocoel, 
presumed to be primitive endoderm (Palmieri et al., 1994; Nichols et al., 1998), and 
absent from trophectoderm, unlike Sox 2. This suggests parallel roles for the 2 factors in 
the maintenance of pluripotentiality (Pesce and Scholer, 2000). The phenotypic 
consequences of the targeted disruption of Oct 4 reveal that it is required for the first 
cell fate decision, as all mutant inner cell mass cells are diverted to a trophectoderm fate 
(Nichols et al., 1998). The zygotic Sox 2 expression is also required for the inner cell 
mass/epiblast lineage, but this is not revealed until after implantation, presumably when 
maternal Sox 2 protein becomes diluted out through the rapid growth of the embryo. In 
 79 
 
the absence of Sox 2, there is no equivalent rapidly proliferating cell population, the 
only surviving cells being trophoblast giant cells. Alternatively, Sox 2 could be essential 
for epiblast cell identity, and in its absence the cells could differentiate into another cell 
type.  
 
2.9.4 Stage-specific embryonic antigen (SSEA 1, SSEA 2, SSEA 3 and SSEA 4) 
There are several types of stage-specific embryonic antigen (SSEA) that found in 
pluripotent of embryonic stem cells, namely SSEA 1, SSEA 3 and SSEA 4. SSEA 1 is a 
globoseries carbohydrate antigen present on the surface of murine embryonic stem cells, 
but not human embryonic stem cells (Kohji et al., 2008). It was localised on the stem 
cells of differentiating solid teratocarcinomas and on the surface of core cells of solid 
embryoid bodies. At the egg cylinder stage the antigen is restricted to embryonic 
ectoderm and visceral endoderm. During subsequent development, SSEA 1 becomes 
localised to portions of the brain and primordial germ cells. In adult murine, the 
epithelium of the oviduct, the endometrium, and the epididymis are the cells most 
reactive with the monoclonal antibody to SSEA 1; although some areas of the brain and 
kidney tubules are weakly positive. SSEA 3 and SSEA 4 is a globoseries carbohydrate 
antigen present on the surface of human embryonic stem cell, but not murine embryonic 
stem cell (Solter and Knowles, 1978; Przyborski, 2001). Upon differentiation, murine 
embryonic stem cells are characterised by the loss of SSEA 1 expression and may be 
accompanied, in same instances, by the appearance of SSEA 3 and SSEA 4 (Solter et 
al., 1979). In contrast, human embryonic stem cells and embryonic carcinoma cells 
typically express SSEA 3 and SSEA 4 but not SSEA 1, while their differentiation is 
characterised by down regulation of SSEA 3 and SSEA 4 and an up regulation of SSEA 
1 (Andrews 1984; Andrews et al., 1987; Fenderson et al., 1987).  
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2.9.5 Alkaline phosphatase (AP) 
Alkaline phosphatase is a stem cell membrane marker. Elevated expression of alkaline 
phosphatase is associated with pluripotent status (Thomson et al., 1998). Alkaline 
Phosphatase is an enzyme in the blood, intestines, liver, and bone cells and exists as 
membrane-bound isoforms of glycoproteins sharing a common protein structure but 
differing in carbohydrate content. These enzymes are most active at alkaline pH-hence 
the name (Thomson et al., 1998). Undifferentiated human embryonic stem cells, 
embryonic carcinoma cells and embryonic germ cells have been shown to express a 
very high level of the liver/bone/kidney isozyme of alkaline phosphatase (Millan and 
Fishman, 1996; Thomson et al., 1995; Shamblott et al., 1998; Draper et al., 2004). 
Expression levels of alkaline phosphatase decrease following stem cell differentiation. 
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2.10 TIMELINE OF EMBRYONIC STEM CELLS 
 
 
Table 2.3 shows the timeline of significant findings in murine and caprine embryonic 
stem cell.  
 
 
Table 2.3: Timeline of significant findings in murine and caprine embryonic stem cell  
 
Year            Author           Species  Significant finding 
1981 
 
1981 
Evans and Kaufman        Murine 
 
Martin et al.                     Murine 
 
First isolation and establishment in 
culture of pluripotent murine 
embryonic stem cells (mESC). 
First successful in vitro culture of 
murine embryonic stem cell 
(mESC). 
1984 Bradley et al.                   Murine Production of chimaeric murine 
using embryonic stem cells. 
1985 Doetschman et al.            Murine Consistent in vitro differentiation 
of murine embryonic stem cells 
(mESC) into various cells. 
1986 Robertson                        Murine Murine embryonic stem cells 
(mESC) can enter the germ line. 
1987 Suemori and Nakatsuji   Murine Primary mouse embryonic 
fibroblasts (MEF) are better than 
STO cells as feeder layer for 
establishment of murine 
embryonic stem cells (mESC). 
1988 
 
 
1988 
Smith et al.                     Murine 
 
 
Williams et al.               Murine 
Identification of leukaemia 
inhibitory factor (LIF) as being 
crucial for maintaining the 
pluripotency of murine embryonic 
stem cells (mESC) in vitro. 
Feeder layer releases leukaemia 
inhibitory factor (LIF) which 
inhibits differentiation of murine 
embryonic stem cells (mESC). 
(Continued) 
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1993 
 
Maltsev et al.                Murine 
 
Induced differentiation of murine 
embryonic stem cell (mESC) into 
various cardiomyocyte types. 
1994 
 
Kawase et al.                Murine 
 
There are variations in embryonic 
stem cell (ESC) derived from 
different strains of murine. 
1995 
 
Bain et al.                     Murine 
 
Induced differentiation of murine 
embryonic stem cell (mESC) into 
neurons. 
1997 Dani et al.                    Murine Induced differentiation of murine 
embryonic stem cell (mESC) into 
adipocytes. 
2000 
 
Munsie                         Murine 
 
Establishment of nuclear transfer 
of embryonic stem cell (ntES) 
lines via somatic cell nuclear 
transfer (SCNT). 
2001 Buttery et al.                Murine Induced differentiation of murine 
embryonic stem cell (mESC) into 
osteoblasts. 
2001 Lumelsky et al.            Murine Induced differentiation of murine 
embryonic stem cell (mESC) into 
pancreatic islets. 
2005 Tesar                            Murine Murine embryonic stem cell 
(mESC) can be derived using 
embryos from 4-cell stage 
onwards. 
2006 
 
 
2007 
 
Yang et al.                   Caprine 
 
 
Hashemi-Tabar et al.   Murine 
 
Mechanical cutting with or 
without the aid of enzyme 
digestion was an effective method 
for passaging caprine embryonic 
stem cell colonies. 
Differentiation of murine 
embryonic stem cell (mESC) 
depends on the dose of inhibitory 
factors. 
(Continued) 
(Continued) 
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2007 
                     
Jia et al.                        Caprine 
 
 
Production of chimaeric caprine 
derived by injecting caprine 
embryonic germ cells into host 
blastocyst. 
2007 Wakayama et al.          Murine Polar bodies can be used to derive 
murine embryonic stem cell 
(mESC). 
2007 
 
 
2009 
Masui et al.                  Murine 
 
  
Pawar et al.                  Caprine 
Sox 2 regulates Oct 3/4 expression 
to maintain the pluripotency of 
murine embryonic stem cell 
(mESC). 
Successfully established caprine 
embryonic stem cell-like 
outgrowths from in vitro produced 
caprine blastocyst. 
 
 
 
2.11 TIMING OF ISOLATION AND INITIATION OF BLASTOCYST  
         PRIMARY CULTURES 
The optimal time for the initiation of blastocyst primary cell cultures for establishing 
ungulate embryonic stem cell lines is not known. The blastocysts of ungulates have an 
extended period of preimplantation development compared to murine and human. The 
blastocysts of the porcine, ovine and bovine first develop at approximately 6 to 7 days 
post-fertilisation. Then, the blastocyst increases in size relatively slowly over the next 
few days of development as a spherical form that increases in diameter (Chang, 1952). 
During this time there is probably only a modest increase in the number of epiblast cells 
in the inner cell mass of the blastocyst compared with the increase in trophectoderm and 
visceral endoderm cells (Carlson, 1981). At 11 to 12 days post-fertilisation, depending 
on the species, the blastocyst elongates by the rapid growth of the trophectoderm and 
visceral endoderm to form a long, thin, filamentous blastocyst greater than 100 mm in 
(Continued) 
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length (Chang, 1952; Carlson, 1981). The epiblast is exposed to the uterine environment 
during this preimplantation development by the loss of the overlaying layer of 
trophectoderm cells, or Rauber’s layer, and the inner cell mass is thereafter referred to 
as the embryonic or germinal disc (Stroband et al., 1984). Gastrulation, marked by the 
formation of the primitive streak in the embryonic disc, begins during this elongation 
phase and at this point mesoderm differentiation and migration from the epiblast is well 
underway (Talbot et al., 2000b; Guillomot et al., 2004). What point in the 
preimplantation development of ungulate blastocysts is best for the isolation and 
establishment of embryonic stem cell lines? Previous report have been used whole 
blastocyst culture of in vivo produced porcine embryos that were judged to be early 
blastocysts, having just emerged from the zona pellucida or blastocysts that had 
“hatched” from the zona pellucid some hours earlier (Chen et al., 1999). Early hatched 
blastocysts had many fewer trophectoderm cells and a less flattened inner cell mass. 
The success rate for the establishment of porcine embryonic stem-like cell cultures was 
decidedly greater [12 cultures (21%) versus none] from recently hatched blastocysts 
than from late hatched blastocysts (Chen et al., 1999). Three of the resulting cultures 
were composed of alkaline phosphatase positive cells, a marker of the undifferentiated 
state, and were purported to differentiate into multiple cell types in vitro, although no 
supporting evidence of this was shown. Another report used in vivo pig blastocysts from 
days 5 to 6 or 10 to 11 of gestation and found that days 10 to 11 blastocysts yielded 
embryonic stem-like cell cultures. Few or none were propagated from days 5 to 6 
embryos or day 11 blastocysts that had elongated (Hochereau-de Reviers and Perreau, 
1993). STO feeder cell layer were required for the survival of porcine and bovine 
epiblast cells in primary culture (Talbot et al., 1993, 1995). Without feeder cell support, 
cultures of primary porcine epiblast cells failed to grow, senesced and died over a 10 to 
14 days period (unpublished observations). Similar results were reported with feeder 
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free, short term, primary cultures of porcine inner cell mass, with or without the 
addition of leukemia inhibitory factor to the medium (Moore and Piedrahita, 1997). It is 
probable that ungulate embryonic stem cell line establishment will therefore require 
feeder cells, at least in their initial culture, as has been true for the establishment of most 
murine and primate embryonic stem cell lines. Although for both murine and human 
embryonic stem cell derivation STO feeder cell layer have been used successfully 
(Martin, 1981; Park et al., 2003), the use of primary or early secondary foetus derived 
feeder cell is often thought to be an advantage. Primary feeder cell populations 
presumably supply different kinds and amounts of factors for the maintenance and 
growth of embryonic stem cells compared with STO feeder cell layer. Moreover, the 
use of homologous primary feeder cells, for example, bovine fibroblast for bovine 
epiblast culture, would presumably remove the potential problem of species specificity 
that exists with some cell ligand or cell receptor systems. However, primary foetal 
fibroblasts of the bovine would be expected to produce bovine leukaemia inhibitory 
factor and basic fibroblast growth factor (bFGF), and most likely several other growth 
factors or cytokines, did not maintain bovine epiblast cells in the undifferentiated state 
in our experience (Keefer et al., 2007). Likewise, caprine foetal fibroblast could in 
some cases maintain caprine embryonic stem-like cells during short term culture but 
usually stimulated these cells to differentiate rapidly (Keefer et al., 2007). It should be 
hoped that through further research it might be possible to replace feeder-dependent 
culture conditions for establishment of ungulate embryonic stem cell lines as has been 
done in murine and human (Pease et al., 1990; Xu et al., 2001; 2005; Wang et al., 
2005).  
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2.12 INNER CELL MASS ISOLATION TECHNIQUES 
 
Inner cell mass isolation technique is an important step of the embryonic stem cell 
establishment successiveness. In intact embryo, trophoblastic cells induce inner cell 
mass differentiation to be 3 embryonic germ layers by suppress Oct 4 and Nanog 
expression level (Roberts et al., 2004). Therefore, completely removed trophoblastic 
cells provide more benefit to inner cell mass cells turn to be embryonic stem cells. The 
inner cell mass could be separated and isolated from the trophectoderm by 5 ways 
namely immunosurgery (Solter and Knowles, 1975), with mechanical processes 
(Bongso et al., 1994), with whole embryo culture of the blastocysts and partial embryo 
culture methods (Kim et al., 2005) or single blastomeres (Chung  et al., 2006) and laser 
dissection (Turetsky et al., 2008). 
 
 
2.12.1 Mechanical Dissection 
 
The inner cell mass of the blastocyst was isolated by using a specially made flexible 
metal needle, made of tungsten, with a diameter of 0.125 mm (Susanne et al., 2007) 
where the tip was made thin and sharp using electrolysis. Another blunter needle was 
used to hold the blastocysts while cutting out the inner cell mass. According to Susanne 
et al. (2007), the needles were fixed to hand-pieces of pencil-thickness for manual 
operation under a stereomicroscope. The blastocyst was first cleaned in 3 or 4 drops of 
culture medium and the last drop were then drawn out with the needle so that the 
blastocyst became attached to the surface of the well. With the blastocyst attached to the 
plastic, it was possible to make a hole in the zone pellucida with the needle to open up 
the blastocyst and by 2 to 3 cuts removing the inner cell mass from the trophectoderm 
and place the inner cell mass onto a fresh feeder plate. The procedure took about 2 to 3 
minutes. This technique is applied manually, and it does not require any expensive 
equipment. Mechanical isolation of the inner cell mass using a simple 2 needle system 
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proved successful. The isolation procedure was fast, and it did not require any major 
financial or time investments. The inner cell masses were isolated from hatched 
blastocysts using mechanical and enzymatic isolation techniques. Mechanical isolation 
was performed using 2 fine glass needles under stereozoom microscope (Olympus, 
SZ61) as described by Verma et al. (2007). Immunosurgery is not the optimal 
derivation method when poor quality, discarded embryos with hardly visible inner cell 
mass are used. By using mechanical isolation or dissection method, we could avoid the 
use of murine antibodies and guinea pig complement, and it was not necessary to use 
pronase or Tyrode’s acid, as the zona pellucid could be cut away at the same time. The 
procedure was therefore also time-saving. The efficient, successful derivation of 5 cell 
lines from 19 blastocysts appeared to be better than using immunosurgery (16 cell lines 
from 100 blastocysts) in similar culture medium (Inzunza et al., 2005). However, it was 
not possible to carry out a comparative study and many other factors may have 
influenced the improved results in the latest series of derivations. Mechanical isolation 
of the inner cell mass has previously been successfully used in the derivation of 2 cell 
lines, as reported by Genbacev et al. (2005) and by Mummery, (2004) and van de 
Stolpe et al. (2010). The properties of inner cell mass and trophectoderm have been 
extensively studied after their microsurgical separation (Gardner and Papaioannou, 
1975; Rossant, 1975a, b; Van Blerkom et al., 1976). However, the difficulty of the 
microsurgical procedure limits the rate at which blastocysts can be dissected. 
Furthermore, some inner cell mass cells may become damaged due to the use of needles 
to pull the inner cell mass away from the overlying trophectoderm. The embryo tended 
to rotate away from the advancing blade when it was cut towards one pole. This could 
be prevented by increasing suction or by using a needle to help immobilise the embryo. 
The choice of well expanded blastocysts enabled trophoblast to be obtained with little 
risk of inclusion of inner cell mass cells.  
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2.12.2 Immunosurgery 
There are 4 inner cell mass isolation methods that include immunosurgery (Solter and 
Knowles, 1975), whole embryo culture, partial embryo culture (Kim et al., 2005) and 
laser dissection (Turetsky et al., 2008). Since trophoblast inhibits proliferation of inner 
cell mass, the isolation of pure inner cell mass with minimal contamination of 
trophoblast. Trophoblastic cells have tendency to grow faster than the inner cell mass 
representing a frequent source of contamination and often a stimulus to differentiation. 
Solter and Knowles (1975) have been established immunosurgery method to isolate 
inner cell mass from murine blastocyst and it is now used in many research groups for 
the same scope (Thomson et al., 1995, 1998; Dattena et al., 2006). The isolation of the 
inner cell mass prior to plating represents a preventive measure towards contamination 
and unplanned differentiation. Immunosurgery is based on destruction of trophoblast by 
reaction of antibody and complement. However, these reagents may contain animal 
pathogen and molecules (Martin et al., 2005). Therefore, this is a drawback of 
immunosurgery for future clinical application of embryonic stem cells. Kim et al. 
(2005) compared immunosurgery, partial inner cell mass isolation method and whole 
blastocyst seeding method using human in vitro fertilised derived blastocysts. Solter and 
Knowles (1975) described the immunosurgery methods, the zona pellucida was first 
removed from cultured blastocysts (3.5 to 4.0 days post-coitus) using pronase (0.5%) 
for 5 minutes. Before exposure to antiserum, blastocysts were incubated at 37ºC in CO2 
(5%) in incubator for 30 minutes. Then, the zona-free blastocysts were then exposed to 
1:100 dilution of rabbit anti-mouse serum (Sigma) for 30 minutes and washed 3 times 
with PBS for 5 minutes. Washed blastocysts were then transferred to guinea pig 
complement (Sigma) at 37ºC in CO2 (5%) for 20 minutes. The blastocysts were then 
washed and each inner cell mass is transferred into a single droplet of trypsin/EDTA 
(0.05%) solution and incubated for 5 minutes to allow disaggregation of the inner cell 
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mass cells. Peripheral lysing cells were detached by active pipetting after addition of 
complement to the damaged trophoblastic layer. Intact expanded blastocysts, hatching, 
or hatched; zona-free blastocysts, and inner cell mass isolated by immunosurgery were 
plated on mouse embryonic fibroblasts and cultured in a chemically defined media with 
10% serum substituted enriched with recombinant LIF (1000 U/ml). Immunosurgery is 
a conventional efficient method to isolate inner cell mass cells from blastocyst but it 
cannot be applied efficiently to a low quality primate cloned blastocyst (Kim et al., 
2005; Byrne et al., 2007). Solter & Knowles (1975) study the purity of recovered inner 
cell mass cells was assessed by the failure to detect trophoblastic-type outgrowths in 
vitro. To determine the purity of inner cell mass, first is no cells could be detected by 
immunofluorescent staining of bound antibody or by presence of melanin granules 
despite the fact that both these markers were present on or in all trophoblast cells before 
immunosurgery. Secondly, the patterns of protein synthesis of the inner cell masses 
showed none of the spots specific for microsurgically-isolated trophectoderm but did 
show inner cell mass specific spots (Van Blerkom et al., 1976). Thirdly, chimaeras 
formed by injection of immunosurgically-isolated inner cell mass into host blastocysts 
showed donor inner cell mass contribution to trophoblast-derived tissues in only 2 
cases. Additional evidence on the purity of immunosurgically isolated inner cell mass 
has come from the analysis of 3 interspecific chimaeras made by injecting 
immunosurgically isolated rat inner cell mass into mouse blastocysts (Gardner and 
Johnson, 1975). The rat inner cell mass contributed only to embryonic ectoderm and to 
extra-embryonic and embryonic endoderm, but not to trophoblast, ectoplacenta and 
extra-embryonic ectoderm, indicating have same developmental potential as 
microsurgically-isolated inner cell mass (Gardner and Johnson, 1975). Through these 
experiments, it can reduced doubts that the inner cell mass are deleteriously affected by 
the process of immunosurgery. The real advantages of immunosurgery are the ease with 
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which larger numbers of blastocysts can be dissected and the possibility of obtaining 
inner cell mass from strains which are difficult to handle microsurgically. Polzin et al. 
(2010) reported that the immunosurgery procedure in caprine species where caprine 
blastocysts were treated with pronase (5%) in Whitten's medium without bovine serum 
albumin (BSA) for 20 to 30 second to remove the zonae pellucidae. Then, zona free 
caprine blastocyst were gently rinsed and cultured in Whitten's medium for 1 to 2 hours 
to allow them to recover from the effects of pronase. Caprine blastocysts were then 
cultured in a 1:8 dilution of non-heat-treated rabbit anti-sheep antiserum for 20 to 30 
minutes at which time the trophoblastic cells began to lyse. The embryos were then 
rinsed 3 times to remove excess antiserum, and finally drawn in and out of a small-bore 
glass pipette (approximately 75 µm) mounted on a Leitz micromanipulator. Lysed 
trophoblastic cells were removed, leaving an intact inner cell mass (Polzin et al., 2010).  
 
 
2.12.3 Laser (XYclone) 
 
The use of murine embryos would be a good model with which to do research to 
discover the best methodologies to use in order to derive new caprine embryonic stem 
cell lines. The aim of the present study was to evaluate a new method of isolation of the 
inner cell mass and derivation of embryonic stem cell lines in a murine and caprine 
blastocyst model using laser drilling to eliminate the trophectoderm cells and compare it 
with the usual control method consisting of culturing the whole murine and caprine 
blastocyst. Usually, laser technology is commonly used for assisted hatching with some 
applications. One of them consists of making the embryonic membrane weaker to make 
the exit of the future blastocyst easier and so favour the derivation (Antinori et al., 
1996). Another consists of blastomere biopsy for preimplantational diagnosis (Sermon 
et al., 2004). Until now, this new laser dissection method has been suggested to derive 
stem cell lines by Wang and Sun (2005), although without presenting any conclusive 
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results. A recent paper, Tanaka et al. (2006) reported preliminary results for a murine 
model using this method; subsequent culture of embryonic stem cells in a serum or cell 
free culture system was achieved. In our opinion, some notion of which of these 
methods are the most efficient for the isolation of inner cell mass is very important for 
future research in this field. Accordingly, we have compared the inner cell mass 
isolation method using laser dissection in a murine and caprine blastocyst with one of 
the most commonly used methods, the whole blastocyst culture (Kim et al., 2005). 
However, with good quality blastocysts with a large and distinct inner cell mass, we 
used the laser drill (Hamilton, USA). We did not use poor quality blastocysts in this 
method for this study because we cannot shoot the inner cell mass if we cannot see it. In 
our experiment, the murine and caprine blastocyst to be treated with laser shot was 
positioned at the centre of the field of view under magnification 40x. The blastocyst 
position was moved when necessary. Blastocysts can be secured by 2 holding pipettes 
with the inner cell mass positioned at ‘9 o’clock’ if desired (Tanaka et al., 2006). After 
focusing on the trophectoderm cells, the object had to be moved so that the part of the 
trophectoderm to be treated was located at the cross-hair position displayed on the 
monitor as the impact location of the laser focus. Thus this new mechanical method 
destroyed the trophectoderm cells by shooting the laser over them carefully without 
damaging the inner cell mass. The length of radiation time of the laser and the number 
of laser shots were controlled by the embryologist. According to the adhesion and 
isolation of the inner cell mass, we observed that the whole embryo culture method of 
the blastocysts is more effective than the laser method (70% vs 52.4%) (Polzin et al., 
2010). Taking into account that we had used the laser drill for the good quality 
blastocysts and that the concealment of the inner cell mass by the trophectoderm cells is 
the only disadvantage of the whole embryo culture method (Bongso et al., 1994), we 
must continue to improve the laser dissection technique so that the trophectoderm cells 
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are destroyed and do not interfere with inner cell mass adhesion (Tanaka et al., 2006). 
Curiously, the blastocysts treated with the laser at day 1 formed a pseudo-
trophectoderm, with a few cells not destroyed by the laser because they were near the 
inner cell mass. Trophectoderm cells disappeared after repeated passages (Polzin et al., 
2010).  
 
2.12.4 Whole Blastocyst Culture 
Only the whole blastocysts seeding method succeeds to establish embryonic stem cell 
lines when low quality blastocysts were obtained (Kim et al., 2005).  A complete 
hatching process is essential to allow blastocysts to properly attach to feeder cells. To 
overcome this problem, establishment of a new method of inner cell mass isolation from 
whole primate cloned blastocysts, using whole bovine cloned blastocysts as a model 
system because bovine oocytes can be acquired easily and the somatic cell nuclear 
transfer protocols are similar to those of primates (Stojkovic et al., 2005; Jang et al., 
2006; French et al., 2008). Production of cloned human blastocysts has been reported 
(Stojkovic et al., 2005; French et al., 2008), and inner cell mass isolation was reported 
in the rhesus monkey (Byrne et al., 2007). However, Byrne et al. (2007) reported that 
primate cloned blastocysts have lower quality than in vitro fertilisation derived 
blastocysts. The whole embryo culture tends to manifest an abundance of both 
trophectoderm and differentiated cells, and the isolation of murine embryonic stem cell-
like colonies from differentiated cells requires a great deal of care and caution. However, 
the poor quality of the blastocysts often results in failures in the attachment of the inner 
cell mass to the dish. Therefore, this procedure runs a much greater risk of 
trophectoderm overgrowth than other methods because the entire trophectoderm is 
cultured along with the inner cell mass. In 1988, murine blastocysts at day 3.5 post-
coitus flushed from uteri of C57Bl/10 murine were cultured by Hollands either as 
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singletons or in groups (Hollands, 1988). Many blastocysts lost their morphology as 
they expanded and attached to plastic within 24 hours. According to Hollands (1988), 
outgrowths of their cells formed cystic embryoid bodies and occasional blood islands, 
sometimes characterised by aggregates of pigmented cells. According to Robertson et al, 
(2004),  the embryonic starting material can either be normal 3.5 days post-coitus 
expanded blastocyst or delayed” blastocyst (which are normally collected 4 to 6 days). 
Both groups the culture procedures are identical, with the only difference being the 
timing of the first disaggregation, as delayed blastocyst will initially grown more slowly 
(Robertson et al., 2004). Approximately 90% of surviving embryos were used to 
prepare as stem cells for injection into recipients. Controls included cell lines from 
blastocysts cultured in vitro for less than 3 days and standard embryonic stem cells as 
described by other investigators (Evans and Kaufman, 1981). Clinical implications of 
these studies are apparent. In a sense, the demonstrable colonising properties of these 
embryo stem cells seemed to resemble those of murine embryonic stem cells injected 
singly into recipient blastocysts. Therefore, such evidence implies that human cell 
outgrowths from blastocysts may retain their multipotency during their period in culture. 
An alternative approach to making embryonic stem cells was tested in Glasgow by 
culturing the intact rabbit inner cell mass of day 6 blastocysts trimmed of its 
trophectoderm or disaggregating the inner cell mass and culturing its component cells 
(Cole and Paul, 1965; Cole et al., 1966). They were characterised by high activities of 
alkaline phosphatase or arginase, characteristics persisting over many generations and 
had a varying morphology with large nuclei and many nucleoli. Nowsaday, many 
investigators routinely apply similar methods, using cultures of intact embryos to 
produce either highly differentiated tissues or culturing disaggregated cells to prepare 
embryonic stem cell lines seemingly suspended in an early phase of differentiation. 
Once embryo stem cell lines could be made in vitro, new experimental approaches were 
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needed to assess developmental capacities of single, marked embryonic stem cells. The 
murine was the ideal species, with many well characterised marker genes enabling cells 
to be traced as they migrated through recipient tissues. Roberts et al. (2004) develop 
microsurgical methods for injecting single embryonic stem cells into blastocoelic 
cavities of recipient blastocysts.  
 
2.13 PASSAGING EMBRYONIC STEM CELLS (ESC) 
Routinely passage embryonic stem cells every 2 to 3 days, otherwise cells will 
spontaneously differentiate (Boris, 2000). Challenge for the establishment of embryonic 
stem cells is the ability to dissociate effectively inner cell mass cells from one another. 
Usually, embryonic stem cells are separated from one another by treatment with 
enzymes such as trypsin, collagenase and pronase or in combination with chemical 
agents such as ethylenediaminetetraacetic acid (EDTA), citrate or Ca
2+
/Mg
2+
 free 
phosphate buffered saline (PBS). With these combination treatments, a suspension of 
individual cells is created so that the culture can be subdivided for continued growth, 
and growth inhibition due to crowding can be reduced. The dissociation into single cells 
breaks down the cell-to-cell signaling that fosters stem cell differentiation. Thus, the 
routine passage of the cell population helps maintain the pluripotency of the cell 
population over time. Species differences appear to exist in the ease with which 
embryonic stem cells can be separated into a single cell or near single cell suspension. 
The dissociation of primate embryonic stem cells into single cell suspensions is a 
complicating factor in the culture of these cell lines. Enyzmatic and chemical 
dissociation of human or monkey embryonic stem cells typically give re-plating 
efficiencies of less than 1% (Thomson and Marshall, 1998). In contrast, murine 
embryonic stem cells are commonly dissociated by treatment with trypsin/EDTA for 
routine passage and maintenance of pluripotency, and their plating efficiencies are 
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usually 20% or greater (Robertson, 1987). This also makes murine embryonic stem cells 
more amenable to techniques fundamental to their use in creating genetically 
engineered murine, such as efficient colony-cloning and blastocyst injection (Bradley, 
1987). Primary colony outgrowths of murine inner cell masses or blastocysts are usually 
dissociated with trypsin/EDTA treatment in combination with mechanical manipulation 
to initiate the secondary passage and establishment of embryonic stem cell lines 
(Robertson, 1987). Primary cultures of alkaline phosphatase positive, undifferentiated, 
embryonic stem cells prepared by the successive immunodissection, culture and 
physical dissection method are extremely sensitive to lysis by either physical 
manipulation, withdrawal of calcium, or exposure to trypsin/EDTA (Talbot et al., 1993, 
1995; Talbot and Garrett, 2001). Check the embryonic stem cells under the microscope 
for sub-confluence and refeed cells 3 hours before passing them (very important), warm 
up reagents briefly before use. Aspirate medium off and wash once or twice with PBS 
(without bivalent cations), add about 1 ml (2 ml) of trypsin/EDTA to each 5 cm (10 cm) 
dish and incubate at 37°C until colonies float off when flicking the plate. Carefully 
transfer trypsin/cell suspension to a sterile falcon which enrich the embryonic stem cell 
or feeder mix for embryonic stem cells and trypsinise for a few more minutes at 37°C. 
Then, dissociate colonies into single cells by "Gilson pipetting", then add several ml of 
embryonic stem cell medium without leukaemia inhibitory facotr to inactivate the 
trypsin, pellet cells by low-speed centrifugation for 5 minutes. Then, remove 
supernatant and resuspend cells in appropriate volume of embryonic stem cell medium 
depending on plate format and splitting ratio. According to Boris (2000), splitting ratios 
for embryonic stem cells can vary from 1:1 to 1:10. Return plates to the 37°C incubator. 
Feeder cell density is very important to achieve optimal growth conditions where they 
should be almost confluent, but each feeder cell should have enough space around itself 
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to spread. Use feedes that are at least one day old because then they will have settled 
nicely and flattened.  
 
2.14 CRYOPRESERVATION OF EMBRYONIC STEM CELLS (ESC) 
Shaw and Jones (2003) reported that cryopreservation method is long term storage by 
cooling of samples to low sub-zero temperatures. There are few reasons for 
cryopreserved the stem cells. Firstly, stem cell will be easier to undergo senescence for 
long term cultured. Secondly, it is possible to cause contamination after prolonged 
culture in vitro. Therefore, it avoids the need to maintain the cell lines in continuous in 
vitro culture and allows the cells to be distributed to other users (Freshney, 1994). 
According to Freshney (1994), the stem cells are typically cooled to a low temperature 
and stored in liquid nitrogen (LN2) at temperature -196°C. This freezing method is 
allowing equilibrium to be established between the rate of water loss from the cells and 
the rate of extracellular ice crystallisation (Shaw and Jones, 2003). Reduce the time the 
embryonic stem cells are in culture before freezing and freeze at a density that allows 
recovery of the culture even if 90% of the cells die during the freezing and thawing 
process (Boris, 2000). Depending on the size and permeability of the particular cell 
type, cryopreservation of embryonic stem cells involves the lowering of the temperature 
at a relatively slow rate (Shaw and Jones, 2003). Dehydration occurred where water 
leaves the cells and thus minimising intracellular ice crystallisation as well as reducing 
cryogenic damage from the highly concentrated solutes (Freshney, 1994).  
 
2.15 THAWING EMBRYONIC STEM CELLS (ESC)  
Always have feeder plates prepared (mitomycin C treatment at least one day before use) 
when thawing embryonic stem cells. Remove embryonic stem cells from freezer or 
liquid nitrogen and quickly thaw in a 37°C waterbath and transfer cell suspension (cell 
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concentration is not very important) to a sterile tube containing several ml of warm 
medium. Then gently mix and pellet the cells by centrifugation or low speed for 5 
minutes. Aspirate off supernatant (removal of dimethyl sulfoxide (DMSO) in freezing 
medium) and resuspend cells into 12 ml (5 ml) of warm embryonic stem cell medium 
and plate out in a 10 cm (5 cm) feeder plate. Ideally, should refeed cells daily with fresh 
embryonic stem medium (Lorthongpanich, personal communication). Boris (2000) 
described the embryonic stem cells need to be passaged or frozen or used for doing 
experiments upon sub-confluence. 
 
2.16 NUCLEAR TRANSFER OF EMBRYONIC STEM CELLS (ntES) 
The first successful cloning experiments in which fully differentiated adult cells 
developed into complete organisms were conducted in plants (Steward et al., 1958) 
approximately 40 years ago. The earliest reports of mammalian embryo cloning 
attempted to address the issue of embryonic cell differentiation. According to Wilmut et 
al. (1997), researchers using vertebrate models overlooked this monumental 
achievement and it took another 39 years for the same feat to be accomplished in 
mammals. Illmensee and Hoppe (1981) reported success in cloning murien by directly 
injecting inner cell mass nuclei into enucleated pronuclear-stage oocytes using 
procedure similar to the amphibian studies (Briggs and King, 1952). Embryonic stem-
like cell lines generated from somatic cells via nuclear transfer of embryonic stem cells 
(ntES) technique were first reported for the bovine (Munsie  et al., 2000) and then the 
murine (Kawase  et al., 2000; Munsie  et al., 2000a). Some reported that nuclear 
transfer of embryonic stem cell lines are capable of differentiating into all 3 germ layers 
in vitro or into spermatozoa and oocytes in chimaeric murine (Wakayama et al., 2001). 
Cloned murine can be obtained from this nuclear transfer of embryonic stem cell lines 
using a second nuclear transfer (Wakayama et al., 2001). Although these techniques 
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have now been applied to basic research, such as to demonstrate irreversible changes to 
DNA in adult lymphocytes (Hochedlinger and Jaenisch, 2002) , not olfactory neurons 
(Eggan et al., 2004; Li et al., 2004b ) and to examine the characteristics of different 
types of cancer cells (Hochedlinger et al., 2004; Blelloch et al., 2006). However, since 
nuclear transfer of embryonic stem cells are not yet fully characterised in terms of the 
effects of the animal strain, genotype or sex of the donor nucleus, therefore such factors 
often affect the successful full-term development of cloned animals (Wakayama and 
Yanagimachi, 2001; Inoue et al., 2003). Here, nuclear transfer of embryonic stem cells 
can be generated from the tissues of both males and females of different murine 
genotypes using different cell types, with higher success rates than for adult somatic cell 
nuclear cloning. 
 
2.17 SPONTANEOUS DIFFERENTIATION OF EMBRYONIC STEM CELLS  
         (ESC) 
Differentiation is the process whereby an unspecialised early embryonic cell acquires 
the features of a specialised cell such as a muscle, liver or heart. Differentiation in vitro 
can be spontaneous or controlled. The most significant challenge hindering the 
establishment of embryonic stem cell lines is the unable to control the spontaneous 
differentiation of embryonic stem cells in in vitro culture (Talbot et al., 1993, 1995). 
Primary cultures of pure porcine, ovine and bovine inner cell mass cells plated on STO 
feeder cells “spontaneously” differentiate into multiple cell types when left undisturbed 
in culture (Talbot et al., 1993, 1994, 1995, 1996, 2002a). According to Talbot et al. 
(1993, 1995), embryonic stem cells loss of alkaline phosphatase activity showed that 
differentiation events begin 48 to 96 hour post-plating of the inner cell mass in vitro 
culture. Usually, larger initial colonies of inner cell mass cells tend to differentiate 
sooner and become senescent and slowly die off. Cytokines and growth factors that 
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inhibit spontaneous differentiation in murine and primate embryonic stem cell lines are 
leukaemia inhibitory factor and basic fibroblast growth factors but do not inhibit this 
differentiation in ungulate inner cell mass primary cultures (Moore and Piedrahita, 
1997; Talbot et al., 1993, 1995). Within a week of passage, early morphological 
differentiation events may be observed in the cells within embryonic stem cells colonies 
(Sathananthan et al., 2002). A wide range of differentiating cell types can be observed 
in ectodermal neuroectoderm, mesodermal muscle, and endodermal organ tissue types 
(Conley et al., 2004; Reubinoff et al., 2000; Sathananthan and Trounson, 2005). The 
embryonic stem cell ball up into embryoid bodies, with differentiation occurring within 
5 to 7 days into the primary embryonic germ lineages (Itskovitz-Eldor et al., 2000). 
Human embryoid bodies have a consistent vesicular appearance and structure 
(Sathananthan, 2003; Conley et al., 2004; Gertow et al., 2004), with a variety of cell 
types that appear to develop in a more random organisation than mouse embryoid 
bodies. In theory, embryonic stem cells can be induced to differentiate into any cell type 
in vitro by providing the correct signals. Embryonic stem cells were found to 
differentiate in vitro into many cell lineages including primitive ectoderm (Rathjen et 
al., 1999), parietal (Keller et al., 1993) and visceral (Soudais et al., 1995; Abe et al., 
1996) endoderm, early mesoderm (Johansson and Wiles, 1995, Rohwedel et al., 1998) 
and into differentiated cell types such as cardiac (Wobus et al., 1991; Maltsev et al., 
1993, 1994; Wobus and Guan, 1998), myogenic (Rohwedel et al., 1994, 1995, 1998), 
chondrogenic (Kramer and Irish, 2000), adipogenic (Dani et al., 1997), hematopoietic 
(Schmitt et al., 1991; Wiles and Keller, 1991; Helgason et al., 1996; Suwabe et al., 
1998), epithelial (Bagutti et al., 1996), neuronal (Bain et al., 1995; Fraichard et al., 
1995; Strubing et al., 1995; Okabe et al., 1996), endothelial (Risau et al., 1988; Vittet et 
al., 1996) and vascular smooth muscle (Drab et al., 1997) cells. In similar, embryonic 
germ cells also have the capacity to differentiate into many cell types when cultivated as 
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embryoid body in vitro (Rohwedel et al., 1996). Although spontaneous differentiation 
of embryonic stem cells revealed only low levels of neuronal differentiation (Strubing et 
al., 1995), transcripts of neuron-specific genes can be detected (Rohwedel et al., 1998; 
Schmidt et al., 2001). Retinoic acid (RA) (Fraichard et al., 1995; Stru  ¨bing et al., 1995) 
and growth factor induced differentiation protocols (Okabe et al., 1996) clearly showed 
different expression patterns of neuronal genes (Guan et al., 2001; Rolletschek et al., 
2001). The differentiation of embryonic stem cells in vitro provides an excellent model 
for studying cell commitment and the potential of stem cell technology (Nishikawa et 
al., 1998; Rathjen et al., 1998).  
 
2.18 INDUCED OR DIRECTED DIFFERENTIATION OF EMBRYONIC STEM  
        CELLS (ESC) 
Induced diiferentiation of embryonic stem cells proofs have been common practice with 
both murine and primate embryonic stem cell lines since the first reports in the literature 
(Martin, 1981; Thomson et al., 1995, 1998). Bovine and porcine embryos have been 
shown to produce teratomas when injected into immunocompromised murine, and so it 
should be with any putative ungulate embryonic stem cell lines (Anderson et al., 1996). 
Although proofs of germline transmission are well established in the murine (Bradley, 
1987; Nagy et al., 1993); however, have never been achieved with the putative 
embryonic stem cells of ungulates. It is more likely that the isolated embryonic cells 
quickly lose their embryonic competence following propagation under suboptimal in 
vitro conditions. The enhancement of differentiation toward a specific lineage can be 
achieved by activating endogenous transcription factors, by transfection of embryonic 
stem cells with ubiquitously expressing transcription factors, by exposure of embryonic 
stem cells to selected growth factors, or by co-culture of embryonic stem cells with cell 
types capable of lineage induction (Lavon et al., 2004; Pera and Trounson, 2004; 
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Trounson, 2005a, b). According to Loebel et al. (2003), embryonic stem cells may be 
induced to form cell types of interest by a combination of growth factors and/or their 
antagonists. Embryonic stem cells derived neurones respond to neurotransmitters and 
generate action potentials as well as make functional synapses (Carpenter et al., 2001). 
Oligodendrocytes derived from embryonic stem cells are able to remylinate neurones of 
the shiver murine model (Nistor et al., 2005). Doperminergic neurons can be formed 
from embryonic stem cells (Park et al., 2004; Perrier et al., 2004) and they are shown to 
be capable of reversing some motor behavioral abnormalities after transplantation into 
the brain of a parkinsonian rat model (Ben-Hur and Noble, 2004). Embryonic stem cells 
may be efficiently directed into neuroectoderm by culture in the presence of an 
antagonist to bone morphogenetic proteins signaling (Pera et al., 2004). Manipulation of 
culture conditions with bone morphogenetic proteins 4 induces epidermogenesis or 
neural crest and dorsal most central nervous system cells, and suppression of sonic 
hedgehog promotes motor neurone formation (Mizuseki et al., 2003; Trounson, 2004). 
Cultures of embryonic stem cells cultured together with mouse visceral endoderm cell 
type will preferentially form beating heart muscle cell colonies (Mummery et al., 2002, 
2003). Similarly, differentiation strategies similar to those developed by Lumelsky et al. 
(2001), Rajagopal et al. (2003), and Sipione et al. (2004) in murine embryonic stem 
cells to produce insulin and C-peptide expressing cells have differentiated human 
embryonic stem cells into insulin producing cells that coexpress insulin and C-peptide 
and glucagon or somatostatin (Segev et al., 2004).  
 
2.19 EMBRYOID BODIES (EB)  
The most essential technique to form embryoid bodies where culture embryonic stem 
cells in suspension without antidifferentiation factors such as leukaemia inhibitory 
factor and feeder layer cells will spontaneously differentiate and form 3 dimensional 
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multicellular aggregates. Embryoid bodies play an important role in the differentiation 
of ES cells into a variety of cell types in vitro. There are several methods for inducing 
the formation of embryoid bodies from embryonic stem cells. The 3 basic methods 
namely, liquid suspension culture in bacterial-grade dishes, culture in methylcellulose 
semisolid media, and culture in hanging drops, are usually used for the formation of 
embryoid bodies to induce the formation of a variety of cell types from embryonic stem 
cells (Keller, 1995; Höpfl et al., 2004). Recently, the methods using a round-bottomed 
96-well plate and a conical tube are adopted for forming embryoid bodies from 
predetermined numbers of embryonic stem cells. For the production of large numbers of 
embryoid bodies, stirred-suspension culture using spinner flasks and bioreactors is 
performed. Each of these methods has its own peculiarity. Therefore, the features of 
formed embryoid bodies depending on the method used. The formation of embryoid 
bodies is the principal step in the differentiation of embryonic stem cells. Thus, the 
features of formed embryoid bodies are considered to be not homogeneous 
embryologically and morphologically. Embryoid bodies are classified as simple 
embryoid bodies or cystic embryoid bodies according to the stage of differentiation 
(Abe et al., 1996; Magyar et al., 2001; Conley et al., 2004). In the case of murine 
embryonic stem cells, simple embryoid bodies show spherical embryonic stem cell 
aggregates with morula-like structures formed in 2 to 4 days in suspension culture. For 
cystic embryoid bodies formation, a central cavity forms in embryoid bodies in 4 to 5 
days in suspension culture; resemble an embryo in the blastula or egg-cylinder stage, 
consisting of a double-layered structure with an inner ectodermal layer and an outer of 
endoderm enclosing the cavity. Cystic embryoid bodies expand to larger cystic 
structures homologous to the visceral yolk sac of postimplantation embryos after 8 to 10 
days in suspension culture. Doetschman et al. (1985) developed a technique of forming 
embryoid bodies from embryonic stem cells in suspension culture using bacterial- grade 
 103 
 
dishes (60 mm or 100 mm in diameter). Seeded embryonic stem cells do not attach to 
the plastic surfaces of the bacterial-grade dishes, and they stick to each other, and form 
aggregates without any movement or shaking. By this method, the differentiation of 
embryonic stem cells into a variety of differentiated cell types, for example, neural 
progenitors (Plachta  et al., 2004), vascular cells (Risau et al., 1988, 2001), 
cardiomyocytes (Klug et al., 1996), chondrocytes (Hwang et al., 2006), hepatic cells 
(Jones  et al., 2002), insulin-producing cells (Soria  et al.， 2000; Morita  et al., 2003), 
and germ cells (Toyooka et al., 2003) are induced from embryoid bodies formed in the 
bacterial-grade dishes for mouse embryonic stem cells. As for human embryonic stem 
cells, neural cells (Itskovitz-Eldor  et al., 2000), hematopoietic cells (Itskovitz-Eldor  et 
al., 2000), cardiomyocytes (Itskovitz-Eldor  et al., 2000; Kehat et al.， 2001), insulin-
producing cells (Assady et al., 2001), and endothelial cells (Levenberg et al.， 2002) 
are also induced from embryoid bodies. The size and shape of the resulting embryoid 
bodies tend to be heterogeneous (Wartenberg et al., 1998). Rotating suspension culture 
was introduced to improve the homogeneity of embrtoid bodies formed in bacterial-
grade dishes (Zweigerdt et al., 2003). Rundnick et al. (1987) introduced 
methylcellulose culture to form cell aggregates of a clonal origin. Methylcellulose 
culture has been used for the study of hematopoietic differentiation of embryonic stem 
cells (Wiles and Keller, 1991; Keller et al., 1993; Kennedy et al., 1997; Potocnik et al., 
1994).  Hanging drop culture is the embryoid body formation induction method that has 
been frequently and widely used to differentiate embryonic stem cells into a variety of 
cell types. Hanging drops provide embryonic stem cells a good environment for 
forming embryoid bodies. Embryoid bodies formed by the hanging drop method have 
been used to generate a broad spectrum of cell types, including neuronal cells (He et al., 
2006), lymphoid (Potocnik et al., 1997), hematopoietic cells (Dang  et al., 2004), 
cardiomyocytes (Wobus  et al., 1991; Metzger et al., 1994; Takahashi   et al., 2003;), 
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smooth muscle cells (Drab  et al.， 1997; Yamada et al., 2002), chondrocytes (Kramer 
and Irish, 2000; Hegert et al., 2002) and gametes (Geijsen  et al., 2004) (Figure 2.8). 
 
 
Figure 2.8: Outlines of methods for inducing embryoid bodies formation (Kurosaw et   
                   al., 2007). 
 
2.20 POTENTIAL OF EMBRYONIC STEM CELLS APPROACHES 
Embryonic stem cells which derived from blastocysts are capable of long-term self-
renewal and differentiation into most tissues while retaining a normal genomic 
structure. It has been shown that human embryonic stem cells can proliferate for 2 
years, including 300 cell cycles, a characteristic that is not shared with any adult stem 
cell (Donovan and Gearhart, 2001). Embryonic stem cells also can be directed towards 
differentiation pathways by changing growth conditions, leading to development of 
specialised cells such as heart muscle cells, neurons or insulin-secreting cells, opening 
the way to the development of new therapies. Examples of the functional correction of 
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the neuro-degenerative diseases in different animal models by the transplantation of a 
low member of differentiated or undifferentiated embryonic stem cells is particularly 
encouraging in this direction (Reubinoff  et al., 2001; Bjorklund  et al., 2002; Liu et al., 
2002). Bsides that, embryonic stem cells can been modified by homologous 
recombination, nuclear transplantation (Vogelstein et al., 2002) or retroviral 
transduction, allowing researchers to dispose of in vitro models to study developmental 
pathways that are mutated in genetic diseases. The best example of the potentiality of 
these combined strategies has been recently reported by Rideout et al. (2002), whose 
work provides the proof of principle for nuclear transplantation combined with gene 
therapy to treat a form of severe combined immune deficiency in murine. Through 
somatic nuclear transfer, it allowed the isolation of embryonic stem cells genetically 
identical to diseased individuals, therefore, avoiding rejection, which remains the main 
obstacle to conventional organ transplantation. Recently, these genetically matched 
embryonic stem cells can then be corrected by homologous recombination (Rideout et 
al., 2002) and induced to differentiate into cells of several different developmental 
lineages. The proliferative capacity of undifferentiated embryonic stem cell is a matter 
of concern. Undifferentiated embryonic stem cells are not suitable for transplantation 
purpose due to the risk of unregulated growth. Thus, the identification of differentiation 
steps at which the risk of tumour formation is minimised becomes a critical point for 
further of research. A fruitful research period has begun all around the world focused on 
the biology of stem cells. Two medical perspectives are around the corner. In 
perspective of developmental medicine, discoveries in this field can help to understand 
physiopathology of both infertility and developmental genetic diseases. The second one 
deals with the so-called ‘regenerative medicine’ that could bypass some therapeutical 
barriers caused by donor organ scarcity and immunological constraints. Therefore, basic 
research should provide further information of importance for future therapeutic usage 
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of stem cells. An alternative approach to assessing gene function during development is 
to randomly create heterozygous phenotypes by insertional mutagenesis of genes using 
gene trapping. Another potent application is to transfect embryonic stem cells to express 
GFP either constitutively, or targeted under the control of a lineage-restricted gene. 
During differentiation in vitro, embryonic stem cells were found to be able develop into 
specialised somatic cells types and to recapitulate processes of early embryonic 
development. These properties allow us to use embryonic stem cells as model system 
for studying early embryonic development by gain or loss of function approaches, or to 
investigate the effects of drugs and environmental factors on differentiation and cell 
function in embryotoxicity and pharmacology. The establishment of ungulate 
embryonic stem cell lines, either from in vivo or in vitro produced blastocysts, carries 
many known and unknown challenges. Approaches to the problem may involve 
innovative genetic manipulation techniques for targeted cell ablation (McWhir et al., 
1996), ectopic gene expression (Chambers et al., 2003) or gene expression knock-down. 
Embryonic stem cell has the potential for treating a variety of major diseases. Patients 
with Type I diabetes mellitus suffer from the autoimmune destruction of beta cells, the 
insulin-producing cells of the pancreas (Chapman et al., 1999). Currently, the treatment 
involves transplantation of pancreatic cells and Islet of Langerhans from donated 
pancreas, which is limited by the scarcity of donated organs (Chapman et al., 1999; 
Assady et al., 2001). This approach is considered a superior alternative to the use of 
pancreatic stem cells to form the islet cells, as only a low number of cells can be derived 
from the pancreas (Bonner-Weir et al., 2000; Assady et al., 2001). Another major 
disease that can be potentially treated with embryonic stem cells therapy is disease of 
the nervous system. A significant problem in treatment of the nervous system is that in 
many cases, the cause of the disease is due to loss of nerve cells, in which most mature 
nerve cells cannot replicate to replace lost cells (Chapman et al., 1999). The use of 
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embryonic stem cells to regenerate these cells circumvents this problem. In the case of 
Parkinson’s disease whereby the patients lack dopaminergic neurons, these neurons 
have been successfully derived from human embryonic stem cells (Kim et al., 2002; 
Schulz et al., 2004; Zeng et al., 2004). Besides the brain region, the clinical potential of 
embryonic stem cells also expands to spinal cord injuries, which was explored by 
Keirstead et al. (2005). The therapeutic potential of embryonic stem cells for 
regenerative medicine will depend on their ability to direct their differentiation into cell 
lineages and pure homogeneous progenitor cell types that can be screened for drug 
discovery, their reliance that they will remain of the tissue type required and not form 
undesirable teratomas or other tissue derivatives (Brustle et al., 1997; Deacon et al., 
1998). It is difficult to identify and monitor the appearance of specific cell types in 
culture because the changes in gene expression may not be visibly identifi able or the 
cell morphology may not be easily recognisable, especially during the early stages of 
differentiation. Clonal derivation of embryonic stem cells is difficult, and hence the 
efficiency of identifying homologous recombination for gene “knock-in” or “knock-
out” has been extremely low. Conventional transfection methods have been successful 
established by Eiges et al. (2001) as have lentiviral methods (Gropp et al., 2003; Ma et 
al., 2003). Zwaka and Thomson (2005) have shown that it is possible to electroporate 
embryonic stem cells to achieve homologous recombination of embryonic stem cells 
colony fragments. Gene function may be determined in embryonic stem cells by using 
small inhibitory RNAs (siRNA) to explore renewal, differentiation, apoptosis and 
oncogenesis (Trounson, 2006).  
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2.21 CHALLENGES IN THE ESTABLISHMENT OF EMBRYONIC STEM  
         CELL LINES 
There are many problems and challenges in establishing embryonic stem cell lines. An 
initial problem in the isolation and culture of embryonic stem cells is in recognising 
contaminating cell types in the primary culture of blastocysts or inner cell masses that 
may be mistaken for embryonic stem cells. When entire blastocyst is used to initiate a 
primary culture, trophectoderm, endoderm and inner cell mass cells may all survive and 
grow in the culture medium together. Although the 3 cell types present, only inner cell 
mass cells are the source of embryonic stem cell lines (Brook and Gardner, 1997). 
According to Solter and Knowles (1975), the blastocyst’s outer trophectoderm cells can 
be eliminated by immunodissection, but the isolated inner cell mass is coednsist of both 
epiblast tissue and a visceral endoderm cell layer (Talbot et al., 1993). Thus, physical 
dissection methods for isolating the inner cell mass should be assumed to always leave 
viable trophectoderm cells attached to the inner cell mass. As with murine and human 
primary blastocyst or inner cell mass cell cultures, trophectoderm and endoderm cells 
may be mistaken for embryonic stem cells and are in one sense “weeds” in the primary 
culture (Robertson, 1987; Talbot et al., 1993). Ungulate embryonic stem cells since 
their trophectoderm and visceral endoderm are very resilient epithelial cells that grow 
rapidly in feeder cell co-cultures (Talbot et al., 1993, 1995, 2000a, 2005; Flechon et al., 
1995; Shimada et al., 2001; Miyazaki et al., 2002). It is important that putative 
embryonic stem cells of ungulates be tested for markers of trophectoderm or visceral 
endoderm cells. For example, a definitive marker of bovine, caprine and ovine 
trophectoderm is the expression of interferontau (Talbot et al., 2000a; Shimada et al., 
2001; Miyazaki et al., 2002). A specific marker is the presence of serum proteins such 
as alpha-fetoprotein and transferrin (Talbot et al., 2000a) for visceral endoderm. It is 
important to appreciate the fact that these 2 cell types, like other polarised or “dome-
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forming” epithelial cells, will make “embryoid-like” bodies if grown without 
attachment to a solid cell culture substrate. Therefore, these and other properties of 
ungulate trophectoderm and endoderm should be carefully evaluated. The spontaneous 
differentiation of the primary epiblast cells to epithelial cell types is rapid and common 
(Talbot et al., 1993; 1995). Many epithelial cells grown on fibroblast feeder cell 
monolayers can look “embryonic stem-like”, especially shortly after passage, for 
example, foetal kidney epithelial cells are often confused with primordial germ cells for 
this reason and also because kidney epithelial cells express the alkaline phosphatase 
gene to a greater extent (Gibson-D’Ambrosio et al., 1987). Talbot et al. reported that 
pig epiblast-derived epithelial cell line exhibits an embryonic stem-like morphology 
shortly after passage and in some cases these epithelial cells may also be alkaline 
phosphatase positive (Talbot et al., 1993, 1995). Finally, the feeder cells themselves 
may be a source of confusion in the identification and proof of ungulate embryonic stem 
cell lines. Mostly, it is common for STO feeder cell layer to adopt the morphology of 
oligodendrocytes, astrocytes or neurons, particularly if they are exposed to various 
members of the fibroblast growth factor family. The use of rodent or oprimary fetal 
fibroblast as feeder cell layer necessarily introduces many different types of cells into 
the embryonic stem cell derivation culture system. For example, macrophages can 
comprise as much as 50% of the “fibroblast” population in the early passage mouse 
fibroblast cultures that are routinely used for preparing feeder cell layer (Talbot et al., 
2004).  
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Chapter 3 
3.0 MATERIALS AND METHODS 
 
 
3.1 GENERAL INTRODUCTION 
In the present study, the research was conducted at 3 main laboratories, namely Animal 
Biotechnology-Embryo Laboratory (ABEL), Embryo Micromanipulation Laboratory 
(EMiL) (Institute of Biological Sciences, ISB), and Nuclear Transfer and 
Reprogramming Laboratory (NaTuRe) (Institute of Postgraduate Studies, IPS) at the 
University of Malaya, Kuala Lumpur, Malaysia. The experimental murine and caprine 
were sourced from Institute of Biological Sciences (ISB) Mini Farm (University of 
Malaya) located approximately 1 km from the laboratories. For caprine sample, oocytes 
were retrieved from live female caprine (donor does) by oocyte retrieval surgery 
(laparoscopic ovum pick-up, LOPU) or ovariectomy was conducted at the NaTuRe 
laboratory once week. Each surgery was carried out either 1 or 2 caprine donors per 
surgery session. The immature oocytes were transported to the EMiL laboratory after 
the oocytes retrieval surgery for conducting the subsequent in vitro maturation, 
fertilisation and culture (IVMFC) experiments. Besides that, the caprine oocytes also 
retrieved from local abattoir (slaughter house) in Shah Alam, Senawang or ISB Mini 
Farm, University of Malaya by slicing technique. For murine, it was carried out to 
produce viable lines of murine embryonic stem cell line using mouse embryonic 
fibroblast as feeder cell layer. The source of embryonic stem cells was produced using 
preimplantation embryos obtained via embryo flushing or somatic cell nuclear transfer 
cloned-murine embryos. Three different murine strains and passage numbers of primary 
mouse embryonic fibroblast were isolated and cryopreserved as bank storage for future 
use. The duration of this study was from November 2008 to May 2011. 
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3.2 MATERIALS 
The materials that used in this study included various facilities, study experimental 
animals, equipment and instruments; glasswares or labwares or disposables, chemicals, 
reagents and media. 
 
3.2.1 Facilities 
In the present study, the facilities used included EMiL laboratory (for preliminary 
experiment on murine; in vitro maturation, fertilisation and culture and nuclear transfer 
experiments in caprine species), NaTuRe laboratory (for caprine oocyte retrieval 
surgery), ISB Mini Farm (sources of live experimental caprine and murine species). 
 
3.2.2 Experimental Animals 
In this study, 2 experimental animals had been used, caprine and murine. For caprine, 
Boer crossbred, local mixed-breed caprine and Jamnapari caprine were used as caprine 
oocyte donors. The caprine age for surgery ranged from 12 to 50 months old. These 
caprine underwent oestrus synchronisation and hyperstimulation. For murine, 3 
different strains were used, which were ICR (white), CBA/ca (brown) and C57BL/6J 
(black) strains. Two different sizes of cages were used: large (43.5 cm x 28.5 cm x 16.0 
cm) and medium (29.5 cm x 22.5 cm x 13.5 cm) sizes. The murine were separated in 
cages according to gender, strain and status of pregnancy. The murine were fed with 
commercial murine pellets and sawdust was used for bedding as well as provided ad 
libitum using water bottles. The murine cages were cleaned and sawdust changed once a 
week. The environment was controlled under natural day and night cycle, with the 
natural lighting period approximately 12 hours at room temperature. For breeding 
purposes, 8 to 12 weeks male murine were mated with female murine (6 to 10 weeks) to 
produce offspring and embryos as needed in this study. 
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3.2.3 Equipment and Instruments 
Equipment and instruments used in present study with manufacture’s and supplier’s 
names as well as model numbers are listed in Appendix Table 1.1 (Appendix 1). 
Common used equipment such as CO2 incubator (Kendro Laboratory Products, 
Germany), autoclave (Hirayama Manufacturing Corporation, Tokyo, Japan), flushing 
and aspiration system (Cook Australia, Australia), inverted microscope (Olympus 
Optical CO., Ltd., Japan) with micromanipulators (Narishige Co., Ltd., Japan), laminar 
flow (Gelman Sciences Pty. Ltd., Australia), oven (Memmert GmbH, Germany), water 
bath (Memmert GmbH, Germany), ultrapure water system (Millipore, USA), pH meter 
(Hanna Instruments, Singapore), stage warmer (Linkam Scientific Instrument, 
England), microgrinder (Narishige Co., Ltd., Japan), micropuller (Sutter Instrument 
Co., USA), microforge (Technical Products Internationals, USA), osmometer (Wescor, 
Inc., USA), stereomicroscope (Olympus Optical Co., Ltd., Japan), laparoscopic system 
(Aesculap A.G. and Company, Germany), centrifuge machine (Kendro Laboratory 
Products, Germany), fluorescent microscope (Carl-Zeiss Inc., Germany), 
stereomicroscope microscope (Nikon, Japan), liquid nitrogen  tank (MVE, USA), La 
banana (self-assembled), surgical set (Aesculap A.G. and Company, Germany) 
micropipette dispenser (Eppendorf, Germany) and laser ablation system, Xyclone 
(Halmiton Thorne Research, Belverly, MA, USA). 
 
3.2.4 Glassware/Labware/Disposable 
Glassware/labware/disposables used are listed in Appendix Table 1.2 (Appendix 1). For 
oocyte retrieved, graduated test tubes (14 ml, Becton Dickinson Lanware, USA) were 
used. Nunc 4-well dishes (Nunc, Denmark) were used for staining and culture 
embryonic stem cells. For in vitro maturation, activation, in vitro culture of oocytes and 
embryos in polystyrene culture dishes (35 mm; Becton Dickinson Labware, USA). The 
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lids of polystyrene culture dishes (35 mm; Becton Dickinson Labware, USA) were used 
for somatic cell nuclear transfer procedure. 
 
3.2.5 Sample Sources 
Caprine and murine oocytes as well as blastocysts were the sample of this present study. 
Caprine oocytes were obtained either by laparoscopic ovum pick-up technique or 
slicing of ovaries collected by ovariectomy or from abattoir source. Uterine flushing of 
in caprine also carried out to obtain blastocyst as a source for goat embryonic stem cell 
production. For murine sample, the oocytes obtained by superovulated with pregnant 
mare serum gonadotrophin and human chorionic gonadotrophin hormones to obtain 
more sample to carry out somatic cell nuclear transfer procedure to produce blastocyst 
as a source for production of embryonic stem cells. Besides in vitro produced embryos 
from somatic cell nuclear transfer technique, in vivo embryos also obtained through in 
vivo flushing at 2-cell stage of murine embryo (oviductal flushing) and subsequently in 
vitro culture until blastocysts and in vivo flushing blastocyst (uterine flushing) as source 
of murine embryonic stem cells production.   
 
3.2.5 (a) Laparoscopic ovum pick-up derived caprine oocytes 
The laparoscopic ovum pick-up procedure was a big project which involved a group of 
people who worked as a team. During the laparoscopic ovum pick-up procedure, a team 
of researchers was involved to carry out various activities such as administration of 
anesthetics, surgery and oocytes pick-up. The surgery was conducted by the supervisors 
and oocytes pick-up was carried out by the embryologists including the author. The 
caprine oocytes obtained from laparoscopic ovum pick-up were subsequently 
subdivided to other researchers for various experiments. 
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3.2.5 (b) Caprine oocyte retrieval via ovariectomy 
Usually, the caprine donor failed to be hyperstimulated after repeated oocyte retrieved 
surgeries or when the ovary was physically abnormal, for example, adhesion, polycystic 
ovary syndrome, degenerative ovary, these ovaries were surgically removed 
(ovariectomy) from the caprine donor. These animals were not hormonally treated for 
oestrus syncronisation and superovulation. A middle skin incision (longitudinal 
abdominal incision) was made (3 to 5 cm) at the abdomen part of the caprine donor. 
The ovaries were then removed and collected in a polystyrene culture dish (35 mm; 
Becton Dickinson Labware, USA) with the warmed flushing medium. The ovary was 
held with the help of forceps and was sliced by using a scalpel blade. The Petri dish was 
then examined under a stereomicroscope (magnification 20x or 40x). Oocytes were then 
washed in flushing medium and cultured according to oocyte grades for subsequent in 
vitro maturation-somatic cell nuclear transfer (SCNT) procedures. 
 
3.2.5 (c) Abattoir-derived caprine ovaries 
Caprine ovaries from abattoir were collected within 1 hour of slaughter in sterile saline 
(0.9% NaCl) supplemented with penicillin-G (100000 IU) and streptomycin sulphate 
(100 mg/liter) and transported to the laboratory at 35ºC to 37ºC within 1 to 2 hours of 
slaughter in a thermos flask (Megatrade Instumental Inc., USA). The breed, origin and 
health status of the does were unknown. Therefore, the collected ovaries were 
regardless of the phase of oestrus cycle and pregnancy.  
 
3.2.5 (d) Caprine blastocyst derived from uterine flushing 
A 4 cm long incision was made on the skin along the mid-abdominal wall which 2 cm 
away from the udder by using a scalpel blade (Size 15, BB515, Aesculap, Germany). 
The incision was continued further on the underlying tissues and peritoneum layer along 
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the linea alba. The uterine horns along with the ovaries were taken out and the number 
of corpora luteum in each ovary was recorded. Using the modified technique of flushing 
of embryos in sheep, a puncture wound was made on each uterine horn near the 
bifurcation of the uterus using a small pair of haemostatic forceps (BH 104, Aesculap, 
Germany). A 2 way size 8 Foley Catheter (Inmed Paediatric Balloon Catheter, USA) 
was then inserted through the puncture to a deep of 3 cm. The balloon of the catheter 
was sufficiently inflated to completely obstruct the lumen at the caudal end of each 
uterine horn. A Teflon intravenous (I.V.) Catheter placement unit fixed with a 20 gauge 
needle (Vasocan, B. Braun, Germany) was introduced closer to the anterior end of the 
uterine horn. Then, the Teflon intravenous Catheter needle was removed and 20 ml 
sterile disposable syringe (Terumo, Japan) fixed to the end of the Teflon Catheter. The 
fluid contents of the uterine horn were collected through the free end of the Foley 
Catheter. This was repeated with a further 20 ml of the flushing medium. Subsequently 
the same procedure was used for the flushing of the other uterine horn if at least one 
corpus luteum was present in the respective ovary. After flushing completed, the 
surgical incision was sutured with catgut (size 2, Aesculap, Germany). The incised skin 
was closed with size 2 surgical grade silk suture material (B. Braun, Germany) and 
sprayed with Gusanex aerosol (1% w/w Dichlofenthione; Coopers, Pitman Moore, 
Malaysia) as a fly repellent (Figure 3.1). 
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Figure 3.1: Surgical instruments for uterine flushing in caprine. 
 
3.2.5 (e) Recovery of murine oocytes  
The superovulated female murine were sacrificed at the time of ovulation was 
conducted by 13-15 hours post hCG injection. The female murine was sacrificed by 
cervical dislocation. The coils of female murine gut were pushed out of the way and the 
2 horns of the uterus that was ovaries and oviducts were located. The upper end of one 
of the uterine horns was grasped fine forceps and gently pulls the uterus, oviduct, ovary 
and fat pad taut and away from the body cavity. This will reveal a fine membrane as the 
mesometrium, which connects the reproductive tract to the body wall and carries a 
prominent blood vessel. In the membrane, a hole was poked that close to the oviduct 
with the closed tips of a pair of fine forceps or scissors. The oviduct was transferred into 
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Petri dish with Hepes Whitten’s medium (50 µl). Oviducts from several murine can be 
collected in the same dish. 
 The freshly ovulated oocytes as cumulus oocyte complexes (COC) that 
surrounded by cumulus cells, are found in the upper part of the oviduct (ampulla), 
which at this time (12 hours post-ovulation) is much enlarged. The fimbriae end of the 
oviduct (infundibulum) is also swollen during ovulation and can be easily be located 
under 20x magnifications in the stereomicroscope. A pair of needle (26 G) was used to 
hold the swollen infundibulum firmly on the bottom of the dish and another to tear the 
ampulla where the cumulus oocyte complexes are located. The cumulus oocyte 
complexes (eggs surrounded with cumulus mass) were released. The cumulus oocyte 
complexes were immediately placed into hyaluronidase (0.2%) to remove the cumulus 
surrounding. The matured murine oocytes with polar bodies were selected for further 
cloning experiment. 
  
3.2.5 (f) Recovery of in vivo produced murine embryos from superovulated female  
              Murine 
 
In vivo produced murine embryos at 2-cell stage and blastocyst were used. Briefly, 
murine were housed in an environmentally controlled room (25ºC) with a constant 
photoperiod (12 light: 12 dark), with commercial pellets and water available ad libitum. 
Female murine (6 to 8 weeks old) were superovulated with an intraperitoneal (i.p.) 
injection of pregnant mare serum gonadotrophin (PMSG; 10 IU) followed by an 
intraperitoneal injection of human chorionic gonadotrophin (hCG; 10 IU) at 46 to 48 
hours later. Each female murine was then placed in a cage with a stud male and 
copulation plug was checked on the next morning (day 1 pregnancy).  
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3.2.5 (f) (i) Recovery 2-cell stage murine embryos 
To collect 2-cell stage murine embryos, oviducts of superovulated female murine were 
excised from day 2 pregnant female that had mated with the male murine. The oviducts 
were flushed with Hepes Whitten’s medium using a flushing needle (32 G) connected to 
a syringe (1 ml). Collected embryos were washed 3 times in equilibrated Whitten’s 
medium  and cultured under purified mineral oil at 37.5ºC in CO2 (5%) in humidified 
air for in vitro development prior to the embryonic stem cell procedures. 
 
3.2.5 (f) (ii) Recovery of murine blastocysts 
Generally, murine blastocyst stage will be located in the uterus. Blastocysts were 
flushed from the uterus between days 3.5 to 4.5 post-coitus. After exposing the 
abdomen of the murine and locating the uterus, the uterus was removed. The uterus was 
held with forceps just above the cervix which was located directly above the bladder. 
The cervix was cut across using fine scissors. The uterus was completely removed by 
cutting below the junction with the oviduct on both horns. After removing the uterus, it 
was place in a Petri dish containing modified Hepes Whitten’s medium. Both horns 
were flushed with Hepes Whitten’s medium using 26 G, ½ inch needles attached to 1 
ml syringes. The blastocysts will be flushed out, detected using stereomicroscope and 
picked-up using puller pipettes. The embryos were then washed with Hepes Whitten’s 
medium for 3 times and Whitten’s medium for 2 times and subsequently in vitro 
cultured in Whitten’s medium at 37ºC incubator.  
 
3.2.6 Chemicals 
All chemicals, reagents and media used were purchased mainly from Sigma-Aldrich 
Co. from USA. A detailed complete list of all the chemicals and reagents with their 
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catalogue numbers, supplier’s and manufacturer’s names are found in Appendix Table 
1.3.  
 
3.3 METHODS 
There are 4 main subsections has been divided in methodology section, namely 1) 
preparations for a successful in vitro produced environment, 2) preparation of stock 
solutions and media, 3) preparation of microtools and 4) experimental procedures.  
 
3.3.1 Preparations for a Successful In Vitro Produced Environment 
For successful cloning and stem cell research, it is very important to ensure that 
facilities and laboratory activities adhere to strict cleanliness regimes throughout all 
experimental procedures. Cleanliness and sterilisation are the main priority when each 
time an experiment is carried out to prevent contamination by microorganisms such as 
bacteria and fungus. A small amount of contaminant will ruin the entire cell culture 
even very little amount where the microorganisms are able to multiply rapidly in the 
nutrient-rich media. It is the responsibility of the laboratory user to maintain the 
laboratory in sterile to optimise the output of cloning and stem cell culture works. It is 
utmost important to minimise the potential introduction of contaminants to the in vitro 
produced work space, especially for oocyte or embryo handling and culture systems.  
 
3.3.1.1 Water quality  
In present study, all the media is mainly prepared using ultrapure water as based 
medium. Therefore, a reliable source of ultrapure water system is necessary to prevent 
bacterial contamination from the environment. We used ultrapure water system (Milli-Q 
UF Plus) which included particular filtration, activated carbon cartridge filtration, 
reverse osmosis (RO) and electrodeionisation (EDI), ultraviolet oxidation system 
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followed by Milli-Q UF Plus of at least 18 MΩ cm. The filtration of the ultrapure water 
system was through a membrane filter (0.22 µm) to eliminate trace particles and prevent 
bacterial contamination. 
 
3.3.1.2 Cleanliness and sterilisation for general laboratory research 
All the solution and media were prepared inside a laminar flow work station (Gelman 
Sciences, Australia). The surface of the laminar flow and work bench were also cleaned 
and wiped with 70% ethanol (HmbG Chemicals, Germany) before and after used. For 
the bottles containing reagents and media, and apparatus such as pipettes were flamed 
before used to make it more sterile. All the Pyrex glass wares and surgical instruments 
were initially soaked in 7x detergent (1% v/v) (Libro, Flow Laboratories, Australia Pte. 
Ltd.), scrubbed thoroughly inside-out using a brush or sponge and then washed under 
running tap water. Then, they were rinsed thoroughly with reversed-osmosis (RO) water 
(Milli-Q System, Millipore Products, USA). After finished rinsed, the cap of glassware 
was places loosely and covered snugly with a layer of aluminium foil. Autoclave tape 
was placed onto the aluminum cover for identification of autoclaved items later. 
Alternatively, conical tubes were placed in an autoclave bag and sealed tightly; a piece 
of autoclave tape was placed on the autoclave bag. They were autoclaved (“Hiclave” 
Model HA-300M11, Hirayama, Tokyo, Japan) at 121°C for 25 minutes and dried in an 
oven at 60°C before stored in a cool, dry plastic container. After autoclaving was done, 
the glassware cap was tightened a little bit to prevent any contaminants from entering. 
The cap was not tightened completely until the glassware had cooled to prevent a 
vacuum forming in the glassware. 
For the reusing pasteur pipettes, they were first thoroughly cleaned by soaking 
them in diluted 7x detergent for at least an hour. The inner walls of the pipettes were 
washed by pipetting up and down with 7x detergent, and then rinsed with tap water until 
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the bubbles from the detergent were gone. The pipettes were further cleaned through the 
same procedure using 70% ethanol. The outer walls were sprayed with 70% ethanol and 
finally rinsed with reversed osmosis water, before being autoclaved. Besides cleaned 
with 70% ethanol before and after used, all apparatus were irradiated using ultra-violet 
(UV) light for 15 to 30 minutes prior to each experiment.  
 
3.3.1.3 Maintenance of carbon dioxide (CO2) incubator 
For culturing the embryos development in vitro in CO2 incubator, 5% concentration of 
CO2 is required to maintain the correct pH (pH 7.2 to 7.4) in bicarbonate-buffered 
culture media systems. The CO2 incubator (HERAcell 240; Kendro Laboratory 
Products, Germany) was monitored regularly and LED display of temperature checked 
with independent readings. It is important to ensure the CO2 incubator must maintain at 
38.5ºC for caprine embryo whereas for murine sample, the temperature for CO2 
incubator should maintain at 37ºC to obtain the optimum cleavage rate. Besides  CO2 
(5%) in humidified air, triple gas mixture of CO2 (5%), O2 (5%) and N2 (90%) gas 
phase was needed to increase the optimum environment for embryos development in 
vitro.  
 Generally, CO2 incubator was cleaned very month involved wiping inside walls, 
doors and racks with sterile reverse osmosis water and sterile towel or gauze. The tray 
was always filled or contained with sterile reverse osmosis water and changes in every 
cleaning regime for providing humidity environment in CO2 incubator. Kept the 
minimum repeated opening and closing of CO2 incubator to stabilise the culture 
environment.  
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3.3.1.4 Mineral oil  
There were various types of oil that were used to overlay the microdroplets for culturing 
oocytes and embryos, namely mineral oil, paraffin oil or silicone oil. In current study, 
mineral oil (M8410; Sigma-Aldrich Co., USA) was used to overlay in vitro maturation, 
somatic cell nuclear transfer and in vitro culture microdroplets. Mineral oil are best for 
this purpose compared to silicone oil because it less toxic to oocytes and embryos as 
well as clear in appearance. The main purpose of using mineral oil is to prevent 
evaporation and delay gas diffusion as well as stabilises the pH, temperature and 
osmolarity of the microenvironment surrounding the oocytes and embryos during taking 
outside the CO2 incubator.  
 
3.3.2 Preparation of Stock Solutions and Media 
 All stock solutions and media were prepared before experiment were carried out. The 
methods of preparations were shown as below: 
 
3.3.2 (a) Preparation of Stock and Solutions and Media 
All fundamental stock solutions prepared were filter-sterilised using syringe-driven 
Millex
©
-GS filter (0.22 mm; Milipore, Ireland), aliquot and stored in the refrigerator (2 
to 8ºC) or freezer (-20ºC) as appropriate. Usually, fresh solution and culture media were 
prepared weekly. For aseptic purposes, all medium and solution preparations were 
carried out in the laminar flow. The purified Milli-Q water was used as the base solution 
for preparing the medium. All chemicals in powder form were measured using a digital 
analytical balance and dissolved in Milli-Q water whereas chemicals in liquid form 
were measured using sterile disposable plastic pipettes. The pH of medium was 
measured using pH meter (7.2 to 7.4) while an osmometer was used to adjust the 
 123 
 
osmolarity (280 to 285 mOsm) of the media. The entire prepared medium was filtered 
by filtration using disposable Millipore filter (0.22 µm). 
  
3.3.2 (a) (i) Preparation of normal saline 
Generally, normal saline was prepared in a 1 L bottle (Duran, Germany) by adding 9 g 
sodium chloride (0.9% w/v; Sigma-Aldrich Co., USA) in 1 L of Mili-Q water for 
surgery without any antibacterial chemicals. Normal saline was autoclaved to make it 
sterile and could kept for 3 months in the refrigerator (2 to 8ºC) for future use. 
 
3.3.2 (a) (ii) Preparation of Dulbecco’s phosphate buffered saline 
Dulbecco’s phosphate buffered saline (DPBS) was usually prepared in 1 L bottle by 
dissolving 10 phosphate buffered saline tablets (Dulbeccos A, BR0014G; Oxoid Ltd., 
England) in 1 L of Mili-Q water. This mean 1 tablet phosphate buffered saline in each 
100 ml of Mili-Q water. Same as normal saline, the Dulbecco’s phosphate buffered 
saline was sterilsed by autoclaving and could kept for 3 months in the refrigerator (2 to 
8ºC) for future use . 
 
3.3.2 (a) (iii) Preparation of ovary collection medium 
Ovary collection medium was prepared as normal saline except it supplemented with 
gentamycin sulphate (G1264; Sigma-Aldrich Co., USA). The purpose of ovary 
collection medium is used for washing and collecting ovaries from abattoir. Gentamycin 
sulphate (30 ug/ml) was weighed and dissolved in normal saline solution that was 
prepared earlier and kept in the refrigerator to obtain the final volume (300 ml) (Table 
3.1). The ovary collection medium was warmed in water bath at 38.5ºC before being 
used. 
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Table 3.1: Composition of ovary collection medium 
Components Concentration Volume/weight 
Autoclaved normal saline 1x 300 ml 
Gentamycin sulphate 30 µg/ml     9 mg 
 Total volume 300 ml 
 
 
3.3.2 (a) (iv) Preparation of ovary slicing medium  
Ovary slicing medium also known as TL-hepes was used for rinsing, washing and 
slicing of ovaries collected either from ovariectomised or abattoir-derived ovaries 
before transferring into the maturation medium. The stock solution of TL-hepes was 
prepared as shown in Table 3.2.  
 
 
Table 3.2: Composition of TL-hepes stock solution 
 
Components Sigma Cat. No. Final Conc. 
(mM) 
g/1000 ml 
NaCl S 5886  114 6.6600 
KCl P 5405   3.2 0.2400 
NaHCO3 S 5761   2.0 0.1680 
NaH2PO4.H2O S 9638   0.4 0.0560 
Na Lactate (60%Syrup) L 7900 10.0 1.8600 ml 
CaCl2.2H2O C 3881   2.0 0.3000 
MgCl2.6H2O M 2393   0.5 0.1000 
HEPES C8H17N2O4SNa H 0763 or H 3784 10.0 1.2000 
C8H18N2O4S H 3375 or H 6147 1.2000 
Penicillin G PEN-NA 100 IU/ml 0.0650 
Phenol Red P 3532  0.0050 
 
The TL-hepes stock solution was check for pH (7.4 ± 0.5) and osmolarity (255 
to 270 mOsm) The TL-hepes stock was filtered (0.2 μm) into sterile bottles and store at 
4
o
C for 1 to 2 weeks. Before using as ovary slicing medium, TL-hepes stock solution 
should supplemented with gentamycin sulphate, sodium pyruvate (P4562) and bovine 
serum albumin-fraction V (A7030) as shown in Table 3.3. 
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Tab le 3.3: Composition of TL-hepes working solution 
 
 
 
Prepare the working solution on the day of use and were filtered (0.2 μm) and used 
freshly. However, TL-hepes working solution can be prepared directly and whole 
solution can be used within 3 to 4 days. 
 
3.3.2 (a) (v) Preparation of flushing medium for laparoscopic ovum pick-up 
Flushing medium (300 ml) was prepared within 12 hours before oocytes retrieval by 
laparoscopic ovum pick-up. The flushing medium was used for flushing microvolumes 
of fluid into the ovarian follicle and aspirated with the oocytes together with fluid from 
the follicle was connected to an aspiration system (a vacuum pump). The aspirated 
medium was collected in test tube to be searched for oocytes under stereomicroscope. 
The flushing medium consisted of Dulbecco’s phosphate buffered saline supplemented 
with gentamycin sulphate (50 µ/ml; Sigma-Aldrich Co., USA) and heparin (50 µ/ml; 
H0777; Sigma-Aldrich Co., USA) as depicted in Table 3.4. The flushing medium was 
filter-strilised using syringe-driven Millex
©
-GS filter (0.22 mm; Milipore, Ireland), 
aliquot into syringe (50 ml; Terumo Corporation, Japan) maintained at 38.5ºC prior to 
oocytes retrieval (Table 3.4). 
 
 
 
 
 
Chemicals Volume/weight 
TL-hepes stock solution      100 ml 
Gentamycin stock solution        50 µl 
Sodium pyruvate (Sigma; P4562) 0.0022 g 
BSA-fraction V (Sigma; A7030) 0.1000 g 
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Table 3.4: Composition of flushing medium (1000 ml or 1 L) 
 
Chemical component 
(Catalogue number) 
Final concentration Quantity/1000 ml 
Phosphate-buffered saline 
(PBS) tablets (P4417) 
1 tablet/100 ml PBS (10 tablets) were dissolved 
in Mili-Q water (100 ml), 
sterilised by autoclaving. 
Gentamycin sulphate 
(G3632) 
50 µg/ml Gentamycin sulphate (50 mg) 
was dissolved in phosphate-
buffered saline solution (1000 
ml) prior to use. 
Heparin (H0777) 50 µg/ml Heparin (50 mg) was dissolved 
in phosphate-buffered saline 
solution (1000 ml) prior to use. 
 
 
3.3.2 (a) (vi) Blood collection and preparation of oestrus goat serum (OGS) 
The caprine blood samples were collected aseptically through jugular vein from caprine 
synchronised for oestrus using vacutainer tubes (without heparin) with a needle (21 G). 
The fresh collected blood was distributed into sterile conical tube (15 ml) and kept in 
laminar flow at room temperature for approximately 3 hours to obtain the serum from 
clotted blood.   
 
3.3.2 (a) (vii) Heat-inactivation  
The conical tubes containing clotted blood were centrifuged (3000 rpm) for 10 minutes 
at 25ºC. The supernatant (serum) was aspirated out the placed in a sterile conical flask 
and heat-inactivated in a water bath for 30 minutes at 56ºC to destroy components that 
might lead to cell lysis by antibody binding. The serum was removed from the water 
bath after 30 minutes of treatment at 56ºC to let it cooling at room temperature (25ºC). 
Prolong heat treatment could cause deterioration of some components of the serum. The 
serum was centrifuged again at 1000 rpm, for 10 minutes at 25ºC to sediment residual 
erythrocytes after cooling to room temperature. The oestrus goat serum was aliquot into 
small microcentrifuge tubes (1.5 ml) and stored at -20ºC for 6 months. 
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3.3.2 (a) (viii) Preparation of oestrus goat serum (OGS) 
Oestrus goat serum (OGS) was supplemented in the culture media to provide additional 
growth factors, hormones and pipettes which may be present in the serum. 
 
3.3.2 (a) (viiii) Preparation of in vitro maturation (IVM) medium 
In vitro maturation (IVM) medium was prepared a day before and equilibrated 
overnight in the CO2 incubator (5%) prior to oocyte retrieval. The maturation medium 
used was TCM 199 supplemented with cystein (0.0085 g; Sigma-Aldrich, Co., USA, 
C2529), bFSH (10 µg/ml; Folltropin-V
R 
, Vetripharm,  L032-B053), 17 β-oestradiol (1 
µg/ml; Sigma-Aldrich, Co., USA,  E8875), sodium pyruvate (0.22 Mm; Sigma- Aldrich 
Co., USA, P-4562), gentamycin sulphate (50 µg/ml; Sigma-Aldrich Co., USA, G3632) 
and foetal bovine serum (10%; Gibco BRL,16000-044) as depicted in Table 3.5. 
 
Table 3.5: Composition of in vitro maturation medium (10 ml) 
Components Volume/ml 
TCM-199  8.9 ml 
Foetal bovine serum  1.0 ml 
TCM-pyruvate 100 μl 
Bfsh   10 μl 
Gentamycin sulphate    5 μl 
 
After added with all the chemicals above, the in vitro maturation medium was filtered 
(0.2 μm) in a 15 ml centrifuge tube. After that, the 17 β-oestradiol stock (1.0 μl/ml) was 
added to the above solution. Pre-incubated the in vitro maturation medium at least 3 
hours in CO2 incubator set at  CO2 (5%), 38.5
o
C in humidified air. 
 
3.3.2 (a) (x) Preparation of hyaluronidase solution (0.2%) 
Hyaluronidase solution was used to denude cumulus complexes oocytes after 
maturation. A type IV-S hyaluronidase from bovine testes (H4272; Sigma-Aldrich Co., 
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USA) was used to prepare hyaluronidase solution. The preparation of mDPBS was 
depicted as Table 3.6. The hyaluronidase solution was prepared by added 
polyvinylpyrrolidone (PVP) (0.05 g) and hyaluronidase (0.10 g) into 50 ml mDPBS 
(Table 3.7). The prepared solution was filter-sterilesed by Millex©-GS filter (0.22 mm; 
Millipore. Ireland) and aliquot (100 µl) in microcentrifuge tubes (0.5 ml; Eppendorf 
GmbH, Germany) and stored for 6 months in the freezer (-20°C) (Tables 3.6 and 3.7). 
 
Table 3.6: Based medium for hyaluronidase solution (mDPBS) 
Components Volume/weight 
NaCl 4.0000 g 
KCl 0.1000 g 
KH2PO4 0.1000 g 
Na2HPO4 0.5750 g 
Glucose 0.5000 g 
Pyruvic acid 0.0180 g 
CaCl2.2HZO 0.0687 g 
MgCl2.6H2O 0.0500 g 
Penicillin-streptomycin (stock 100 x)     500 µl 
Ultrapure water     500 ml 
 
 
Table 3.7: Composition of hyaluronidase solution (0.2%) 
Components Volume/weight 
Hyaluronidase 0.1000 g 
Polyvinylpyrrolidone (PVP360) 0.0500 g 
mDPBS        50 ml 
 
 
3.3.2 (a) (xi) Preparation of polyvinylpyrrolidone (PVP) (10%) 
The polyvinylpyrrolidone (PVP 360; Sigma-Aldrich Co., USA) was used in somatic 
cell nuclear transfer during donor cell injection. The function of polyvinylpyrrolidone is 
to make the donor cell became swollen and easier to break the membrane of donor cell 
during nuclear transfer procedure. Usually 10% of polyvinylpyrrolidone was used in 
this study. The polyvinylpyrrolidone was prepared as shown in Table 3.8. 
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Table 3.8: Composition of polyvinylpyrrolidone  
Components Volume/weight 
Polyvinylpyrrolidone 0.1000 g 
TL-HEPES working solution    1000 ml 
 
 
3.3.2 (a) (xii) Preparation of cytochalasin B (CB) stock 
Preparation of cytochalasin B stock was in 100x which cytochalasin B (1 mg) was 
mixed with dimethyl sulfoxide (DMSO) (2 ml) to make sure that cytochalasin B is 
completely dissolved and aliquot into small microcentrifuge tube (10 µl) and could be 
stored at -20°C (Table 3.9). Before the experiment, the working solution of cytochalasin 
B was prepared by adding with holding medium (990 µl) (Table 3.10) and mixed well 
and it will be ready to use. 
 
Table 3.9: Preparation of cytochalasin B (CB) stock 
Components Volume/weight 
Cytochalsain B (CB) 1 mg 
DMSO 2 ml 
 
 
Table 3.10 Preparation of cytochalasin B (CB) working solution 
Components Volume/weight 
TL-hepes working solution 990 µl 
Cytochalasin B (stock)   10 µl 
 
 
3.3.2 (a) (xiii) Preparation of calcium ionophore solution 
Calcium ionophore (Ca
2+
 ionophore; I0634; Sigma-Aldrich Co., USA) was used to 
activate caprine oocytes after the somatic cell nuclear transfer. A solution containing 
dimethyl sulfoxide and absolute ethanol in 3:1 ratio was prepared and the whole content 
of calcium ionophore vial (1 mg) was dissolved into dimethyl sulfoxide-ethanol 
solution (1.34 ml),labeled as ‘Stock A’. The concentration of ‘Stock A’ solution was 1 
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mM. The ‘Stock A’ was aliquot (10 µl) into each microcentrifuge tube (0.2 µl; 
Eppendorf GmbH, Germany) and wrapped in aluminium foil and could be stored up to 
6 months in the freezer (-20°C). On the day of experiment, one tube of ‘Stock A’ was 
taken out from freezer and in vitro culture medium (90 µl) was added. The solution with 
(100 µl) was mixed properly and labeled as ‘Stock B’ with concentration 100 µM. From 
‘Stock B’, 10 µl was withdrawn and diluted again with in vitro culture medium (90 µl) 
to make it final concentration (10 µM) to activate caprine oocytes. 
 
3.3.2 (a) (xiiii) Preparation of 6-dimethylamino pyridine (6-DMAP) solution 
In present study, 0.2 M concentration is the final concentration for activation in caprine 
oocytes. 0.25 mg of 6-dimethylamino pyridine was diluted with 7.7 ml to make 0.2 M 
concentration. After diluted, the 6-dimethylamino pyridine was aliquot into small 
microcentrifuge tubes (10 µl) and stored at -20°C as ‘Stock A’. The day before 
treatment, 10 µl of ‘Stock A’ was withdrawn and diluted again with in vitro culture 
medium (990 µl) to use for activated caprine oocytes. 
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3.3.2 (a) (xv) Preparation of k simplex optimisation medium (KSOM) stock  
              solution for caprine  
 
The k simplex optimisation medium (KSOM) stock solution was prepared as shown in 
Tables 3.11 and 3.12 
 
Table 3.11: Composition of KSOM stock solution for caprine 
 
Component Cat.No. Mol.wt Conc. (mmol/l) g/100ml g/200ml 
NaCl S-5886   58.45    95 0.5553  1.1106  
KCl p-5405   74.56   2.5 0.0186  0.0373  
KH2PO4 P-5655 136.09 0.35 0.0048  0.0095  
MgSO4 M-7506   120.4  0.2 0.0024  0.0048  
Lactate L-7900   112.1   10 0.1860 ml  0.3720 ml  
Pyruvate P-4562 110.04  0.2 0.0022  0.0044  
D-Glucose G-6152 179.86  0.2 0.0036  0.0072  
NaHCO3 S-5761   84.02   25 0.2101  0.4201  
CaCl2 C-5670      111 1.71 0.0190  0.0380  
L-Glutamine G-3126   146.1      1 0.0146  0.0292  
EDTA E-9884   292.2 0.01 
0.0004  (10 μl of 
0.5 M EDTA, pH 
8.0) 
0.0007  (10 μl of 
0.5 M EDTA, pH 
8.0)  
 
Filter (0.2 µ) and store at 4
0
C for up to 4 weeks. 
 
 
Table 3.12: Composition of KSOM working solution 
 
Component Cat.No. Amount/10 ml 
Stock -     9.85 ml 
BSA A-6003 0.0400 g 
MEM M-7145       50 µl 
BME B-6766     100 µl 
 
After prepared the working solution of KSOM, the medium was filtered (0.2 µm) and 
preincubate for at least 2 hours in CO2 incubator before used. An additional D-glucose 
(0.004g) was added into KSOM working solution for culturing later stage of bovine and 
caprine embryos (P.J. Kwong, personal communication). 
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3.3.2 (b) Preparation of Media and Solution for Murine Sample 
Various medium were used in the present study in murine experiment. These media 
were the in vitro culture medium (modified Whitten’s Medium), embryo handling 
medium (modified Hepes Whitten’s  medium), mouse embryonic fibroblasts culture 
medium, mouse embryonic fibroblasts washing medium, mouse embryonic fibroblasts 
cryopreservation medium and embryonic stem cell culture medium. Media were 
prepared and stored in scotch bottles (100 ml and 250 ml) and could kept at 4°C in the 
refrigerator. Media without the addition of bovine serum albumin (BSA) can be stored 
for up to 3 months. After the addition of bovine serum albumin to media (Whitten’s 
medium and Hepes Whitten’s medium), they must be used within a week. 
 
3.3.2 (b) (i) Preparation of Modified Whitten’s medium (WM medium) 
Modified Whitten’s medium was prepared based on Whitten’s medium with a few 
modifications such as the addition of sodium ethylenediaminetetraacetic acid (EDTA). 
This medium was used for the in vitro culture of murine embryos develop to the 
blastocyst stage. The Whitten’s medium that supplemented with 
ethylenediaminetetraacetic acid enhances embryo development into blastocysts 
(Abramczuk et al., 1977). Sodium ethylenediaminetetraacetic acid stock (10 mM) was 
prepared separately beforehand by dissolving a measured amount of sodium 
ethylenediaminetetraacetic acid in Milli-Q water. Along with other chemical ingredients 
except bovine serum albumin was dissolved in Milli-Q water to make up 100 ml of 
stock WM medium. The pH of medium was checked using the pH meter and adjusted to 
pH 7.25. The osmolarity of was checked by using the osmometer and adjusted to 285 
mOsm. The stock medium was then filtered using sterile filters (0.22 µm pore size) into 
Scott bottle (250 ml). Bovine serum albumin (3%) was added to the stock medium 
before used for experiment (Table 3.13).  
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Table 3.13: Chemicals used in the preparation of modified WM medium 
 
Chemicals g / 100 ml 
NaCl 0.5140 
KCl 0.0356 
KH2PO4 0.0162 
MgSO4.7H2O 0.0294 
NaHCO3 0.1900 
Glucose 0.1000 
Calcium lactate 0.0338 
Lactic acid 0.37 ml 
Natrium pyruvate 0.0029 
Penicillin 0.0075 
Streptomycin 0.0050 
L-glutamine 0.0146 
Taurine 0.0125 
Phenol red 0.0010 
Na2 EDTA 0.10 ml 
BSA 0.3000 
 
3.3.2 (b) (ii) Preparation of Modified Hepes Whitten’s medium (HWM medium) 
Hepes Whitten’s medium was used for embryo manipulation outside the incubator, such 
as embryo washing and embryo pick-up. All chemicals except for bovine serum 
albumin were diluted in Milli-Q water (50 ml). After all the chemicals had dissolved, 
additional Milli-Q water was added to make a stock solution of 100 ml. pH of this 
medium was checked and adjusted to 7.25 and osmolarity adjusted to 275 to 325 
mOsm. The medium was then filtered with sterile filter and stored at 4°C in the 
refrigerator. Same as the Whitten’s Medium, the stock medium were aliquot and bovine 
serum albumin (3%) was added. The chemicals used in the preparation of modified 
HWM medium as given in Table 3.14. 
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Table 3.14: Chemicals used in the preparation of modified HWM medium 
 
Chemicals g / 100 ml 
NaCl 0.5140 
KCl 0.0356 
KH2PO4 0.0162 
MgSO4.7H2O 0.0294 
NaHCO3 0.1900 
Glucose 0.1000 
Calcium lactate 0.0338 
Lactic acid 0.37 ml 
Natrium pyruvate 0.0029 
Penicillin 0.0075 
Streptomycin 0.0050 
L-glutamine 0.0146 
Taurine 0.0125 
Phenol red 0.0010 
Na2 EDTA 0.10 ml 
BSA 0.3000 
 
3.3.2 (b) (iii) Preparation of strontium chloride (Sr
2+
) for oocyte activation 
Strontium chloride is used for murine oocyte activation after nuclear transfer. 
SrCl2.6H2O powder was weight 2.666 g and directly put into 100 ml of Milli-Q water. 
Then, let the powder completely dissolved and aliquot small volume into the vials 
(10ul/vial) and keep 4°C.  
 
3.3.2 (b) (iv) Preparation of tissue culture medium for mouse embryonic  
                        fibroblasts 
 
There were 2 types of tissue culture medium for mouse embryonic fibroblasts, namely 
alpha minimum essential medium (αMEM) and Dulbecco’s modified eagle medium 
(DMEM). For alpha minimum essential medium, the tissue culture medium was 
prepared by adding alpha minimum essential medium (αMEM) (M0644- 1L; Sigma-
Aldrich Co., USA) with sodium bicarbonate (NaHCO3, 2.2 g; Sigma-Aldrich Co., USA) 
into 1 L sterile Mili-Q water and mixed well by magnetic stirrer. The Dulbecco’s 
modified eagle medium (D5796-1L) component comes prepared in solution form which 
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purchase from ready-made stock solution from Sigma-Aldrich Co., USA consisted 4500 
mg glucose/L, L-glutamine, NaHCO3, pyridoxine and HCL. Thus only foetal bovine 
serum and antibiotics need to be added. The foetal bovine serum must be heat-
inactivated in the water bath at 56°C for 30 minutes before used. The medium was then 
filtered with sterile filter and stored at 4°C in the refrigerator and can last for 1 month 
(Tables 3.15, 3.16 and 3.17).  
 
Table 3.15: Alpha minimum essential medium (αMEM) stock solution (1 L) 
Chemicals  Amount 
αMEM (powder) Whole bottle 
NaHCO3 2.2 g 
Mili-Q water 1   L 
 
Table 3.16: Alpha minimum essential medium (αMEM) working solution (100 ml) 
Chemical Amount 
αMEM (Stock solution)   90 ml 
Foetal bovine serum   10 ml 
Penicillin-streptomycin 300 µl (3X) or 100 µl (1X) 
 
Table 3.17: Dulbecco’s modified eagle medium (DMEM) working solution (100 ml) 
Chemical Amount 
DMEM (Stock solution)   90 ml 
Foetal bovine serum   10 ml 
Penicillin-streptomycin 300 µl (3X) or 100 µl (1X) 
 
 
3.3.2 (b) (v) Freezing medium for mouse embryonic fibroblasts 
In freezing medium, the percentage of foetal bovine serum is higher compared to tissue 
culture medium which is 20%. Besides that, the freezing medium also with the addition 
of dimethyl sulfoxide (20%) which is sensitive to light. Therefore, the prepared freezing 
medium should be wrapped with aluminium foil after being filtered and was stored at 
4°C in the refrigerator. The freezing medium could last for 1 to 2 weeks.  
 
 136 
 
3.3.2 (b) (vi) Embryonic stem cells culture medium 
Embryonic stem cells culture medium (Table 3.18) was used to culture both the inner 
cell mass outgrowth from the blastocyst as well as subsequent passages of embryonic 
stem cells. Alpha minimum essential medium and Dulbecco’s modified eagle medium 
(αMEM and DMEM) were used as the base medium to campare the growth rate of 
embryonic stem cells in different medium. The only differences from the mouse 
embryonic fibroblast culture medium are the addition of leukaemia inhibitory factor and 
beta-mercaptoethanol to maintain the embryonic stem cells in an undifferentiated state. 
Filtering was done and was stored in 4°C refrigerator for 1 month. The medium was 
warmed up to 38°C before used. The components of embryonic stem cells culture 
medium are given in Table 3.18. 
 
Table 3.18: Embryonic stem cell culture medium (50 ml) 
Chemicals Volume Concentration 
α-MEM/DMEM 38.5 ml  
Foetal bovine serum    10 ml   20% 
Penicillin-streptomycin    50 µl   Standard 
L-glutamine   0.5 ml       1mM 
MEM-NEAA   0.5 ml    0.1 mM 
β-merchaptoethanol   0.5 ml    0.1 mM 
Leukaemia inhibitory factor    10 µl 1000 IU/ml 
 
3.3.2 (b) (vii) Freezing medium for embryonic stem cells 
For cryopreserved the embryonic stem cells, freezing medium was prepared as depicted 
in Table 3.19. Foetal bovine serum (10%) was added as well as dimethyl sulfoxide 
(20%) into freezing medium. Besides that, penicillin and streptomycin were also added 
to prevent bacteria growth. Since the dimethyl sulfoxide was sensitive to light, the 
prepared freezing medium was wrapped with aluminium foil after being filtered and 
was stored at 4°C in the refrigerator. The freezing medium could last for 1 to 2 weeks. 
The components of freezing medium for embryonic stem cells as given in Table 3.19.  
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Table 3.19: Freezing medium for embryonic stem cells (10 ml) 
Chemicals Volume 
Embryonic stem cell culture medium 6 ml 
Foetal bovine serum (Hyclone; 
SH30070.03) 
2 ml 
DMSO 2 ml 
 
3.3.3 Preparation of Solutions in Murine 
In the present study, there were several types of hormones and solutions used. For 
example,  superovulation hormones (pregnant mare’s serum gonadotrophin and human 
chorionic gonadotrophin), cell washing solution (PBS-; phosphate buffered saline 
without Ca
2+
 and Mg
2+
), trypsinisation solution, gelatin (0.1%), mitomycin C and 
pronase (0.5%). 
 
3.3.3 (a) Preparation of hormone solutions 
There were 2 types of hormones namely, pregnant mare’s serum gonadotrophin and 
human chorionic gonadotrophin were administered to the female murine to induce 
superovulation and control the time of ovulation for timed mating. This will allow a 
large number of embryos to be obtained. The hormones were prepared from stock vials 
and filtered using sterile filters (0.22 µm pore size). Saline solution (0.9%) was used as 
the base solution, and was prepared beforehand by diluting 0.9 g NaCl in 100 ml Milli-
Q water and filtered with sterile filter. They were stored in sterile syringes (1 ml) in the 
freezer (-20°C). Before using, the frozen hormones were thawed to room temperature. 
The prepared hormones can last for 3 months. 
 
3.3.3 (a) (i) Preparation of Pregnant mare’s serum gonadotrophin (PMSG) 
A bottle of pregnant mare’s serum gonadotrophin vials contain 1000 IU of white, 
freeze-dried crystalline plug. Generally, they were dissolved in 20 ml of filtered saline 
(0.9%) and made up to 50 IU/ml. Aliquot the pregnant mare’s serum gonadotrophin 
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hormone into 1 ml syringe and labelled properly as well as stored in freezer (-20°C) for 
future use. 
 
3.3.3 (a) (ii) Preparation of Human chorionic gonadotrophin (hCG) 
A vial of human chorionic gonadotrophin contain 5000 IU of white, freeze-dried 
crystalline plug and they were dissolved in 100 ml of filtered saline (0.9%) and made up 
to 50 IU/ml. Same as preparation of pregnant mare’s serum gonadotrophin, the human 
chorionic gonadotrophin hormone was aliquot into 1 ml syringe and labeled properly 
and kept in freezer (-20°C) for future use. 
 
3.3.3 (b) Preparation of Modified phosphate buffered saline (PBS-) 
Phosphate buffered saline with Ca
2+
 and Mg
2+
 free solution (Table 3.20) was used as the 
base medium for trypsin and for washing cell cultures. The phosphate buffered saline 
with Ca
2+
 and Mg
2+
 free solution was prepared by adding NaCl (Sigma-Aldrich Co., 
USA), KCl (Sigma-Aldrich Co., USA), Na2HPO4 (Sigma-Aldrich Co., USA), KH2PO4 
(Sigma-Aldrich Co., USA) into ultrapure water (1 L) as shown at Table 3.20. The 
solution could be stored in the refrigerator (4°C) for up to 6 months. The constituents of 
PBS (-) as given in Table 3.20. 
 
 
Table 3.20: Preparation of phosphate buffered saline with Ca
2+
 and Mg
2+
 free (PBS-) 
 
Chemicals Volume/weight 
NaCl    10 g 
KCl 0.25 g 
Na2HPO4 1.44 g 
KH2PO4 0.25 g 
Ultra pure water      1 L 
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3.3.3 (c) Preparation of Trypsin/EDTA (0.25%) 
The trypsinisation of stem cell medium was prepared by adding the trypsin (Sigma-
Aldrich Co., USA; from porcine pancrease) and EDTA powders into 100 ml of 
phosphate buffered saline with Ca
2+
 and Mg
2+
 free solution as described in Table 3.21 
and stirred using a magnetic stirrer. The solution could be stored after filtering using a 
sterile filter.  
 
Table 3.21: Prepration of trypsin/EDTA (0.25%) 
 
Chemicals Volume/ weight 
Trypsin 0.25 g 
EDTA 0.04 g 
PBS (-)  100 ml 
 
 
3.3.3 (d) Preparation of Gelatin (0.1%) 
The preparation of 0.1% gelatin solution involve the simple addition of gelatin powder 
(0.100 g; Sigma-Aldrich Co., USA, G-8150) into phosphate buffered saline without 
calcium and magnesium solution and mixed thoroughly and stirred by using a magnetic 
stirrer. After dispensing into a scotch bottle, the solution was autoclaved and 
subsequently stored in the refrigerator (-4°C) (Table 3.22).  
 
Table 3.22: Composition of gelatin (0.1%) 
Chemicals Volume/weight 
Gelatin  0.1 g 
PBS (-) 100 ml 
 
3.3.3 (e) Preparation of Mitomycin C (MTC) stock 
To prepare stock mitomycin C solution, diluted 2 mg of mitomycin C (Sigma-Aldrich 
Co., USA, M-4287) with 2 ml of Dulbecco’s modified eagle medium or alpha minimum 
essential medium was as described in Table 3.23. After that, the stock mitomycin C was 
aliquots into small vials which each vials contained 55 µl/vial were made and stored at -
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20°C and could last for 2 to 3 months. For mitotic inactivation, 50 µl of stock 
mitomycin C was diluted in 5 ml of Dulbecco’s modified eagle medium or alpha 
minimum essential medium culture medium in a conical tube to obtain a final 
concentration (10 µg/ml). The solution was shaken gently to mix well. It could be used 
up to 1 week and kept at 4°C. 
 
Table 3.23: Composition of mitomycin C stock 
 
Chemicals Volume/weight 
Mitomycin C  2 mg 
DMEM or αMEM 2 ml 
 
 
3.3.3 (f) Preparation of Pronase (0.5%) 
Pronase powder (0.5 g; Sigma-Aldrich Co., USA, P-8811) was weighed and diluted in 
mDPBS solution (50 ml) and stirrer using a magnetic stirrer. The solution was then 
filtered and aliquot into 1.5 ml centrifuge tubes. It could be kept for up to 6 months at -
20°C. The chemical composition is detailed in Table 3.24. 
 
Table 3.24: Composition of pronase (0.5%) 
Chemicals Volume/weight 
Pronase 0.5000 g 
mDPBS       50 ml 
 
3.3.4 Preparation of Microtools and Accessories 
Microtools that were used in present study included holding pipette, cutting needle, 
biopsy needle, injection needle and La banana (oocytes or embryos picking and 
denudation pipette). All the glass pipette were prepared ‘in-house’ in the laboratory. 
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3.3.4.1 Preparation of hand-controlled micropipette  
The purpose of a hand-controlled pipette was for handling the oocytes and embryos and 
the pulled-haematocrit capillary attached to silicone tubing at one end. The other end of 
the silicone tubing was completely sealed with silicone glue. The glass capillary was 
softened by rotating it in a fine flame until the glass became soft and the glass was 
immediately withdrawn from the heat and both ends were quickly pulled smoothly to 
produce a tube with an internal diameter of approximately 200 µm and 400 µm for 
embryos and cumulus oocyte complexes, respectively. The pulled portion of the 
capillary was scribed with a diamond-tip pen and snapped at the scribed portion for a 
neat break to obtain evenly snapped straight tip because a jagged capillary end may 
cause damage to the zona pellucida during manipulation of oocyte or embryo. Besides 
that, the pipette with sharp edges were easily caught by the plastic surface of the culture 
dish and causing the pipette to break and tend to collect more debris during 
manipulation, particularly in handling the cumulus oocytes complex. The tip of the 
pipette was fire polished by touching the flame quickly to achieve a smooth edge of the 
micropipette tip.  
 
3.3.4.2 Capillary cleaning and sterilisation 
The capillary tubes were soaked overnight in 7x (FlowLab
TM
, Australia). Then, they 
were washed thoroughly and rinsed vigorously 5 times first with tap water followed by 
reverse osmosis water. The washed capillary tubes and Borosilicate glass tubing for 
making holding pipette, cutting needle, biopsy needle and injection needle were soaked 
in hydrochloric acid (10%; HmbG Chemicals, Germany) overnight before being washed 
20 times in Milli-Q water. Lastly, the capillary for La banana were sterilized by 
autoclaving at 121°C for 20 minutes and were dried in the oven at 60°C. The capillaries 
 142 
 
for holding pipettes and other injection needles were kept properly in a sterile container 
followed by drying and sterilisation in the oven at 180°C for 4 hours. 
 
3.3.4.3 Preparation of holding pipettes 
Capillary tube were placed and fixed into the micropuller. According to the need, the 
parameters were set to a programme. For this study, the parameters were set at 
programme 0 (heat: 780, pull=80, velocity=130 and time=20). The pull button (green) 
was switched on. The filament is gradually heated up, became red hot and produced 2 
uniform sized pulled pipettes or needles. The pulled micropipette was placed into the 
holder of the microforge horizontal to the glass bead. The pipette was squared and 
broke at a diameter between 150 to 180 µm (Figure 3.2). After squaring, the pipette 
placed vertically; the opening of the pipette should be on the top of the glass bead. The 
filament was fired polished in such a way that the inner diameter (ID) of the opening 
becomes approximately 25 µm. The pipette was placed again horizontal to the glass 
bead.  The pipette was bent to an angle of 19˚C. The holding pipette was cleaned 3 
times with HFL (10%) and rinsed 10 times with Mili-Q water (blown only).  After 
preparing holding pipettes, sterilised these are at 150˚C for 2 hours in an oven before 
cloning procedure. Sterilisation can also be done by applying ultra-violet light inside the 
laminar flow work station for 30 minutes.  Holding pipettes was stored in a stainless 
steel container that is wrapped up with a layer of aluminium foil or in sterilised recycled 
needle and pipette holders. 
 143 
 
 
Figure 3.2: The inner and outer diameter of the holding pipette. 
 
3.3.4.4 Preparation of cutting needle 
The pulled micropipette was placed into the holder of the microforge horizontal to the 
glass bead (in the same procedure for a holding pipette). The needle was squared and 
broke and placed vertically; the opening of the needle should be on the top of the glass 
bead. The filament was switched on and brought towards the needle. The filament was 
pulled it up and down to make a sharp end without a hole. The cutting needle was 
placed again horizontal to the glass bead. The cutting needle was bent to an angle of 
19˚C. The holding pipette was cleaned 3 times with HFL (10%) and rinsed 10 times 
with Mili-Q water (blown only).  After preparing cutting needle, it was sterilised at 
150˚C for 2 hours in an oven before cloning procedure. Sterilisation can also be done by 
applying ultraviolet light inside the laminar flow work station for 30 minutes.  Cutting 
needle (Figure 3.3) was stored in a stainless steel container that was wrapped up with a 
layer of aluminium foil or in sterilised recycled needle and pipette holders. 
 
 
150-180 µm 
25 
µm 
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Figure 3.3: Cutting needle. 
 
3.3.4.5 Preparation of biopsy needle 
The pulled micropipette was placed into the holder of the microforge horizontal to the 
glass bead (in the same procedure for a holding pipette). The needle was squared and 
broke is at a diameter 30 to 35 µm. After squaring, the pipette was placed vertically; the 
opening of the pipette should be on the top of the glass bead. The filament was switched 
on and fire polished was (just to make it in blunt shape) in such a way that the ID of the 
opening becomes approximately 30 µm. The pipette was placed again horizontal to the 
glass bead and bended to an angle of 19˚C. The pipette was cleaned 3 times with HFL 
(10%) and rinsed 10 times with Mili-Q water (blown only). After preparing biopsy 
needle, it was sterilised at 150˚C for 2 hours in an oven before cloning procedure. 
Sterilisation can also be done by applying ultraviolet light inside the laminar flow work 
station for 30 minutes. Biopsy needles (Figure 3.4) were stored in a stainless steel 
container that is wrapped up with a layer of aluminium foil or in sterilised recycled 
needle and pipette holders. 
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Figure 3.4: Biopsy needle. 
 
3.3.4.6 Preparation of injection needle  
The pulled micropipette was placed into the holder of the microforge horizontal to the 
glass bead (in the same procedure for a holding pipette). After squaring, the pipette 
placed vertically; the opening of the pipette should be on the top of the glass bead. The 
filament was fired polished in such a way that the inner diameter (ID) of the opening 
becomes approximately 10 µm. The pipette was placed again horizontal to the glass 
bead.  Injection needle were bended to an angle of 19˚C for easy and better cloning 
performance. The injection needle with blunt end was cleaned 3 times with HFL (10%) 
and rinsed 10 times with Mili-Q water (blown only).  After preparing injection needle, 
sterilised these are at 150˚C for 2 hours in an oven before cloning procedure. 
Sterilisation can also be done by applying ultra-violet light inside the laminar flow work 
station for 30 minutes.  Injection needle was stored in a stainless steel container that is 
wrapped up with a layer of aluminium foil or in sterilised recycled needle and pipette 
holders.  
 
 
30-35 µm 
30 µm 
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3.3.5 Experimental Procedures 
Following are different experimental procedures mainly employed to obtain murine and 
caprine blastocysts derived from different embryo techniques (parthenogenesis, somatic 
cell nuclear transfer and in vivo flushing) in an attempt to produce caprine and murine 
embryonic stem cells lines using mouse embryonic fibroblasts as a feeder layer with 
special reference to inner cell mass isolation techniques.  
 
3.3.5.1 Sources of blastocyst obtained in caprine and murine species 
Caprine and murine blastocysts could be obtained from 2 sources, namely in vitro or in 
vivo techniques.   
 
3.3.5.1 (A) In vitro-derived blasotcyst in caprine species 
Caprine blastocysts in vitro were derived from somatic cell nuclear transfer (SCNT) and 
parthenogenetic activation of oocytes. The cloned-caprine blastocysts and 
pathenogenetic blastocysts were used as a source for production of caprine embryonic 
stem cell lines.   
 
3.3.5.1 (A) (a) Caprine oocyte retrieval 
Different methods of oocytes retrieval techniques were carried out in caprine and 
murine. In caprine oocytes retrieval, the oocytes were collected from laparoscopic ovum 
pick-up, ovariectomy (via laparotomy) and ovary slicing from abattoir at Shah Alam 
and Senawang, whereas the oocyte retrieval from murine by superovulation and 
subsequently retrieved oocyte from ampulla. 
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3.3.5.1 (A) (b) Caprine oocyte retrieval through laparoscopic ovum pick-up  
                         (LOPU) procedure 
 
Several essential steps were carried out to retrieve caprine oocytes through laparoscopic 
ovum pick-up procedure, namely oestrus synchronisation, superovulation, anaesthesia 
and sedation, disinfection of surgical instruments and skin area of the donor does.  
 
3.3.5.1 (A) (b) (i)  Oestrus synchronisation of caprine donor 
Before retrieving the oocytes through laparoscopic ovum pick-up procedure, the 
experimental does underwent oestrus synchronisation to manipulate the oestrous cycle 
of the does to facilitate planning the time and date of oocytes retrieval during 
laparoscopic ovum pick-up. In order to synchronise the oestrous cycle, a Controlled 
Intravaginal Drug Release device (CIDR, 0.3 g progesterone; EAZI BREED
TM
, CIDR
®
, 
Pharmacia and Upjohn Limited, New Zealand) was inserted into the vagina of the 
caprine donor with the help of a clean and sterile controlled intravaginal drug release 
(CIDR) applicator (Pharmacia and Upjohn Limited, New Zealand) with water-based 
lubricant (K-Y Jelly, Pharmedica Lab Pty Ltd., South Africa). The controlled 
intravaginal drug release device remained in the vagina for 14 days (at 0900 hours on 
day 0 was the day of CIDR insertion) before being removed. The controlled intravaginal 
drug release device is made of an inert silicone elastomer that is non-porous and does 
not readily absorb bodily fluids; once properly inserted deep into the donor’s vagina, the 
controlled intravaginal drug release device unfolds into a “T” like formation that aids in 
retention. Daily monitoring of the device was performed to confirm that it had not been 
inadvertently removed. At approximately 36 hours prior to controlled intravaginal drug 
release device removal, a luteolytic treatment of Estrumate
®
 (125 µg cloprostenol; 
Schering-plough, Australia) was injected intramuscularly (at 0900 hours on day 12) to 
regress the corpus luteum that facilitates initiation of pro-oestrus and eventually resulted 
in oestrogen surge for the onset of oestrus (heat). Upon removal of controlled 
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intravaginal drug release device (at 2100 hours on day 13), a gonadotrophin treatment 
of Ovidrel
TM
 (250 IU) was injected intramuscularly 60 hours post-Ovidrel
TM
 to 
stimulate multiple follicular development prior to oocyte retrieval surgery (at 0900 
hours on day 16) (Figure 3.5). 
 
  
Figure 3.5: (a) Controlled intravaginal drug release device (CIDR), controlled  
                   intravaginal drug release device applicator, sterile gauze and K-Y Jell. (b)  
                   Insertion of CIDR. (c) Removal of CIDR.  
 
3.3.5.1 (A) (b) (ii) Superovulation of caprine donor 
On day 0 (day of CIDR insertion), controlled intravaginal drug release device was 
inserted on the selected female caprine at 0900 hours. On day 9, Estrumate (0.5 ml) was 
injected to the same female caprine at 0900 hours. On day 10, controlled intravaginal 
drug release device was removed at 2100 hours. After the controlled intravaginal drug 
release device removal, Ovidrel was injected as well. Two days after the controlled 
intravaginal drug release device removal, the female caprine was prepared for 
laparoscopic ovum pick-up. The oestrus was detected by the twigling of its tail and by 
using a teaser buck. 
 
3.3.5.1 (A) (b) (iii) Sedation and anaesthetisation of caprine donor 
Identification tag of the caprine was determined and the donor doe was off-feed and 
water (at 0900 hours on day 15) for 18 to 24 hours before to oocyte retrieval surgery (at 
0900 hours on day16), the caprine donors were prepared in an area separated from 
a b c 
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where surgery was performed. Anaesthesia to a caprine with mixture of xylazine 
hydrochloride (0.22 mg/kg body weight; Ilium Xylazine-20; Troy Laboratorries Pty 
Ltd, Australia) and ketamine hydrochloride (11 mg/kg body weight; Ketamil; Troy 
Laboratorries Pty Ltd, Australia) via intramascular (i.m.) injection. The caprine donor 
was maintained under anaesthesia with Ketamine hydrochloride (0.1 mg/kg bwt) 
injected intramuscularly as maintenance doses every 20 to 30 minutes or as required.  
 
3.3.5.1 (A) (b) (iv) Disinfection of surgical instruments and skin area of female  
                               caprine 
 
The anaesthetised caprine donor was placed on a clean small ruminant restraining 
cradle. The restraining cradle was set at a 45º angle where the head of the animal 
lowered to facilitate the laparoscopy procedure. By using clean gauzes, the abdominal 
area of the caprine donor was disinfected with diluted Hibiscrub (10%; ZENECA 
Limited, UK) and the hair was shaved. After shaving, the bare skin was disinfected 
again with absolute Hibiscrub (100%) and subsequently with iodine solution (10%; 
Weak iodine; ICN Biomedicals, USA). The caprine donor was then covered with a 
sterile drape with an opening that revealed the disinfected bare skin and was ready for 
oocyte retrieval surgery. The drape used was isolated the surgical site and minimise 
wound contamination. The drape was positioned without the fabric dragging across a 
non-sterile surface and secured in place with towel clamps at the 4 corners of the 
surgical site.  
 
3.3.5.1 (A) (b) (v) Laparoscopic ovum pick-up equipment and surgical instruments 
All the surgical instruments and washable laparoscopic ovum pick-up equipment (CO2 
tube, grey endoscope tube, endoscope, trocar, cannula, verrus needle) were washed and 
soaked into 20% Gigasept FF (Schulke and Mary GmbH, Germany) for 10 minutes and 
rotated periodically after 15 minutes. Then, they were rinsed and soaked for 15 minutes 
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in autoclaved reverse osmosis water to rinse off the antiseptic. After rinsing, all surgical 
instruments and the CO2 tube were packed and sealed in the autoclaved bag and 
autoclaved at 120ºC for 20 to 25 minutes (Hiclave, Model HA-300M II, Hirayama, 
Tokyo, Japan). Then, the autoclaved instruments were transferred into the oven 
(Memmert, Germany) to dry. The other laparoscopic ovum pick-up equipment were 
dried and packed in sterile plastic bags. The day before surgery, all surgical instruments 
and the CO2 tube were put under ultra-violet light overnight. 
 
3.3.5.1 (A) (b) (vi) Preparation of surgical instruments on surgical trolley 
On the day before the surgery, non-autoclavable surgical instruments,  such as 
atraumatic grasper, trocar and cannula, fibre optic cable, light probe for endoscope, 
flushing system tubing, CO2 gas tubing, vacuum pump tubing and collection bottle for 
vacuum pump, were disinfected by immersing completely in Gigasapt solution (10%; 
Schulke and Mary GmbH, Germany) for 10 minutes (fully submerged, opening of 
instruments were flushed using a 50 ml syringe), then rinsed twice in sterile autoclaved 
distilled water, and subsequently drained dry before placing in a sterile surgical table-
cum-trolley. Autoclavable surgical instruments in the autoclave bag were ready to use 
on the day of surgery after being autoclaved and dried completely in the oven (56ºC) for 
overnight. Before opening a sterilised surgical pack (for example, surgical set, scalpel 
blade, catgut suture, sterile gauze, sterile towels, sterile gloves, sterile drapes, round 
bottom tubes and aspiration needle), the sterilisation date and adhesive indicator tape 
(appropriate colour change for autoclaved instruments) and pack description (for 
example, surgical sets for laparoscopic ovum pick-up or laparotomy, size of drapes for 
animal and size of sterile gloves) must be checked properly. The outer wrapping of the 
surgical pack was opened and carefully unfolded without touching the sterilised 
instruments inside. All the surgical instruments were assembled and arranged in a 
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consistent order on a sterile surgical trolley were routinely placed in a sequential order 
so that items used first were placed on top (Figure 3.6). 
 
 
Figure 3.6: Surgery instruments which were used in laparoscopic ovum pick-up.  
 
3.3.5.1 (A) (b) (vii) Responsibility of the surgery team 
In our laboratory setting, all members involved in the surgery paid strict attention to 
aseptic techniques. However, with semi-equipped surgical facilities, only certain 
sophisticated sterile procedures were performed, such as the requirements of all 
members to wear an appropriate clean laboratory coat (dedicated for surgery purpose 
only), face mask and sterile gloves. Each member had his/her own duty during the 
surgery carried out such as embryologist, surgeon, passing embryos or oocytes tubes, 
recording the condition and history of animal, anaesthetic, antibiotic, setting up CCD 
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camera and CO2 gas insufflators, cleaning as well as arrangement of surgical trolley to 
ensure the surgery ran smoothly.    
 
3.3.5.1 (A) (b) (viii) Laparoscopic ovum pick-up (LOPU) 
The laparoscopic system and the accessories used were purchased from Aesculap A.G. 
and Company, Germany. The laparoscopic system composed of a paediatric Storz 
laparoscope (7.0 mm; PE 688A), an Aesculap endoscopic camera system (PV431), a 
CCD camera (David3; PV430), a light probe with fibre optic cable (OP913), a light 
system (Light source 300 W; OP927), an electronic CO2 gas insufflators unit (PG001), 
a Verrus needle (PG3) attached to a plastic tubing, a trocar and canula (7.0 mm) for the 
endoscope (EJ457), an antraumatic grasping forceps or paediatric grasper (PO951R) 
and a small trocar with cannula (5.5 mm; EJ456) for passing the grasper. The flushing 
and aspiration system was purchased from Cook, Australia which composed of a pedal 
operated aspiration pump (Aspiration system, K-MAR-5100) for proving a constant 
vacuum  for laparoscopic ovum pick-up, a flushing pump (a microprocessor controlled 
pump for automated follicle flushing) (Flushing system; K-MAR-4000), a test tube 
heater (K-FTH-1012) for maintaining a constant aspirated temperature during 
laparoscopic ovum pick-up, a connecting tubing that connects an ovum pick-up needle 
to a vacuum pump and a series of collection tubes. A pair of flushing and aspiration 
pedal (Herga Electric Limited, UK), connected, respectively, to the flushing and 
aspiration system through cable. A follicle puncture or ovum pick-up needle (FAS Set 
C2) was purchased from Gynetics Medical Product, Belgium. The collection tubes were 
graduated test tubes (14 ml; Becton Dickinson Labware, USA) with inlet and outlet 
ports in the stopper. The vacuum pressure was regulated with a flow valve (-100 mm 
Hg) and measured as drops of flushing medium per minute entering the collection tube 
and was adjusted to 50 to 70 drops per minute. The anaesthetised caprine was restrained 
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in a cradle in the standard position for laparoscopic surgery, a small incision was made 
on the disinfected abdominal area and a trocar connected to a CO2 gas insufflator and a 
filter was inserted into the incision to insufflate the abdominal cavity with CO2. The 
uterine horns were gently manipulated by the grasper to allow visualisation of each 
stimulated ovary. Once an ovary was indentified, the ovarian ligament was grasped 
using a forceps without damaging the oviduct, to effectively stabilise the ovary for 
follicular puncture. When flushing the follicles, extra care was taken to avoid leakage of 
follicular fluid and the inadvertent oocytes loss from the follicle. The collection tube 
containing aspirated fluid was dispensed into a sterile Petri dish for oocytes isolation 
and searched by embryologist under a stage warmer stereomicroscope (38.5ºC). 
Oocytes were then washed in flushing medium and cultured according to oocyte grades 
for subsequent in vitro maturation-somatic cell nuclear transfer procedures. After 
aspiration, the ovary was rinsed repeatedly with warm heparinised (38.5ºC) 
physiological saline using a syringe (50 ml) introduced through one of the trocars to aid 
in reducing adhesion following oocytes aspiration. The ovary was then released and the 
contra-lateral ovary was similarly aspirated. The incisions were closed with suture and 
the animal was monitored for 24 to 40 hours after the surgery. In general, 30 to 40 
minutes were needed to complete the oocytes retrieval procedure, depending on the 
quality of the ovary and number of follicles to be aspirated. 
 
3.3.5.1 (A) (b) (viiii) Post-surgical treatment of the doe 
The incisions on the abdomen were sutured and the doe was carefully removed from the 
cradle. The sutured incision area was sprayed with antiseptic and insecticide containing 
cyphenothrin. The doe was injected intramascularly (i.m.) with antibiotic 
(Tetracyclines; 20 mg/kg body weight) once in 4 days within the duration of 2 weeks to 
prevent possible post-surgery infection. 
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3.3.5.1 (A) (c) Oocyte retrieval through ovariectomy 
Ovariectomy was carried out when the doe failed to be hyperstimulated after repeated 
oocytes retrieval surgeries or when the ovary was having minor or major adhesion, and 
consequently the doe was not suitable for laparoscopic ovum pick-up procedure. The 
ovaries were surgically removed from the doe using laparotomy technique. Briefly, a 
mid-ventral abdominal incision was made (3 to 5 cm) at the abdomen part on the 
anaesthetised doe. The uterine horns were exposed through mid-ventral incision and 
blood vessel leading to each ovary was clamped with a forceps. The blood vessels were 
tied off with suture and the ovary was excised anterior to the sutures. After removal of 
the ovaries, muscle layers and the skin layer were sutured with strong synthetic sutures. 
A wound dressing was sprayed onto the incison. After completion of surgery, the doe 
received antibiotic to prevent infection.  
 
3.3.5.1 (A) (c) (i) Ovary slicing 
Under the laminar flow, each ovary was freed from the surrounding tissues and 
overlaying bursa using surgical scissors and forceps. The ovary was placed in a Petri 
dish (60 mm) containing TL-hepes working solution (5 ml) on a stage warmer at 
38.5ºC. The ovary was held with the help of forceps and each ovary was sliced 
individually. Systematic slices were given along the whole ovarian surface using a 
sharp razor blade. While retrieving the oocytes by slicing method, the ovary was kept 
completely dipped in the TL-hepes working solution. The Petri dish (60 mm) was kept 
undisturbed for 3 minutes (38.5ºC), allowing the oocytes to settle. After sedimentation, 
excess medium was taken out using a pulled Pasteur pipette, without disturbing the 
oocytes at the bottom of the Petri dish. The Petri dish was then examined under a warm 
stereomicroscope (38.5ºC) under magnification 20x or 40x. Oocytes were then washed 
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in TL-hepes working solution and cultured according to oocyte grades for subsequently 
in vitro maturation-cloning procedures. 
 
3.3.5.1 (A) (d) Oocyte retrieval from abattoir-derived ovaries 
The caprine ovaries were obtained from the Department of Veterinary Services and 
Abattoir Complex, Shah Alam (Selangor) and Senawang (Negeri Sembilan). Two 
thermoses (one for rinsing the ovaries and another one for collecting the ovaries) were 
filled with warmed (38.5ºC) saline supplemented with penicillin and streptomycin 
sulphate. A pair of surgical scissors was brought over and used to cut the ovaries from 
the slaughtered caprine. The excess tissues and some blood of the ovaries were trimmed 
and rinsed with the warmed saline before transferred to the thermos.  
 The ovaries that were collected from slaughterhouse were transported to the 
laboratory within 1 to 2 hours in warm saline medium which were maintained between 
30˚C to 38˚C. In laboratory, the ovaries were washed thoroughly with warm saline 
medium (37˚C) and were placed in a beaker containing fresh saline medium. The 
caprine ovaries were placed in a Petri dish (60 mm) containing TL-hepes working 
solution (5 ml) on a stage warmer (38.5ºC). The ovary was held with the help of forceps 
and each ovary was sliced individually. The whole ovarian surface was sliced using a 
quarter sections of a stainless steel razor blade held with a sterile haemostat (Figure 
3.7). While retrieving the oocytes by slicing method, the ovary was kept completely 
dipped in the TL-hepes working solution. After finished slicing, the ovaries were rinsed 
with TL-hepes working solution in a small beaker to ensure that all oocytes were 
retrieved. The contents of the beaker were poured into a Petri dish was then examined 
under a stereomicroscope (magnification 20x to 40x). The beaker was rinsed thoroughly 
to ensure that all the oocytes were transferred into Petri dish. Since the caprine oocytes 
were very sensitive to temperature so it was important to monitor carefully the 
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temperature throughout the collection procedures as fluctuations could easily occur. 
Caprine oocytes were then washed with TL-hepes working solution followed by in vitro 
maturation medium prior cultured according to oocytes grading (if sufficient number of 
oocytes available) for subsequent experiment. Caprine oocytes were classified 
according to the character of the cumulus cells and cytoplasm morphology under a 
stereomicroscope. The oocytes were washed several times with maturation medium to 
ensure that the oocytes used for maturation were free from unwanted chemical 
substances which may affect the maturation process. The cumulus oocyte complexes 
were cultured in a microdroplets (50 µl) of maturation medium overlaid with mineral oil 
and then it was culutred at 38.5˚C in CO2  (5%) incubator in humidified atmosphere. 
 
  
 
Figure 3.7: (a) Caprine ovary was collected from slaughterhouse. (b) Slicing of ovary. 
 
 
 
 
 
 
 
 
 
 
a b 
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3.3.5.1 (A) (e) Grading of retrieved caprine oocytes 
The caprine oocytes were graded and cultured in separated droplets based on the criteria 
stated in Table 3.25. 
 
Table 3.25: Oocyte grading based on cumulus cell layers and cytoplasm uniformity  
Oocyte grade Cumulus cell layers and cytoplasm 
uniformity 
Grade A ≥5 multi-layered compact cumulus cells 
with evenly granulated cytoplasm 
Grade B 3 to 4 layers of cumulus cells with evenly 
granulated cytoplasm 
Grade C 1 to 2 layers of cumulus cells with evenly 
granulated cytoplasm 
Grade D No layers of cumulus cells (denuded) with 
evenly granulated cytoplasm 
Grade E Pale-coloured or heterogeneous 
cytoplasm* 
(Adapted from Rahman, 2008) 
*Heterogeneous cytoplasm: non-homogenous cytoplasm, in which the oocyte 
cytoplasm showed   pigmentation in some areas. 
 
 Cumulus oocyte complexes of all grades were selected for subsequent use and 
each in vitro maturation droplet (50 µl) contained not more than 10 cumulus oocyte 
complexes according to the oocyte grades. In vitro maturation was performed at 38.5ºC 
in humidified atmosphere with CO2 (5%) in air subjected to different oocyte maturation 
duration. At the end of the maturation culture, cumulus expansion was scored into 2 
categories, namely either complexes floating in the maturation medium and surrounded 
by a light colour fully expanded cumulus mass which was defined as “cumulus-
expanded” (matured oocyte) or vice versa defined as “cumulus-unexpanded” (immature 
oocyte). 
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3.3.5.1 (A) (f) In vitro maturation procedure in caprine oocytes 
In vitro maturation medium was prepared in microdroplets (50 µl) and overlaid with 
equilibrated mineral oil in a small polystyrene culture dish (35 mm; Becton Dickinson 
Labware, USA). The prepared dish was placed in the CO2 incubator (5%) and 
equilibrated at least for 3 hours. After finished washed and graded, the selected caprine 
oocytes were placed in in vitro maturation microdroplets (10 oocytes/50 µl). The 
carpine oocytes were cultured for 18 to 21 hours (laparoscopic ovum pick-up derived 
oocytes) and 24 to 27 hours (ovariectomy and abattoir derived oocytes) at 38.5ºC in the 
presence of CO2 (5%) in air in humidified atmosphere of a CO2 incubator (HERAcell 
240; Kendro Laboratory Products, Germany). 
 
3.3.5.1 (A) (g) Preparation of recipient caprine oocytes 
After in vitro maturation, the caprine cumulus oocyte complexes were treated with 
hyaluronidase (0.2%; 100 µl). All the caprine oocytes were transferred into 
hyaluronidase in a microcentrifuge tube (1.5 ml) and using the disposable yellow tips 
(100 µl), attached with micropipettor (10 to 100 µl) to suck up and down for 80 times to 
make the cumulus cells dispersed and removed totally from the caprine oocytes. After 
denuding, if the caprine oocytes were still surrounded cumulus cells, the oocyte were 
denuded again by gentle pipetting in and out using a narrow-bored Pasture pipette (80 to 
100 µm) in hyaluronidase (0.2%) covered with mineral oil (< 5 minutes) and washed 5 
times in TL-hepes working solution (100 µl/microdroplet). After denuding, the caprine 
oocytes were washed in TL-hepes working solution, supplemented with cytochalasin B 
droplets to observe the present of first extruding polar body (M II) (< 5 minutes). Only 
the metaphase II caprine oocytes with first extruding polar body were choosen as 
recipient oocytes (cytoplasts). The metaphase II caprine oocytes were transferred into 
TL-hepes holding medium with cytochalasin B (7.5 µg/ml) droplet covered with 
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mineral oil on the enucleation Petri dish (35 mm) (Figure 3.8). The caprine oocytes 
without first polar bodies were considered immature and discarded. 
 
 
                            Holding medium with cytochalasin B 
                                                                            30 µl microdroplet 
 
 
Mineral oil 
                                                                            30 µl microdroplet 
 
            Holding medium: TL-hepes working solution 
 
Figure 3.8: Washing Petri dish for enucleated oocytes. 
 
3.3.5.1 (A) (h) Somatic cell nuclear transfer procedure 
The somatic cell nuclear transfer technique included dish preparation, 
micromanipulation system, needle alignment, oocytes enucleation, donor cells 
preparation and nuclear transfer. 
 
3.3.5.1 (A) (h) (i) Preparation of blank and somatic cell nuclear transfer dish 
The blank dish was prepared to align the nuclear transfer needle and the holding pipette 
(OD: 80 to 100 µm; ID: 25 µm) by using cover lid of Petri dish (35 mm). After 
preparing a blank dish, nuclear transfer dish was prepared. Three microdroplets (20 µl) 
of TL-hepes solution with cytochalasin B were prepared and overlaid with mineral oil 
for align the holding pipette and cutting needle or biopsy needle. 
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3.3.5.1 (A) (h) (ii) Micromanipulation system 
In the present study, an Olympus inverted microscope (IX71; Olympus Optical Co., 
Ltd, Japan) with Normarski optics using Hoffman contrst system and fitted with 
Narishige hydraulic micromanipulators (Narishige Co. Ltd., Japan) to perform somatic 
cell nuclear transfer. The micromanipulation system was comprised: a set of left and 
right that could be controlled both mechanically and manually by their respective 
joysticks. Usually, the holding pipette holder was set on left hand side, while the 
injection holder was set on right hand side. The joysticks allowed the control of coarse 
and fine 3 dimensional positioning as well as also gaveprecise linear displacement 
simultaneously. The joysticks had a hydraulic (de Fonbrune’s system). The holding and 
injection needles were filled entirely with air. Both the holding and injection pipettes 
were comprised of completely airtight syringes connected to the micropipette holder by 
Teflon plastic tubing with airtight fittings. 
 
3.3.5.1 (A) (h) (iii) Micromanipulator and micropipette alignment 
The nuclear transfer was performed on the lid of a small polystyrene culture dish (35 
mm; Becton Dickinson Labware, USA) under the inverted microscope fitted with 
hydraulic micromanipulators (Narishige, Japan). All the knobs and the knob syringes 
were adjusted to the centre of the scale. A blank Petri dish (35 mm) was placed on the 
inverted microscope with stage warmer heated to 38.5◦C. The holding pipette was 
inserted to the needle holder (right micromanipulator) and tightened well. Alignment 
was done following by the injection needle, biopsy needle or cutting needle. The tip of 
both needles were touched in the mineral oil and was focused which parallel to the 
microscope stage under low magnification. The end of both pipettes was filled with oil-
medium-oil to maintain the pressure for easy to control and manipulated the oocytes. 
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Finally, both needles were checked under high magnification (40x) to assure the 
accurate alignment which sharply in focus and parallel.  
 
3.3.5.1 (A) (h) (iv) Caprine oocyte enucleation 
There were 2 enucleation techniques applied to caprine matured oocytes, namely 
squeezing technique and laser shooting technique. The holding needle and cutting 
needle or biopsy needle were aligned in the washing droplet (30 µl) containing holding 
medium with cytochalasin B (7.5 µg/ml) which overlaid with equilibrated mineral oil 
on the enucleation Petri dish (35 mm) (Figure 3.9). The oocytes were focused and 
aligned in one line. The matured caprine oocytes were held using holding needle (OD: 
75 to 100 µm; ID: 25 µm), placing the polar body at 12 o’clock position. Subsequently, 
cutting needle was used to pierce the zona pellucida and the polar body was squeezed 
out or using laser to make a small hole and pushed out together with 10% of cytoplast. 
The whole enucleation process must be completed within 30 minutes for each batch of 
oocytes (10 to 15 oocytes per batch) due to cytochalasin B will cause damage to the 
oocyte if expose too long in cytochalasin B (7.5 µg/ml) medium. After enucleation, the 
enucleated oocytes were washed in TL-hepes holding medium (without cytochalasin B). 
The enucleated caprine cytoplasts were allowed to recover at 38.5ºC in in vitro culture 
(KSOM) medium for at least 30, 60, 90 or 120 minutes  (pre-incubated) prior to 
injection with donor cells.  
 
                                                                                        20 µl microdroplet 
                                                                                                                           Holding   
medium with 
                         Mineral oil                                         60 µl microdroplet    cytochalasin  
                       B  
 
                                                                                                   20 µl microdroplet 
 
 
               Figure 3.9: Enucleation Petri dish (35 mm). 
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3.3.5.1 (A) (h) (iv) (a) Squeezing technique for enucleation in caprine cytoplast 
The matured caprine oocytes were held by holding pipette and the first polar body was 
positioned at 12 o’clock. A slit at the matured oocyte zona pellucida was made and the 
polar body as a guide to remove the recipient nucleus by squeezing it with holding 
pipette and cutting needle. 
 
3.3.5.1 (A) (h) (iv) (b) Laser shoots technique for enucleation in caprine cytoplast 
Laser shoot is a new and advance technique that has been used to enucleate recipient 
oocytes (cytoplast). In comparasion with squeezing technique, laser shoot technique is 
easier in enucleating the caprine oocytes, as it uses the power (100%), pulse (190 µs), 
laser beam (red colour) and 140ºC (hole size, orange colour) to make a hole on zona 
pellucida. Briefly, a hole was made near the first polar body as a guide to remove the 
recipient nucleus. The nucleus and first polar bodies were pushed out by holding pipette 
(left side) and biopsy needle (right side) on the both side together. Around 10% of the 
cytoplasm was removed.  
Isotherm Rings™  (Figure 3.10) appeared on the screen as a series of six 
concentric circles of varying colours and indicate the maximum temperature reached at 
the ring diameter at various laser pulse durations. At longer pulse duration, it is apparent 
that temperatures radiate farther into the centre of the embryo, increasing the likelihood 
of blastomere damage. The orange ring (second from center) is also a useful indicator of 
the drill hole size at the selected pulse duration. With this interactive Isotherm Rings™ 
feature, a user could now "see" the heating and drill hole size and eliminate the 
temperature "guesswork." 
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Figure 3.10: Isotherm Ring
TM
 shown is laser system. (Adapted from 
http://www.hamiltonthorne.com/products/lasers/lykos/safety.htm). 
 
The heat conduction into the embryo, as shown by the Isotherm Rings™ (Figure 
3.10), is based on published scientific algorithms that are built into the software. For 
increased embryo safety, the Isotherm Rings™ are hardwired and their specifications 
cannot be altered or deleted by users. With the Isotherm Rings™ it is accurate and 
determined according to scientific definitions. The heat penetrates further into the 
embryo as the pulse length increases. So even if the actual drill hole (orange ring) does 
not come close to the blastomeres, the blastomeres are exposed to the heat generated by 
the laser beam at longer pulse lengths. By using the Isotherm Rings™ feature of the 
ZILOS-tk, the heat conduction prior to treatment and the pulse length are adjusted and 
the embryo is position accordingly.  
Isotherm Rings™ were derived by calculation of the heat diffusion based on the 
assumption that the zona pellucida thermal conductivity was close to that of water. 
Since the zona pellucida is composed of approximately 80% water, this was most likely 
a very good assumption. This assumption was even on the conservative side, since the 
presence of proteins would lessen the conductivity and the resultant rings would even 
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be smaller. Lasers produce light beams of varying intensity, and are categorized in 
accordance with the emitted power. There are several vital components inherent to a 
laser microsurgery apparatus. In addition to the laser itself, a collimating lens, a dichroic 
mirror, and an objective that can transmit the beam are required: 
a) Laser: 1450 µm, Infrared Class 1  
b) Collimating Lens: A lens used to produce a beam of parallel light rays  
c) Dichroic Mirror: An optical device which acts like an optical gate to split light 
into two colors ("di" = two, "chroic" = pertaining to color). The dichroic mirror 
reflects the infrared laser beam up through the objective, while the visible light 
passes through.  
d) Objective: Must allow transmission of laser beam to the sample.  
 
Once the optimum translational and angular alignments and beam quality are achieved, 
the laser is "locked" into place, and does not move position. This "locking" process is 
similar to that used for aligning and locking microscope objectives. It is similar to 
aligning the inside components of microscope objectives. Therefore, it is not need to 
align the internal components of the XYClone, even the microscope is switch on-off 
(Figure 3.11). 
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Figure 3.11: Components of XYclone laser system (Adapted from 
http://www.hamiltonthorne.com/products/lasers/xyclone/module.htm). 
 
3.3.5.1 (A) (i) Caprine donor cell preparation 
Nuclear donor cells were obtained from 2 different cell types in this study, namely fresh 
caprine cumulus cells and caprine ear fibroblast cells.  
 
3.3.5.1 (A) (i) (i) Preparation of caprine donor cells (fresh caprine cumulus cells) 
The fresh cumulus cells were usually obtained from a pool of in vitro matured oocytes 
harvested either from laparoscopic ovum pick-up or abattoir ovaries. After 24 hours 
onset of maturation, the cumulus cells were isolated by pipetting in hyaluronidase 
(0.2%) within 5 minutes at 37
o
C. All fresh cumulus cells were collected and washed in 
holding medium (TL-hepes working solution) and centrifuged for 5 minutes. Cumulus 
cell pellet was formed and the supernatant was removed. TL-hepes working solution 
(100 µl) was added into the pellet and sucked up and down to make the fresh cumulus 
cells became single cell (7 to 8 µm) and were ready for use as donor cells (Figure 3.12). 
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     Hyaluronidase (0.2%) 
                                                                          30 µl microdroplet 
 
 
Mineral oil 
                                                                                               30 µl microdroplet 
 
                              Holding medium: TL-hepes working solution 
 
Figure 3.12: Denuding Petri dish (35 mm). 
 
3.3.5.1 (A) (i) (ii) Preparation of caprine ear fibroblast cells 
For preparing the caprine eat fibroblast cells, Katjang caprine’s ear tissue cells were 
collected. Hair of caprine ear tissues was removed. Coverslip was sterilised rinsed in 
70% ethanol and it was flamed it until it dry and sterile.  Epidermis of caprine ear 
tissues was cut into small pieces. Each small piece of caprine ear epidermis tissues was 
placed on the culture dish (60 mm). The caprine ear fibroblast cells were covered with 
coverslip. The culture dish was filled with αMEM+FBS+PS (300 µl). The culture dish 
was covered and kept in the incubator at 37˚C, 5% CO2. After 8 to 10 days, the caprine 
ear fibroblast cells reached >80% confluency and further sub-cultured and 
cyroperserved for future use. Caprine ear fibroblast cells were thawed, washed and 
plated in Petri dish prior to oocyte reconstruction. Donor cells were trypsinised 1 to 2 
hours before being transferred to enucleated caprine oocytes. A single caprine ear 
fibroblast cell (10 to 15 µm) was ready to be used as donor cell for nuclear transfer. 
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3.3.5.1 (A) (j) Caprine somatic cell nuclear transfer 
In this study, whole cell intracytoplasmic injection (WCICI) technique was used for 
nuclear transfer in production of cloned-caprine embryos. 
 
3.3.5.1 (A) (k) Injection of caprine donor cells by whole cell intracytoplasmic  
                        injection (WCICI) technique in caprine species  
 
After pre-incubated (30, 60, 90 or 120 minutes), the enucleated oocytes were washed 
for 5 times in TL-hepes holding medium (Figure 3.13). 
 
                 Holding medium: TL-hepes (without cytochalasin B) 
                                                                           30 µl microdroplet  
         (wash before inject) 
 
 
Mineral oil                                                    30 µl microdroplet   
                                                                                 (Wash after inject) 
 
                                                                             
Figure 3.13: Washing medium for injected oocytes. 
 
Subsequently, the holding needle and injection needle were aligned in the washing 
droplet containing holding medium (without cytochalasin B) on the enucleation Petri 
dish. The oocytes were transferred in the injection droplet as well as the donor cell in 
10% polyvinylpyrrolidone  (PVP)  droplet on the injection Petri dish. The oocytes were 
focused and aligned in one line. A single fresh cumulus cell (7 to 8 µm) or caprine ear 
fibroblast cell (10 to 15 µm) was injected as a donor cell into enucleated caprine oocyte 
by the direct insertion of the whole somatic donor cell content into the cytoplast. (care 
was taken to transfer the donor cell content with the minimum amount of the media and 
pressure.) The nuclei of cumulus cell or ear fibroblast cell was isolated just before 
injection with shear stress using a blunt end pipette 7 to 10 µm in diameter which 
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sucked in and out to remove the cell membrane of donor cell in the 
polyvinylpyrrolidone (10%) to make the donor cell swollen. Then, single nuclei were 
aspirated into the pipette and injected into a enucleated caprine oocyte in TL-hepes 
holding medium without cytochalasin B (Figure 3.14). After injection, the enucleated 
oocytes were washed in TL-hepes holding medium. The reconstructed caprine oocytes 
were washed in KSOM medium 3 times and pre-incubated at least 60 minutes before 
activation. No fusion was needed to fuse the cell-cytoplast couplets.  
 
                                                                      20 µl microdroplet (holding medium) 
                                                                                  
                                                                                60 µl microdroplet (holding medium) 
    Mineral oil 
                                                                                10 µl microdroplet (10% PVP) 
                                         20 µl micridroplet (holding medium)   
  
Figure 3.14: Injection Petri dish (35 mm). 
 
 
3.3.5.1 (A) (l) Caprine oocyte activation  
The reconstructed oocytes were chemically activated by incubating for 5 minutes in 
KSOM working solution containing calcium ionophore (5 µm), washed thoroughly in 
KSOM working solution and then incubates for 4 hours in KSOM working solution 
containing 6-dimethylaminopurine (2 mM) at 38.5
o
C under CO2 (5%). Following, the 
activated caprine embryos were cultured in groups of embryos (10 to 15) in KSOM 
medium (50 µl microdroplets) covered with mineral oil. 
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3.3.5.1 (A) (m) In vitro culture (IVC) in caprine embryos 
The in vitro culture medium was incubated for at least 3 hours before culture of oocytes. 
Generally, 7 microdroplets (100 µl) was prepared on a small culture dish (35 mm) and 
overlaid with equilibrated mineral oil. Caprine oocytes were reconstructed and in vitro 
cultured in KSOM medium in CO2 incubator at 38.5ºC for further development. The in 
vitro culture medium was changed at days 3 and 5 with KSOM working solution with 
supplementation of glucose (0.004 g). The caprine embryos were checked under 
stereomicroscope on days 3 and 5, and accordingly their developmental stages were 
recorded. The cloned-caprine blastocyst obtained (inner cell mass) was used as a source 
for producing the caprine embryonic stem cell lines.  
 
 
3.3.5.1 (B) In vitro-derived blastocyst in murine species 
The murine blastocysts were in vitro derived from somatic cell nuclear transfer (SCNT) 
technique to become a source of blastocyst for production of murine embryonic stem 
cell lines.  
 
3.3.5.1 (B) (a) Superovulation of female murine 
In order to obtain the optimum quality and quantity of murine oocytes to conduct the 
cloning procedure, the mature female of the 3 pure strains murine were superovulated 
by intraperitoneal injection of pregnant mare’s serum gonadotrophin (PMSG) (10 IU) 
on day 1 at 1800 hours and followed by intraperitoneal injection of human chorionic 
gonadotrophin (hCG) (10 IU), 48 hours apart. The time of ovulation normally occurred 
by 13 to 15 hours post-hCG injection. 
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3.3.5.1 (B) (a) (i) Intraperitoneal injection 
In intraperitoneal injection technique, the murine was picked up by the scruff of its neck 
which was close to the ears. Enough skin was hold up to prevent the murine from 
turning its head and biting. Care must be taken not to suffocate or hurt the murine in the 
process by grabbing enough skin but not squeezing the murine neck. The murine tail 
was held by twisting it around the little finger to hold properly to prevent the murine 
struggle and move while being injected. Hormones were injected intraperitoneally at the 
centre point between the 4 tits of the abdomen by using 26 G, ½ inch hypodermic 
needles. After injected, the needle stayed for 10 seconds before withdrawn out to 
prevent the solution from seeping out. 
 
3.3.5.1 (B) (b) Oocyte collection in murine 
The superovulated female murine was sacrificed at the time of ovulation that is 13 to 15 
hours post-hCG injection. The female murine’s coils of gut were pushed out of the way 
and located the 2 horns of the uterus after which the ovaries and oviducts were 
identified. The upper end of one of the uterine horns was grasped with fine forceps and 
gently pulled the uterus, oviduct, ovary and fat pad taut and away from the body cavity. 
In the membrane, a hole that was near to the oviduct was poked with the closed tips of a 
pair of fine forceps or scissors. The oviduct was transferred and attached segment of 
uterus into the silicone oil overlay in Petri dish with Hepes Whitten’s medium. The 
freshly ovulated oocytes as cumulus oocyte complexes that surrounded by cumulus 
cells are found in the upper part of the oviduct (ampulla), which at this time (12 hours 
post-ovulation) is much enlarged.  The fimbriae end of the oviduct (infundibulum) is 
also swollen during ovulation and can be easily be located under stereomicroscope (20x 
magnification). A pair of needle (26 G) was used to hold the swollen infundibulum 
firmly on the bottom of the dish and another to tear the ampulla where the cumulus 
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oocyte complexes are located. The cumulus oocyte complexes were released. If the 
cumulus oocyte complexes did not flow out, a fine forceps was used to push them out 
by gently squeezing the oviduct. The cumulus oocyte complexes were placed 
immediately in the hyaluronidase (0.2%).   
 
 
3.3.5.1 (B) (c) Preparation of murine recipient oocytes 
After denuding, the murine oocytes were washed in holding medium (Hepes Whitten’s 
medium) supplemented with cytochalasin B droplets to observe the present of first 
extruding polar body (metaphase II) and pre-incubated 5 minutes (37
o
C). 
 
                                   HWM with cytochalasin B 
 
 
                                                                            30 µl microdroplet 
 
 
Mineral oil 
                                                                                   
                                                                                  30 µl microdroplet 
 
                              
 
                
                  
 
Figure 3.15: Preparation of murine emucleation Petri dish (35 mm). 
 
                                       
Only the metaphase II oocyte with first extruding polar body will be choose as murine 
recipient oocyte. The metaphase II oocytes were transferred into holding medium with 
cytochalasin B droplet covered with mineral oil on the enucleation Petri dish (Figure 
3.15). 
 
3.3.5.1 (B) (d) Enucleation of murine oocyte 
The holding needle and cutting needle or biopsy needle were aligned in the washing 
droplet containing holding medium with cytochalasin B (7.5 µg/ml) on the enucleation 
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Petri dish (35 mm) (Figure 3.16). The oocytes were focused and aligned the oocyte in 
one line. The oocytes were held using holding needle where placing the spindle at 12 
o’clock position. Following, cutting needle or biopsy needle was used to pierce the zona 
pellucida and squeeze out or pushed out the murine spindle. The whole enucleation 
process must finish within 30 minutes for each batch of oocytes (10 to 15 oocytes per 
batch).  
 
 
 
                                                                                                  20 µl microdroplet 
 
                                                                                                      60 µl microdroplet      
HWM with 
cytochalasin B             Mineral oil                                                                                
                                                                                                    20µl microdroplet 
 
                                                              
 
Figure 3.16: Murine enucleation Petri dish (35 mm). 
 
 
 
After enucleation, the enucleated oocytes were washed in holding medium (without 
cytochalasin B). The oocytes were washed in Whitten’s medium 3 times and incubate 
30 to 120 minutes before injection. 
 
3.3.5.1 (B) (e) Preparation of fresh murine donor cells (fresh murine cumulus cells) 
The cumulus cells were isolated by pipetting the cumulus oocyte complexes in and out 
using a narrow-bored pasture pipette in 0.2% hyaluronidase within 5 minutes at 37
o
C. 
All single cumulus cells was collected and washed in holding medium (Hepes Whitten’s 
medium) (Figure 3.17). The isolated cumulus cells kept in the last droplet of holding 
medium and were ready for use as donor cells.    
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Hyaluronidase (0.2%) 
 
                                                                          30 µl microdroplet 
 
 
Mineral oil 
                                                                                                
                                                                                                      30 µl microdroplet 
 
 
                                       
 
                                        Holding medium: Hepes Whitten’s Medium 
  
 
Figure 3.17: Denuding murine Petri dish (35 mm). 
 
3.3.5.1 (B) (f) Injection of murine donor cells  
After 30, 60, 90 or 120 minutes, the enucleated murine oocytes were washed 5 times in 
holding medium. 
  
                     Holding medium (Hepes Whiten’s medium) 
 
 
                                                                            30 µl microdroplet 
(wash before inject) 
 
 
Mineral oil 
                                                                             
                                                                              30 µl micridroplet 
(wash after inject) 
 
                                  
 
                                           
                        
Figure 3.18: Washing of enucleated murine Petri dish. 
 
 
Following, the holding needle and injection needle were aligned in the washing droplet 
containing holding medium (without cytochalasin B) on the enucleation Petri dish 
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(Figure 3.18). The oocytes were transferred in the injection droplet as well as the donor 
cell in PVP (10%) droplet on the injection Petri dish (Figure 3.19). The murine oocytes 
were focused and aligned in one line. Tthe donor cell was injected into enucleated 
murine oocyte by the direct insertion of the whole somatic donor cell content into the 
cytoplast.  
 
 
                                                                                                 HWM microdroplet (20 µl) 
                                                                                                          
             HWM microdroplet (60 µl) 
                   Mineral oil                                                                                                      
                                                                                                    PVP microdroplet (10 µl) 
   
                                                                                                 HWM microdroplet (20 µl)  
 
 
 
Figure 3.19: Injection of murine Petri dish. 
 
 
After injection, the enucleated murine oocytes were washed in holding medium. The 
oocytes were washed in Whitten’s medium 3 times and incubate at least 60 minutes 
before activation. 
 
3.3.5.1 (B) (g) Activation and in vitro culture murine embryos 
The reconstructed murine embryos were chemically activated by incubation for 6 hours 
activation medium containing SrCl2+CB+CZB (free of Ca
2+
) at 38.5
o
C under CO2 (5%). 
Following, culture the activated embryos in groups of around 10 to 15 embryos in 50 µl 
droplets of Whitten’s medium covered with mineral oil. 
 
3.3.5.2 In vivo-derived blastocysts in caprine and murine species 
The caprine and murine blastocysts could be derived through in vivo flushing technique 
either oviductal or uterine flushing. Theoretically, the in vivo derived blastocysts were 
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produced higher quality than in vitro derived blastocysts due to more stabilised in the 
body condition development rather than in vitro environment development. 
 
3.3.5.2 (A) Uterine flushing in caprine species 
The caprine donor was superovulated with FSH (160 mg) for 4 days consecutively. The 
caprine donor was inserted with Controlled Intravaginal Drug Release device for 17 
days. The Controlled Intravaginal Drug Release device was removed out on day 18 and 
heat check was carried out to detect the oestrus. Once the caprine donor had oestrus, she 
was mated by fertile buck 3 times per day (0800 hours to 0900 hours; 1300 hours to 
1400 hours; 1700 hours to 1800 hours) for 2 to 3 days until the end of oestrus in caprine 
donor. Fertile buck was changed for every mating session to produce good quality and 
quantity of sperm to fertilise the oocytes once ovulation happened. The caprine donor 
was off-fed and water the day before the surgery (18 to 24 hours). The blastocyst 
recovery was on day 7 through uterine flushing. On the day of surgery, a 2-way size 8 
Foley Catheter (Inmed Paediatric Balloon Catheter, USA) was then inserted through the 
puncture to a deep of 3 cm. The balloon of the catheter was sufficiently inflated to 
completely obstruct the lumen at the caudal end of each uterine horn. A Teflon 
intravenous (I.V.) Catheter placement unit fixed with a 20 gauge needle (Vasocan, B. 
Braun, Germany) was introduced closer to the anterior end of the uterine horn. Then, 
the Teflon intravenous Catheter needle was removed and 20 ml sterile disposable 
syringe (Terumo, Japan) fixed to the end of the Teflon Catheter. The fluid contents of 
the uterine horn were collected through the free end of the Foley Catheter. This was 
repeated with a further 20 ml of the flushing medium. Subsequently the same procedure 
was used for the flushing of the other uterine horn if at least one corpus luteum was 
present in the respective ovary. After flushing completed, the surgical incision was 
sutured with catgut (size 2, Aesculap, Germany). The incised skin was closed with size 
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2 surgical grade silk suture material (B. Braun, Germany) and sprayed with Gusanex 
aerosol (1% w/w Dichlofenthione; Coopers, Pitman Moore, Malaysia) as a fly repellent 
(Figure 3.20). 
 
Figure 3.20: (a) Corpus luteum on caprine ovaries. (b) Insertion of Foley Catheter into  
                     uterus of caprine. (c) Insertion of intravenous catheter needle into oviduct  
                     of caprine.  
 
3.3.5.2 (A) (a) Mouse embryonic fibroblast (MEF) feeder cell preparation 
Requirement of mouse embryonic fibroblasts are vital in production of embryonic stem 
cell lines to maintain embryonic stem cells in an undifferentiated state and to support its 
growth. The techniques preparation of mouse embryonic fibroblasts included (1) 
isolation of primary mouse embryonic fibroblast, (2) harvesting of mouse embryonic 
fibroblast, (3) passage of mouse embryonic fibroblast cultures, (4) cryopreservation of 
mouse embryonic fibroblast, (5) thawing of mouse embryonic fibroblast and (6) 
preparation of feeder layers through the mitotic inactivation of mouse embryonic 
fibroblast. 
 
3.3.5.2 (A) (a) (i) Isolation of primary mouse embryonic fibroblasts 
Mouse embryonic fibroblasts were prepared from 13.5 to 14.0 days post-coitus murine 
foetuses. The mouse embryonic fibroblasts were cultured in Dulbecco’s modified eagle 
medium or alpha minimum essential medium supplemented with 10% foetal bovine 
serum (FBS; Invitrogen), 200 mM L-glutamine (Invitrogen) and 3x 
a b c 
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Penicillin/steptomycin (Sigma). The whole uterus was surgical removed from the 
murine and kept in PBS-. The uterus was surgical open with scissor then each foetal sac 
was removed out of the uterus. The foetuses were washed in PBS-, head limbs and 
internal organ was removed from the foetuses. The foetuses were minced into the small 
pieces and the mincing tissues were taken to a beaker. The optimal volume of 
trypsin/EDTA was added in the beaker and stir on the magnetic stirrer for 30 minutes. 
After that, it was filtered through nylon mesh into the conical tube (50 ml). Culture 
media (3x) was added to the supernatant (1.5 fold of supernatant volume) and 
centrifuged at 3000 rpm for 5 minutes (2 times). The supernatant was removed, re-
suspended the pellet with culture media and seed to the medium culture dish (60 mm). 
The primary mouse embryonic fibroblasts were cultured at 37°C, CO2 (5%) until the 
cell reaching 80 to 90% confluent. At 80 to 90% confluent, subculture the mouse 
embryonic fibroblast cell for expanded (split ratio is ~ 1:5) and then freezing as the 
feeder cell bank for future use.  
 
 
3.3.5.2 (A) (a) (ii) Passages of mouse embryonic fibroblasts 
Mouse embryonic fibroblasts cell cultures can be harvested after they reach 80% 
confluency. All media were sucked out and removed using a pasteur pipette. The cells 
were washed with PBS- solution (around 2 ml) twice to remove the remaining media. 
This is because presence of excessive culture media would inhibit the subsequent 
trypsinisation step. Next, the cells were detached by adding 2 to 3 ml of trypsin/EDTA 
into each culture dish. The dishes were then incubated in an incubator for 2 to 3 minutes 
to allow the enzymatic reaction to take place. After that, the dishes were returned to the 
laminar flow and the solution was sucked in and out using pasteur pipette to physically 
detached the cells. This can be observed as a layer “peeling-off” the bottom of the 
culture dish. The cell suspension was then transferred to a conical tube (15 ml). Mouse 
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embryonic fibroblast washing media (supplement with only 3% FBS) were added at a 
ratio of 1:1.5 media and the tubes were then centrifuged at 2000 rpm for 5 minutes. 
After centrifugation has completed, a pellet would form at the bottom of the conical 
tube. If there were still pellets attached to the walls, centrifugation was repeated for 
another 5 minutes. The supernatant was removed and culture media (1x) were added 
accurately using a micropipettor (100 to 1000 µl) to make up 2 to 4 ml. The solution 
containing cells were mixed gently by pipetting in and out while avoided the formation 
of bubbles to produce isolated, single cells. Vigorous pipetting may damage the protein 
of cells. Mouse embryonic fibroblasts were seeded at around 5.0x10
5
 viable cells per 
dish by dispersing droplets of the mouse embryonic fibroblasts mixture onto the dishes 
using Pasteur pipettes. The cells were grown until confluent (2 to 4 days) and the media 
were refreshed every subsequent day by replacing half of the media. The steps can be 
repeated for further passages.  
 
3.3.5.2 (A) (a) (iii) Cryopreservation of mouse embryonic fibroblasts 
The culture media was removed from the confluent culture dish. PBS- was added just to 
cover the cells and then sucked it out. Trypsin/EDTA was added just to cover the cells 
and incubated it for 2 to 3 minutes. The cell was pipetted by Pasteur pipette to break the 
cell into single cell. All the cells in trypsin were taken to conical tube and culture media 
(1.5 fold of trypsin/EDTA volume) was added as well as centrifuged at 3000 rpm for 5 
minutes. After centrifuged, supernatant was removed and resuspended the pellet (1ml of 
culture media) and counted the cell to know the concentration. The volume of culture 
media was adjusted to the desire concentration (that the total volume was from 2 part 
evenly; one from culture media and another from freezing media). Freezing medium 
(0.5 ml) was dispensed into cryovials with the number of cryovials depending on the 
volume of mouse embryonic fibroblasts cells mixture. For each cryovial, 0.5 ml of 
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mouse embryonic fibroblasts mixture was added to give a final volume of 1.0 ml. The 
freezing medium were added slowly into the resuspended cell (small volume each time) 
in the same volume and shaked well. The cell in the cryo-tube was aliquot and labelled 
as well as inserted into cryocanes and the cryocanes labeled. The cryocanes were placed 
into the freezer (-20°C) for 15 minutes. They were sealed within autoclave bags and 
placed into insulated containers containing ice packs. The ice packs were pre-loaded 
into the containers to lower the temperature within the containers. The cryocanes were 
then carried to the lab at the Institute of Postgraduate Studies where the whole journey 
takes around 10 minutes. The cryocanes were then placed into -80°C freezer for 
overnight. After that, the cryocanes were transported back to ABEL lab within insulated 
containers containing liquid nitrogen and removed from the autoclave bags and placed 
into liquid nitrogen tanks for storage. 
 
3.3.5.2 (A) (a) (iv) Thawing of mouse embryonic fibroblasts 
Cryovials were removed from cryocanes in liquid nitrogen tank without exposing the 
cryocanes for too long outside liquid nitrogen tanks. The cryovials were then 
immediately thawed by placing the lower portion of the vials into water bath, taking 
care to avoid contact between the cap and the water. After the mixture has thawed for 
about 2 minutes, the vials were removed from the water bath and sprayed with 70% 
alcohol to make it sterile. The cap was flamed and removed in the laminar flow. The 
contents were transferred into conical tubes (15 ml) containing 2 ml of mouse 
embryonic fibroblasts washing media. If many vials were thawed at once, vials from the 
same batch can be pooled together into the same conical tube, while maintaining the 
ratio to mouse embryonic fibroblasts washing media at around 1:1.5. The tubes were 
then centrifuged at 2000 rpm for 5 minutes. After completed centrifuged, a pellet was 
formed at the bottom of the conical tube. Culture media (1x) were added accurately 
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using a micropipettor (100 to 1000 µl) to make up 1 or 2 ml. The solution containing 
cells were mixed gently by pipetting in and out. They were then seeded onto small 
culture dishes containing 2 ml of MEF culture media according to the desired cell 
density. The cells were seeded at 3.0x10
5
 viable cells per small Petri dish (35 mm). The 
cells were cultured in the incubator at 37ºC to confluence and the media was changed 
on every alternate day. 
 
3.3.5.2 (A) (b) Feeder cell management for caprine embryonic stem cells 
The culture media was removed from the confluent culture dish.  Mitomycin C (50 μl) 
was added to 5 ml of culture media (αMEM+10% FBS or DMEM+10% FBS) for a 
final concentration (10 μg/ml) and incubated for 3 hours in the culture incubator at 
37ºC. After 3 hours, the mitomycin C was removed and washed 3 to 5 times with PBS(-
). Trypsin/EDTA was added just to cover the cells and leaved it for 3 minutes. Pipetting 
to break the cell into single cell and all the cell in trypsin were taken to conical tube, 
culture media (1.5 fold of trypsin/EDTA volume) was added and centrifuged at 3000 
rpm for 5 minutes. The supernatant was removed, resuspended the pellet (1ml of culture 
media) and count the cell to know the concentration. Adjust to the optimal 
concentration for each culture dish type shown in Table 3.26. 
 
Table 3.26: Concentration of mouse embryonic fibroblast cells seeding in different size  
                    of culture Petri dish   
 
Size of culture Petri dish Cell concentration 
35 mm      4x10
5
 cell/dish 
60 mm     1x10
6
 cell/dish 
4-well dish  1.2x10
5
 cell/well 
 
The cell was seeded and cultured in the incubator (37 °C, 5% CO2). The culture Petri 
dish was shaked well in the direction shown below to make sure the cell will distributed 
cover all the bottom area of the culture Petri dish (Figure 3.21). 
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Figure 3.21: Direction of distributed mouse embryonic fibroblast in the culutre Petri  
                     dish. 
 
 
The feeder cell should be prepared 1 day prior to use as the feeder layer for 
embryonic stem cell and should be incubated with embryonic stem cell culture media at 
least 3 hours before used. Before seeding the cell in to culture Petri dish, the feeder 
layers were prepared by expanding mouse embryonic fibroblast cultures on gelatinised 
culture Petri dishes. Culture dishes were gelatinised by covering the dish with 0.1% 
gelatin solution and left for 15 minutes in the laminar flow. After that, the gelatin 
solution was removed and the dishes let to dry prior to culturing mouse embryonic 
fibroblasts. The source of mouse embryonic fibroblasts could be obtained either from 
freshly passaged mouse embryonic fibroblasts or thawed from frozen stocks. Usually, 
they were seeded at 3.0x10
5
 viable cells per dish to allow confluency to be reached 
within 2 to 3 days. After the mouse embryonic fibroblasts culture reaches 80% 
confluency, the media was removed. 2 ml of mitomycin C (10 μg/ml; Sigma) solution 
was added and the cells were incubated for 3 hours. The solution was then aspirated, 
and the cells were washed twice times with PBS- solution. Around 2 ml of murine 
embryonic stem cells culture media were added to the culture Petri dishes and incubated 
for at least 3 hours.  
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3.3.5.2 (A) (c) Isolation of caprine embryonic stem cells  
Embryonic stem cells were usually obtained by isolating undifferentiated outgrowths 
that originate from the inner cell mass of the blastocysts. The caprine embryonic stem 
cells were expanded, passaged, frozen and tested for pluripotency via differentiation. 
Outgrowths from the inner cell mass of caprine blastocysts can be derived through 3 
techniques, namely culture of whole culture of caprine blastocysts, mechanical 
dissection or manual cut (30 G needle) and lasser dissection of inner cell mass from the 
caprine blastocysts and subsequently cultured to obtain primary outgrowths. In culture 
of whole caprine blastocysts technique, the zona pellucida of caprine blastocysts were 
removed by using pronase (0.5%). The caprine blastocysts were observed under 
stereomicroscope until the zona pellucida has degraded. The caprine blastocysts were 
then washed 3 to 5 times in embryonic stem cells culture medium (30 µl). The washed 
caprine blastocyst was isolated via different methods. After isolation of inner cell mass, 
inner cell masses were placed on inactivated mouse embryonic fibroblasts in a 
humidified atmosphere of  CO2 (5%) in air at 37˚C for culturing. After 5 to 12 days 
later, the growing colonies were individually dissociated into clumps after treating with 
a mixture of trypsin/EDTA (0.05%). The resultant small clumps containing 
approximately 20 to 50 cells were transferred to a new well with a fresh feeder layer 
and medium. The new colonies were inspected daily and subcultured at an interval of 
approximately 6 to10 days according to their size and growth rate. Culture medium was 
changed every other day. The washed caprine blastocysts were proceed to the next step. 
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3.3.5.2 (A) (c) (i) Culture of whole caprine blastocysts 
The washed caprine blastocysts were then directly transferred onto feeder layers of 
inactivated feeder cell layer on a gelatinised 35 mm culture Petri dish. The free zona 
pellucida caprine blastocyst were placed directly on top of the feeder cells. Sufficient 
gap was left between each caprine blastocyst. A small Petri dish could be cultured up to 
10 to15 caprine blastocysts. The culture dishes were carefully carried and placed back 
into the incubator, minimising shaking in the process and were left for 2 days without 
moving them because the caprine blastocysts were very sensitive in attachment onto the 
feeder cells once it moving. The culture media were changed on day 2 and every 
alternate day. 
 
3.3.5.2 (A) (c) (ii) Manual cut (30 G) in isolation of caprine inner cell mass 
After removing the zona pellucida of caprine blastocyst, a single blastocyst was 
transferred onto a droplet of embryonic stem cells culture media. A cut was performed 
on the caprine blastocyst by using 2 30 G needles, one needle to hold the caprine 
blastocyst in place and another to perform the cut. The inner cell mass was isolated via 
the cut. Care must be taken to prevent cutting too deep on the surface of the dish, or else 
the inner cell mass may get stuck on the Petri dish. After cut, the inner cell mass was 
carefully transferred onto a feeder layer of inactivated feeder cell layer. The caprine 
inner cell mass were placed onto the feeder layer with sufficient gap in between. A 
single dish may contain up to 10 to 15 caprine inner cell masses. After transferring all 
inner cell masses, the culture dishes were carefully placed back into the incubator. They 
were left for 2 days without any interference. The culture was observed on day 2 and 
media were changed on every other day. 
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3.3.5.2 (A) (c) (iii) Laser isolation of caprine inner cell mass 
In laser isolation technique, the zona pellucida of caprine blastocyts was not removed. 
The inner cell mass isolation was carried out on the micromanipulator system where the 
holding pipette (left side) and biopsy needle (right side) were used in manipulated the 
caprine blastocyst. The inner cell mass was located at the 9 o’clock positioned. The 
caprine blastocyst was hold by holding pipette and the laser was shot along the way 
between the inner cell mass cells and trophectoderm cells. After shooting, the biopsy 
needle was sucked on the other side of the caprine blastocyst to remove the zona 
pellucida and trophectoderm from the inner cell mass. All the manipulation processed 
was done in PBS- medium. The isolated inner cell mass was washed with murine 
embryonic stem cell culture medium for several times before cultured onto the 
inactivated feeder cell layer. They were left for 2 days without any interference. The 
culture was observed on day 2 and media were changed on every other day. 
 
3.3.5.2 (A) (d) Sub-culture of primary caprine inner cell mass outgrowths 
The primary caprine inner cell mass outgrowths were sub-culture using 2 techniques, 
namely trypsinisation and mechanical dissection procedures by trypsin/EDTA (0.05%). 
After around 4 to 6 days of culture, the primary outgrowths from the caprine inner cell 
mass were picked. Suitable outgrowths were those of undifferentiated cells, 
characterised by slightly dark-pigmented clumps of cells with clearly defined borders. 
The inner cell mass that selected should have characters included dome shape colony 
surrounded with primitive endoderm, homogeneous and higher nuclear to cytoplasm 
ratio (bigger nucleus). Unwanted outgrowths were typically those of round, loosely 
arranged cells without a clear, defined border. They have a slightly refractal and were 
located directly next to the outgrowths. Outgrowths from the trophectoderm (TE) were 
characterised by the presence of giant cells, and these are not wanted. The suitable 
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outgrowths were picked before differentiation occurs. Outgrowths beginning to 
differentiate will exhibit dark pigmentation.  
 
 
3.3.5.3 (A) (d) (i) Trypsinisation procedure for sub-culture caprine inner cell mass  
                  outgrowth 
 
Culture Petri dish with feeder layer in murine embryonic stem cell culture medium at 
least 3 hours was incubated in incubator at 37 °C, 5% CO2 before use. For 
trypsinisation, the outgrowths were lift up from feeder cell and transferred to wash in 
drops of PBS- for 4 times before incubating in 0.05% trypsin/EDTA for 3 min at 37°C. 
Then gently pipetting up and down several times to break the outgrowth into small 
pieces which contains about 20 to 30 cells/piece. Then the small pieces were washed in 
murine embryonic stem cell culture medium for 4 times before spread onto a new feeder 
cell pre-incubated with murine embryonic stem cell culture medium. After 24 hours, 
change half of the media everyday. The cell colony will appear 3 to 4 days after 
trypsinisation (passage 1). Subculture when the colonies get bigger (should not let it 
bigger than 400 μm).  
 
3.3.5.2 (A) (d) (ii) Mechanical sub-culture caprine inner cell mass outgrowth 
The pulled Pasteur pipette connected with mouth piece will be used to cut the colony 
into smaller pieces (avoid the primitive endoderm). Using a micropipette (2 to 20 µl), 
the wanted outgrowths were detached and transferred onto a 30 µl droplet of PBS- for 
washing. Then, they were transferred to a droplet of 30 µl of trypsin/EDTA (0.05%) and 
gently disaggregated into smaller aggregates. The clumps were not disaggregated into 
single cells. The cell was transferred into prepared 4 well dish and incubated at 37 °C, 
CO2 (5%). After 24 hours, the media was changed half everyday. The colony will 
appear sooner when compared with trypsinisation procedure. Checked the cell carefully 
everyday and selected the one with caprine embryonic stem cell character for 
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subculture. For embryonic stem cell mechanical procedure were recommended in the 
first 3 to 4 passages. The good character colony for subculture was selected is highly 
recommended. 
 
3.3.5.2 (B) Superovulation in female murine for embryos recovery 
Female murine (6 to 8 weeks) were injected intraperitoneally with PMSG (10 IU). After 
48 hours, female murine were injected intraperiotneally with hCG and mated suddenly 
with male murine (8 to 12 weeks) for 12 hours. The vaginal plug was observed in 
female murine at 12 hours post mated to make sure the female murine were successfully 
mated. The blastocyst collection from uterus will be run 72 to 78 hr after vaginal plug 
observation whereas in vivo flushing at 2-cell stage was carried out on day 1.5 after 
hCG injection (Table 3.27).  
 
Table 3.27: Superovulation regime in murine species 
  
Day Time Activities/embryo stages 
Monday 1800 hours PMSG 
Wednesday 1800 hours hCG+mating 
Thursday 0600 hours Vaginal plug observation (day 0.5) 
Friday 0600 hours 2-cell stage embryo (day 1.5) 
Saturday 0600 hours Morula (day 2.5) 
Sunday 0600 hours Balstocyst (day 3.5) 
Monday 2400 hours Expanded blastocyst (day 4.0) 
 
 
3.3.5.2 (B) (a) Recovery of preimplantation embryos (in vivo flushing) 
In order to obtain blastocysts as source for production of murine embryonic stem cell, 2 
approaches were carried out. First involves the recovery of 2-cell stage embryos via 
flushing of the oviduct and subsequent in vitro culture up to the blastocyst stage, while 
another approach involves direct recovery of blastocysts through uterine flushing. 
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3.3.5.2 (B) (a) (i) Recovery of 2-cell stage embryos through oviductal flushing 
In between day 1.5 and 2.0 post-coitus, the female murine which mated and plugged 
were sacrificed by cervical dislocation. The murine oviducts were removed and placed 
into 20 µl droplets of warmed modified Hepes Whitten’s medium to keep it moisture. 
The droplets were prepared on sterile Petri dishes before sacrificing the murine. Embryo 
flushing was prepared by attached a sterile blunt stainless steel hypodermic needle (32 
G) a syringe (1 ml) containing modified Hepes Whitten’s medium. The oviduct was 
held in place using sterile fine forceps, the flushing needle was then inserted into the 
infundibulum located among the coils of the oviduct. The modified Hepes Whitten’s 
medium was injected into the infundibulum to flush out the murine embryos (Figure 
3.22).  
 
 
Figure 3.22 : Oviductal flushing through murine infundibulum. 
 
The collected 2-cell stage embryos were observed under a stereomicroscope microscope 
and picked up using sterile puller pasteur pipette, controlled either by using a mouth 
piece or hand piece. The embryos were washed 3 times in modified Hepes Whitten’s 
medium droplets until no debris was visible under the dissecting microscope, followed 
by 2 droplets of modified Whitten’s medium (Figure 3.23). The 2-cell embryos were 
then transferred into equilibrated microdroplet cultures and in vitro culture up to 
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blastocyst stage. In this present study, 2-cell stage embryos can be obtained by flushing 
at 36 to 48 hours (1.5 to 2.0 days post-coitus).  
 
 
 
 
 
 
  
                                Figure 3.23: Washing medium for collected murine embryos.  
 
3.3.5.2 (B) (a) (ii) Recovery of blastocysts 
The flushed murine blastocysts were flushed at day 3.5 days post-coitus and cultured 
(day 4) were used as a source for production of murine embryonic stem cells according 
to the blastocyst stages (early blastocyst, mid blastocyst, expanded blastocyst, hatching 
blastocyst and hatched blastocyst). Murine blastocysts were flushed from the uterus 
between day 3.5 to 4.5 post-coitus as described by Hogan et al. (1986). The murine 
uterus was held with forceps just above the cervix which was located directly above the 
bladder. The cervix was cut across using fine scissors. The mesometrium holding the 
uterus to the body wall was trimmed by pulling the uterus upward to stretch the 
membrane. The uterus was completely removed by cutting below the junction with the 
oviduct on both horns. The uterus was placed in a Petri dish containing modified Hepes 
Whitten’s medium. Both horns were flushed with Hepes Whitten medium using 26 G, 
½ inch needles and 1 ml syringes. The blastocysts will be flushed out and detected 
HWM (100 µl) WM (100 µl) 
4 
5 
2 
3 
Petri dish 
1 
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using an stereomicroscope microscope as well as picked up using puller pasteur 
pipettes. The blastocysts were then washed in droplets of Hepes Whitten’s medium and 
Whitten medium (Figure 3.24) before in vitro culture in Whitten’s medium in an 
incubator similar as recovery 2-cell stage embryos.  
 
 
 
 
 
 
 
                                Figure 3.24: Culture medium for muirne embryos. 
 
 
3.3.5.2 (B) (b) Mouse Embryonic Fibroblast (MEF) feeder cell preparation 
Requirement of mouse embryonic fibroblasts are vital in production of embryonic stem 
cell lines to maintain embryonic stem cells in an undifferentiated state and to support its 
growth. The techniques preparation of mouse embryonic fibroblasts included (1) 
isolation of primary mouse embryonic fibroblast, (2) harvesting of mouse embryonic 
fibroblast, (3) passage of mouse embryonic fibroblast cultures, (4) cryopreservation of 
mouse embryonic fibroblast, (5) thawing of mouse embryonic fibroblast and (6) 
preparation of feeder layers through the mitotic inactivation of mouse embryonic 
fibroblast.  
 
 
 
 
 
WM (50 µl) 
Mineral oil 
Petri dish 
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3.3.5.2 (B) (b) (i) Isolation of primary mouse embryonic fibroblasts 
Mouse embryonic fibroblasts were prepared from 13.5 to 14.0 days post-coitus murine 
foetuses. The mouse embryonic fibroblasts were cultured in Dulbecco’s modified eagle 
medium or alpha minimal essential medium supplemented with foetal bovine serum 
(10%, FBS; Invitrogen), 200 mM L-glutamine (Invitrogen) and 3x 
Penicillin/steptomycin (Sigma). The whole uterus was surgical removed from the 
murine and kept in PBS- (Figure 3.25). The uterus was surgical open with scissor then 
each foetal sac was removed out of the uterus. The foetuses were washed in PBS-, head 
limbs and internal organ was removed from the foetuses. The foetuses were minced into 
the small pieces and the mincing tissues were taken to a beaker. The optimal volume of 
trypsin/EDTA was added in the beaker and stir on the magnetic stirrer for 30 minutes 
(Figure 3.26). After that, it was filtered through nylon mesh into the conical tube (50 
ml). Culture media (3x) was added to the supernatant (1.5 fold of supernatant volume) 
and centrifuged at 3000 rpm for 5 minutes (2 times) (Figure 3.27). The supernatant was 
removed, re-suspended the pellet with culture media and seed to the medium culture 
dish (60 mm) (Figure 3.28). The primary mouse embryonic fibroblasts were cultured at 
37°C, CO2 (5%) until the cell reaching 80 to 90% confluent. At 80 to 90% confluent, 
subculture the mouse embryonic fibroblast cell was sub-cultured for expanded (split 
ratio is ~ 1:5) and then was frozen as the feeder cell bank for future use.  
 
 
 
Figure 3.25: (a) Murine foetuses contained in the uterine sac. (b) Isolation of foetus  
                     from the uterine sac. (c) Washing of foetuses in PBS- solution. 
 
a b c 
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Figure 3.26: (a) Removal of limbs, organs and red blood cells from the foetus. (b)  
                     Mincing and trysinisation of foetuses into small pieces. (c) Further  
                     trysinisation and breaking down of the pieces of foetus using a magnetic  
                     stirrer. 
 
 
 
Figure 3.27: (a) Adding DMEM solution to the cell mixture at a ratio of 1.5 to 1.0. (b)  
                     Centrifugation for 5 minutes at 5000 rpm. (c) Formation of cell pellet after  
                     centrifugation. 
 
 
 
Figure 3.28: (a) The cell pellet was diluted to the desired cell concentration and                   
                      sucked in and out to obtain a single cell suspension. (b) Dispensing of  
                      mouse embryonic fibroblast into culture dishes. (c) Gently shaking of the  
                      culture dishes to spread the mouse embryonic fibroblast evenly before  
                      culture in the CO2 incubator. 
 
3.3.5.2 (B) (b) (ii) Passages of mouse embryonic fibroblasts 
Mouse embryonic fibroblasts cell cultures can be harvested after they reach 80% 
confluency. All media were sucked out and removed using a pasteur pipette. The cells 
were washed with PBS- solution (around 2 ml) twice to remove the remaining media. 
a b c 
a b c 
a b c
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This is because presence of excessive culture media will inhibit the subsequent 
trypsinisation step. Next, the cells were detached by adding 2 to 3 ml of trypsin/EDTA 
into each culture dish. The dishes were then incubated in an incubator for 2 to 3 minutes 
to allow the enzymatic reaction to take place. After that, the dishes were returned to the 
laminar flow and the solution was sucked in and out using pasteur pipette to physically 
detached the cells. This could be observed as a layer “peeling-off” the bottom of the 
culture dish. The cell suspension was then transferred to a conical tube (15 ml). Mouse 
embryonic fibroblast washing media (supplement with only 3% FBS) were added at a 
ratio of 1:1.5 media and the tubes were then centrifuged at 2000 rpm for 5 minutes. 
After centrifugation completed, a pellet would form at the bottom of the conical tube. If 
there were still pellets attached to the walls, centrifugation was repeated for another 5 
minutes. The supernatant was removed and culture media (1x) were added accurately 
using a micropipettor (100 to 1000 µl) to make up 2 to 4 ml. The solution containing 
cells were mixed gently by pipetting in and out while avoided the formation of bubbles 
to produce isolated, single cells. Vigorous pipetting may damage the protein of cells. 
Mouse embryonic fibroblasts were seeded at around 5.0x10
5
 viable cells per dish by 
dispersing droplets of the mouse embryonic fibroblasts mixture onto the dishes using 
pasteur pipettes. The cells were grown until confluent (2 to 4 days) and the media were 
refreshed every subsequent day by replacing half of the media. The steps could be 
repeated for further passages.  
 
3.3.5.2 (B) (b) (iii) Cryopreservation of mouse embryonic fibroblasts 
The culture media was removed from the confluent culture dish. PBS- was added just to 
cover the cells and then sucked it out. Trypsin/EDTA was added just to cover the cells 
and incubated it for 2 to 3 minutes. The cell was pipetted by Pasteur pipette to break the 
cell into single cell. All the cells in trypsin were taken to conical tube and culture media 
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(1.5 fold of trypsin/EDTA volume) was added as well as centrifuged at 3000 rpm for 5 
minutes. After centrifuged, supernatant was removed and resuspended the pellet (1 ml 
of culture media) and counted the cell to know the concentration. The volume of culture 
media was adjusted to the desire concentration (the total volume will be from 2 part 
evenly; one from culture media and another from freezing media). Freezing media (0.5 
ml) was dispensed into cryovials with the number of cryovials depending on the volume 
of mouse embryonic fibroblasts cells mixture. For each cryovial, 0.5 ml of mouse 
embryonic fibroblasts mixture was added to give a final volume of 1.0 ml. The freezing 
media were added slowly into the resuspended cell (small volume each time) in the 
same volume and shaked well. The cell in the cryo-tube was aliquot and labelled as well 
as inserted into cryocanes and the cryocanes labeled. The cryocanes were placed into 
the freezer (-20°C) for 15 minutes. They were sealed within autoclave bags and placed 
into insulated containers containing ice packs. The ice packs were pre-loaded into the 
containers to lower the temperature within the containers. The cryocanes were then 
carried to the lab at the Institute of Postgraduate Studies where the whole journey took 
around 10 minutes. The cryocanes were then placed into -80°C freezer for overnight. 
After that, the cryocanes were transported back to ABEL lab within insulated containers 
containing liquid nitrogen and removed from the autoclave bags and placed into liquid 
nitrogen tanks for storage. 
 
3.3.5.2 (B) (b) (iv) Thawing of mouse embryonic fibroblasts 
Cryovials were removed from cryocanes in liquid nitrogen tank without exposing the 
cryocanes for too long outside liquid nitrogen tanks. The cryovials were then 
immediately thawed by placing the lower portion of the vials into water bath, taking 
care to avoid contact between the cap and the water. After the mixture has thawed for 
about 2 minutes, the vials were removed from the water bath and sprayed with 70% 
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alcohol to make it steriled. The cap was flamed and removed in the laminar flow. The 
contents were transferred into conical tubes (15 ml) containing 2 ml of mouse 
embryonic fibroblasts washing media. If many vials were thawed at once, vials from the 
same batch can be pooled together into the same conical tube, while maintaining the 
ratio to mouse embryonic fibroblasts washing media at around 1:1.5. The tubes were 
then centrifuged at 2000 rpm for 5 minutes. After completed centrifuged, a pellet was 
formed at the bottom of the conical tube. Culture media (1x) were added accurately 
using a micropipetter (100 to 1000 µl) to make up 1 or 2 ml. The solution containing 
cells were mixed gently by pipetting in and out. They were then seeded onto small 
culture dishes containing 2 ml of MEF culture media according to the desired cell 
density. The cells were seeded at 3.0x10
5
 viable cells per small Petri dish (35 mm). The 
cells were cultured in the incubator at 37ºC to confluence and the media was changed 
on every alternate day. 
 
3.3.5.2 (B) (c) Feeder cell management for murine embryonic stem cell 
The culture media was removed from the confluent culture dish.  Mitomycin C (50 μl) 
was added to 5 ml of culture media (αMEM+10% FBS or DMEM+10% FBS) for a 
final concentration (10 μg/ml) and incubated for 3 hours in the culture incubator at 
37ºC. After 3 hours, the mitomycin C was removed and washed 3 to 5 times with PBS(-
). Trypsin/EDTA was added just to cover the cells and leaved it for 3 minutes. Pipetting 
to break the cell into single cell and the entire cell in trypsin were taken to conical tube, 
culture media (1.5 fold of trypsin/EDTA volume) was added and centrifuged at 3000 
rpm for 5 minutes. The supernatant was removed, resuspended the pellet (1ml of culture 
media) and count the cell to know the concentration. The cell was seeded and cultured 
in the incubator (37°C, 5% CO2). The culture Petri dish was shaked well to make sure 
the cell will distributed cover all the bottom area of the culture Petri dish. The feeder 
 195 
 
cell should be prepared 1 day prior to use as the feeder layer for embryonic stem cell 
and should be incubated with embryonic stem cell culture media at least 3 hours before 
used. Before seeding the cell in to culture Petri dish, the feeder layers were prepared by 
expanding mouse embryonic fibroblast cultures on gelatinised culture Petri dishes. 
Culture dishes were gelatinised by covering the dish with gelatin (0.1%) solution and 
left for 15 minutes in the laminar flow. After that, the gelatin solution was removed and 
the dishes let to dry prior to culturing mouse embryonic fibroblasts. The source of 
mouse embryonic fibroblasts could be obtained either from freshly passaged mouse 
embryonic fibroblasts or thawed from frozen stocks. Usually, they were seeded at 
3.0x10
5
 viable cells per dish to allow confluency to be reached within 2 to 3 days. After 
the mouse embryonic fibroblasts culture reaches 80% confluency, the media was 
removed. 2 ml of mitomycin C (10 μg/ml; Sigma) solution was added and the cells were 
incubated for 3 hours. The solution was then aspirated, and the cells were washed twice 
times with PBS- solution. Around 2 ml of murine embryonic stem cells culture media 
were added to the culture Petri dishes and incubated for at least 3 hours.  
 
3.3.5.2 (B) (d) Isolation of murine embryonic stem cells  
Embryonic stem cells were usually obtained by isolating undifferentiated outgrowths 
that originate from the inner cell mass of the blastocysts. The murine embryonic stem 
cells were expanded, passaged, frozen and tested for pluripotency via differentiation. 
Outgrowths from the inner cell mass of murine blastocysts can be derived through 3 
techniques, namely culture of whole cell culture murine blastocysts, mechanical 
dissection or manual cut (30 G needle) and lasser dissection of inner cell mass from the 
murine blastocysts and subsequently cultured to obtain primary outgrowths. In culture 
of whole muirne blastocysts technique, the zona pellucida of muirne blastocysts was 
removed by using pronase (0.5%). The murine blastocysts were observed under 
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stereomicroscope until the zona pellucida has degraded. The murine blastocysts were 
then washed 3 to 5 times in murine embryonic stem cells culture medium (30 µl). The 
washed murine blastocyst was isolated via different methods. After isolation of inner 
cell mass, inner cell masses were placed on inactivated mouse embryonic fibroblasts in 
a humidified atmosphere of  CO2 (5%) in air at 37˚C for culturing. After 6 to 8 days 
later, the growing colonies were individually dissociated into clumps after treating with 
a mixture of trypsin/EDTA (0.05%). The resultant small clumps containing 
approximately 20 to 50 cells were transferred to a new well with a fresh feeder layer 
and medium. The new colonies were inspected daily and subcultured at an interval of 
approximately 6 to10 days according to their size and growth rate. Culture medium was 
changed every other day. The washed blastocysts were proceeded to the next step. 
 
3.3.5.2 (B) (d) (i) Culture of whole murine blastocysts 
The washed murine blastocysts were then directly transferred onto feeder layers of 
inactivated feeder cell layer on a gelatinised culture Petri dish (35 mm). The free zona 
pellucida murine blastocyst was placed directly on top of the feeder cells. Sufficient gap 
was left between each blastocyst. A small Petri dish could be used to culture 10 to15 
murine blastocysts. Special care and precaution should be taken to ensure the culture 
dishes were carried and placed back into the incubator to minimise shaking and were 
left there for 2 days due to the murine blastocysts  sensitiveness in attachment onto the 
feeder cells during culture dish movement. The culture medium was changed on day 2 
and consecutive alternate days. 
 
3.3.5.2 (B) (d) (ii) Manual cut (30 G) in isolation of murine inner cell mass 
After removing the zona pellucida of murine blastocyst, a single murine blastocyst was 
transferred onto a droplet of embryonic stem cell culture medium. A cut was performed 
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on the murine blastocyst by using 2 needles (30 G), one needle to hold the murine 
blastocyst in place and another to perform the cut. The murine inner cell mass was 
isolated after the cutting. Care must be taken to prevent cutting too deep on the surface 
of the Petri dish, or else the inner cell mass may get stuck on the Petri dish. After cut, 
the murine inner cell mass was carefully transferred onto a feeder layer of inactivated 
feeder cell layer. The murine inner cell masses were placed onto the feeder layer with 
sufficient gap in between them. A single culture dish may contain up to 10 to 15 murine 
inner cell masses. After transferring all murine inner cell masses, the culture dishes 
were carefully placed back into the incubator. They were left for 2 days without any 
interference. The primary outgrowth of the culture was observed under an inverted 
microscope on day 2 and medium were changed on every other day. 
 
3.3.5.2 (B) (d) (iii) Laser isolation of inner cell mass 
In laser isolation technique, the zona pellucida of murine blastocyts was not removed. 
The inner cell mass isolation was carried out on the micromanipulator system where the 
holding pipette (left side) and biopsy needle (right side) were used in manipulated the 
murine blastocyst. The inner cell mass was located at the 9 o’clock positioned. The 
murine blastocyst was held by holding pipette and the laser was shot along the way 
between the inner cell mass cells and trophectoderm cells. After shooting, the biopsy 
needle was sucked on the other side of the murine blsatocyst to remove the zona 
pellucida and trophectoderm from the inner cell mass. The isolated murine inner cell 
mass was washed with murine embryonic stem cell culture medium for several times 
before cultured onto the inactivated feeder cell layer. They were left for 2 days without 
any interference. The primary outgrowth of the culture was observed under an inverted 
microscope on day 2 and medium were changed on every other day. 
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3.3.5.2 (B) (e) Sub-culture of primary murine inner cell mass outgrowth 
The primary murine inner cell mass outgrowths were sub-culture using 2 techniques, 
namely trypsinisation and mechanical dissection procedures by trypsin/EDTA (0.05%). 
After around 4 to 6 days of culture, the primary outgrowths from the murine inner cell 
mass were picked. Suitable outgrowths were those of undifferentiated cells, 
characterised by slightly dark-pigmented clumps of cells with clearly defined borders. 
The inner cell mass that selected should have characters included dome shape colony 
surrounded with primitive endoderm, homogeneous and higher nuclear to cytoplasm 
ratio (bigger nucleus). Unwanted outgrowths were typically those of round, loosely 
arranged cells without a clear, defined border. They had a slightly refractal and were 
located directly next to the outgrowths. Outgrowths from the trophectoderm were 
characterised by the presence of giant cells, and these were not wanted and discarded. 
The suitable outgrowths were picked before differentiation occurred. Outgrowths 
beginning to differentiate will exhibit dark pigmentation.  
 
3.3.5.2 (B) (e) (i) Trypsinisation procedure for sub-culture murine inner cell mass  
                             outgrowth 
 
Culture Petri dish with feeder layer in murine embryonic stem cell culture medium at 
least 3 hours was incubated in incubator at 37°C, 5% CO2 before use. For trypsinisation, 
the murine outgrowths were lift up from feeder cell and transferred to wash in drops of 
PBS- for 4 times before incubating in trypsin/EDTA (0.05%) for 3 minutes at 37°C. 
Then gently pipetting up and down several times to break the outgrowth into small 
pieces which contains about 20 to 30 cells/piece. Then the small pieces were washed in 
embryonic stem cell culture medium for 4 times before spread onto a new feeder cell 
pre-incubated with embryonic stem cell culture medium. After 24 hours, change half of 
the media everyday. The cell colony appeared 3 to 4 days after trypsinisation (Passage 
1). Sub-culture when the colonies get bigger (should not let it bigger than 400 μm).  
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3.3.5.2 (B) (e) (ii) Mechanical sub-culture for murine inner cell mass outgrowth 
The pulled Pasteur pipette connected with mouth piece will be used to cut the colony 
into smaller pieces (avoid the primitive endoderm). Using a micropipette (2 to 20 µl), 
the wanted outgrowths were detached and transferred onto a droplet of PBS- (30 µl) for 
washing. Then, they were transferred to a droplet of trypsin/EDTA (30 µl; 0.05%) and 
gently disaggregated into smaller aggregates. The clumps were not disaggregated into 
single cells. The cell was transferred into prepared 4 well dish and incubated at 37°C, 
5% CO2. After 24 hours, the medium was changed half everyday. The colony appeared 
sooner when compared with trypsinisation procedure. Checked the cell carefully 
everyday and selected the one with murine embryonic stem cell character for 
subculture. For murine embryonic stem cell mechanical procedure were recommended 
in the first 3 to 4 passages. The good character colony for subculture was selected is 
highly recommended. 
 
 
3.3.5.3 Immunofluorescent staining on caprine and murine embryonic stem cells 
The caprine and murine embryonic stem cells can be confirmed by immunofluorescent 
staining. All the media were removed out from culture Petri dish and washed with 
PBS(-) for 3 times to remove all the remaining protein out of the cell. Then, they were 
fixed with paraformaldehyde (4%) for 30 minutes. After 30 minutes, the cell was 
washed with PBS(-) for 5 times and blocking solution (10% FBS+PBS-) was added just 
cover the cell and leave it for 2 hours at room temperature. The primary antibody (such 
as Oct 4, SSEA1, SSEA3, SSEA4, TRA-1-80 and TRA-1-60) was prepared at the 
optimal concentration with the ratio (1: 250). After 2 hours of blocking solution, the 
blocking solution was removed and the diluted primary antibody was added just to 
cover the cell and incubated overnight at 4 °C. The embryonic stem cell marker sample 
kit of primary antibody (Catalogue no. SCR002) was obtained from Millipore Company 
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from USA. After that, the primary antibody was removed out and washed 5 times with 
PBS(-). The washing step takes 10 to 15 minutes/time. Next, secondary antibody 
(diluted in ratio 1:1000) was added just to cover the cell and incubated 2 hours in dark 
environment due to its sensitivity to light. The second antibody (Alexa 488) that use in 
immunofluorescent staining depends on what species used for the primary antibody, for 
example, murine Oct 4 (primary antibody) must be used together with murine second 
antibody. After 2 hours, the secondary antibody was discarded out and washed again 5 
times with PBS(-). The washing step also took 10 to 15 minutes/time. Lastly, Hoechst 
33342 (5 μg/ml) was added just cover the cell and incubate 5 minutes in dark condition. 
The staining cell was observed under fluorescent microscope. The expression was 
detect by the glow of secondary antibody and the nucleus were be detected by the glow 
of Hoechst 33342. The colour of the protein markers detected depended on the second 
antibody used. 
 
3.3.5.4 Alkaline phosphatase activity on caprine and murine embryonic stem cells 
The alkaline phosphatase detection kit (Catalogue no. SCR004) was purchased from 
Millipore Company, USA. All the media was removed out from culture dish and 
washed with PBS(-) for 3 times to remove all the remaining protein out of the cell. The 
cell was fixed with paraformaldehyde (4%) for 30 minutes. After 30 minutes, they were 
washed with PBS(-) for 5 times the the alkaline phosphatase was added to the substrate 
just to cover the cell and incubated for 15 to 30 minutes in dark environment. After 15 
to 30 minutes, washed again with PBS(-) for 2 times and PBS(-) was added just to cover 
the cell and observed under fluorescent microscope.  
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3.4 EXPERIMENTAL DESIGN 
Several experiments were carried out in this study. This study was designed with the 
following specific goals: (1) to establish mouse embryonic fibroblasts as a feeder layer 
for caprine and murine embryonic stem cell lines production, (2) to evaluate the sources 
of caprine inner cell mass from blastocyst for production caprine embryonic stem cell 
lines, (3) to determine the effects of culture medium, mouse embryonic fibroblasts 
freezing and stages of blastocyst on production of embryonic stem cell lines using 
whole blasotcyst culture technique (4) to develop inner cell mass isolation techniques in 
production of caprine and murine embryonic stem cells lines and (5) to confirm caprine 
and murine embryonic stem cell lines by immunofluorescent staining of embryonic 
stem cells protein markers. 
 
3.4.1 Establishment of Mouse Embryonic Fibroblast as Feeder Cell Layer for  
         Production of Murine Embryonic Stem Cell Lines (Experiment1) 
 
The objective of this experiment was to determine the suitable murine strain for 
producing mouse embryonic fibroblast cell lines for use as feeder layer for embryonic 
stem cells culture, based on the growth rate. Primary mouse embryonic fibroblasts were 
obtained using days 13.5 to 14 post-coitus pregnant murine from the ICR, C57/6J and 
CBA/ca strains. They were passaged up to Passage 2 (P2) and the cells were frozen at 
each passage. In this study, the mouse embryonic fibroblasts were frozen at density of 
5.0x10
6
 cells/cryovial. The cells were thawed when there were embryos for embryonic 
stem cells culture. Feeder cell layer were prepared by seeding 4x10
5
 cell/dish in small 
culture Petri dish (35 mm). Both fresh and frozen-thawed mouse embryonic fibroblasts 
from both P1 and P2 were used. Their growth rate was compared, based on the number 
of days needed to reach 80% confluency. Confluent dishes were mitomitically 
inactivated and prepared for use as feeder layers. Two different culture media were also 
compared in order to obtain the good quality of embryonic stem cells culture. Data 
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obtained were analysed using one-way analysis of variance (ANOVA), followed by 
Duncan’s Multiple Range Test (DMRT). 
 
3.4.2 Production of Blastocysts as a Source of Inner Cell Mass for the  
         Establishment of Caprine Embryonic Stem Cell Lines (Experiment 2) 
 
The objectives of this experiment were (a) to compare the quality and efficiency of 
embryonic stem cells growth from in vitro or in vivo derived caprine blastocysts, (b) to 
compare the squeezing and laser enucleation teachniques in deriving the blasotcyst as 
source for caprine embryonic stem cells production and (c) to compare the pre-injection 
duration for 30, 60, 90 and 120 minutes in production of high caprine blastocyst rates. 
In addition, bovine somatic cell nuclear transfer and parthenogenesis to produce 
blastocysts as a comparative study (control) to caprine species were included in this 
experiment. Data obtained were analysed using one-way analysis of variance 
(ANOVA), followed by Duncan’s Multiple Range Test (DMRT). 
 
3.4.3 Effects of Culture Medium and Mouse Embryonic Fibroblast Freezing on  
           Production of Murine Embryonic Stem Cell Lines Using Whole Blastocyst  
           Culture Technique (Experiment 3) 
 
This experiment was designed to compare the efficiency of early-, mid-, expanded-, 
hatching- and hatched blastocysts for deriving embryonic stem cell lines. The 
blastocysts obtained were segregated according to sources of blastocyts obtained and 
blastocyst stages. They were then cultured on mouse embryonic fibroblasts as feeder 
layers. The success rate of murine and caprine blastocyst attachment was compared. 
The inner cell mass outgrowths were then isolated and passaged up to Passage 3 (P3). 
The number of outgrowths that were successfully cultured in an undifferentiated state to 
Passage 1 (P1), Passage 2 (P2) and Passages (P3) were compared among the different 
culture media and the different passages number of mouse embryonic fibroblasts used. 
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Data obtained were analysed using one-way analysis of variance (ANOVA), followed 
by Duncan’s Multiple Range Test (DMRT). 
 
3.4.4 Effects of Inner Cell Mass Isolation Techniques, Culture Medium and Mouse  
          Embryonic Fibroblast Freezing on Production of Murine and Caprine  
          Embryonic Stem Cell Lines Using Mouse Embryonic Fibroblast as Feeder   
          Cell Layer (Experiment 4) 
 
The aim of this experiment was to compare the efficiency of murine and caprine 
embryonic stem cells derived 3 different techniques, namely whole blastocyst culture, 
manual cut and laser dissection for deriving murine and caprine embryonic stem cells. 
They were then cultured on fresh or frozen mouse embryonic fibroblasts as feeder 
layers. The success rates of blastocyst attachment were compared. The inner cell mass 
outgrowths were then isolated and passaged up to passage 3 (P3). The number of 
outgrowths that can be successfully cultured in an undifferentiated state to P1, P2 and 
P3 were compared among the in vitro and in vivo derived blastocysts. Data obtained 
were analysed using one-way analysis of variance (ANOVA), followed by Duncan’s 
Multiple Range Test (DMRT). 
 
3.4.5 Confirmation of Caprine and Murine Embryonic Stem Cells by  
         Immunofluorescent Staining Protein Markers (Experiment 5) 
 
The objective of this experiment was to confirm the embryonic stem cells derived from 
caprine and murine species. Embryonic stem cells protein markers (immunofluoresent 
staining) were used in determined the embryonic stem cells formation. Alkaline 
phosphatase staining was carried out to determine the alkaline phosphatase activities 
that found in the caprine and murine embryonic stem cell lines. Purplish colour 
confirmed the presence of true embryonic stem cells. As for embryonic stem cells 
protein markers staining, specific colours were shown for specific staining protein 
markers (Oct 4: green (murine); red (caprine), SSEA 1: green (murine), SSEA3: green 
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(caprine), SSEA4, TRA-1-60 and TRA-1-180) to indicate the presence of true 
embryonic stem cells.   The results of the staining of the embryonic stem cells were 
observed and recorded.  
 
3.5 STATISTICAL ANALYSIS 
Using SPSS statistical programme (SPSS 16.0 version), means were obtained and 
analysed using one-way analysis of variance (ANOVA and differences among the 
means were determined using Duncan’s Multiple Range Test (DMRT). The obtained 
data were presented as mean ± standard error of means (SEM). For Experiment 1, 
effects of factors (murine strain, culture medium, fresh and frozen mouse embryonic 
fibroblast) on parameters (growth rates and passages number of murine embryonic 
fibroblast cell lines) measured were determined. Also, effects of factors (pre-
intracytoplasmic injection duration and murine strain) on parameters (cleavage rates and 
successful superovulation rates). For Experiment 2, effects of factors (enucleation 
techniques, pre-intracytoplasmic injection duration, oocyte grading and sources of 
oocytes and blastocysts) on parameters (cleavage rates) measured were determined in 
caprine species. Also, effects of factors (enucleation techniques, oocyte grading and 
sources of blastocysts) on parameters (cleavage rates). Comparison between caprine and 
bovine species, effects of factors (species, oocyte grading, enucleation techniques) on 
parameter (cleavage rates) measured were determined. For Experiment 3,  effects of 
factors (murine strain, culture medium, fresh and frozen-thawed mouse embryonic 
fibroblasts, blastocyst stages ) on parameters (inner cell mass attachment rate, primary 
inner cell mass outgrowths rate, successful rate of passages murine embryonic stem cell 
lines) measured were determined in murine species. For Experiment 4, effects of factors 
(inner cell mass isolation techniques, culture medium, fresh and frozen-thawed mouse 
embryonic fibroblast as well as in vivo- and in vitro-derived blastocyst) on parameters 
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(inner cell mass attachment rate, primary inner cell mass outgrowth rate and successful 
rate of passages caprine embryonic stem cell lines) measeured were determined in 
caprine species. Lastly, for Experiment 5, effects of factors (staining of embryonic stem 
cell protein markers and alkaline phosphatase) on parameters (expression of staining 
colour and alkaline phosphatase activity) were observed in caprine and murine species 
(Table 3.29). 
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Oviduct flushing 
(2-cell stage) 
Uterine flushing 
(blastocyst) 
Experiment 3 (ICM attachment rate, primary ICM 
outgrowth rate, successful passages mESC lines rates) 
Stage of blastocyst (murine) 
 (early-, mid-, expanded-, hatching- and hatched blastocyst, 
strains, culture medium, fresh and frozen-thawed MEF ) 
Outgrowth of ICM 
Expansion and passages 
of ESC 
Experiment 5 (colour of 
ESC staining) 
 Staining ESC 
marker (Oct 4, 
SSEA; TRA ) 
 Alkaline 
phosphatase 
staining 
In vivo derived blastocysts 
Uterine flushing 
(blastocyst) 
M II oocyte 
enucleation 
 
SCNT 
 
Whole Cell Intracytolasmic Injection (WCICI)  
 
Activation 
(caprine: CaI, 5 min; 6-DMAP, 4 hr; murine: Sr
2+
, 6 hr ) 
 
In vitro culture (IVC) 
(caprine: KSOM; murine: WM) 
 
 
 
Fresh cumulus cell Ear fibroblast cell 
Blastocyst 
Oocyte enucleation (squeezing vs. laser) 
(pre-incubate: 30 min, 60 min, 90 min and 120 min) 
 PA 
Oocytes denudation  
 
In vitro derived blastocysts 
Experiment 1(Growth rates, passages number MEF, cleavage rates) 
Murine (strains, culture medium, fresh and frozen-thawed MEF, pre-ICI 
durations, successful superovulation rates) 
Superovulation  
10 IU PMSG; 10 IU hCG 48 hr 
later 
  
In vivo matured oocyte 
(post-hCG injection 13 to15 hr) 
 
Ovary slicing 
Oocytes grading 
LOPU Ovariectomy Abattoir 
Isolation primary MEF 
(13.5 to 14 d.p.c.)  
(strain: ICR; CBA/ca; 
C57BL/6J) 
 
Passage MEF Cryopreserved MEF 
Feeder cell preparation 
(mitotic inactivation by MTC) 
Thawing MEF 
Bovine (enucleation 
techniques, oocyte 
grading) 
Caprine 
(sources of oocyte, oocyte grading, pre-ICI durations, enucleation 
techniques) 
IVM  
 
Culture ICM on feeder layer 
(DMEM+10%FBS; αMEM+10%FBS) 
Experiment 4 (ICM attachment rate, primary 
ICM outgrowth rate, successful passages gESC 
and mESC lines rates) 
Isolation of ICM (caprine and murine) 
(whole blastocyst culture, manual cut, laser 
system, culture medium, fresh and frozen-thawed 
MEF, in vivo- and in vitro-derived blastocysts) 
Experiment 2 (cleavage rates) 
Blastocyst sources 
In vivo derived blastocysts 
In vitro culture (IVC) 
 
 
 
 
Blastocyst 
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Figure 3.29: Flow of experimental design. 
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Chapter 4 
4.0 RESULTS 
 
4.1 ESTABLISHMENT OF MOUSE EMBRYONIC FIBROBLAST AS FEEDER  
      CELL LAYER FOR PRODUCTION OF MURINE EMBRYONIC STEM  
       CELL LINES (EXPERIMENT 1) 
Murine strains (ICR, CBA/ca and C57BL/6J) were evaluated to determine their 
suitability for producing mouse embryonic fibroblast cell lines for use as feeder cell 
layer for embryonic stem cells culture, based on their growth rate. The mouse 
embryonic fibroblast was passaged up to Passage 2 (P2) and the cells were frozen at 
each passage. The fresh and frozen-thawed mouse embryonic fibroblast at Passage 1 
(P1) and Passage 2 (P2) were compared to determine their efficacies in producing 
murine embryonic stem cell lines. Besides that, 2 different culture media (DMEM and 
αMEM) were also compared to produce the good quality mouse embryonic fibroblast 
cell lines. Murine embryonic stem cells were obtained from 2 sources of blastocysts, 
namely in vivo superovulation-flushing embryos (2-cell stage embryos and blastocysts) 
and in vitro superovulated oocytes somatic cell nuclear transfer derived embryos.  
 
4.1.1 Effects of Murine Pure-strains on Superovulation Responses  
The production of embryos obtained from successful superovulation in 3 different 
murine pure-strains had been studied with the aim to determine the suitable strains of 
murine for use as the source of blastocysts for embryonic stem cells production.  
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Table 4.1: Percent successful superovulation (%, mean±SEM) in 3 different pure-strains  
                 of murine 
 
Murine 
strains 
Number of 
murine 
injected 
Number of murine 
successful 
superovulated 
Percent successful superovulated 
female murine 
 
ICR 329 281 75.34±3.66
x
 
CBA/ca 302 243 77.00±3.81
x
 
C57BL/6J 306 228 65.71±4.13
x
 
Total 937 752                  72.74±2.25 
 
x
 Means with same superscript in a column were not significantly different (P>0.05). 
 
Table 4.1 shows the percentage of successful superovulation in 3 different pure-strains 
of murine. A total of 752 out of 937 female murine were successfully superovulated. 
Out of total 329, 302, and 306 of ICR, CBA/ca and C57BL/6J, 281 (75.34±3.66%), 243 
(77.00±3.81%) and 228 (65.71±4.13%) murine, respectively, were successful 
superovulated using PMSG and hCG. The successful superovulation was not 
significantly different (P>0.05) among the pure-strains of murine used in this 
experiment. Although no significant differences among the 3 different pure-strains 
murine were detected, the CBA/ca (77.00±3.81%) strain showed the highest percent 
successful superovulation followed by ICR (75.34±3.66%) and C57BL/6J 
(65.71±4.12%). 
Table 4.2 shows the number of oocytes, 2-cell and blastocyst obtained from 
superovulation in 3 different pure-strains of murine. Total number of murine used in 
producing oocytes, 2-cell and blastocyst were 377, 864 and 212, respectively. There 
were significant differences (P<0.05) in number of oocytes for ICR and CBA/ca with 
C57BL/6J with values of 12.29±0.51 and 13.30±0.47 versus 14.98±0.53, respectively.  
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Table 4.2: Number of oocytes, 2-cell and blastocyst embryos obtained from superovulation (mean±SEM) in 3 different pure-strains of  
                 murine 
 
Murine 
strains 
Oocytes 
 
2-cell Blastocyst 
 Total no. 
of selected 
females 
used 
Total no. 
of oocytes 
obtained 
No. of 
oocytes/female 
used 
Total no. 
of selected 
females 
used 
Total no. of 
2-cell 
obtained 
No. of 2-
cell/female 
used 
Total no. 
of selected 
females 
used 
Total no. of 
blastocyst 
obtained 
No. of 
blastocyst/female 
used 
ICR 174 2048    12.29±0.51
x
 297 2999 10.62±0.61
x
 121 191      1.89±0.18
x
 
CBA/ca 128 1660    13.30±0.47
x
 278 2402 11.07±0.76
x
  37   70      2.03±0.23
x
 
C57BL/6J  75 1111    14.98±0.53
y
 289 2143  9.21±0.71
x
  54   72      1.52±0.30
x
 
Total 377 4819    13.22±0.30 864 7544 10.32±0.40 212 333      1.81±0.13 
 
xy
 Means with different superscript in a column were significantly different (P<0.05). 
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              Figure 4.1: Murine oocytes with first polar body.  
 
           
 Figure 4.2: A 2-cell stage murine of embryo.   Figure 4.3: Blastocyst stage of murine  
                                                                                                      embryos. 
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4.1.2 Effect of Murine Sources on the Percent Cleavage for the Production of      
          Blastocysts 
 
In this experiment, the murine blastocysts were obtained from in vivo and in vitro 
produced embryos. In the former, the murine embryos underwent in vivo oviduct (2-cell 
stage) or uterine (blastocyst) flushing. Somatic cell nuclear transfer was carried out in 
murine species to obtain in vitro-derived blastocysts. A total of 864 and 212 murine 
were used in vivo oviduct flushing and in vivo uterine flushing, whereas 377 murine 
were used in vitro-derived blastocyst through somatic cell nuclear transfer. 
 
Table 4.3: Cleavage rates from 2-cell flushed embryos up to blastocyst stage (%,                       
                   mean±SEM) in 3 different pure-strains of murine 
 
Murine 
strains 
No. of 
selected 
females 
No. of 
2-cell 
Percent cleavage 
(n) 
   4-cell 
(n) 
8-cell 
(n) 
Morula 
(n) 
Blastocyst 
(n) 
ICR 297 2999 89.69±1.41
a,x 
(2755) 
88.07±1.45
a,x 
(2673) 
87.19±1.48
a,x 
(2628) 
86.39±1.62
a,x 
(2589) 
CBA/ca 278 2402 89.65±0.85
b,x 
(2137) 
86.63±1.07
ab,x 
(2052) 
84.77±1.25
a,x 
(2000) 
84.26±1.33
a,x 
(1988) 
C57BL/6J 289 2143 87.53±1.95
a,x 
(1924) 
84.98±2.00
a,x 
(1843) 
82.86±2.07
a,x 
(1783) 
81.84±2.09
a,x 
(1747) 
Total 864 7544    89.01±0.86   86.70±0.90 85.14±0.95  84.36±1.00 
 
ab
 Means with different superscript in a row were significantly different (P<0.05). 
x
 Means with same superscript in a column were not significantly different (P>0.05). 
 
After in vitro culture, a total of 6324 (84.36±1.00%) murine blastocyst obtained 
from 7544 two-cell stage murine embryos through in vivo oviduct flushing.  Out of 864 
blastocysts obtained, 2589 (86.39±1.62%), 1988 (84.26±1.33%) and 1747 
(81.84±2.09%) blastocysts were obtained from the ICR, CBA/ca and C57BL/6J murine 
pure-strains, respectively. Table 4.3 shows the results of percent cleavage among 3 
different pure-strains of murine from 2-cell stage embryos up to blastocysts (Figure 
4.4). There were no significant differences (P>0.05) among the 3 different pure-strains 
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of murine. However, there were significant differences (P<0.05) between 4-cell stage 
(89.65±0.85%) embryos versus the morula and blastocyst (84.77±1.25% and 
84.26±1.33%) embryos in CBA/ca strain. The percent blastocyst obtained in ICR 
(86.39±1.62%) was the highest followed by CBA/ca (84.26±1.33%) and C57BL/6J 
(81.84±2.09%). 
 
       Figure 4.4: a) 4- and 8-cell murine embryos. b) Morula and early blastocyst  
                          murine embryos. c) Hatching and hatched murine blastocysts.  
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Table 4.4: Average number (mean±SEM) of blastocyst obtained from 3 different pure-                  
                  strains of murine through in vivo uterine flushing 
 
Murine strains No. of females No. of blastocysts Average (blastocyst) (n) 
ICR  121 191 1.89±0.18
x
 
CBA/ca   37   70 2.03±0.23
x
 
C57BL/6J   54   72 1.52±0.30
x
 
Total 212 333 1.81±0.13 
 
x
 Means with same superscript in a column were not significantly different (P>0.05). 
 
From Table 4.4, the data were collected from ICR (n=121), CBA/ca (n=37) and 
C57BL/6J (n=54) murine, which produced 191, 70 and 72 murine blastocysts, 
respectively. There were no significant differences (P>0.05) among the 3 different pure-
strains murine which ICR (1.89±0.18), CBA/ca (2.03±0.23) and C57BL/6J (1.52±0.30). 
Table 4.5 shows the cleavage rate of murine embryos from in vitro culture 
through somatic cell nuclear transfer. A total of 377 female murine from 3 different 
murine pure-strains were used in this experiment represented by 174, 128 and 75 for 
ICR, CBA/ca and C57BL/6J, respectively. There were no significant differences 
(P>0.05) in enucleation and injection rates from 3 different pure-strains of murine, 
except maturation rate, where C57BL/6J gave the highest maturation rate 
(61.00±2.26%) compared to ICR (57.15±1.73%) and CBA/ca (54.73±1.73%). It was 
observed that cleavage rates were decreasing from 2-cell stage embryos up to hatched 
blastocysts in 3 different pure-strains of murine. It was evident that ICR always showed 
the highest cleavage rates at 2-cell (42.79±3.00%), 4-cell (32.04±2.88%), 8-cell 
(25.69±2.67%), morula (22.46±2.50%) and blastocyst (18.02±2.30%) followed by 
C57BL/6J with the values of 39.53±3.95%, 25.89±3.21%, 17.50±2.76%, 12.57±2.32%, 
10.10±1.81% and CBA/ca with the values of 35.43±3.03%, 20.99±2.43%, 
13.48±2.09%, 9.55±1.69%, 7.35±1.39% for 2-, 4-, 8-cell, morula and blastocyst, 
respectively. However, C57BL/6J showed significant different (P<0.05) in percent 
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hatched blastocyst with the highest values (5.87±1.47%) followed by CBA/ca 
(1.22±0.51%) and ICR (1.28±0.28%). 
Murine cleavage rates based on murine pure-strains and pre-intracytoplasmic 
injection (pre-ICI) durations through somatic cell nuclear transfer are shown in Table 
4.6. Obviously, there were significant differences in pre-intracytoplasmic injection 
durations treatments at 90 minutes pre-intracytolasmic injection duration whereby it 
gave the highest cleavage rate in 3 different pure-strains murine compared to 
simultaneous injection as well as 30, 60 and 120 minutes pre-intracytoplasmic injection 
durations. Simultaneous injection right after enucleation showed the lowest cleavage 
rates in ICR (2-cell: 9.59±4.66%; 4-, 8-cell, morula, blastocyst and hatched blastocyst: 
0.00±0.00%), CBA/ca (2-cell: 18.30±7.19%; 4-cell: 5.16±3.49%; 8-cell, morula, 
blastocyst and hatched blastocyst: 0.00±0.00%) and C57BL/6J (2-cell: 21.12±5.12%; 4-
cell: 13.12±5.11%; 8-cell: 8.69±4.47%; morula: 1.43±1.43%; blastocyst and hatched 
blastocyst: 0.00±0.00%). Development of murine embryos from 2, 4-cell, morula, 
blastocyst and hatched blastocysts through somatic cell nuclear transfer technique as 
shown in Figure 4.5. 
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        Table 4.5: Percent cleavage rate (%, mean±SEM) of murine embryos from in vitro culture through somatic cell nuclear transfer 
                  
 
abcde
 Means with different superscripts in a row within a group were significantly different (P<0.05). 
xy
 Means with different superscripts in a column were significantly different (P<0.05). 
 
 
 
Murine 
strains 
No. of 
females 
No. of 
oocytes 
Maturation 
rate  
(n) 
Enucleation 
rate  
(n) 
Injection 
rate 
(n) 
Percent cleavage 
(n)  
      2-cell 
(n) 
4-cell 
(n) 
8-cell 
(n) 
Morula 
(n) 
Blastocyst 
(n) 
Hatched 
blastocyst  
(n) 
ICR 174 2048 57.15±1.73
xy 
(1198) 
61.10±1.99
x 
(766) 
65.22±2.51
x 
(534) 
42.79±3.00
e,x 
(291) 
32.04±2.88
d,y 
(229) 
25.69±2.67
cd,y 
(159) 
22.46±2.50
bc,y 
(165) 
18.02±2.30
b,y 
(130) 
1.28±0.28
a,y 
(56) 
CBA/ca 128 1660 54.73±1.73
x 
(948) 
57.63±2.66
x 
(567) 
61.82±2.84
x 
(367) 
35.43±3.03
 e,x 
(167) 
20.99±2.43
d,x 
(102) 
13.48±2.09
c,x 
(68) 
9.55±1.69
bc,x 
(46) 
7.35±1.39
b,x 
(35) 
1.22±0.51
a,x 
(8) 
C57BL/6J   75 1111 61.00±2.26
y 
(693) 
63.13±2.53
x 
(459) 
67.55±3.45
x 
(305) 
39.53±3.95
d,x 
(149) 
25.89±3.21
c,xy 
(99) 
17.50±2.76
b,x 
(69) 
12.57±2.32
ab,x 
(51) 
10.10±1.81
ab,x 
(40) 
5.87±1.47
a,y 
(25) 
Total 377 4819  57.03±1.08 60.22±1.40 64.43±1.66  39.39±1.89 26.68±1.68  19.48±1.52 15.64±1.37 12.43±1.20  4.64±0.79 
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                         Figure 4.5: Development of murine embryos from 2-, 4-cell, morula, blastocyst and hatched blastocysts through somatic cell  
                                                   nuclear transfer technique. 
2
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Table 4.6: Percent murine cleavage (%, mean±SEM ) based on murine pure-strains and pre-intracytoplasmic injection (pre-ICI) durations through  
                 somatic cell nuclear transfer  
 
  
Murine 
strains 
Pre-ICI 
durations 
Percent cleavage 
(n) 
  2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst (n) 
 
 
 
 
 
ICR 
Simultaneous   9.59±4.66
b,w 
(7/52)* 
  0.00±0.00
a,w 
(0/52) 
  0.00±0.00
a,w 
(0/52) 
 0.00±0.00
a,w 
(0/52) 
0.00±0.00
a,w 
(0/52) 
0.00±0.00
a,w 
(0/52) 
30 min 39.25±6.62
c,x 
(24/56) 
23.85±6.41
b,x 
(15/56) 
19.97±5.75
b,x 
(13/56) 
17.91±5.46
b,x 
(11/56) 
14.73±4.29
ab,x 
(9/56) 
0.27±0.27
a,w 
(2/56) 
60 min 55.54±6.21
d,y 
(58/97) 
43.76±5.94
cd,y 
(45/97) 
35.95±5.32
bc,y 
(36/97) 
32.91±5.03
bc,y 
(33/97) 
24.24±4.68
b,y 
(22/97) 
0.59±0.28
a,w 
(4/97) 
90 min 67.76±2.87
d,y 
(160/237) 
60.14±3.11
cd,z 
(139/237) 
52.04±3.76
bc,z 
(122/237) 
47.26±3.84
b,z 
(111/237) 
42.85±3.92
b,z 
(99/237) 
4.14±0.74
a,x 
(50/237) 
120 min 34.75±5.18
b,x 
(42/92) 
22.93±4.69
c,x 
(30/92) 
11.89±4.07
b,x 
(18/92) 
6.49±2.68
ab,w 
(10/92) 
0.00±0.00
a,w 
(0/92) 
0.00±0.00
a,w 
(0/92) 
 Total    42.79±3.00   32.04±2.88     25.69±2.67 22.46±2.50   18.02±2.30     7.05±1.61 
 
 
 
 
 
CBA/ca 
Simultaneously 18.30±7.19
b,w 
(11/29) 
5.16±3.49
a,w 
(3/29) 
0.00±0.00
a,w 
(0/29) 
0.00±0.00
a,w 
(0/29) 
0.00±0.00
a,w 
(0/29) 
0.00±0.00
a,w 
(0/29) 
30 min 24.14±7.51
b,w 
(12/40) 
5.95±4.14
a,w 
(3/40) 
3.57±3.57
a,wx 
(2/40) 
1.79±1.79
a,w 
(1/40) 
0.00±0.00
a,w 
(0/40) 
0.00±0.00
a,w 
(0/40) 
60 min 34.61±6.58
c,w 
(23/62) 
20.43±4.62
b,x 
(14/62) 
12.64±3.88
ab,x 
(9/62) 
10.73±3.42
ab,x 
(7/62) 
10.73±3.42
ab,x 
(7/62) 
0.00±0.00
a,w 
(0/62) 
90 min 57.60±3.58
e,x 
(93/157) 
46.05±2.80
d,y 
(68/157) 
36.40±3.60
c,y 
(53/157) 
26.70±3.59
b,y 
(38/157) 
19.55±3.11
b,y 
(28/157) 
4.57±1.77
a,x 
(8/157) 
120 min 28.81±6.17
c,w 
(28/79) 
12.68±4.14
b,wx 
(14/79) 
2.85±1.72
a,w 
(4/79) 
0.00±0.00
a,w 
(0/79) 
0.00±0.00
a,w 
(0/79) 
0.00±0.00
a,w 
(0/79) 
 Total    35.43±3.03   20.99±2.43   13.48±2.09    9.55±1.69    7.35±1.39     1.22±0.51 
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C57BL/6J 
Simultaneously 21.12±5.12
c,w 
(11/45) 
13.12±5.11
bc,w 
(7/45) 
8.69±4.47
ab,w 
(4/45) 
1.43±1.43
a,w 
(1/45) 
0.00±0.00
a,w 
(0/45) 
0.00±0.00
a,w 
(0/45) 
30 min 37.33±8.84
c,w 
(18/44) 
19.16±7.28
b,w 
(10/44) 
10.84±4.31
ab,w 
(6/44) 
7.09±3.48
ab,w 
  (4/44) 
5.84±3.01
ab,w 
  (3/44) 
0.00±0.00
a,w 
(0/44) 
60 min 35.07±8.93
c,w 
(15/36) 
21.57±6.93
bc,w 
(9/36) 
9.88±4.36
ab,w 
(5/36) 
7.80±3.63
ab,w 
(4/36) 
6.13±2.80
ab,w 
(3/36) 
0.00±0.00
a,w 
(0/36) 
90 min 60.51±6.06
d,x 
(93/142) 
44.19±4.92
c,x 
(66/142) 
35.45±4.35
bc,x 
(52/142) 
28.86±3.84
ab,x 
(41/142) 
23.75±2.50
ab,x 
(33/142) 
17.24±2.54
a,x 
(25/142) 
120 min 24.20±9.12
c,w 
(12/38) 
13.69±5.35
a,w 
(7/38) 
3.17±3.17
a,w 
(2/38) 
1.59±1.59
a,w 
(1/38) 
1.59±1.59
a,w 
(1/38) 
0.00±0.00
a,w 
(0/38) 
 Total    39.53±3.95   25.89±3.21   17.50±2.76 12.57±2.32 10.10±1.81     5.87±1.47 
 
abcde
 Means with different superscripts in a row within a group were significantly different (P<0.05). 
wxyz
 Means with different superscripts in a column within a group were significantly different (P<0.05). 
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4.1.3 Effect of 3 Different Pure-strains of Murine for Mouse Embryonic Fibroblast  
         Cell Lines on Murine Embryonic Stem Cells Lines Performance 
 
This experiment was to evaluate the suitable murine pure-strains for use to derive the 
mouse embryonic fibroblast cell lines used as feeder cell layer for murine embryonic 
stem cell lines production. A total of 3 mouse embryonic fibroblast cell lines were 
derived from 3 different pure-strain of murine (ICR, CBA/ca and C57BL/6J). There 
were no observable differences in terms of morphology of mouse embryonic fibroblasts 
from different strains and passages number, as well as before and after frozen-thawed.  
 
Table 4.7: Growth rates of mouse embryonic fibroblast cell lines in 3 different pure-                  
                 strains of murine 
 
Murine 
strains 
No. of 
females 
No. of 
replicates 
Growth rate  
(n) 
   P0  
(n) 
P1  
(n) 
P2  
(n) 
ICR 45 32 95.31±2.62
a,x 
(42) 
100.00±0.00
a,x 
(42) 
96.88±2.17
a,x 
(40) 
CBA/ca 23 22 88.64±6.52
a,x 
(20) 
86.36±7.49
a,x 
(19) 
81.81±8.42
a,x 
(18) 
C57BL/6J 21 18 88.89±6.46
a,x 
(18) 
86.11±7.89
a,x 
(16) 
83.33±9.04
a,x 
(15) 
Total 89 72    91.67±2.80    92.36±3.07    88.89±3.60 
 
a
 Means with same superscript in a row were not significantly different (P>0.05). 
x
 Means with same superscript in a column were not significantly different (P>0.05). 
 
 
Table 4.7 shows the growth rate of mouse embryonic fibroblast cell lines in 3 
different pure-strains of murine (ICR, CBA/ca and C57BL/6J). There were no 
significant differences (P>0.05) in mouse embryonic fibroblast growth rates for P0, P1 
and P2 as well as 3 different pure-strains of murine. Therefore, 3 different pure-strains 
of murine also could be used as feeder cell layers for production of murine embryonic 
stem cell lines. Growth rate and confluency of mouse embryonic fibroblast cells were 
shown in Figure 4.6. 
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Figure 4.6: a) 50% growth rate mouse embryonic fibroblast cells. b) 80% confluency of  
                   mouse embryonic fibroblast cells.  
 
Table 4.8: Successful growth rates of mouse embryonic fibroblast cell lines in 3  
                 different pure-strains of murine after frozen-thawed at Passage 1 (P1) 
 
 
a
 Means with same superscript in a row were not significantly different (P>0.05). 
x
 Means with same superscript in a column were not significantly different (P>0.05). 
 
 
In Table 4.8, a total of 89 pregnant murine females from ICR (45), CBA/ca (23) 
and C57BL/6J (21) were used in this experiment to produce 77 (Passage 1)  and 73 
(Passages 2) mouse embryonic fibroblast cell lines as a bank store for used as feeder 
cell layers for cultured murine embryonic stem cells. There were no significant 
differences (P>0.05) in growth rates after frozen-thawed mouse embryonic fibroblast 
cells between Passage 1 (P1) and Passage 2 (P2) for 3 different pure-strains of murine. 
 
 
Murine 
strains 
No. of 
females 
No. of 
replicates 
P1 
(n) 
P2 
(n) 
Growth rates after frozen-thawed 
(n) 
     P1  
(n) 
P2  
(n) 
ICR 45 32 42 40 93.75±3.72
a,x 
(39/42) 
92.19±3.96
a,x 
(36/40) 
CBA/ca 23 22 19 18 77.27±9.14
a,x 
(17/20) 
72.73±9.72
a,x 
(16/18) 
C57BL/6J 21 18 16 15 86.11±7.89
a,x 
(16/18) 
72.22±10.86
a,x 
(13/15) 
Total 89 72 80 73     86.81±3.83  81.25±4.47 
b a 
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Table 4.9: Growth rates of different culture media for mouse embryonic fibroblast cell  
                 lines 
 
Culture 
media 
No. of 
females 
No. of 
replicates 
Growth rates 
(n) 
   P0  
(n) 
P1  
(n) 
P2  
(n) 
DMEM+10% 
FBS 
45 36 97.22±1.94
a,x 
(43) 
98.61 ±1.39
a,x 
(42) 
97.22±1.94
a,x 
(40) 
αMEM+10% 
FBS 
44 36 95.83±3.07
a,x 
(42) 
94.44±5.19
a,x 
(40) 
90.28±4.37
a,x 
(37) 
Total 89 72    96.53±1.80    96.53±2.68    93.75±2.41 
 
a
 Means with same superscript in a row were not significantly different (P>0.05). 
x
 Means with same superscript in a column were not significantly different (P>0.05). 
 
 
Table 4.9 shows the growth rates of mouse embryonic fibroblast cell lines in 2 
different culture media (DMEM+10%FBS and αMEM+10%FBS). There were no 
significant differences (P>0.0.5) between DMEM+10% FBS and αMEM+10% FBS 
culture media for mouse embryonic fibroblast cells at P0 (97.22±1.94% versus 
95.83±3.07%), P1 (98.61±1.39% versus 94.44±5.19%) and P2 (97.22±1.94% versus 
90.28±4.37%), respectively. Therefore, both DMEM+10% FBS and αMEM+10% FBS 
culture media could be used in cultured the mouse embryonic fibroblast cell lines.  
 
Table 4.10: Successful growth rates of different culture media for mouse embryonic  
                   fibroblast cell lines after frozen-thawed at Passage 1 (P1) 
 
 
a
 Means with same superscript in a row were not significantly different (P>0.05). 
x
 Means with same superscript in a column were not significantly different (P>0.05). 
Culture 
media 
No. of 
females 
No. of 
replicates 
P1 
(n) 
P2 
(n) 
Growth rates after frozen-thawed 
(n) 
     P1  
(n) 
P2  
(n) 
DMEM+10% 
FBS 
24 18 24 23 94.44±5.56
a,x 
(23/24) 
97.22±2.78
a,x 
(22/23) 
αMEM+10% 
FBS 
22 18 22 19 88.89±6.46
a,x 
(19/22) 
91.67±6.06
a,x 
(17/19) 
Total 46 36 46 42     91.67±4.23   94.44±3.32 
  
222 
 
Successful growth rates of different culture media for mouse embryonic 
fibroblast cell lines after frozen-thawed at Passage 1 (P1) was shown in Table 4.10. 
Similar as Table 4.9, there were no significant differences (P>0.0.5) between 
DMEM+10%FBS and αMEM+10%FBS culture media for mouse embryonic fibroblast 
cells after frozen-thawed at Passage 1 (P1) with the values of 94.44±5.56% versus 
88.89±6.46% and 97.22±2.78% versus 91.67±6.06% for Passage 1 (P1) and Passage 2 
(P2), respectively. However, culture medium for DMEM+10% FBS gave the highest 
growth rates (P1: 94.44±5.56%; P2: 97.22±2.78%) compared to αMEM+10% FBS 
culture medium (P1: 88.89±6.46%; P2: 91.67±6.06%).  
 
4.2 PRODUCTION OF CAPRINE BLASTOCYSTS AS A SOURCE OF INNER  
      CELL MASS FOR THE ESTABLISHMENT OF CAPRINE EMBRYONIC  
      STEM CELL LINES (EXPERIMENT 2) 
The objectives of this experiment were (a) to compare the efficiency and quality of 
embryonic stem cells growth from in vitro or in vivo derived caprine blastocysts, (b) to 
compare the squeezing and laser enucleation techniques in deriving the blasotcysts as 
source for caprine embryonic stem cells production and (c) to compare the pre-
intracytoplasmic injection durations for simultaneous, 30 and 60 minutes in production 
of high caprine blastocysts. In addition, bovine somatic cell nuclear transfer and 
parthenogenesis to produce blastocysts as a comparative study (control) to caprine 
species were included in this experiment. 
 
4.2.1 Production of Bovine Blastocysts Through Somatic Cell Nuclear Transfer  
         and Parthenogenesis (Control) 
 
Table 4.11 shows the cleavage rates of bovine embryos through somatic cell nuclear 
transfer by 2 different enucleation techniques, namely squeezing and laser enucleation. 
There were no significant differences (P>0.05) in maturation, enucleation and injection 
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rates between squeezing and laser enucleation techniques. However, embryos 
development at various stages were significantly higher in laser enucleation technique 
compared to squeezing enucleation technique with values of 63.72±4.04% versus 
20.12±5.35%, 50.30±4.33% versus 13.72±4.38%,   37.74±4.31% versus 7.95±3.79%, 
23.84±3.79% versus 1.71±1.33%; 7.01±1.42% versus 0.20±0.20% and 2.98±0.77% 
versus 0.10±0.10% for 2-, 4-, 8-cell, morula, blastocyst and hatched blastocyst, 
respectively. For both enucleation techniques, the cleavage rates were decreasing as the 
stages of development progressing. No blastocysts were obtained for squeezing 
enucleation technique.  
Table 4.12 shows the cleavage rate of bovine embryos based oocytes grading 
regardless of enucleation techniques. Grade A oocytes showed the highest maturation 
(49.77±3.21%), enucleation (84.34±3.12%) and injection (86.73±3.03%) rates followed 
by Grades B (33.62±3.66%; 57.60±5.39%; 57.19±5.40%), C (21.61±3.75%; 
30.47±5.23%; 29.37±5.08%), D (8.44±2.39%; 13.27±3.83%; 13.61±3.88%) and E 
(9.79±2.38%; 17.89±4.38%; 17.25±4.28%), respectively. Similarly, cleavage rates for 
each developmental stage decreased as the grades of oocytes decreased (2-cell: 5.51 to 
49.16%; 4-cell: 2.92 to 40.55%; 8-cell: 2.92 to 29.93%; morula: 2.08 to 18.04%; 
blastocyst: 0.14 to 5.78% and hatched blastocyst: 0.00 to 2.56%). 
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Table 4.11: Cleavage rates of bovine embryos (%, mean±SEM) from in vitro culture through different enucleation techniques                  
 
abcde
 Means with different superscripts in a row were significantly different (P<0.05). 
xy
 Means with different superscripts in a column within a group were significantly different (P<0.05). 
 
 
 
 
 
 
 
 
Enucleation 
techniques 
No. of 
ovaries 
No. of 
oocytes 
Maturation 
rate  
(n) 
Enucleation 
rate 
 (n) 
Injection 
rate 
(n) 
 Percent cleavage   
(n)  
      2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst  
(n) 
Squeezing 72 1420 37.00±3.53
x 
(512) 
82.73±3.81
x 
(375) 
87.87±2.86
x 
(320) 
20.12±5.35
c,x 
(94) 
13.72±4.38
bc,x 
(71) 
7.95±3.79
ab,x 
(45) 
1.71±1.33
a,x 
(19) 
0.20±0.20
a,x 
(2) 
0.10±0.10
a,x 
(1) 
Laser 148 1734 46.02±3.76
x 
(806) 
88.64±3.21
x 
(699) 
92.38±1.97
x 
(644) 
63.72±4.04
e,y 
(413) 
50.30±4.33
d,y 
(327) 
37.74±4.31
c,y 
(257) 
23.84±3.79
b,y 
(195) 
7.01±1.42
a,y 
(71) 
2.98±0.77
a,y 
(33) 
Total 220 3154 42.01±2.65 86.01±2.47 90.38±1.69 44.35±4.14 34.04±3.76   24.50±3.40    14.01±2.53   3.89±0.89  1.65±0.46 
2
2
4
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Table 4.12: Percent cleavage of bovine embryos (%, mean±SEM) based on oocyte grading  
 
abcd
 Means with different superscripts in a row within a group were significantly different (P<0.05). 
wxyz
 Means with different superscripts in a column within a group were significantly different (P<0.05). 
 
  
 
Oocyte 
Grades 
No. of 
oocytes 
Maturation rate 
(n) 
Enucleation 
rate  
(n) 
Injection rate 
(n) 
Percent cleavage  
(n)  
     2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst 
 (n) 
A 1417 49.77±3.21
z 
(690) 
84.34±3.12
z 
(589) 
86.73±3.03
z 
(538) 
49.16±4.51
d,y 
(317) 
40.55±4.29
d,y 
(267) 
29.93±4.11
c,x 
(209) 
18.04±3.11
b,x 
(152) 
5.78±1.31
a,y 
(50) 
2.56±0.70
a,y 
(24) 
B 821 33.62±3.66
y 
(341) 
57.60±5.39
y 
(256) 
57.19±5.40
y 
(223) 
24.45±4.27
c,x 
(105) 
16.06±3.21
b,x 
(77) 
7.46±2.09
a,w 
(51) 
4.84±1.68
a,w 
(36) 
2.70±1.01
a,x 
(17) 
1.13±0.43
a,x 
(9) 
C 452 21.61±3.75
x 
(155) 
30.47±5.23
x 
(123) 
29.37±5.08
x 
(110) 
9.98±2.95
c,w 
(47) 
5.85±2.02
bc,w 
(30) 
4.89±1.89
abc,w 
(23) 
3.35±1.55
ab,w 
(14) 
0.56±0.35
ab,w 
(4) 
0.14±0.14
a,wx 
(1) 
D 141 8.44±2.39
w 
(57) 
13.27±3.83
w 
(50) 
13.61±3.88
w 
(42) 
6.02±2.31
b,w 
(20) 
3.40±1.41
ab,w 
(12) 
2.06±1.00
ab,w 
(7) 
3.70±2.01
ab,w 
(5) 
0.23±0.23
a,w 
(1) 
0.00±0.00
a,w 
(0) 
E 323 9.79±2.38
w 
(75) 
17.89±4.38
w 
(56) 
17.25±4.28
wx 
(51) 
5.51±2.37
b,w 
(18) 
2.92±1.65
ab,w 
(12) 
2.92±1.65
ab,w 
(12) 
2.08±1.47
ab,w 
(7) 
0.14±0.14
a,w 
(1) 
0.00±0.00
a,w 
(0) 
Total 3154  24.65±1.62  40.72±2.44   40.83±2.44  18.52±1.74 13.76±1.43  9.45±1.20  6.40±0.97  1.88±0.36  0.77±0.17 
2
2
5
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Maturation rates of bovine oocytes based on enucleation techniques for Grades 
A, B, C, D and E are shown in Tables 4.13, 4.14, 4.15, 4.16 and 4.17.  In all cases (even 
though majority insignificance), laser enucleation technique apparently gave higher 
maturation rates in all the grades of oocytes studied, except Grade E. The values were 
60.10±3.68% versus 36.87±4.71%, 36.53±5.22% versus 29.98±5.04%, 21.78±5.23% 
versus 21.41±5.42%, 10.12±3.69% versus 6.35±2.79% and 7.22±2.73% versus 
13.00±4.12% for Grades A, B, C, D and E, respectively. Enucleation rates of bovine 
oocytes based on enucleation techniques for Grades A, B, C, D and E are shown in 
Tables 4.13, 4.14, 4.15, 4.16 and 4.17.  There were no significant differences (P>0.05) 
between squeezing and laser enucleation techniques for Grades B, C, D and E, except 
Grade A where the laser percent enucleation was higher than squeezing enucleation 
(91.93±2.50% versus 74.85±5.93%). Also, there were significant differences (P<0.05) 
in percent injection between squeezing (78.11±6.21%) and laser (93.63±1.65%) 
enucleation for Grade A bovine oocytes.  Percentage of 2-cell stage embryos up to 
hatched blastocyst using laser enucleation technique showed the highest cleavage rate 
for all the oocytes grading compared to squeezing enucleation, except Grade E (Tables 
4.13, 4.14, 4.15, 4.16 and 4.17). It was clearly evident shown that laser enucleation 
technique apparently gave the highest cleavage rate for all the grades compared to 
squeezing enucleation technique. The cleavage rates from 2-cell up to hatched 
blastocyst stages were significantly decreasing from Grades A to E. In overall, Grades 
A, B and C were better than Grades D and E on embryo developmental at various 
stages. 
Table 4.18 shows cleavage rates of bovine embryos in somatic cell nuclear 
transfer and parthenogenesis treatments. There were significant differences (P<0.05) 
between parthenogenesis and somatic stem cell nuclear transfer, where the 
parthenogenesis showed higher cleavage rates with the values of 62.24±4.96%, 
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49.49±4.94%, 40.70±4.21%, 31.41±3.28%, 12.66±2.18% and 2.15±0.71% for 2-, 4-, 8-
cell, morula, blastocyst and hatched blastocyst stages compared to somatic cell nuclear 
transfer with the values of 44.35±4.14%, 34.04±3.76%, 24.50±3.40%, 14.01±2.53%, 
3.89±0.89% and 1.65±0.46%, respectively. The cleavage rates consecutively decreased 
from 2-cell stage embryos to hatched blastocysts for both parthenogenesis and somatic 
cell nuclear transfer. Figure 4.7 shows the development of bovine embryos from 2-cell 
stage up to hatching blastocyst through somatic cell nuclear transfer technique. 
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Table 4.13: Percent maturation, enucleation, injection and cleavage rates of bovine oocytes (%, mean±SEM) based on enucleation techniques for   
                    Grade A oocytes 
 
 
abcd
 Means with different superscripts in a row within a group were significantly different (P<0.05). 
xy
 Means with different superscripts in a column within a group were significantly different (P<0.05). 
 
 
 
 
 
 
 
 
 
 
  
 
Enucleation 
techniques 
No. of 
oocytes 
Maturation 
rate (n) 
Enucleation 
rate  
(n) 
Injection rate 
(n) 
Percent cleavage  
(n)  
     2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst 
 (n) 
Squeezing 708 36.87±4.71
x 
(283) 
74.85±5.93
x 
(220) 
78.11±6.21
x 
(190) 
21.12±5.49
c,x 
(71) 
14.61±4.57
bc,x 
(52) 
   7.83±3.87
ab,x 
(31) 
 2.15±1.55
a,x 
(15) 
  0.20±0.20
a,x 
(2) 
0.10±0.10
a,x 
(1) 
Laser 709 60.10±3.68
y 
(407) 
91.93±2.50
y 
(369) 
93.63±1.65
y 
(348) 
71.59±4.31
d,y 
(246) 
61.30±4.72
d,y 
(215) 
 47.61±5.28
c,y 
(178) 
30.76±4.57
b,y 
(137) 
10.25±2.09
a,y 
(48) 
4.53±1.17
a,y 
(23) 
Total 1417   49.77±3.21   84.34±3.12   86.73±3.03 49.16±4.51  40.55±4.29   29.93±4.11 18.04±3.11   5.78±1.30  2.56±0.70 
2
2
8
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Table 4.14: Percent maturation, enucleation, injection and cleavage rates of bovine oocytes (%, mean±SEM) based on enucleation techniques for       
                   Grade B oocytes 
 
 
ab
 Means with different superscripts in a row within a group were significantly different (P<0.05). 
xy
 Means with different superscripts in a column within a group were significantly different (P<0.05). 
 
 
  
  
 
Enucleation 
techniques 
No. of 
oocytes 
Maturation 
rate (n) 
Enucleation 
rate  
(n) 
Injection rate 
(n) 
Percent cleavage  
(n)  
     2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst 
 (n) 
Squeezing 339 29.8±5.04
x 
(132) 
55.56±7.83
x 
(93) 
59.34±8.07
x 
(77) 
12.03±5.04
b,x 
(15) 
  5.39±2.91
ab,x 
(12) 
  2.92±2.12
a,x 
(7) 
 0.00±0.00
a,x 
(0) 
 0.00±0.00
a,x 
(0) 
0.00±0.00
a,x 
(0) 
Laser 482 36.53±5.22
x 
(209) 
59.23±7.49
x 
(163) 
55.47±7.34
x 
(146) 
34.39±6.17
b,y 
(90) 
24.59±4.92
b,y 
(65) 
11.09±3.26
a,x 
(44) 
 8.71±2.90
a,y 
(36) 
 4.85±1.76
a,y 
(17) 
2.03±0.74
a,y 
(9) 
Total 821  33.62±3.66  57.60±5.39   57.19±5.40  24.45±4.27 16.06±3.21   7.46±2.09   4.84±1.68   2.70±1.01  1.13±0.43 
2
2
9
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Table 4.15: Percent maturation, enucleation, injection and cleavage rates of bovine oocytes (%, mean±SEM) based on enucleation techniques for      
                   Grade C oocytes 
 
 
abc
 Means with different superscripts in a row were significantly different (P<0.05). 
xy
 Means with different superscripts in a column within a group were significantly different (P<0.05). 
 
 
 
 
 
 
 
Enucleation 
techniques 
No. of 
oocytes 
Maturation 
rate (n) 
Enucleation 
rate  
(n) 
Injection rate 
(n) 
Percent cleavage  
(n)  
     2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst 
 (n) 
Squeezing 150 21.41±5.42
x 
(44) 
31.77±8.07
x 
(25) 
28.39±7.36
x 
(20) 
0.00±0.00
x 
(0) 
0.00±0.00
x 
(0) 
0.00±0.00
x 
(0) 
 0.00±0.00
a,x 
(0) 
0.00±0.00
a,x 
(0) 
0.00±0.00
a,x 
(0) 
Laser 302 21.78±5.23
x 
(111) 
29.43±6.94
x 
(98) 
30.16±7.07
x 
(90) 
16.31±4.83
c,y 
(47) 
10.53±3.48
bc,y 
(30) 
   8.80±3.28
abc,y 
(23) 
6.03±2.74
ab,x 
(14) 
1.00±0.62
a,x 
(4) 
0.25±0.25
a,x 
(1) 
Total 452  21.61±3.75  30.47±5.23   29.37±5.08    9.98±2.95   5.85±2.02    4.89±1.89 3.35±1.55  0.56±0.35  0.14±0.14 
2
3
0
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Table 4.16: Percent maturation, enucleation, injection and cleavage rates of bovine oocytes (%, mean±SEM) based on enucleation techniques for   
                   Grade D oocytes 
 
 
ab
 Means with different superscripts in a row were significantly different (P<0.05). 
xy
 Means with different superscripts in a column within a group were significantly different (P<0.05). 
 
 
 
 
 
 
 
Enucleation 
techniques 
No. of 
oocytes 
Maturation 
rate (n) 
Enucleation 
rate  
(n) 
Injection rate 
(n) 
Percent cleavage  
(n)  
     2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst 
 (n) 
Squeezing 43   6.35±2.79
x 
(10) 
10.31±5.07
x 
(7) 
10.94±5.38
x 
(5) 
0.00±0.00
x 
(0) 
0.00±0.00
x 
(0) 
0.00±0.00
x 
(0) 
 0.00±0.00
a,x 
(0) 
 0.00±0.00
a,x 
(0) 
0.00±0.00
a,x 
(0) 
Laser 98 10.12±3.69
x 
(47) 
15.64±5.61
x 
(43) 
15.75±5.54
x 
(37) 
10.83±4.03
b,y 
(20) 
  6.13±2.47
ab,y 
(12) 
 3.71±1.76
a,x 
(7) 
3.75±2.63
a,x 
(5) 
 0.42±0.42
a,x 
(1) 
0.00±0.00
a,x 
(0) 
Total 141   8.44±2.39  13.27±3.83   13.61±3.88    6.02±2.31    3.40±1.41   2.06±1.00  2.08±1.47   0.23±0.23  0.00±0.00 
2
3
1
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Table 4.17: Percent maturation, enucleation, injection and cleavage rates of bovine oocytes (%, mean±SEM) based on enucleation techniques for  
                   Grade E oocytes 
 
 
ab
 Means with different superscripts in a row were significantly different (P<0.05). 
x
 Means with same superscripts in a column within a group were not significantly different (P>0.05). 
 
 
 
 
 
Enucleation 
techniques 
No. of 
oocytes 
Maturation 
rate (n) 
Enucleation 
rate  
(n) 
Injection rate 
(n) 
Percent cleavage  
(n)  
     2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst 
 (n) 
Squeezing 180   13.00±4.12
x 
(43) 
22.92±7.25
x 
(30) 
22.40±7.16
x 
(28) 
 5.63±3.62
a.x 
(8) 
5.00±3.36
a,x 
(7) 
 5.00±3.36
a,x 
(7) 
 3.75±3.17
a,x 
(4) 
 0.00±0.00
a,x 
(0) 
0.00±0.00
a,x 
(0) 
Laser 143    7.22±2.73
x 
(32) 
13.88±5.33
x 
(26) 
13.13±5.14
x 
(23) 
 5.42±3.18
b,x 
(10) 
 1.25±1.25
ab,x 
(5) 
1.25±1.25
ab,x 
(5) 
0.75±0.75
a,x 
(3) 
 0.25±0.25
a,x 
(1) 
0.00±0.00
a,x 
(0) 
Total 323    9.79±2.38  17.89±4.38   17.25±4.28  5.51±2.37    2.92±1.65  2.92±1.65  2.08±1.47   0.14±0.14  0.00±0.00 
2
3
2
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Table 4.18: Percent cleavage of bovine embryos (%, mean±SEM) on 2 different treatments 
 
abcde
 Means with different superscripts in a row were significantly different (P<0.05). 
xy
 Means with different superscripts in a column were significantly different (P<0.05). 
*n=number of embryos (2-, 4-, 8-cell, morula, blastocyst and hatched blastocyst)/number of injected oocytes. 
 
 
Treatments No. of 
ovaries 
No. of 
oocytes 
Maturation rate 
(n) 
Percent cleavage  
(n) 
    2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst (n) 
PA   75   759 61.50±3.65
y 
(471) 
62.24±4.96
e,x 
(274) 
49.49±4.94
d,x 
(220) 
40.70±4.21
cd,x 
(178) 
31.41±3.28
c,y 
(133) 
12.66±2.18
b,y 
(59) 
2.15±0.71
a,x 
(12) 
SCNT 220 3175 42.01±2.65
x 
(1315) 
44.35±4.14
e,x 
(506/964)* 
34.04±3.76
d,x 
(398/964)* 
24.50±3.40
c,x 
(302/964)* 
14.01±2.53
b,x 
(211/964)* 
3.89±0.89
a,x 
(70/964)* 
1.65±0.46
a,x 
(33/964)* 
Total 295 3934    45.37±2.41  47.43±3.60 36.71±3.27 27.29±2.97  17.01±2.28    5.40±0.89 1.74±0.40 
2
3
3
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Figure 4.7: (a-f) Development of bovine embryos from 2-, 4-, 8-cell, morula, blastocyst and hatching blastocyst through somatic cell  
                                  nuclear transfer technique.
2
3
4
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4.2.2 Production of Caprine Blastocysts Through Somatic Cell Nuclear Transfer  
          and Parthenogenesis (control) 
 
Table 4.19 shows the cleavage rates of caprine embryos through somatic cell nuclear 
transfer by 3 different sources of oocytes, namely laparoscopic ovum pick-up (LOPU), 
ovariectomy and abattoir. There were significant differences (P<0.05) in maturation and 
enucleation rates for these 3 different sources with the values of 61.99±3.12% and 
66.16±5.21% versus 51.23±3.37% as well as 97.85±1.23% and 98.32±1.16% versus 
90.27±2.72% for laparoscopic ovum pick-up, ovariectomy and abattoir sources, 
respectively. Even though insignificance, the embryo development at 2-, 4-, 8-cell and 
morula was higher in laparoscopic ovum pick-up, followed by ovariectomy and abattoir 
with values of 74.12±5.30% versus 65.86±7.87% versus 66.61±6.64%; 63.40±5.48% 
versus 56.83±6.51% versus 51.46±7.33%; 53.30±5.84% versus 50.18±9.05% versus 
43.48±8.14%; 48.56±5.38% versus 44.68±8.94% versus 26.28±8.19%, respectively. 
However, ovariectomy showed the highest blastocysts and hatched blastocysts rates 
(24.52±8.53% and 18.42±6.79%), followed by laparoscopic ovum pick-up 
(13.33±3.68% and 8.12±2.29%) and abattoir (10.06±5.83% and 5.01±3.19%), 
respectively. 
Table 4.20 shows cleavage rates of caprine embryos based on caprine oocyte 
grading from Grades A to E. A total of 1296 caprine oocytes obtained from Grade A 
(366), Grade B (362), Grade C (306), Grade D (111) and Grade E (151). There were no 
significant differences (P>0.05) in percent cleavage at Grades A, B and C with values of 
46.40±5.26%, 42.89±5.11%, 34.63±4.91%; 31.06±4.76%, 13.91±3.56% and 
6.88±1.90%; 48.34±5.08%, 40.43±4.85%, 33.57±4.70%; 29.79±4.48% and 
9.86±2.95%, 5.99±1.92%; 40.15±5.17%, 32.78±5.01%, 30.25±5.00%, 26.62±4.76%, 
8.21±2.80% and 5.38±2.01% for 2-, 4-, 8-cell, morula, blastocyst and hatched 
blastocyst, respectively. However, Grades A, B and C showed better cleavage rates than 
Grades D and E for all stages of embryo development. The development of caprine-
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cloned embryos stained hatching blastocyst with Hoechst 3342 are shown in Figures 4.8 
and 4.9. Fiigure 4.10 shows the grading of caprine oocytes from Grade A to Grade E. 
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Table 4.19: Cleavage rates of caprine embryos (%, mean±SEM) from in vitro culture through somatic cell nuclear transfer by 3 different sources of  
                    oocytes            
       
 
abcde
 Means with different superscripts in a row within a group were significantly different (P<0.05). 
xy
 Means with different superscripts in a column within a group were significantly different (P<0.05). 
 
 
 
 
 
 
Source of 
oocytes 
No. of 
ovaries 
No. of 
oocytes 
Maturation 
rate  
(n) 
Enucleation 
rate  
(n) 
Injection 
rate 
(n) 
Percent cleavage  
(n)  
      2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst  
(n) 
LOPU 91 487 61.99±3.12
xy 
(297) 
97.85±1.23
y 
(292) 
98.26±0.92
x 
(287) 
74.12±5.30
d,x 
(227) 
63.40±5.48
cd,x 
(207) 
53.30±5.84
bc,x 
(186) 
48.56±5.38
b,x 
(169) 
13.33±3.68
a,x 
(66) 
8.12±2.29
a,xy 
(43) 
Ovariectomy 19 168 66.16±5.21
y 
(115) 
98.32±1.16
y 
(111) 
97.78±2.22
x 
(110) 
65.86±7.87
c,x 
(75) 
56.83±6.51
c,x 
(65) 
50.18±9.05
c,x 
(54) 
44.68±8.94
bc,x 
(45) 
24.52±8.53
ab,x 
(29) 
18.42±6.79
a,y 
(21) 
Abattoir     99 641 51.23±3.37
x 
(355) 
90.27±2.72
x 
(312) 
94.61±2.25
x 
(289) 
66.61±6.64
e,x 
(216) 
51.46±7.33
de,x 
(190) 
43.48±8.14
cd,x 
(166) 
26.28±8.19
bc,x 
(136) 
10.06±5.83
ab,x 
(75) 
 5.01±3.19
a,x 
(35) 
Total 209 1296 59.76±2.28 95.99±1.10 97.28±0.86 71.23±3.83 59.59±3.99 50.43±4.32 42.45±4.20 13.85±2.93  8.57±1.86 
2
3
7
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Figure 4.8: (a-b) Development of caprine-cloned embryos at day 3 (4- to 8-cells) and day 5 (blastocysts). 
 
 
2
3
8
 
  
43 
 
 
                 Figure 4.9: a) Hatching cloned caprine-blastocyst observed under steromicroscope (magnificantion 20x). b) hatching cloned- 
                                              caprine blastocyst staining with Hoechst 3342 and observed under fluorescent microscope (magnificantion 20x). 
 
 
 
 
 
 
a b 
2
3
9
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Table 4.20: Percent cleavage of caprine embryos (%, mean±SEM) based on oocyte grading  
 
abcd
 Means with different superscripts in a row within a group were significantly different (P<0.05). 
xy
 Means with different superscripts in a column within a group were significantly different (P<0.05). 
 
 
 
 
 
 
 
 
 
Oocyte 
Grades 
No. of 
oocytes 
Maturation rate 
(n) 
Enucleation rate 
(n) 
Injection rate 
(n) 
Percent cleavage (n)  
     2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst 
 (n) 
A 366 51.73±4.83
y 
(253) 
64.09±5.47
y 
(246) 
63.53±5.45
y 
(240) 
46.40±5.26
d,y 
(185) 
42.89±5.11
bc,y 
(171) 
34.63±4.91
bc,y 
(149) 
31.06±4.76
b,y 
(133) 
13.91±3.56
a,y 
(67) 
6.88±1.90
a,y 
(39) 
B 362 46.94±4.48
y 
(202) 
63.22±5.43
y 
(190) 
63.31±5.54
y 
(185) 
48.34±5.08
c,y 
(144) 
40.43±4.85
bc,y 
(129) 
33.57±4.70
b,y 
(114) 
29.79±4.48
b,y 
(99) 
  9.86±2.95
a,y 
(48) 
5.99±1.92
a,y 
(28) 
C 306 44.71±5.07
y 
(180) 
54.73±5.67
y 
(166) 
54.74±5.70
y 
(154) 
40.15±5.17
c,y 
(116) 
32.78±5.01
bc,y 
(101) 
30.25±5.00
bc,y 
(87) 
26.62±4.76
b,y 
(74) 
  8.21±2.80
a,xy 
(39) 
5.38±2.01
a,y 
(21) 
D 111 12.40±3.30
x 
(67) 
15.14±4.06
x 
(60) 
16.00±4.26
x 
(60) 
12.33±3.46
c,x 
(47) 
 7.67±2.71
bc,x 
(38) 
 7.67±2.71
bc,x 
(38) 
 3.96±2.06
ab,x 
(28) 
  2.33±1.64
ab,x 
(14) 
1.83±1.29
a,xy 
(11) 
E 151 14.21±3.34
x 
(65) 
19.67±4.47
x 
(53) 
19.13±4.39
x 
(47) 
  9.44±3.00
b,x 
(26) 
8.33±2.83
b,x 
(23) 
 6.67±2.63
ab,x 
(18) 
 5.33±2.15
ab,x 
(16) 
 1.33±0.94
a,x 
(2) 
0.00±0.00
a,x 
(0) 
Total 1296    34.00±2.09 43.37±2.51 43.34±2.52 31.33±2.18 26.42±2.05 22.56±1.95 19.35±1.82   7.13±1.16 4.02±0.73 
2
4
0
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   Figure 4.10: a) Grade A, b) Grade B, c) Grade C, d) Grade D and d) Grade E of caprine oocytes. 
 
 
2
4
1
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Table 4.21: Cleavage rates of caprine embryos (%, mean±SEM) from in vitro culture through different enucleation techniques                  
 
abcd
 Means with different superscripts in a row were significantly different (P<0.05). 
xy
 Means with different superscripts in a column within a group were significantly different (P<0.05). 
 
 
Enucleation 
techniques 
No. of 
ovaries 
No. of 
oocytes 
Maturation 
rate  
(n) 
Enucleation 
rate 
 (n) 
Injection 
rate 
(n) 
Percent cleavage  
(n)  
      2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst  
(n) 
Squeezing  89   516 51.74±3.19
x 
(267) 
95.23±1.73
x 
(236) 
94.71±1.76
x 
(215) 
58.15±6.76
d,x 
(125) 
42.04±6.53
c,x 
(95) 
25.73±6.05
b,x 
(57) 
16.36±5.22
b,x 
(35) 
 0.00±0.00
a,x 
(0) 
 0.00±0.00
a,x 
(0) 
Laser 120   780 66.42±2.87
y 
(500) 
96.61±1.42
x 
(479) 
99.41±0.38
y 
(471) 
82.07±3.45
c,y 
(393) 
74.14±3.62
bc,y 
(367) 
70.93±3.87
b,y 
(349) 
64.08±3.91
b,y 
(315) 
25.33±4.66
a,y 
(170) 
15.68±2.99
a,y 
(99) 
Total 209 1296 59.76±2.28 95.99±1.10 97.28±0.86  71.23±3.83 59.59±3.99 50.43±4.32  42.45±4.20  13.85±2.93   8.57±1.86 
2
4
2
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Table 4.21 shows the cleavage rates of caprine embryos through somatic cell 
nuclear transfer by 2 different enucleation techniques, namely squeezing and laser 
enucleation. There were no significant differences (P>0.05) in enucleation rates 
between squeezing and laser enucleation techniques. However, embryos development at 
various stages were significantly higher in laser enucleation technique compared to 
squeezing enucleation technique with values of 82.07±3.45% versus 58.15±6.76%, 
74.14±3.62% versus 42.04±6.53%, 70.93±3.87% versus 25.73±6.05%, 64.08±3.91% 
versus 16.36±5.22%; 25.33±4.66% versus 0.00±0.00% and 15.68±2.99% versus 
0.00±0.00% for 2-, 4-, 8-cell, morula, blastocyst and   hatched blastocyst, respectively. 
For both enucleation techniques, the cleavage rates were decreasing as the stages of 
development progressing. No blastocysts were obtained for squeezing enucleation 
technique.  
Percent maturation, enucleation and injection of caprine oocytes based 2 
different enucleation techniques, namely squeezing and laser enucleations for Grades A, 
B, C, D and E are shown in Tables 4.22, 4.23, 4.24, 4.25 and 4.26. In overall, laser 
enucleation gave the highest maturation, enucleation and injection rates for Grade B 
(62.09±5.49%, 81.45±5.92%, 82.68±5.94%), Grade D (18.24±5.35%, 21.20±6.34%, 
21.95±6.54%) and Grade E (16.94±4.79%, 22.68±6.37%, 23.78±6.65%), except for 
Grades A and C. There were significant differences (P<0.05) between squeezing and 
laser enucleation techniques for percent maturation, enucleation and injection rates for 
Grades A and B. Also, in all cases, laser enucleation technique showed significantly 
higher percent 2-cell up to hatched blastocyst for all oocytes grades, except Grade A 
compared to squeezing enucleation technique. Conversely, the squeezing enucleation at 
2-cell stages embryos showed higher percent cleavage compared to laser enucleation 
technique with the values of 47.84±7.79% versus 445.21±7.21% for Grade A. In 
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overall, embryo developmental at various stages for Grade A, B and C were better than 
Grades D and E.   
Table 4.27 shows percent cleaved caprine embryos based on different pre-
intracytoplasmic injection (pre-ICI) durations. It was vividly shown that  for each 
embryo developmental stages from 2-, 4-, 8-cell, morula, blastocyst and hatched 
blastocyst the cleavage rates were significantly higher (P<0.05) for 60 minutes pre-
intracytoplasmic injection duration followed by simultaneous injection  and 30 minutes 
pre-intracytoplasmic injection (pre-ICI) durations with the values of 83.33±3.10% 
versus 61.17±10.65% versus 45.39±9.03%, 74.42±4.20% versus 42.42±8.77% versus 
33.82±7.47%, 62.42±5.47% versus 37.12±8.97% versus 28.93±7.11%, 53.10±5.61% 
versus 29.39±7.74% versus 24.83±7.37%, 20.49±4.16% versus 7.68±5.93% versus 
0.45±0.45% and 12.95±2.71% versus 4.29±3.41% versus   0.00±0.00%, respectively. 
 Average number of caprine blastocyst obtained from in vivo uterine flushing 
was shown in Table 4.28. Two different hormones were used in this experiment, namely 
PMSG and hCG. A total of 27 blastocysts were obtained through in vivo uterine 
flushing from 23 does. Obviously, the average number of blastocysts obtained in FSH 
treatment gave higher than that of PMSG treatment with the values of 41.54 and 0.00, 
respectively. Figure 4.11 shows the in vivo-derived caprine blastocyst from uterine 
flushing. 
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Table 4.22: Percent maturation, enucleation, injection and cleavage rates of caprine oocytes (%, mean±SEM) based on enucleation techniques for   
                   Grade A oocytes 
 
 
abc
 Means with different superscripts in a row within a group were significantly different (P<0.05). 
xy
 Means with different superscripts in a column within a group were significantly different (P<0.05). 
 
 
 
 
 
 
 
 
 
 
 
Enucleation 
techniques 
No. of 
oocytes 
Maturation 
rate (n) 
Enucleation 
rate  
(n) 
Injection rate 
(n) 
Percent cleavage  
(n)  
     2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst 
 (n) 
Squeezing 150 65.73±6.31
y 
(101) 
79.61±6.57
y 
(94) 
79.12±6.60
y 
(90) 
47.84±7.79
c,x 
(56) 
42.13±7.51
c,x 
(48) 
   24.63±6.38
b,x 
(29) 
 19.04±5.67
b,x 
(20) 
  0.00±0.00
a,x 
(0) 
0.00±0.00
a,x 
(0) 
Laser 216 40.95±6.73
x 
(152) 
51.22±7.90
x 
(152) 
50.61±7.83
x 
(150) 
45.21±7.21
b,x 
(129) 
43.52±7.06
b,x 
(123) 
 42.93±7.07
b,x 
(120) 
41.03±7.00
b,y 
(113) 
25.44±5.95
ab,y 
(67) 
12.58±3.23
a,y 
(39) 
Total 366   51.73±4.83   64.09±5.47   63.53±5.45 46.40±5.26  42.89±5.11   34.63±4.91 31.06±4.76   13.91±3.56  6.88±1.90 
2
4
5
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Table 4.23: Percent maturation, enucleation, injection and cleavage rates of caprine oocytes (%, mean±SEM) based on enucleation techniques for   
                   Grade B oocytes 
 
 
abc
 Means with different superscripts in a row within a group were significantly different (P<0.05). 
xy
 Means with different superscripts in a column within a group were significantly different (P<0.05). 
 
Enucleation 
techniques 
No. of 
oocytes 
Maturation 
rate (n) 
Enucleation 
rate  
(n) 
Injection rate 
(n) 
Percent cleavage  
(n)  
     2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst 
 (n) 
Squeezing 127 28.66±6.05
x 
(52) 
41.25±8.25
x 
(45) 
39.95±8.35
x 
(41) 
25.74±6.81
c,x 
(26) 
19.80±6.22
bc,x 
(21) 
  8.43±4.24
ab,x 
(9) 
   6.37±4.10
a,x 
(5) 
   0.00±0.00
a,x 
(0) 
 0.00±0.00
a,x 
(0) 
Laser 235 62.09±5.49
y 
(150) 
81.45±5.92
y 
(145) 
82.68±5.94
y 
(144) 
67.09±6.01
c,y 
(118) 
57.53±6.08
bc,y 
(108) 
54.42±6.20
bc,y 
(105) 
 49.21±5.96
b,y 
(94) 
 18.04±5.07
a,y 
(48) 
10.96±3.33
a,y 
(28) 
Total 362  46.94±4.48  63.22±5.43   63.31±5.54  48.34±5.08 40.43±4.85 33.57±4.70  29.79±4.48    9.86±2.95   5.99±1.92 
2
4
6
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Table 4.24: Percent maturation, enucleation, injection and cleavage rates of caprine oocytes (%, mean±SEM) based on enucleation techniques for  
                   Grade C oocytes 
 
 
abc
 Means with different superscripts in a row were significantly different (P<0.05). 
xy
 Means with different superscripts in a column within a group were significantly different (P<0.05). 
 
 
 
 
 
 
 
Enucleation 
techniques 
No. of 
oocytes 
Maturation 
rate (n) 
Enucleation 
rate  
(n) 
Injection rate 
(n) 
Percent cleavage  
(n)  
     2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst 
 (n) 
Squeezing 154 44.07±7.41
x 
(82) 
56.81±8.35
x 
(73) 
57.27±8.48
x 
(64) 
29.22±6.65
c,x 
(37) 
14.24±5.04
b,x 
(23) 
11.99±4.82
ab,x 
(16) 
  7.40±3.98
ab,x 
(10) 
  0.00±0.00
a,x 
(0) 
0.00±0.00
a,x 
(0) 
Laser 152 45.25±7.02
x 
(98) 
53.01±7.80
x 
(93) 
52.64±7.78
x 
(90) 
49.22±7.46
b,x 
(79) 
48.16±7.39
b,y 
(78) 
45.39±7.48
b,y 
(71) 
42.57±7.20
b,y 
(64) 
15.01±4.90
a,y 
(39) 
0.25±0.25
a,y 
(21) 
Total 306  44.71±5.07  54.73±5.67   54.74±5.70 40.15±5.17 32.78±5.01  30.25±5.00 26.62±4.76    8.21±2.80  5.38±2.01 
2
4
7
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Table 4.25: Percent maturation, enucleation, injection and cleavage rates of caprine oocytes (%, mean±SEM) based on enucleation techniques for   
                   Grade D oocytes 
 
 
ab
 Means with different superscripts in a row were significantly different (P<0.05). 
xy
 Means with different superscripts in a column within a group were significantly different (P<0.05). 
 
 
 
 
 
 
 
Enucleation 
techniques 
No. of 
oocytes 
Maturation 
rate (n) 
Enucleation 
rate  
(n) 
Injection rate 
(n) 
Percent cleavage  
(n)  
     2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst 
 (n) 
Squeezing 29   5.36±3.05
x 
(12) 
 7.84±4.46
x 
(10) 
 8.82±4.94
x 
(10) 
  4.41±2.47
a,x 
(5) 
  2.94±2.05
a,x 
(3) 
  2.94±2.05
a,x 
(3) 
0.00±0.00
a,x 
(0) 
 0.00±0.00
a,x 
(0) 
0.00±0.00
a,x 
(0) 
Laser 82 18.24±5.35
x 
(55) 
21.20±6.34
x 
(50) 
21.95±6.54
x 
(50) 
18.90±5.83
b,y 
(42) 
  11.59±4.61
ab,x 
(35) 
 11.59±4.61
ab,x 
(35) 
7.24±3.70
ab,x 
(28) 
 4.27±2.98
a,x 
(14) 
1.52±1.52
a,x 
(11) 
Total 111  12.40±3.30  15.14±4.06  16.00±4.26 12.33±3.46     7.67±2.71    7.67±2.71 3.96±2.06   2.33±1.64  0.83±0.83 
2
4
8
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Table 4.26: Percent maturation, enucleation, injection and cleavage rates of caprine oocytes (%, mean±SEM) based on enucleation techniques for     
                   Grade E oocytes 
 
 
ab
 Means with different superscripts in a row were significantly different (P<0.05). 
xy
 Means with different superscripts in a column within a group were not significantly different (P>0.05). 
 
 
 
 
 
 
 
Enucleation 
techniques 
No. of 
oocytes 
Maturation 
rate (n) 
Enucleation 
rate  
(n) 
Injection rate 
(n) 
Percent cleavage  
(n)  
     2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst 
 (n) 
Squeezing 56   10.91±4.59
x 
(20) 
16.04±6.21
x 
(14) 
13.53±5.37
x 
(10) 
 1.47±1.47
a.x 
(1) 
0.00±0.00
a,x 
(0) 
0.00±0.00
a,x 
(0) 
 0.00±0.00
a,x 
(0) 
 0.00±0.00
a,x 
(0) 
0.00±0.00
a,x 
(0) 
Laser 95    16.94±4.79
x 
(45) 
22.68±6.37
x 
(39) 
23.78±6.65
x 
(37) 
 16.06±5.16
c,y 
(25) 
 15.24±4.95
c,y 
(23) 
12.19±4.66
bc,y 
(18) 
9.76±3.82
abc,y 
(16) 
 2.44±1.70
ab,x 
(2) 
0.00±0.00
a,x 
(0) 
Total 151    14.21±3.34  19.67±4.47   19.13±4.39  9.44±3.00    8.33±2.83  6.67±2.63  5.33±2.15   1.33±0.94  0.00±0.00 
2
4
9
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Table 4.27: Percent cleaved caprine embryos (%, mean±SEM) based on different pre-intracytoplasmic injection (pre-ICI) durations 
 
abcd
 Means with different superscripts in a row were significantly different (P<0.05). 
xy
 Means with different superscripts in a column were significantly different (P<0.05). 
  *n=number of embryos (2-, 4-, 8-cell, morula blastocyst and hatched blastocyst)/number of injected oocytes. 
 
 
 
 
Pre-ICI 
durations 
No. of 
ovaries 
No. of 
oocytes 
 Percent cleavage 
 (n) 
   2-cell 
(n) 
4-cell 
(n) 
8-cell 
(n) 
Morula 
(n) 
Blastocyst 
(n) 
Hatched 
blastocyst  
(n) 
 
Simultaneous   68   322   61.17±10.65
d,x 
(96/125)* 
42.42±8.77
cd,x 
(76/125) 
37.12±8.97
c,x 
(69/125) 
29.39±7.74
bc,x 
(59/125) 
7.68±5.93
ab,xy 
(30/125) 
 4.29±3.41
a,xy 
(17/125) 
 
30 min   31   194 45.39±9.03
c,x 
(49/89) 
33.82±7.47
bc,x 
(36/89) 
28.93±7.11
bc,x 
(26/89) 
24.83±7.37
b,x 
(18/89) 
 0.45±0.45
a,x 
(1/89) 
0.00±0.00
a,x 
(0/89) 
 
60 min 110   780 83.33±3.10
d,y 
(383/472) 
74.42±4.20
cd,y 
(350/472) 
62.42±5.47
bc,y 
(309/472) 
53.10±5.61
b,y 
(273/472) 
20.49±4.16
a,y 
(139/472) 
12.95±2.71
a,y 
(82/472) 
 
Total 209 1296   71.23±3.83 59.59±3.99 50.43±4.32 42.45±4.20 13.85±2.93   8.57±1.86  
2
5
0
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Table 4.28: Average number of caprine blastocysts (mean±SEM) obtained from in vivo  
                   uterine flushing 
 
 
        
                Figure 4.11: (a-d) In vivo-derived caprine blastocyst from uterine flushing. 
 
 
In Table 4.29, parthenogenesis and somatic cell nuclear transfer have been compared 
for their cleavage rates. There were no significant differences (P>0.05) between the 
parthenogensis and somatic cell nuclear transfer treatments in percent cleavage. Although 
insignificance, the percent cleavage of somatic cell nuclear transfer were higher than with 
parthenogenesis respective values of 71.23±3.83% versus 65.95±5.08%, 59.59±3.99% versus 
Hormone 
treatments 
No. of caprine No. of ovaries No. of CL No. of 
blastocyst 
Average no. of 
blastocyst 
PMSG 12 24 12 0 0.00 
FSH 11 22 65 27 41.54 
Total 23 46 77 27 35.06 
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56.66±5.36%; 50.43±4.32% versus 49.37±6.18%; 42.45±4.20% versus 30.27±5.96% and 
8.57±1.86% versus 4.67±2.51 for 2-, 4- and 8-cell, morula and hatched blastocyst, except 
blastocyst (13.85±2.93% versus 17.18±5.38%), respectively. 
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Table 4.29: Percent cleavage of caprine embryos (%, mean±SEM) on 2 different treatments 
 
abcd
 Means with different superscripts in a row within a group were significantly different (P<0.05). 
x
 Means with same superscripts in a column were not significantly different (P>0.05). 
*n=number of embryos (2-, 4-, 8-cell, morula, blastocyst and hatched blastocyst)/number of oocytes injected. 
 
 
 
 
Treatments No. of 
ovaries 
No. of 
oocytes 
Maturation rate 
(n) 
Percent cleavage  
(n) 
    2-cell  
(n) 
4-cell  
(n) 
8-cell 
 (n) 
Morula 
 (n) 
Blastocyst 
 (n) 
Hatched 
blastocyst (n) 
PA   51   438 63.73±4.25
x 
(255) 
65.95±5.08
d,x 
(152) 
56.66±5.36
cd,x 
(125) 
49.37±6.18
c,x 
(96) 
30.27±5.96
b,x 
(54) 
17.18±5.38
ab,x 
(26) 
4.67±2.51
a,x 
(4) 
SCNT 209 1296 59.76±2.28
x 
(767) 
71.23±3.83
d,x 
(528/686)* 
59.59±3.99
c,x 
(462/686)* 
50.43±4.32
bc,x 
(404/686)* 
42.45±4.20
b,x 
(350/686)* 
13.85±2.93
a,x 
(170/686)* 
8.57±1.86
a,x 
(99/686)* 
Total 260 1734    60.42±2.03   70.35±3.30 59.10±3.44 50.26±3.73 40.42±3.66 14.40±2.59 7.92±1.61 
2
5
3
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4.2.3 Comparison Between Caprine and Bovine Species on Production of  
         Blastocysts Through Somatic Cell Nuclear Transfer and Parthenogenesis 
 
Table 4.30 shows the percent cleavage between caprine and bovine embryos through 
somatic cell nuclear transfer. There were significant differences (P<0.05) in maturation, 
enucleation and injection rates between caprine and bovine species with values of 
59.76±2.28% versus 42.01±2.65%, 95.99±1.10% versus 86.01±2.47% and 97.28±0.86 
versus 90.83±1.69%, respectively. There were obviously significant differences 
(P<0.0.5) between caprine and bovine in percent embryos development for 2-, 4-, 8-
cell, morula, blastocyst and hatched blastocyst with values of 71.23±3.83%  versus 
44.35±4.14%, 59.59±3.99% versus  34.04±3.76%, 50.43±4.32% versus  24.50±3.40%, 
42.45±4.20% versus 14.01±2.53%, 13.85±2.93%  versus 3.89±0.89%  and 8.57±1.86%  
versus 1.65±0.46%, respectively. 
Percent maturation, enucleation, injection and cleavage rates between caprine 
and bovine oocytes based on oocyte grading are shown in Tables 4.31, 4.32, 4.33, 4.34 
and 4.35. There were significant differences (P<0.05) in caprine and bovine maturation 
rates between Grades B and C with values of 46.94±4.48% versus 33.62±3.66% and 
44.71±5.07% versus 21.61±3.75%, respectively. However, percent maturation in 
caprine was higher than bovine species (51.73±4.83% versus 49.77±3.21%, 
46.94±4.48% versus 33.62±3.66%, 44.71±5.07% versus 21.61±3.75%, 12.40 ±3.30% 
versus 8.44±2.39% and 14.21±3.34% versus  9.79±2.38% ) for Grades A, B, C, D and 
E, respectively. Also, there were significant differences (P<0.05) in percent enucleation 
and injection between caprine and bovine at Grades A and C with represented values of 
64.09±5.47% versus 84.34±3.12% and 54.73±5.67% versus 30.47±5.23% for percent 
enucleation as well as 63.53±5.45% versus 86.73±3.03% and 54.74±5.70% versus 
29.37±5.08% for percent injection, respectively. Obviously, caprine species showed the 
highest percent embryo development for all cell stages in all the oocyte grading from 
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Grades A to E. Most of the values showed decreasing trend from Grades A to E as well 
as from 2-cell up to hatched blastocyst, consecutively.   
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Table 4.30: Percent cleavage between caprine and bovine embryos (%, mean±SEM) through somatic cell nuclear transfer 
 
abcde
 Means with different superscripts in a row within a group were significantly different (P<0.05). 
xy
 Means with different superscripts in a column within a group were significantly different (P<0.05). 
 
 
 
 
 
 
  
 
Species No. of 
ovaries 
No. of 
oocytes 
Maturation 
rate  
(n) 
Enucleation 
rate  
(n) 
Injection 
rate 
(n) 
Percent cleavage  
(n)  
      2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst  
(n) 
Caprine 260   1296 59.76±2.28
y 
(767) 
95.99±1.10
y 
(715) 
97.28±0.86
y 
(686) 
71.23±3.83
d,y 
(528) 
59.59±3.99
c,y 
(462) 
50.43±4.32
bc,y 
(404) 
42.45±4.20
b,y 
(350) 
13.85±2.93
a,y 
(170) 
8.57±1.86
a,y 
(99) 
Bovine 220 3175 42.01±2.65
x 
(1315) 
86.01±2.47
x 
(1074) 
90.38±1.69
x 
(964) 
44.35±4.14
e,x 
(506) 
34.04±3.76
d,x 
(398) 
24.50±3.40
c,x 
(302) 
14.01±2.53
b,x 
(211) 
  3.89±0.89
a,x 
(70) 
1.65±0.46
a,x 
(33) 
Total 480 4471 51.07±1.89 91.10±1.39 93.90±0.98 58.06±3.02  47.08±2.93 37.73±2.95 28.52±2.73   8.97±1.60 5.18±1.01 
2
5
6
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Table 4.31: Percent maturation, enucleation, injection and cleavage rates between caprine and bovine oocytes (%, mean±SEM) based on Grade A  
                   oocytes 
 
 
abcd
 Means with different superscripts in a row within a group were significantly different (P<0.05). 
xy
 Means with different superscripts in a column within a group were significantly different (P<0.05). 
 
 
 
 
 
 
 
Speices No. of 
oocytes 
Maturation 
rate (n) 
Enucleation 
rate  
(n) 
Injection rate 
(n) 
Percent cleavage  
(n)  
     2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst 
 (n) 
Caprine 366 51.73±4.83
x 
(253) 
64.09±5.47
x 
(246) 
63.53±5.45
x 
(240) 
46.40±5.26
c,x 
(185) 
42.89±5.11
bc,x 
(171) 
   34.63±4.91
bc,x 
(149) 
31.06±4.76
b,y 
(133) 
  13.91±3.56
a,y 
(67) 
6.88±1.90
a,y 
(39) 
Bovine 1417 49.77±3.21
x 
(690) 
84.34±3.12
y 
(589) 
86.73±3.03
y 
(538) 
49.16±4.51
d,x 
(317) 
40.55±4.29
d,x 
(267) 
 29.93±4.11
c,x 
(209) 
18.04±3.11
b,x 
(152) 
   5.78±1.30
a,x 
(50) 
2.56±0.70
a,x 
(24) 
Total 480   50.77±2.91  74.01±3.28  74.89±3.28 47.75±3.47 41.74±3.34    32.33±3.21  24.69±2.91     9.93±1.95  4.76±1.04 
2
5
7
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Table 4.32: Percent maturation, enucleation, injection and cleavage rates between caprine and bovine oocytes (%, mean±SEM) based on Grade B  
                   oocytes 
 
 
abc
 Means with different superscripts in a row within a group were significantly different (P<0.05). 
xy
 Means with different superscripts in a column within a group were significantly different (P<0.05). 
 
 
 
 
Species No. of 
oocytes 
Maturation 
rate (n) 
Enucleation 
rate  
(n) 
Injection rate 
(n) 
Percent cleavage  
(n)  
     2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst 
 (n) 
Caprine 362 46.94±4.48
y 
(202) 
63.22±5.43
x 
(190) 
63.31±5.54
x 
(185) 
48.34±5.08
c,y 
(144) 
40.43±4.85
bc,y 
(129) 
 33.57±4.70
b,y 
(114) 
  29.79±4.48
b,y 
(99) 
 9.86±2.95
a,y 
(48) 
 5.99±1.92
a,y 
(28) 
Bovine 821 33.62±3.66
x 
(341) 
57.60±5.39
x 
(256) 
57.19±5.40
y 
(223) 
24.45±4.27
c,x 
(105) 
16.06±3.21
b,x 
(77) 
   7.46±2.09
a,x 
(51) 
   4.84±1.68
a,x 
(36) 
 2.70±1.01
a,x 
(17) 
 1.13±0.43
a,x 
(9) 
Total 1183  40.41±2.95  60.47±3.82   60.31±3.86  36.64±3.46 28.49±3.09 20.78±2.81   17.57±2.63   6.35±1.61  3.61±1.02 
2
5
8
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Table 4.33: Percent maturation, enucleation, injection and cleavage rates between caprine and bovine oocytes (%, mean±SEM) based on Grade C  
                   oocytes 
 
 
abcd
 Means with different superscripts in a row were significantly different (P<0.05). 
xy
 Means with different superscripts in a column within a group were significantly different (P<0.05). 
 
 
 
 
 
 
 
Species No. of 
oocytes 
Maturation 
rate (n) 
Enucleation 
rate  
(n) 
Injection rate 
(n) 
Percent cleavage  
(n)  
     2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst 
 (n) 
Caprine 306 44.71±5.07
y 
(180) 
54.73±5.67
y 
(166) 
54.74±5.70
y 
(154) 
40.15±5.17
c,y 
(116) 
32.78±5.01
bc,y 
(101) 
30.25±5.00
bc,y 
(87) 
 26.62±4.76
b,y 
(74) 
8.21±2.80
a,y 
(39) 
5.38±2.01
a,y 
(21) 
Bovine 452 21.61±3.75
x 
(155) 
30.47±5.23
x 
(123) 
29.37±5.08
x 
(110) 
  9.98±2.95
d,x 
(47) 
 5.85±2.02
bc,x 
(30) 
  4.89±1.89
abc,x 
(23) 
 3.35±1.55
ab,x 
(14) 
0.56±0.35
ab,x 
(4) 
0.14±0.14
a,x 
(1) 
Total 758  33.40±3.30  42.85±3.98   42.32±3.95  25.37±3.25 19.59±2.95  17.83±2.90  15.22±2.71 4.46±1.47 2.81±1.05 
2
5
9
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Table 4.34: Percent maturation, enucleation, injection and cleavage rates between caprine and bovine oocytes (%, mean±SEM) based on Grade D  
                   oocytes 
 
 
abc
 Means with different superscripts in a row were significantly different (P<0.05). 
xy
 Means with different superscripts in a column were significantly different (P<0.05). 
 
 
 
 
 
 
 
Species No. of 
oocytes 
Maturation 
rate  
(n) 
Enucleation 
rate  
(n) 
Injection rate 
(n) 
Percent cleavage  
(n)  
     2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst 
 (n) 
Caprine 111   12.40±3.30
x 
(67) 
 15.14±4.06
x 
(60) 
 16.00±4.26
x 
(60) 
  12.33±3.46
c,x 
(47) 
  7.67±2.71
bc,x 
(38) 
  7.67±2.71
bc,x 
(38) 
3.96±2.06
ab,x 
(28) 
 2.33±1.64
ab,x 
(14) 
1.83±1.29
a,xy 
(11) 
Bovine 141 8.44±2.39
x 
(57) 
13.27±3.83
x 
(50) 
13.61±3.88
x 
(42) 
6.02±2.31
b,x 
(20) 
3.40±1.41
ab,x 
(12) 
 2.06±1.00
ab,x 
(7) 
3.70±2.01
ab,x 
(5) 
 0.23±0.23
a,x 
(1) 
0.00±0.00
a,x 
(0) 
Total 252  10.46±2.05  14.23±2.79  14.83±2.88     9.24±2.11     5.58±1.55    4.92±1.48 3.83±1.43   1.30±0.85  0.94±0.66 
2
6
0
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Table 4.35: Percent maturation, enucleation, injection and cleavage rates between caprine and bovine oocytes (%, mean±SEM) based on Grade E oocytes 
 
ab
 Means with different superscripts in a row were significantly different (P<0.05). 
x
 Means with same superscripts in a column were not significantly different (P>0.05). 
  
 
 
 
 
 
Species No. of 
oocytes 
Maturation 
rate (n) 
Enucleation 
rate  
(n) 
Injection rate 
(n) 
Percent cleavage  
(n)  
     2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst 
 (n) 
Caprine 151   14.21±3.34
x 
(65) 
19.67±4.47
x 
(53) 
19.13±4.39
x 
(47) 
 9.44±3.00
b.x 
(26) 
8.33±2.83
b,x 
(23) 
6.67±2.63
ab,x 
(18) 
 5.33±2.15
ab,x 
(16) 
 1.33±0.94
a,x 
(2) 
0.00±0.00
a,x 
(0) 
Bovine 323     9.79±2.38
x 
(75) 
17.89±4.38
x 
(56) 
17.25±4.28
x 
(51) 
 5.51±2.37
b,x 
(18) 
 2.92±1.65
ab,x 
(12) 
2.92±1.65
ab,x 
(12) 
2.08±1.47
ab,x 
(7) 
 0.14±0.14
a,x 
(1) 
0.00±0.00
a,x 
(0) 
Total 474    12.04±2.07  18.80±3.12   18.21±3.06  7.52±1.92    5.68±1.67  4.83±1.57  3.74±1.31  0.75±0.48  0.00±0.00 
2
6
1
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Table 4.36 shows the percent enucleation by 2 different enucleation techniques, namely 
squeezing and laser enucleations between caprine and bovine species. There were 
significant differences (P<0.05) between caprine and bovine species in percent 
enucleation for squeezing and laser enucleation techniques with the values of 
95.23±1.73% versus 82.73±3.81% and 96.61±1.42% versus 88.64±3.21, respectively. 
The percent enucleation was higher in the caprine compared to bovine in both 
enucleation techniques. 
 
Table 4.36: Percent enucleation (%, mean±SEM) by 2 different enucleation techniques  
                  between caprine and bovine species 
 
Species No. of ovaries No. of oocytes Percent enucleation (n) 
   Squeezing  
(n) 
Laser 
(n) 
Caprine 209 1296 95.23±1.73
a,y 
(236/267) 
96.61±1.42
a,y 
(479/500) 
Bovine 220 3175   82.73±3.81
a,x 
(375/509) 
88.64±3.21
a,x 
(699/806) 
Total 429 4471   89.17±2.18   92.67±1.79 
 
a
 Means with same superscripts in a row were not significantly different (P>0.05). 
xy
 Means with different superscripts in a column were significantly different (P<0.05). 
*n=number of enucleated oocytes/number of matured oocytes used. 
 
 
 
The cleavage rates between caprine and bovine species are shown in Tables 
4.37, 4.38, 4.39, 4.40, 4.41 and 4.42 for 2-, 4-,8-cell, morula, blastocyst and hatched 
blastocyst embryos in 2 different enucleation techniques (squeezing and laser 
enucleation). Most of the cleavage values were significantly higher in laser enucleation 
technique for both species. Caprine species always showed higher percent cleavage than 
bovine species for both enucleation techniques. 
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Table 4.37: Percent 2-cell embryos (%, mean±SEM) and enucleation techniques  
                   between caprine and bovine species  
 
Species No. of ovaries No. of oocytes Percent 2-cell (n) 
   Squeezing  
(n) 
Laser 
(n) 
Caprine 209 1296 58.15±6.76
a,y 
(135/215)* 
  82.07±3.45
b,y 
(393/471) 
Bovine 220 3175 20.12±5.35
a,x 
      (94/320) 
63.7±4.04
b,x 
(412/644) 
Total 429 4471   39.71±4.91    73.01±2.83 
 
ab
 Means with different superscripts in a row were significantly different (P<0.05). 
xy
 Means with different superscripts in a column were significantly different (P<0.05). 
*n=number of 2-cell embryos/number of injected oocytes.  
 
 
 
Table 4.38: Percent 4-cell embryos (%, mean±SEM) and enucleation techniques  
                   between caprine and bovine species  
 
Species No. of ovaries No. of oocytes Percent 4-cell (n) 
   Squeezing  
(n) 
Laser 
(n) 
Caprine 209 1296 42.04±6.53
a,y 
(95/215)* 
74.14±3.62
b,y 
(367/471) 
Bovine 220 3175 13.72±4.38
a,x 
      (71/320) 
50.30±4.33
b,x 
(327/644) 
Total 429 4471   28.31±4.32   62.37±3.10 
 
ab
 Means with different superscripts in a row were significantly different (P<0.05). 
xy
 Means with different superscripts in a column were significantly different (P<0.05). 
*n=number of 4-cell embryos/number of injected oocytes. 
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Table 4.39: Percent 8-cell embryos (%, mean±SEM) and enucleation techniques  
                   between caprine and bovine species  
 
Species No. of ovaries No. of oocytes Percent 8-cell (n) 
   Squeezing  
(n) 
Laser 
(n) 
Caprine 209 1296 25.73±6.05
a,y 
(57/215)*
 
70.93±3.87
b,y 
(347/471) 
Bovine 220 3175 7.95±3.79
b,x 
      (45/320) 
37.74±4.31
b,x 
(257/644) 
Total 429 4471  17.11±3.76   54.54±3.42 
 
ab
 Means with different superscripts in a row were significantly different (P<0.05). 
xy
 Means with different superscripts in a column were significantly different (P<0.05). 
*n=number of 8-cell embryos/number of injected oocytes. 
 
 
Table 4.40: Percent morula embryos (%, mean±SEM) and enucleation techniques  
                   between caprine and bovine species  
 
Species No. of ovaries No. of oocytes Percent morula (n) 
   Squeezing  
(n) 
Laser 
(n) 
Caprine 209 1296 16.36±5.22
a,y 
(35/215)*
 
64.08±3.91
b,y 
(315/471) 
Bovine 220 3175 1.71±1.33
a,x 
     (16/320) 
23.84±3.79
b,x 
(195/644) 
Total 429 4471    9.26±2.89   44.21±3.52 
 
ab
 Means with different superscripts in a row were significantly different (P<0.05). 
xy
 Means with different superscripts in a column were significantly different (P<0.05). 
*n=number of morula embryos/number of injected oocytes. 
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Table 4.41: Percent blastocyst embryos (%, mean±SEM) and enucleation techniques  
                   between caprine and bovine species  
 
Species No. of ovaries No. of oocytes Percent blastocyst (n) 
   Squeezing  
(n) 
Laser 
(n) 
Caprine 209 1296 0.00±0.00
a,x 
(0/215)*
 
25.33±4.66
b,y 
(170/471) 
Bovine 220 3175 0.00±0.00
a,x 
      (0/320) 
7.01±1.42
b,x 
(70/644) 
Total 429 4471    0.00±0.00  16.28±2.65 
 
ab
 Means with different superscripts in a row were significantly different (P<0.05). 
xy
 Means with different superscripts in a column were significantly different (P<0.05). 
*n=number of blastocyst embryos/number of injected oocytes. 
 
 
Table 4.42: Percent hatched blastocyst embryos (%, mean±SEM) and enucleation  
                   techniques between caprine and bovine species  
 
Species No. of ovaries No. of oocytes Percent hatched blastocyst (n) 
   Squeezing  
(n) 
Laser 
(n) 
Caprine 209 1296 0.00±0.00
a,x 
(0/215)*
 
15.68±3.00
b,y 
(99/471) 
Bovine 220 3175 0.00±0.00
a,x 
      (0/320) 
2.98±0.77
b,x 
(33/644) 
Total 429 4471    0.00±0.00    9.40±1.71 
 
ab
 Means with different superscripts in a row were significantly different (P<0.05). 
xy
 Means with different superscripts in a column were significantly different (P<0.05). 
*n=number of hatched blsatocyst embryos/number of injected oocytes. 
 
 
Comparisons of cleavage rates between caprine and bovine embryos in 
parthenogenesis treatment are shown in Table 4.43. A total of 1197 oocytes obtained 
from caprine and bovine were 438 and 759, respectively. There were no significant 
differences (P>0.05) in maturation rates between caprine and bovine with the values of 
63.73±4.25% versus 61.50±3.65%, respectively. Similarly, cleavage rates for caprine 
and bovine showed no significant differences (P>0.05) (65.95±5.08% versus 
62.24±4.96%, 56.66±5.36% versus 49.49±4.94%, 49.37±6.18% versus 40.70±4.21%, 
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30.27±5.96% versus 31.41±3.28%, 17.18±5.38% versus 12.66±2.18% and 4.67±2.51% 
versus 2.15±0.71%) for 2-, 4-, 8-cell, morula, blastocyst and hatched blastocyst, 
respectively. There was a significant decrease in percent cleavage from 2-cell embryos 
up to hatched blastocyst for caprine and bovine species. 
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Table 4.43: Percent cleavage between caprine and bovine embryos (%, mean±SEM) in parthenogenesis  
 
abcde
 Means with different superscripts in a row were significantly different (P<0.05). 
x
 Means with same superscripts in a column within a group were not significantly different (P>0.05). 
 
 
 
 
  
 
Species No. of 
ovaries 
No. of 
oocytes 
Maturation rate  
(n) 
Percent cleavage  
(n)  
    2-cell  
(n) 
4-cell  
(n) 
8-cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst  
(n) 
Caprine    51       438 63.73±4.25
x 
(255) 
65.95±5.08
d,x 
(152) 
56.66±5.36
cd,x 
(125) 
49.37±6.18
c,x 
(96) 
30.27±5.96
b,x
 
(53) 
17.18±5.38
ab,x 
(26) 
4.67±2.51
a,x 
(4) 
Bovine   75    759 61.50±3.65
x 
(471) 
62.24±4.96
e,x 
(274) 
49.49±4.94
d,x 
(220) 
40.70±4.21
cd,x 
(178) 
31.41±3.28
c,x 
(133) 
12.66±2.18
b,x 
(59) 
2.15±0.71
a,x 
(12) 
Total 126 1197 62.62±2.76 64.09±3.51 53.07±3.64 45.03±3.76 30.84±3.34 14.92±2.88 3.41±1.30 
2
6
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4.3 EFFECTS OF STRAINS, CULTURE MEDIUM AND MOUSE EMBRYONIC  
      FIBROBLAST FREEZING ON PRODUCTION OF MURINE EMBRYONIC  
      STEM CELL LINES USING WHOLE BLASTOCYST CULTURE    
       TECHNIQUE (EXPERIMENT 3) 
The aims of this experiment were to a) determine the effects of murine strains, b) 
culture medium and c) fresh and frozen-thawed mouse embryonic fibroblast on 
production of murine embryonic stem cell lines performance by using whole blastocyst 
culture technique. Five different stages of murine blastocyst have been studied, namely 
early-, mid-, expanded-, hatching- and hatched blastocyst to produce good quality of 
murine embryonic stem cell lines.  
 
4.3.1  Effects of Murine Strains on Production of Murine Embryonic Stem Cells  
           Lines Using Whole Blastocyst Culture Technique 
 
Table 4.44 shows the percent successful attachment of blastocysts and consecutive 
passages of murine embryonic stem cells up to Passage 3 (P3) derived from 3 different 
pure-strains of murine (ICR, CBA/ca and C57BL/6J). There were no significant 
differences (P>0.05) among the 3 different pure-strains of murine in percent successful 
consecutive passages murine embryonic stem cell lines up to Passage 3 (P3). However, 
CBA/ca gave the highest percent attachment of blastocysts and successful consecutive 
passages murine embryonic stem cell lines with the values of 62.68±20.90% 
(attachment rate), 41.32±3.49% (P1), 31.00±3.56% (P2) and 19.81±3.51% (P3), 
respectively. 
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Table 4.44: Percent successful attachment of blastocysts and consecutive passages of murine embryonic stem cells (%, mean±SEM) up  
                   to Passage 3 (P3) from 3 different pure-strains of murine 
 
Strain No. of 
females 
No. of 
replicates 
No. of 
blastocysts 
Percent attachment 
(n) 
Percent successful consecutive passages 
(n) 
  P1 
(n) 
P2 
(n) 
P3 
(n) 
ICR 63 35 971 56.74±3.18
d,x 
(777) 
35.20±2.61
c,x 
(443) 
23.77±2.48
b,x 
(207) 
9.00±1.65
a,x 
(71) 
CBA/ca 34 18 758 62.68±20.90
b,x 
(429) 
41.32±3.49
ab,x 
(237) 
31.00±3.56
ab,x
 
(109) 
19.81±3.51
a,y
 
(38) 
C57BL/6J 39 18 709 44.68±2.53
c,x
 
(359) 
40.71±4.49
c,x
 
(160) 
22.10±3.75
a,x
 
(64) 
8.50±2.59
a,x
 
(22) 
Total 136 71 2438     55.18±5.55 38.15±1.93  25.18±1.80 11.62±1.39 
 
abcd
Means with different superscripts in a row within a group were significantly different (P<0.05). 
xy
Means with different superscripts in a column within a group were not significantly different (P>0.05). 
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Table 4.45: Percent successful attachment of blastocysts and consecutive passages of murine embryonic stem cell lines up to passage 3 (P3)  
                   (mean±SEM) from 5 different blastocyst stages 
 
Blastocyst stage No. of 
females 
No. of 
replicates 
No. of 
blastocysts 
Percent attachment 
(n) 
Percent successful consecutive passages 
(n) 
  P1 P2 P3 
Early   82 71 256   65.17±24.88
b,x
 
(198) 
27.88±3.79
ab,x
 
(105) 
 20.28±3.70
a,xy
 
(46) 
9.18±2.98
a,x 
(14) 
Mid 115 71 488 48.08±4.00
c,x
 
(278) 
45.35±5.60
c,y
 
(164) 
 28.11±4.29
b,yz 
(81) 
15.16±3.47
a,x
 
(30) 
Expanded 129 71 666 68.78±3.38
d,x
 
(465) 
52.79±3.92
c,y
 
(262) 
37.55±4.36
b,z
 
(138) 
17.24±3.67
a,x
 
(55) 
Hatching 122 71 682 57.01±3.65
d,x
 
(418) 
43.01±3.67
c,y
 
(224) 
 28.02±3.81
b,yz
 
(89) 
11.60±2.95
a,x
 
(25) 
Hatched  97 71 346 37.45±4.58
c,x
 
(206) 
24.53±3.53
b,x 
(85) 
11.92±3.26
a,x
 
(26) 
8.08±2.94
a,x
 
(7) 
Total    545       355     2438         55.44±5.48       38.71±1.94       25.18±1.80     12.27±1.44 
 
abcd
Means with different superscripts in a row within a group were significantly different (P<0.05). 
xyz
Means with different superscripts in a column within a group were significantly different (P<0.05). 
2
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Table 4.46 shows percent successful attachment of blastocysts and consecutive passages of 
murine embryonic stem cells derived from 3 different pure-strains of murine and 5 different 
blastocyst stages. A total of 971, 758 and 709 blastocysts were used in this experiment for 
ICR, CBA/ca and C57BL/6J. Expanded blastocyst stage always showed the highest percent 
successful attachment of blastocysts and consecutive passages up to passage 3 (P3) 
throughout the 3 different pure-strains of murine compared to other blastocyst stages. The 
percent successful consecutive passages from Passage 1 (P1) up to Passage 3 (P3) showed 
significant decrease for ICR, CBA/ca and C57BL/6J. Murine blastocyst stages are shown in 
Figure 4.12. 
Percent successful attachment of blastocysts and consecutive passages of murine 
embryonic stem cell lines up to Passage 3 (P3) from 5 different blastocyst stages (early-, 
mid-, expanded-, hatching- and hatched blastocyst) are shown in Table 4.45. There were no 
significant differences (P>0.05) in percent attachment for early-, mid-, expanded-, 
hatching- and hatched blastocyst with the values of 65.17±24.88%, 48.08±4.00%, 
68.78±3.38%, 57.01±3.65% and 37.45±4.58%, respectively. Although each blastocyst 
stage could passage up to Passage 3 (P3) in producing murine embryonic stem cell lines, 
expanded blastocyst stage showed the highest percent successful attachment of blastocysts 
and successful consecutive passages compared to other blastocyst stages with the values of 
68.78±3.38% (attachment rate), 52.79±3.92% (P1), 37.55±4.36% (P2) and 17.24±3.67% 
(P3), respectively. 
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Table 4.46: Percent successful attachment of blastocysts and consecutive passages of murine embryonic stem cells (%, mean±SEM) derived  
                   from 3 different pure-strains of murine and 5 different blastocyst stages 
 
Murine 
strains 
No. of 
replicates 
Blastocyst 
stages 
No. of 
blastocysts 
Percent 
attachment 
(n) 
Percent successful consecutive passages 
(n) 
 
 
    P1 
(n)
 
P2 
(n)
 
P3 
(n)
 
 
 
 
ICR 
35 Early   96 35.78±7.35
c,x 
(76) 
28.80±5.88
bc,xy 
(54)
 
 19.05±5.03
ab,xy 
(23)
 
 7.38±3.53
a,xy 
(6)
 
35 Mid 187 57.93±6.96
c,y 
(145)
 
41.64±6.62
bc,yz 
(92)
 
 26.92±5.67
ab,xy 
(44)
 
11.90±4.44
a,xy 
(16)
 
35 Expanded 288 78.01±5.26
c,z 
(250)
 
   49.28±5.93
b,z 
(143)
 
    35.17±6.19
b,y 
(80)
 
  16.68±4.87
a,y 
(36)
 
35 Hatching 240   63.76±6.52
d,yz 
(181)
 
   39.64±5.86
c,yz 
(103)
 
24.07±5.48
b,xy 
(42)
 
  6.67±2.74
a,xy 
(9)
 
35 Hatched 160   48.20±7.52
c,xy 
(125)
 
   22.35±4.18
b,x 
(51)
 
13.62±4.85
ab,x 
(18)
 
2.38±8.03
a,x 
(4)
 
Total     175  971     56.74±3.18    36.34±2.64     23.77±2.48    9.00±1.65 
 
 
 
CBA/ca 
18 Early   85 10.50±7.66
a,x 
(76)
 
22.97±6.38
a,x 
(31)
 
21.85±6.89
a,xy 
(13)
 
15.74±7.91
a,x 
(4)
 
18 Mid 160 35.05±5.27
a,x 
(69)
 
45.07±7.34
a,yz 
(40)
 
36.30±9.36
a,xy 
(21)
 
25.19±8.10
a,x 
(8)
 
18 Expanded 208 65.14±5.13
c,x 
(125)
 
61.37±6.59
bc,z 
(73)
 
43.15±7.88
b,y 
(36)
 
18.89±7.78
a,x 
(10)
 
18 Hatching 260 50.38±4.67
b,x 
(140)
 
49.17±5.82
b,yz 
(80)
 
38.71±6.30
ab,y 
(34)
 
25.37±8.03
a,x 
(13)
 
18 Hatched   45 20.75±7.90
a,x 
(19)
 
28.04±9.40
a,xy
 
(13)
 
15.00±7.85
a,x 
(5)
 
13.89±7.89
a,x 
(3)
 
Total 90  758    62.68±20.90     41.32±3.49    31.00±3.56  19.81±3.51 
2
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C57BL/6J 
 
18 Early   75 43.16±7.38
c,xy 
(46)
 
  31.00±7.44
bc,x 
(20)
 
   21.11±8.74
ab,xy 
(10)
 
6.94±4.87
a,x 
(4)
 
18 Mid 141   41.96±4.58
ab,xy 
(64)
 
  52.84±16.74
b,x 
(32)
 
   22.26±8.95
ab,xy 
(16)
 
11.48±6.68
a,x 
(6)
 
18 Expanded 170    54.49±5.36
b,y 
(90)
 
51.03±7.94
b,x 
(46)
 
   36.57±9.77
ab,y 
(22)
 
16.67±8.08
a,x 
(9)
 
18 Hatching 182    50.52±4.39
c,y 
(97)
 
43.40±6.95
b,x 
(41)
 
25.00±8.37
ab,xy 
(13)
 
7.41±5.75
a,x 
(3)
 
18 Hatched 141 33.25±5.35
b,x 
(62) 
25.25±6.69
b,x 
(21) 
5.56±4.04
a,x 
(3) 
0.00±0.00
a,x 
(0) 
Total 90  709    44.68±2.53     40.71±4.49    22.10±3.75    8.50±2.59 
 
abcd
Means with different superscripts in a row within a group were significantly different (P<0.05). 
xyz
Means with different superscripts in a column within a group were significantly different (P<0.05). 
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Figure 4.12: Blastocyst stages: a) early blastocyst, b) mid-blastocyst, c) expanded blastocyst, d) hatching blastocyst and e) 
                                         hatched blastocyst. 
 
 
 
2
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4.3.2 Effects of Culture Medium on Production of Murine Embryonic Stem Cell  
          Lines Using Whole Blastocyst Culture Technique  
 
Table 4.47 shows percent successful attachment of blastocysts and consecutive passages 
of murine embryonic stem cells up to Passage 3 (P3) on 2 different culture media, 
namely DMEM+10% FBS and αMEM+10% FBS. There were no significant 
differences  (P>0.05) between DMEM+10% FBS and αMEM+10% FBS with the 
values of 56.78±13.59% versus 53.13±2.51%, 41.60±3.64% versus 37.05±2.23%, 
29.85±3.20% versus 22.78±2.22% and 15.75±2.50% versus 9.36±1.68% for percent 
attachment, Passage 1 (P1), Passage 2 (P2) and Passage 3 (P3), respectively. However, 
the DMEM+10% FBS culture medium showed higher percent successful attachment 
and consecutive passages than αMEM+10% FBS culture medium.  
Percent successful attachment of blastocysts and consecutive passages of murine 
embryonic stem cells on DMEM+10%FBS and αMEM+10%FBS culture media based 
on 5 different blastocyst stages are shown in Table 4.48. A total of 881 and 1442 of 
murine blastocyst for DMEM+10%FBS and αMEM+10%FBS culture media were used 
in this experiment, respectively. There were no significant differences (P>0.05) for 
percent successful attachment of blastocysts in Passages 1, 2 and 3 at early blastocyst 
stage for DMEM+10%FBS culture medium only with the values of 34.60±7.27%, 
28.78±7.01%, 22.26±6.62% and 14.29±5.81%, respectively.  
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Table 4.47: Percent successful attachment of blastocysts and consecutive passages of murine embryonic stem cells (%, mean±SEM) up to   
                   Passage 3 (P3) on 2 different culture media 
 
Culture medium No. of 
females 
No. of 
replicates 
No .of 
blastocysts 
Percent attachment 
(n) 
Percent successful consecutive passages 
(n) 
   P1 
(n) 
P2 
(n) 
P3 
(n) 
DMEM+10% FBS  51 140   881 56.78±13.59
d,x 
(563) 
41.60±3.64
c,x 
(333) 
29.85±3.20
b,x
 
(185) 
15.75±2.50
a,x
 
(80) 
αMEM+10%  FBS 77 205 1442 53.13±2.51c,x 
(935) 
37.05±2.23
bc,x
 
(471) 
22.78±2.22
ab,x
 
(189) 
9.36±1.68
a,y
 
(51) 
Total 128 345 2356       54.61±5.70     38.89±1.98       25.65±1.86     11.95±1.43 
 
abcd
Means with different superscripts in a row within a group were significantly different (P<0.05). 
xy
Means with different superscripts in a column within a group were significantly different (P<0.05). 
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Table 4.48: Percent successful attachment of blastocysts and consecutive passages of murine embryonic stem cells (%, mean±SEM) on 2 different  
                   culture media based on 5 different blastocyst stages 
 
Culture medium No. of 
replicates 
Blastocyst 
stages 
No. of 
blastocysts 
Percent attachment 
(n) 
Percent successful consecutive passages 
(n) 
 
 
    P1 
(n)
 
P2 
(n)
 
P3 
(n)
 
 
 
 
DMEM+10% FBS 
  28 Early   96 34.60±7.27
a,xy 
(69) 
      28.78±7.01
a,x 
(35)
 
22.26±6.62
a,xy 
(19)
 
14.29±5.81
a,xy 
(9)
 
  28 Mid 199  43.69±5.99
ab,xy 
(112)
 
 61.26±11.60
b,z 
(83)
 
 41.50±7.87
ab,yz 
(50)
 
26.90±6.86
a,y 
(23)
 
  28 Expanded 275 65.65±5.31
b,z 
(177)
 
55.63±6.53
b,yz 
(110)
 
47.57±7.50
b,z 
(71)
 
     21.99±6.32
a,y 
(34)
 
  28 Hatching 249  49.47±6.42
c,yz 
(145)
 
  37.60±6.61
bc,xy 
(73)
 
   28.77±6.80
ab,xyz 
(37)
 
14.40±5.56
a,xy 
(12)
 
  28 Hatched   62 26.22±6.52
b,x 
(61)
 
27.15±6.23
b,x 
(32)
 
        10.95±5.38
a,x 
(8)
 
3.57±2.48
a,x 
(2)
 
Total 140  881        43.93±3.02       42.09±3.66         30.21±3.23     16.23±2.57 
 
 
 
αMEM+10% FBS 
   41 Early 153       39.46±6.06
c,x 
(104)
 
     29.28±4.93
bc,x 
(58)
 
19.51±4.94
ab,xy 
(24)
 
 8.13±3.78
a,x 
(5)
 
   41 Mid 278       50.11±5.54
c,xy 
(158)
 
34.66±4.87
b,xy 
(76)
 
19.86±4.69
a,xy 
(30)
 
 7.89±3.28
a,x 
(7)
 
   41 Expanded 373       69.62±4.53
d,z 
(271)
 
      50.45±5.14
c,z 
(138)
 
33.73±5.70
b,y 
(66)
 
14.84±4.63
a,x 
(21)
 
   41 Hatching 422 61.45±4.42
d,yz 
(265)
 
 47.83±4.31
c,yz 
(149)
 
27.65±4.68
b,xy 
(51)
 
10.24±3.33
a,x 
(13)
 
   41 Hatched 216 45.00±6.21
c,x 
(137)
 
23.02±4.39
b,x
 
(50)
 
13.17±4.32
ab,x 
(18)
 
 5.69±3.47
a,x 
(5)
 
Total 205  1442        53.13±2.51       37.05±2.23        22.78±2.22        9.36±1.68 
       
abcdMeans with different superscripts in a row within a group were significantly different (P<0.05). 
xyzMeans with different superscripts in a column within a group were significantly different (P<0.05). 
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4.3.3 Effects of Fresh and Frozen-thawed Mouse Embryonic Fibroblast on  
         Production of Murine Embryonic Stem Cell Lines Using Whole  
         Blastocyst Culture Technique 
 
In Table 4.49 shows percent successful attachment of blastocysts and consecutive 
passages of murine embryonic stem cells up to Passage 3 (P3) based on fresh and 
frozen-thawed mouse embryonic fibroblast. A total of 128 number of female murine, 70 
(fresh mouse embryonic fibroblast) and 58 (frozen-thawed mouse embryonic fibroblast) 
were used in this experiment. There were no significant differences (P>0.05) between 
fresh and frozen-thawed mouse embryonic fibroblast for percent successful attachment 
of blastocysts, consecutive passages with the values of 50.35±2.93% versus 
48.22±2.41%, 38.18±2.61% versus 39.78±3.05%, 26.59±2.53% versus 24.63±2.72% 
and 13.82±2.06% versus 10.10±2.01%, respectively.  
Percent successful attachment of blastocysts and consecutive passages of murine 
embryonic stem cells derived from 5 different blastocyst stages based on fresh and 
frozen-thawed mouse embryonic fibroblast are shown in Table 4.50. Obviously, 
majority of expanded blastocysts gave the highest percent attachment of blastocysts and 
successful consecutive passages in both fresh and frozen-thawed mouse embryonic 
fibroblast with the values of 76.05±4.24% (attachment rate), 44.34±6.05% versus 
31.11±6.41% (P2) and 21.68±5.43% versus 12.90±5.02% (P3), respectively.  
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Table 4.49: Percent successful attachment of blastocysts and consecutive passages of murine embryonic stem cells (%, mean±SEM)  
                           up to Passage 3 (P3) on fresh and frozen-thawed mouse embryonic fibroblasts 
 
MEF No. of 
females 
No. of 
replicates 
No .of 
blastocysts 
Percent 
attachment 
(n) 
Percent successful consecutive passages 
(n) 
   P1 
(n) 
P2 
(n) 
P3 
(n) 
Fresh   70 190 1117 50.35±2.93
d,x 
(758) 
38.18±2.61
c,x 
(458) 
26.59±2.53
b,x
 
(232) 
13.82±2.06
a,x
 
(90) 
Frozen-thawed   58 155 1264 48.22±2.41
d,x
 
(741) 
39.78±3.05
c,x
 
(354) 
24.63±2.72
b,x
 
(142) 
10.10±2.01
a,x
 
(41) 
Total 128 345 2381     49.39±1.94    38.90±1.99     25.71±1.85    12.15±1.45 
 
abcd
Means with different superscripts in a row within a group were significantly different (P<0.05). 
x
Means with same superscripts in a column were within a group not significantly different (P>0.05). 
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 Table 4.50: Percent successful attachment of blastocysts and consecutive passages of murine embryonic stem cells (%, mean±SEM) derived from 5  
                    different blastocyst stages based on fresh and frozen-thawed mouse embryonic fibroblasts 
 
MEF No. of 
replicates 
Blastocyst 
stages 
No. of 
blastocysts 
Percent attachment 
(n) 
Percent successful consecutive passages 
(n) 
 
 
    P1 
(n)
 
P2 
(n)
 
P3 
(n)
 
 
 
 
Fresh 
  38 Early   104 30.16±6.37
b,x 
(69) 
23.50±5.27
ab,x 
(42)
 
18.16±4.87
ab,xy 
(22)
 
  9.43±4.08
a,xy 
(7)
 
  38 Mid    231  47.92±6.17
b,xy 
(140)
 
42.17±6.14
b,y 
(92)
 
31.61±6.34
ab,yz 
(50)
 
16.32±4.80
a,xy 
(20)
 
  38 Expanded    340 76.05±4.24
d,z 
(261)
 
59.34±5.40
c,z 
(162)
 
      44.34±6.05
b,z 
(94)
 
    21.68±5.43
a,y 
(41)
 
  38 Hatching    337 58.96±5.81
c,y 
(213)
 
42.55±5.45
b,y 
(126)
 
28.77±5.29
ab,yz 
(57)
 
15.09±4.50
a,xy 
(19)
 
  38 Hatched    105 38.65±7.38
c,x 
(75)
 
23.33±5.03
b,x 
(36)
 
      10.04±3.98
ab,x 
(9)
 
6.58±3.85
a,x 
(3)
 
Total 190  1117       50.35±2.93      38.18±2.61       26.59±2.53     13.82±2.06 
 
 
 
Frozen-thawed 
  31 Early    145 46.47±6.48
c,xy 
(104)
 
32.69±5.88
bc,xy 
(53)
 
24.73±6.46
ab,x 
(21)
 
12.10±5.30
a,x 
(7)
 
  31 Mid    246  47.00±5.14
b,xy 
(130)
 
49.48±10.28
b,y 
(67)
 
24.99±5.99
a,x 
(30)
 
14.73±5.37
a,x 
(10)
 
  31 Expanded    308 58.16±5.12
c,y 
(187)
 
45.30±5.79
bc,xy 
(92)
 
31.11±6.41
b,x 
(43)
 
12.90±5.02
a,x 
(14)
 
  31 Hatching    334 53.67±4.35
c,y 
(197)
 
45.06±5.00
c,xy 
(96)
 
27.29±5.82
b,x 
(31)
 
 8.06±3.85
a,x 
(6)
 
  31 Hatched    231 35.82±5.13
c,x 
(123)
 
26.38±5.24
bc,x
 
(46)
 
15.00±5.66
ab,x 
(17)
 
 2.69±1.91
a,x 
(4)
 
Total 155  1264       48.22±2.41     39.78±3.05        24.63±2.72    10.10±2.01 
 
     abc Means with different superscripts in a row within a group were significantly different (P<0.05). 
     xyz Means with different superscripts in a column within a group were significantly different (P<0.05). 
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Table 4.51 shows percent successful attachment of blastocysts and consecutive 
passages of murine embryonic stem cells on fresh and frozen-thawed mouse embyonic 
fibroblast at Passages 1 and 2. There were no significant differences (P>0.05) in percent 
successful consecutive passages on murine embryonic stem cell lines between Passage 
1 (P1) and Passage 2 (P2) for fresh mouse embryonic fibroblast with values of 
37.83±3.18% versus 38.61±4.35%, 23.57±3.00% versus 30.32±4.25% and 
13.13±2.85% versus 14.67±2.97% for Passages 1, 2 and 3, respectively. Whereas for 
Passsages 1 and 2 on frozen-thawed mouse embyonic fibroblast, there were significant 
differences (P<0.05) at Passage 3 (P3) with values of 5.40±1.61 versus 18.64±4.66, 
respectively. 
Table 4.52 shows percent successful attachment of blastocysts and consecutive 
passages of murine embryonic stem cells derived from 5 different blastocyst stages on 
fresh and frozen-thawed mouse embryonic fibroblast at Passage 1 (P1) and Passage 2 
(P2). The expanded blastocysts showed the highest percent attachment of blastocysts  
and consecutive passages for both Passages 1 and 2 in fresh mouse embryonic fibroblast 
with the respective values of 77.10±5.68%, 56.14±6.65%, 38.23±7.54% and 
19.44±7.35% for murine embryonic stem cells lines at Passages 1, 2 and 3  (P1) and 
74.74±6.56%, 63.29±9.00%, 51.88±9.74% and 24.45±8.26% for murine embryonic 
stem cell lines at Passages 1 and 2 only. 
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Table 4.51: Percent successful attachment of blastocysts and consecutive passages of murine embryonic stem cells (%, mean±SEM) on fresh and  
                    frozen-thawed mouse embryonic fibroblast at Passage 1 (P1) and Passage 2 (P2) 
 
MEF No. passages 
MEF 
No. of 
replicates 
No. of 
blastocysts 
Percent attachment 
(n) 
Percent successful consecutive passages 
(n) 
     P1 
(n) 
P2 
(n) 
P3 
(n) 
Fresh P1 105 648 56.01±3.91
d,y 
(442) 
37.83±3.18
c,x 
(248) 
23.57±3.00
b,x 
(100) 
13.13±2.85
a,x 
(31) 
P2   85 469 43.35±4.33
c,x 
(316) 
 38.61±4.35
bc,x 
(210) 
30.32±4.25
b,x 
(132) 
14.67±2.97
a,x 
(59) 
Total  190 1117        50.35±2.93      38.18±2.61      26.59±2.53   13.82±2.06 
Frozen-thawed P1 100 794 50.10±3.10
d,x 
(493) 
35.56±3.09
c,x 
(231) 
21.64±3.16
b,x 
(89) 
  5.40±1.61
a,x 
(20) 
P2   55 470 44.82±3.80
b,x 
(248) 
47.46±6.43
b,x 
(123) 
     30.05±5.01
a,x 
(53) 
18.64±4.66
a,y 
(21) 
Total  155 1264       48.22±2.41      39.78±3.05      24.63±2.72   10.10±2.01 
 
abcd 
Means with different superscripts in a row within a group were significantly different (P<0.05). 
xy 
Means with different superscripts in a column within a group were significantly different (P<0.05). 
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Table 4.52: Percent successful attachment of blastocysts and consecutive passages of murine embryonic stem cells (%, mean±SEM) derived from 5  
                   different blastocyst stages on fresh and frozen-thawed mouse embryonic fibroblast at Passage 1 (P1) and Passage 2 (P2)  
 
MEF No. 
passages 
MEF 
No. of 
replicates 
Blastocyst 
stages 
No. of 
blastocysts 
Percent 
attachment 
(n) 
Percent successful consecutive passages 
(n) 
 
      P1 P2 P3 
 
 
 
 
 
 
 
 
 
 
Fresh 
 
 
 
 
 
 
 
 
P1 
  21 Early   64   35.86±9.37
a,x 
(42) 
  26.33±6.98
a,x 
(26) 
  17.46±5.83
a,x 
(12) 
13.49±6.86
a,x 
(4) 
  21 Mid 129 50.28±8.49
c,xy 
(72) 
 32.13±6.42
bc,xy 
(37) 
21.68±7.36
ab,xy 
(14) 
 8.73±5.35
a,x 
(3) 
  21 Expanded 180   77.10±5.68
c,z 
(141) 
  56.14±6.65
b,z 
(80) 
  38.23±7.54
ab,y 
(37) 
19.44±7.35
a,x 
(12) 
  21 Hatching 220   66.12±6.79
c,yz 
(144) 
47.24±5.96
b,yz 
(86) 
27.63±5.97
a,xy 
(32) 
13.79±5.67
a,x 
(10) 
  21 Hatched   55   47.55±10.49
b,xy 
(43) 
  25.05±7.43
a,x 
(19) 
  11.51±5.47
a,x 
(5) 
 9.52±6.56
a,x 
(2) 
 105 Total 648   55.48±3.91   37.47±3.17   23.34±2.98    13.00±2.83 
 
 
 
 
P2 
17 Early   40   23.11±8.27
a,x 
(27) 
20.00±8.18
b,x 
(16) 
 19.02±8.37
a,xy 
(10) 
4.41±3.21
a,x 
(3) 
17 Mid 102   45.01±9.22
a,x 
(68) 
  54.58±10.68
a,yz 
(55) 
43.89±10.34
a,yz 
(36) 
25.69±8.06
a,y 
(17) 
17 Expanded 160   74.74±6.56
b,y 
(120) 
   63.29±9.00
b,z 
(82) 
 51.88±9.74
b,z 
(57) 
24.45±8.26
a,y 
(29) 
17 Hatching 117   46.24±9.74
b,x 
(69) 
  33.98±9.67
ab,xy 
(40) 
 28.56±9.33
b,x 
(25) 
15.88±7.13
a,xy 
(9) 
17 Hatched   50   27.65±9.91
b,x 
(32) 
21.20±6.70
ab,x 
(17) 
   8.24±5.96
ab,x 
(4) 
     2.94±2.94
a,x 
(1) 
  85 Total 1117   43.35±4.33   38.61±4.35  30.32±4.25    14.67±2.97 
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abc 
Means with different superscripts in a row within a group were significantly different (P<0.05). 
xyz 
Means with different superscripts in a column within a group were significantly different (P<0.05). 
  
 
 
 
 
 
 
 
 
 
 
 
Frozen-
thawed 
 
 
 
 
 
P1 
20 Early   89 43.23±7.75
c,x 
(62) 
  27.38±6.28
bc,xy 
(34) 
23.33±8.12
b,x 
(12) 
  2.50±2.50
a,x 
(1) 
20 Mid 149 49.94±7.28
b,x 
(86) 
 37.32±7.49
b,xy 
(39) 
17.95±5.88
a,x 
(16) 
  7.00±3.85
a,x 
(4) 
20 Expanded 193 61.77±6.82
b,x 
(130) 
46.13±7.84
b,y 
(64) 
25.72±7.37
a,x 
(29) 
10.00±5.53
a,x 
(9) 
20 Hatching 202 53.24±5.77
c,x 
(121) 
46.09±6.53
c,y 
(63) 
 26.30±7.29
b,x 
(19) 
 5.83±3.26
a,x 
(3) 
20 Hatched 161 42.32±6.63
c,x 
(94) 
20.89±4.66
b,x 
(31) 
  14.92±6.86
ab,x 
(13) 
 1.67±1.67
a,x 
(3) 
 100 Total 794    50.10±3.10    35.56±3.09     21.64±3.16      5.40±1.61 
 
 
 
 
P2 
11 Early  56  52.35±11.94
a,y 
(42) 
42.35±11.90
a,x 
(19) 
27.27±11.13
a,x 
(9) 
29.55±12.98
a,x 
(6) 
11 Mid  97 41.65±6.02
a,xy 
(44) 
71.59±24.99
a,x 
(28) 
37.80±12.60
a,x 
(14) 
28.79±12.73
a,x 
(6) 
11 Expanded 115   51.60±7.38
b,y 
(57) 
43.79±8.38
ab,x 
(28) 
40.91±12.02
ab,x 
(14) 
   18.18±10.16
a,x 
(5) 
11 Hatching 132   54.46±6.68
b,y 
(76) 
43.19±7.98
b,x 
(33) 
29.09±10.13
ab,x 
(12) 
   12.12±9.29
a,x 
(3) 
11 Hatched  70   24.02±6.99
b,x 
(29) 
  36.36±11.89
ab,x 
(15) 
15.15±10.41
ab,x 
(4) 
     4.55±4.55
a,x 
(1) 
  55 Total 1264   44.82±3.80   47.46±6.43  30.05±5.01    18.64±4.66 
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4.4  EFFECTS OF INNER CELL MASS ISOLATION TECHNIQUES,    
       CULTURE MEDIUM AND MOUSE EMBRYONIC FIBROBLAST     
       FREEZING ON PRODUCTION OF MURINE AND CAPRINE  
       EMBRYONIC STEM CELL LINES USING MOUSE EMBRYONIC  
       FIBROBLAST AS FEEDER CELL LAYER (EXPERIMENT 4) 
The objectives of this experiment were a) to determine the effects of blastocyst isolation 
techniques, b) culture medium and c) fresh and frozen-thawed mouse embryonic 
fibroblasts on production of murine and caprine embryonic stem cell lines using mouse 
embryonic fibroblasts as feeder cell layer. In murine species, a total of 6831 female 
murine (ICR: 2879, CBA/ca: 2093, C57BL/6J: 1859) have been used in this 
experiment. The total number of murine and caprine blastocyst used in this project were 
6831 and 169, respectively.   
 
4.4.1 Effects of Inner Cell Mass Isolation Techniques, Culture Medium and Mouse  
         Embryonic Fibroblast Freezing on Production of Murine Embryonic Stem  
         Cell Lines 
 
In Table 4.53 shows percent attachment of inner cell mass, primary inner cell mass 
outgrowth and successful consecutive passages of murine embryonic stem cell lines on 
3 different inner cell mass isolation techniques, namely whole blastocyst culture, 
manual cut and laser dissection. A total of 6831 murine blastocysts were used in this 
experiment consisting of 2438, 2062 and 2331 for whole blastocyst culture, manual cut 
and laser dissection techniques, respectively. There were significant differences 
(P<0.05) in percent attachment of inner cell mass for 3 different inner cell mass 
isolation techniques with the values of 66.52±2.18%, 78.03±0.94% and 71.06±1.11% 
for whole blastocyst culture, manual cut and laser dissection techniques, respectively. 
Manual cut inner cell mass isolation technique gave the highest percent primary 
outgrowth of inner cell mass with the values of 78.35±1.24%, followed by laser 
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dissection (75.67±0.85%) and whole blastocyst culture (75.32±1.73%). There was 
significant decrease in percent successful consecutive passages from Passages1, 2 and 3 
for 3 different inner cell mass isolation techniques. Figure 4.13 shows the 3 different 
inner cell mass isolation techniques with their ICM outgrowth. 
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Table 4.53: Percent attachment of inner cell mass, primary inner cell mass outgrowth and successful consecutive passages of murine embryonic stem  
                   cell lines (%, mean±SEM) on 3 different inner cell mass isolation techniques  
 
Isolation techniques No. of 
females 
No. of 
blastocysts 
Percent ICM 
attachment 
(n) 
Percent primary 
ICM outgrowth 
(n) 
Percent successful consecutive passages 
(n) 
     P1 
(n) 
P2 
(n) 
P3 
(n) 
Whole blastocyst 
culture 
 
241 2438 66.52±2.18
c,x 
(1565) 
75.32±1.73
d,xy 
(1167) 
72.51±2.25
cd,y 
(841) 
41.62±3.23
b,x 
(380) 
25.77±3.34
a,x 
(131) 
Manual cut 
 
494 2062 78.03±0.94
d,z 
(1624) 
78.35±1.24
d,y 
(1295) 
67.84±1.60
c,y 
(906) 
52.06±1.94
b,y 
(545) 
36.52±2.45
a,y 
(255) 
Laser dissection 
 
357 2331 71.06±1.11
d,y 
(1690) 
75.67±0.85
d,x 
(1275) 
58.75±2.25
c,x 
(843) 
45.06±2.35
b,x 
(457) 
30.49±2.52
a,xy 
(194) 
Total 1092 6831    72.97±0.79   75.67±0.85      65.70±1.19     47.23±1.39   31.96±1.57 
 
abcd 
Means with different superscripts in a row within a group were significantly different (P<0.05). 
xyz 
Means with different superscripts in a column within a group were significantly different (P<0.05). 
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Figure 4.13: A) Whole blastocyst culture, B) manual cut ICM and C) laser dissection   
              ICM isolation techniques with theirs ICM outgrowth shown by arrow. 
 
 
Three different pure-strains of murine and 3 different inner cell mass isolation 
techniques are shown in Table 4.54 with special reference to their percent attachment of 
inner cell mass, primary inner cell mass outgrowth and successful consecutive passages 
of murine embryonic stem cell lines. There were significant differences (P<0.05) in 
percent successful consecutive passages in 3 different inner cell mass isolation 
techniques in ICR strain with the values of 75.34±3.34% versus 43.86±4.99% versus 
22.86±4.31% (whole blastocyst culture); 72.36±1.46% versus 59.58±2.55% versus 
39.36±3.37% (manual cut) and 70.58±1.74% versus 52.95±2.02% versus 38.77±2.81% 
(laser dissection) for Passages 1, 2 and 3, respectively. Furthermore, C57BL/6J showed 
the highest inner cell mass attachment, primary inner cell mass outgrowth and 
consecutive passages of murine embryonic stem cells lines rates followed by ICR and 
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CBA/ca by manual cut isolation techniques. Similar as previous table shown, there was 
significant decrease in percent successful consecutive passages from Passages 1, 2 and 
3 for 3 different inner cell mass isolation techniques in 3 different pure-strains of 
murine.  
In Table 4.55 shows percent attachment of inner cell mass, primary inner cell 
mass outgrowth and successful consecutive passages of murine embryonic stem cells on 
2 different culture media, namely DMEM+10% FBS and αMEM+10% FBS and 3 
different inner cell mass isolation techniques. In percent attachment of inner cell mass, 
manual cut technique gave the highest attachment rate compared to laser dissection 
followed by whole blastocyst with the values of 77.92±1.41%, 69.68±1.53% and 
68.30±2.86% in DMEM+10% FBS culture medium, respectively. Manual cut always 
gave the highest percent successful consecutive passages of murine embryonic stem cell 
lines in both culture media. There was obviously significant decrease in percent 
successful consecutive passages from Passage 1 up to Passage 3 in both DMEM+10% 
FBS and MEM+10% FBS culture media.  
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Table 4.54: Percent attachment of inner cell mass, primary inner cell mass outgrowth and successful consecutive passages of murine embryonic stem  
                   cells (%, mean±SEM) derived from 3 different pure-strains of murine and 3 different inner cell mass isolation techniques 
 
Murine 
strains 
ICM 
isolation 
techniques 
No. of selected 
blastocysts 
Percent ICM 
attachment 
(n) 
Percent primary 
ICM outgrowth 
(n) 
Percent successful consecutive passages 
(n) 
 
 
    P1 
(n)
 
P2 
(n)
 
P3 
(n)
 
 
 
ICR 
Whole 
blastocyst 
971 81.05±1.88
c,y 
(777) 
79.05±2.54
c,x 
(606) 
75.34±3.34
c,x 
(444)
 
43.86±4.99
b,x 
(207)
 
22.86±4.31
a,x 
(71)
 
Manual cut 725 80.60±1.37
d,y 
(583)
 
78.80±1.21
d,x 
(463)
 
72.36±1.46
c,x 
(340)
 
59.58±2.55
b,y 
(212)
 
39.36±3.37
a,y 
(96)
 
Laser 
dissection 
1183 73.24±1.54
c,x 
(862)
 
75.89±1.48
c,x 
(659)
 
70.58±1.74
c,x 
(459)
 
52.95±2.02
b,y 
(250)
 
38.77±2.81
a,y 
(107)
 
Total  2879     77.82±0.97       77.72±1.00       72.50±1.26       52.52±1.88     34.47±2.06 
 
 
 
CBA/ca 
Whole 
blastocyst 
758 55.83±2.81
b,x 
(429)
 
74.22±2.30
c,y 
(315)
 
74.21±3.15
c,z 
(237)
 
43.69±2.61
a,y 
(109)
 
34.74±6.16
a,y 
(38)
 
Manual cut 722 70.25±1.32
d,z 
(516)
 
68.88±2.24
d,y 
(365)
 
56.56±3.25
c,y 
(203)
 
35.21±3.14
b,y 
(84)
 
24.59±4.61
a,y 
(26)
 
Laser 
dissection 
613 64.29±2.11
d,y 
(413)
 
57.26±2.70
d,x 
(258)
 
32.38±4.11
b,x 
(118)
 
18.20±4.46
b,x 
(40)
 
7.80±3.62
a,x 
(8)
 
Total  2093     65.72±1.19       66.18±1.59       52.12±2.62        31.54±2.34     21.14±2.96 
 
 
 
C57BL/6J 
 
Whole 
blastocyst 
709 48.96±2.54
bc,x 
(359)
 
69.17±3.81
d,x 
(246)
 
65.30±4.99
cd,x 
(160)
 
35.19±7.88
ab,x 
(64)
 
22.46±8.02
a,x 
(22)
 
Manual cut 615 84.51±1.36
d,z 
(525)
 
88.73±1.38
d,y 
(467)
 
76.50±1.82
c,y 
(363)
 
63.91±2.47
b,y 
(249)
 
47.47±3.64
a,y 
(133)
 
Laser 
dissection 
535 74.51±1.86
c,y 
(415)
 
83.33±1.94
d,y 
(358)
 
66.76±2.87
bc,x 
(266)
 
59.91±2.71
b,y 
(167)
 
40.42±5.16
a,y 
(79)
 
Total  1859     74.18±1.72       83.08±1.40       71.07±1.68       56.91±2.40     40.20±3.02 
 
                abcd Means with different superscripts in a row within a group were significantly different (P<0.05). 
             xyz 
Means with different superscripts in a column within a group were significantly different (P<0.05). 
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Table 4.55: Percent attachment of inner cell mass, primary inner cell mass outgrowth and successful consecutive passages of murine  
                               embryonic stem cells (%, mean±SEM) on 2 different culture media using 3 different inner cell mass isolation techniques 
 
Culture medium ICM 
isolation 
techniques 
No. of 
blastocysts 
Percent ICM 
attachment 
(n) 
Percent 
primary ICM 
outgrowth 
(n) 
Percent successful consecutive passages 
(n) 
 
 
    P1 
(n)
 
P2 
(n)
 
P3 
(n)
 
 
 
DMEM+10% FBS 
Whole 
blastocyst 
1398 68.30±2.86
c,x 
(894) 
74.81±2.47
c,xy 
(663) 
74.56±3.28
c,z 
(492)
 
42.71±4.43
b,x 
(241)
 
27.98±4.62
a,x 
(95)
 
Manual 
cut 
1127 77.92±1.41
d,y 
(890)
 
78.68±1.92
d,y 
(719)
 
65.26±2.52
c,y 
(494)
 
55.01±2.70
b,y 
(315)
 
35.66±3.30
a,x 
(153)
 
Laser 
dissection 
1146 69.68±1.53
d,x 
(823)
 
68.91±2.36
d,x 
(605)
 
55.66±3.67
c,x 
(404)
 
42.57±3.76
b,x 
(220)
 
28.57±3.76
a,x 
(88)
 
Total  3671  72.90±1.10  74.59±1.31  64.48±1.87  47.93±2.05  31.49±2.19 
 
 
αMEM+10% FBS 
Whole 
blastocyst 
1040 64.23±3.37
c,x 
(671)
 
75.98±2.41
d,x 
(504)
 
69.86±2.93
cd,y 
(349)
 
40.22±4.75
b,x 
(139)
 
22.91±4.81
a,x 
(36)
 
Manual 
cut 
935 78.16±1.23
d,z 
(734)
 
77.98±1.52
d,x 
(576)
 
70.76±1.83
c,y 
(412)
 
49.61±2.70
b,x 
(230)
 
37.49±3.69
a,y 
(102)
 
Laser 
dissection 
1185 72.30±1.58
d,y 
(867)
 
76.82±1.04
d,x 
(670)
 
61.51±2.69
c,x 
(439)
 
47.29±2.93
b,x 
(237)
 
32.21±3.41
a,xy 
(106)
 
Total  3160  73.05±1.12  76.82±1.04   67.02±1.45  46.79±1.86 32.47±2.26 
 
abcd 
Means with different superscripts in a row within a group were significantly different (P<0.05). 
xyz 
Means with different superscripts in a column within a group were significantly different (P<0.05). 
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In Table 4.56 shows the percent successful attachment of inner cell mass and 
consecutive passages of murine embryonic stem cell lines based on 3 different inner cell 
mass isolation techniques on fresh and frozen-thawed mouse embryonic fibroblasts. In 
fresh mouse embryonic fibroblast, there were no significant differences (P>0,05) for 3 
different inner cell mass isolation techniques with the values of 79.05±2.54%, 
78.80±1.21% and 75.89±1.48% for whole blastocyst culture, manual cut and laser 
dissection techniques, respectively. There were significantly different (P<0.05) between 
whole blastocyst culture and manual cut as well as laser dissection in frozen-thawed 
mouse embryonic fibroblast with the values of 52.39±1.95% versus 76.92±1.20% 
versus 74.51±1.86%, repsectively. There were no significant differences (P>0.05) at 
Passage 1 (P1) murine embryonic stem cell lines for both fresh and frozen-thawed 
mouse embryonic fibroblast for 3 different inner cell mass isolation techniques. 
However, there were significantly different (P<0.05) in inner cell mass attachment and 
primary inner cell mass outgrowth rates between whole blastocyst culture and manual 
cut as well as laser dissection in frozen-thawed mouse embryonic fibroblast whereby 
the laser dissection isolation techniques gave higher primary inner cell mass outgrowth 
rate (83.33±1.94%) followed by manual cut (78.16±1.70%) and whole blastocyst 
culture (71.69±2.24%) techniques in frozen-thawed mouse embryonic fibroblasts. Also, 
laser dissection technique gave the higher passages of murine embryonic stem cell lines 
at Passages 2 and 3 compared with manual cut and whole blastocyst culture techniques. 
Figure 4.14 shows the development of murine embryonic stem cell from primary sub-
cultured up to Passage 3 and embryonic stem cell colonies obtained. Differentiated 
murine embryonic stem cells with outgrowth of differentiated cells surrounding the 
inner cell mass is shown in Figure 4.15. 
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Table 4.56: Percent successful attachment of inner cell mass and consecutive passages of murine embryonic stem cell lines (%, mean±SEM) based on  
                   3 different inner cell mass isolation techniques on fresh and frozen-thawed mouse embryonic fibroblasts 
 
MEF ICM 
isolation 
techniques 
No. of 
blastocysts 
Percent ICM 
attachment 
(n) 
Percent primary 
ICM outgrowth 
(n) 
Percent successful consecutive passage 
(n) 
 
 
    P1 
(n)
 
P2 
(n)
 
P3 
(n)
 
 
 
Fresh MEF 
Whole 
blastocyst 
971 81.05±11.10
c,y 
(777) 
79.05±2.54
c,x 
(606) 
75.34±3.34
c,x 
(444)
 
43.86±4.99
b,x 
(207)
 
22.86±4.31
a,x 
(71)
 
Manual cut 725 80.60±1.37
d,y 
(583)
 
78.80±1.21
d,x 
(463)
 
72.36±1.46
c,x 
(340)
 
59.58±2.55
b,y 
(212)
 
39.36±3.37
a,y 
(96)
 
Laser 
dissection 
1183 73.24±1.54
c,x 
(862)
 
75.89±1.48
c,x 
(659)
 
70.58±1.74
c,x 
(459)
 
52.95±2.02
b,y 
(250)
 
38.77±2.81
a,y 
(107)
 
Total  2879   77.82±0.97   77.72±1.00   72.50±1.26   52.52±1.88   34.47±2.06 
 
 
 
Frozen-thawed 
MEF 
Whole 
blastocyst 
1467 52.39±1.95
a,x 
(788)
 
71.69±2.24
d,x 
(561)
 
69.75±3.00
d,x 
(397)
 
39.44±4.15
b,x 
(173)
 
28.60±5.09
a,x 
(60)
 
Manual cut 1337 76.92±1.20
d,y 
(1041)
 
78.16±1.70
d,y 
(832)
 
65.88±2.18
c,x 
(566)
 
48.77±2.49
b,x 
(333)
 
35.29±3.20
a,x 
(159)
 
Laser 
dissection 
1148 74.51±1.86
c,y 
(828)
 
83.33±1.94
d,y 
(616)
 
66.76±2.87
bc,x 
(384)
 
59.91±2.71
b,y 
(207)
 
40.42±5.16
a,x 
(87)
 
Total  3952   70.87±1.20   77.67±1.21   66.93±1.54   48.77±1.87   34.74±2.41 
 
abcd 
Means with different superscripts in a row within a group were significantly different (P<0.05). 
xy 
Means with different superscripts in a column within a group were significantly different (P<0.05). 
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Figure 4.14: a) Blastocyst without the zona pellucida. b) Attachment and primary  
                         outgrowth of ICM at day 3. c) Primary ICM outgrowth was sub- 
                         cultured by 0.05% trypsin/EDTA (Passage 1). d) Passage 2 of murine  
                         embryonic stem cell was sub-cultured by manual dissociation before  
                         differentiation occurred. e) Undifferentiated murine embryonic stem  
                         cells at Passage 3 with the sharp and clear edge as well as dome-shape                          
                         f) Embryonic stem cell colonies obtained. Arrow: inner mass (ICM).    
                          
 
 
 
 
 
          Figure 4.15: Differentiated murine embryonic stem cells with outgrowth of              
                               differentiated cells surrounding the inner cell mass. 
Giant cell 
(differentiated cell) 
ICM  
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4.4.2 Effects of Caprine Blastocyst Isolation Techniques, Culture Medium and  
         Mouse Embryonic Fibroblasts Freezing on Production of Caprine Embryonic  
         Stem Cell Lines 
 
A total of 169 caprine blastocysts were used as a source of inner cell mass isolation for 
production of caprine embryonic stem cell lines. Percent attachment of caprine inner 
cell mass, primary inner cell mass outgrowth and successful consecutive passages 
caprine embryonic stem cell lines on whole blastocyst culture, manual cut and laser 
dissection techniques are shown in Table 4.57. There were no significant differences 
(P>0.05) in percent attachment of inner cell mass and primary inner cell mass 
outgrowth for 3 different inner cell mass isolation techniques with the values of 
62.92±6.65%, 74.36±7.45% and 74.00±7.25% as well as 83.33±8.33%, 71.60±7.49% 
and 80.44±7.68%, respectively. However, manual cut technique shows the highest 
percent attachment of inner cell mass, followed by laser dissection and whole blastocyst 
culture with the values of 74.36±7.45%, 74.00±7.25% and 62.92±6.65%, respectively. 
In percent successful consecutive passages of caprine embryonic stem cell lines, manual 
cut technique always show the highest percent passages compared to laser dissection 
and whole blastocyst culture techniques. Morphology of primary outgrowth of caprine 
inner cell mass is shown in Figure 4.16. 
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Table 4.57: Percent attachment of inner cell mass, primary inner cell mass outgrowth and successful passages of caprine embryonic stem cell lines  
       (%, mean±SEM) on 3 different inner cell mass isolation techniques  
 
Isolation techniques No. of 
replicates 
No. of 
blastocysts 
Percent ICM 
attachment 
(n) 
Percent primary 
ICM outgrowth 
(n) 
Percent successful consecuitve passages 
(n) 
     P1 
(n) 
P2 
(n) 
P3 
(n) 
Whole blastocyst 
culture 
 8 26 62.92±6.65
bc,x 
(16) 
83.33±8.33
c,x 
(13) 
39.58±12.96
ab,x 
(6) 
22.90±13.00
ab,x 
(3) 
12.50±12.50
a,x 
(1) 
Manual cut 
 
22 90 74.36±7.45
b,x 
(79) 
71.60±7.49
b,x 
(68) 
71.28±9.00
b,y 
(59) 
46.44±9.19
a,x 
(43) 
35.04±9.05
a,x 
(25) 
Laser dissection 
 
15 53 74.00±7.25
cd,x 
(42) 
80.44±7.68
d,x 
(34) 
43.89±7.39
ab,xy 
(19) 
30.00±6.10
bc,x 
(13) 
12.20±4.90
a,x 
(5) 
Total 45 169    72.20±4.50    76.63±4.68    56.52±5.85    45.30±6.40   27.13±5.91 
 
abcd 
Means with different superscripts in a row within a group were significantly different (P<0.05). 
xy 
Means with different superscripts in a column within a group were significantly different (P<0.05). 
 
* Caprine blastocysts derived from both in vivo and in vitro sources of blastocyst.  
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        Day after whole blastocyst culture/manual cut/laser dissection ICM isolation 
        Day 0     Day 5    Day 12         Day 3 (P1)                 Day 3 (P2)  Day 3 (P3) 
 
                                            
Figure 4.16:  Morphology of primary outgrowth of caprine ICM development after (day 0 to day 12). On day 12, the primary ICM  
                     outgrowth was subcultured by 0.05% trypsin/EDTA but the later passages were performed by manual dissociation. 
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Table 4.58: Percent attachment of inner cell mass, primary inner cell mass outgrowth and successful consecutive passages of caprine                   
                   embryonic stem cell lines (%, mean±SEM) on 2 different culture  media 
 
Isolation techniques No. of 
replicates 
No. of 
blastocysts 
Percent ICM 
attachment 
(n) 
Percent primary 
ICM outgrowth 
(n) 
Percent successful consecutive passages 
(n) 
     P1 
(n) 
P2 
(n) 
P3 
(n) 
DMEM+10% FBS 22 65 79.02±7.01
c,x 
(55) 
82.12±6.57
c,x 
(48) 
67.65±7.86
bc,x 
(37) 
48.11±7.52
ab,x 
(23) 
32.58±9.14
a,x 
(12) 
αMEM+10% FBS 
 
23 104 65.69±5.51
bc,x 
(82) 
71.39±6.60
c,x 
(67) 
45.87±8.18
b,x 
(47) 
42.61±10.39
ab,x 
(36) 
21.92±7.62
a,x 
(19) 
Total 45 169   72.20±4.50   76.63±4.68     56.52±5.85    45.30±6.40   27.13±5.91 
 
abc 
Means with different superscripts in a row within a group were significantly different (P<0.05). 
x 
Means with same superscripts in a column within a group were significantly different (P>0.05). 
 
2
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Table 4.58 shows percent attachment of inner cell mass, primary inner cell mass 
outgrowth and successful consecutive passages of caprine embryonic stem cell lines on 
2 different culture media, namely DMEM+10% FBS and αMEM+10% FBS. A total of 
45 replicates were carried out which 22 replicates for DMEM+10% FBS and 23 
replicates for αMEM+10% FBS. 169 total of caprine blastocyst were used to determine 
the quality of caprine embryonic stem cell lines in 2 different culture media. There were 
no significant differences (P>0.05) in percent attachment of inner cell mass, primary 
inner cell mass outgrowth, successful consecutive passages from Passage 1 up to 
Passage 3. However, DMEM+10% FBS culture medium gave higher percent 
attachment of inner cell mass, primary inner cell mass outgrowth, successful 
consecutive passages than αMEM+10% FBS culture medium.  
In Tables 4.59, 65 and 104 number of caprine blastocyst were used for 
DMEM+10% FBS and αMEM+10% FBS in this experiment.  Manual cut technique 
always show the highest percent attachment of blastocysts, primary outgrowth inner cell 
mass and successful consecutive passages caprine embryonic stem cell lines in both 
DMEM+10% FBS and αMEM+10% FBS culture media compared to whole blastocyst 
culture and laser dissection techniques. However, there were no significant differences 
(P>0.05) in percent attachment of inner cell mass, primary inner cell mass outgrowth, 
and consecutive passages caprine embryonic stem cell lines in both culture media.  
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Table 4.59: Percent attachment of inner cell mass, primary inner cell mass outgrowth and successful consecutive passages of caprine embryonic  
                   stem cells (%, mean±SEM) on 2 different culture media using 3 different inner cell mass isolation techniques 
 
Culture medium No. of 
replicates 
ICM 
isolation 
techniques 
No. of 
blastocysts 
Percent ICM 
attachment 
(n) 
Percent 
primary ICM 
outgrowth 
(n) 
Percent successful consecutive passages 
(n) 
 
 
     P1 
(n)
 
P2 
(n)
 
P3 
(n)
 
 
 
DMEM+10%FBS 
 5 Whole 
blastocyst 
  25 60.67±10.98
bc,x 
(24) 
93.33±6.67
c,x 
(22) 
53.33±16.16
b,x 
(21)
 
30.00±20.00
ab,x 
(15)
 
0.00±0.00
a,x 
(11)
 
10 Manual 
cut 
  17 87.50±10.03
a,x 
(10)
 
85.00±10.08
a,x 
(9)
 
88.00±9.98
a,x 
(5)
 
64.17±9.94
a,x 
(2)
 
66.67±12.91
a,y 
(0)
 
7 Laser 
dissection 
  23 80.00±14.47
c,x 
(21)
 
70.00±13.97
bc,x 
(17)
 
48.81±12.66
bc,x 
(11)
 
38.10±101.0
ab,x 
(6)
 
7.14±7.14
a,x 
(1)
 
Total 22    65 79.02±7.01 82.12±6.57 67.65±7.86 48.11±7.52 32.58±9.14 
 
 
αMEM+10%FBS 
 3 Whole 
blastocyst 
  65 66.67±0.00
a,x 
(55)
 
66.67±16.67
a,x 
(46)
 
16.67±16.67
a,x 
(38)
 
33.33±33.33
a,x 
(28)
 
33.33±33.33
a,x 
(14)
 
12 Manual 
cut 
   9 63.40±10.00
b,x 
(6)
 
60.44±10.11
b,x 
(4)
 
57.35±13.29
b,x 
(1)
 
31.67±13.59
ab,x 
(1)
 
8.68±5.86
a,x 
(1)
 
 8 Laser 
dissection 
  30 68.75±5.62
ab,x 
(30)
 
89.58±7.00
b,x 
(17)
 
 39.58±8.87
a,x 
(8)
 
62.50±18.30
ab,x 
(7)
 
37.50±15.67
a,x 
(4)
 
Total 23  104  65.69±5.51  71.39±6.60  45.87±8.18 42.61±10.39 21.92±7.62 
 
      abc 
Means with different superscripts in a row within a group were significantly different (P<0.05). 
      x 
Means with same superscripts in a column within a group were significantly different (P>0.05). 
 
3
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Table 4.60 shows the percent attachment of inner cell mass, primary inner cell mass 
outgrowth and successful consecutive passages of caprine embryonic stem cell lines on 
fresh and frozen-thawed mouse embryonic fibroblast. A total of 169 number of 
blastocysts were used in fresh (98) and frozen-thawed (71) mouse embryonic fibroblast 
in this experiment. There were no significant differences (P>0.05) in percent attachment 
of inner cell mass, primary inner cell mass outgrowth, successful consecutive passages 
of caprine embryonic stem cell lines for fresh and frozen-thawed mouse embryonic 
fibroblast. However, fresh mouse embryonic fibroblast gave higher percent attachment 
of inner cell mass, primary inner cell mass outgrowth and successful consecutive 
passages up to Passage 3 (P3) than frozen-thawed mouse embryonic fibroblast with the 
values of 79.53±6.38% versus 63.04±5.7%, 80.27±6.09% versus 72.10±7.31%, 
63.53±7.99% versus 47.75±8.37%, 46.33±7.45% versus 44.00±11.20% and 
28.67±8.31% versus 25.21±8.54%, respectively.  
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Table 4.60: Percent attachment of inner cell mass, primary inner cell mass outgrowth and successful consecutive passages of caprine embryonic stem  
                   cell lines (%, mean±SEM) on fresh and frozen-thawed mouse embryonic fibroblasts 
 
MEF No. of 
replicates 
No. of 
blastocysts 
Percent ICM 
attachment 
(n) 
Percent primary 
ICM outgrowth 
(n) 
Percent successful consecutive passages 
(n) 
     P1 
(n) 
P2 
(n) 
P3 
(n) 
Fresh MEF 20 98 79.53±6.38
c,x 
(77) 
80.27±6.09
c,x 
(64) 
 63.53±7.99
bc,x 
(46) 
  46.33±7.45
ab,x 
(35) 
28.67±8.31
a,x 
(19) 
Frozen-thawed MEF 
 
25 71 63.04±5.76
bc,x 
(60) 
72.10±7.31
c,x 
(51) 
47.75±8.37
abc,x 
(38) 
44.00±11.20
ab,x 
(24) 
25.21±8.54
a,x 
(12) 
Total 45 169   72.20±4.50   76.63±4.68  56.52±5.85   45.30±6.40   27.13±5.91 
 
abc 
Means with different superscripts in a row within a group were significantly different (P<0.05). 
x 
Means with same superscripts in a column within a group were significantly different (P>0.05). 
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A total of 45 replicates have been carried with 20 replicates for fresh mouse embryonic 
fibroblast and 25 replicates for frozen-thawed mouse embryonic fibroblasts in this 
experiment as shown in Table 4.60. Out of 9 (whole blastocyst culture), 59 (manual cut) 
and 30 (laser dissection) number of caprine blastocyst have been cultured on fresh 
mouse embryonic fibroblast (Table 4.61). There were no significant differences 
(P>0.05) in percent attachment of inner cell mass and primary caprine inner cell mass 
outgrowth on fresh mouse embryonic fibroblast for 3 different inner cell mass isolation 
with represented values of 66.67±0.00% versus 56.76±11.89% versus 68.75±5.62% for 
percent attachment of caprine blatocysts and 65.67±16.67% versus 56.36±12.74% 
versus 59.58±7.00% for primary outgrowth of caprine inner cell mass, respectively. 
There were also no significant differences (P>0.05) in percent attachment of inner cell 
mass, primary inner cell mass outgrowth and passage caprine embryonic stem cell lines 
up to Passage 2 on frozen-thawed mouse embryonic fibroblast cultured for 3 different 
inner cell mass isolation techniques.     
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Table 4.61: Percent successful attachment of inner cell mass, primary inner cell mass outgrowth and consecutive passages of caprine embryonic stem  
                   cells (%, mean±SEM) derived from 3 different inner cell mass isolation techniques using 5 different blastocyst stages 
 
MEF No. of 
replicates 
ICM 
isolation 
techniques 
No. of 
blastocysts 
Percent ICM 
attachment 
(n) 
Percent primary 
ICM outgrowth 
(n) 
Percent successful consecutive passages 
(n) 
 
 
     P1 
(n)
 
P2 
(n)
 
P3 
(n)
 
 
 
Fresh MEF 
 3 Whole 
blastocyst 
  9 66.67±0.00
a,x 
(6) 
65.67±16.67
a,x 
  (4) 
46.67±16.67
a,x 
(1)
 
  33.33±33.33
a,x 
(1)
 
33.33±33.33
a,x 
(1)
 
 9 Manual cut 59 56.76±11.89
b,x 
(50)
 
56.36±12.74
b,x 
(43)
 
55.36±14.11
b,y 
(37)
 
  31.11±15.67
ab,x 
(27)
 
  11.57±7.66
a,x 
(14)
 
 8 Laser 
dissection 
30 68.75±5.62
ab,x 
(21)
 
59.58±7.00
b,x 
(17)
 
39.58±8.87
a,xy 
(8)
 
62.50±18.30
ab,x 
(7)
 
37.50±15.67
a,x 
(4)
 
Total 20  98   79.53±6.38   80.27±6.09   63.53±7.99   46.33±7.45   28.67±8.31 
 
 
 
Frozen-thawed 
MEF 
 5 Whole 
blastocyst 
17   70.67±10.98
c,x 
(10)
 
63.33±6.67
bc,x 
(9)
 
53.33±16.16
b,x 
(5)
 
30.00±20.00
ab,x 
(2)
 
0.00±0.00
a,x 
(0)
 
13 Manual cut 31    86.54±8.31
b,x 
(29)
 
80.77±8.62
ab,x 
(25)
 
75.38±12.02
ab,x 
(22)
 
57.05±10.67
ab,x 
(16)
 
51.28±12.72
a,y 
(11)
 
 7 Laser 
dissection 
23 80.00±14.47
c,x 
(21)
 
 70.00±13.97
bc,x 
(17)
 
48.81±12.66
bc,x 
(11)
 
38.10±10.10
ab,x 
(6)
 
7.14±7.14
a,x 
(1)
 
Total 25  71    63.04±5.76    72.10±7.31    47.75±8.37  44.00±11.20  25.21±8.54 
 
abc 
Means with different superscripts in a row within a group were significantly different (P<0.05). 
xy 
Means with different superscripts in a column within a group were significantly different (P<0.05). 
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Comparison between in vivo and in vitro caprine blastocysts sources are shown in Table 
4.62. There was highly significant differences (P<0.05) between in vivo and in vitro 
derived blastocyst sources in percent caprine embryonic stem cell lines Passages 1 and 
3 with the values of  95.00±5.00% versus 52.76±6.10% and 79.20±12.50% versus 
20.83±5.53%, respectively. There were highly significant differences (P<0.05) between 
in vivo-derived blastocysts and in vitro-derived blastocysts whereby the percent 
attachment of inner cell mass, primary inner cell mass outgrowth and consecutive 
caprine embryonic stem cell lines passages were higher in the former with the values of 
100.00±0.00% versus 69.49±4.73%, 87.50±7.98% versus 75.57±5.06%, 95.00±5.00% 
versus 52.76±6.10%, 81.25±11.97% versus 41.79±6.70% and 79.20±12.50% versus 
20.83±5.53%, respectively. 
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Table 4.62: Percent successful attachment of inner cell mass and consecutive passages of caprine embryonic stem cells (%, mean±SEM)            
                   derived from in vivo and in vitro sources of blastocyst 
 
Treatment No. of 
replicates 
No. of 
blastocysts 
Percent ICM 
attachment 
(n) 
Percent 
primary ICM 
outgrowth 
(n) 
Percent successful consecutive passages 
(n) 
 
 
    P1 
(n)
 
P2 
(n)
 
P3 
(n)
 
In vivo 
 
 4   13 100.00±0.00
a,x 
(13) 
87.50±7.98
a,x 
(11) 
95.00±5.00
a,y 
(10)
 
81.25±11.97
a,x 
(8)
 
79.20±12.50
a,y 
(7)
 
In vitro* 41 156 69.49±4.73
c,x 
(124)
 
75.57±5.06
c,x 
(104)
 
52.76±6.10
b,x 
(74)
 
 41.79±6.70
b,x 
(51)
 
20.83±5.53
a,x 
(24)
 
Total 45 169  72.20±4.50  76.63±4.68  56.52±5.85  45.30±6.40  34.74±2.41 
 
abc 
Means with different superscripts in a row within a group were significantly different (P<0.05). 
xy 
Means with different superscripts in a column within a group were significantly different (P<0.05). 
 
*In vitro included somatic cell nuclear transfer and parthenogenesis treatments. 
3
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4.5 CONFIRMATION OF CAPRINE AND MURINE EMBRYONIC STEM  
      CELLS BY IMMUNOFLUORESCENT STAINING PROTEIN MARKERS       
      (EXPERIMENT 5) 
 
4.5.1 Confirmation of Murine Embryonic Stem Cells by Specific Embryonic Stem  
         Cell Markers  
 
Embryonic stem cells protein markers (immunofluorescent staining) were used in 
determining the embryonic stem cells formation. Specific embryonic stem cell markers 
were found in murine embryonic stem cells such as Oct 4 (green) and SSEA 1(green) in 
this experiment. There were no colour shown for TRA-1-60 and TRA-1-81 embryonic 
stem cell markers in murine species (Figure 4.17). Therefore, it indicated the presence 
of embryonic stem cells in murine species. Alkaline phosphatase staining was carried 
out to determine the alkaline phosphatase activities that found in the murine embryonic 
stem cell lines. Purplish colour was shown in murine embryonic stem cells after 
underwent alkaline phosphatase staining. It confirmed the presence of true murine 
embryonic stem cells which showed alkaline phosphatase activities.  
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Figure 4.17: Murine embryonic stem cells were confirmed by the expression of murine  
                    specific embryonic stem cell markers (Oct 4, SSEA 1) and human  
                    embryonic stem cell specific markers (TRA-1-60 and TRA-1-81) as      
                    negative control. Transmission light images and Hoechst DNA staining  
                    were showed in the first and second column. The alkaline phosphatase  
                    activities were positive and showed in the bottom line of the picture.  
 
4.5.2 Confirmation of Caprine Embryonic Stem Cells by Specific Embryonic Stem  
         Cell Markers  
 
Embryonic stem cell markers used in caprine embryonic stem cells in this experiment 
were Oct 4 (green) and SSEA 1(green) (Figure 4.18). It indicates the presence of 
embryonic stem cells in caprine species. Alkaline phosphatase staining was carried out 
to determine the alkaline phosphatase activities that found in the caprine embryonic 
stem cell lines.  Purplish colour was shown in caprine embryonic stem cells after 
underwent alkaline phosphatase staining. It was confirmed that by alkaline phosphatase 
activities indicating the presence of caprine embryonic stem cells.  
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 Figure 4.18: Caprine embryonic stem cells were confirmed by the expression of  
                      caprine specific embryonic stem cell markers that is Oct 4 (red) and  
                      SSEA3 (green). The alkaline phosphatase activities were shown in caprine   
                      embryonic stem cells which gave purplish colour for alkaline phosphatase  
                      staining.  
 
 
Table 4.63: Summarised results in comparison between murine and caprine embryonic  
                   stem cells  
 
Pluripotent markers  Murine 
embryonic stem cells 
 Caprine 
embryonic stem cells 
AP  +  + 
SSEA-1  +  - 
SSEA-3  -  + 
SSEA-4  -  - 
TRA-1-60  -  - 
TRA-1-81  -  - 
Oct-4  +  + 
Feeder cell  Need  Need 
Cytokine factor control 
self-renew  
LIF and some growth 
factors that work through 
GP130 receptor 
 LIF and some growth 
factors that work through 
GP130 receptor 
Morphology of 
undifferentiated colony  
Multi layers clump, dome 
shape, clear edge 
 Mono layer clump, loose, 
flat colony 
 
 
 
AP Oct 4 
SSEA-3, 4 
ICM 
SSEA 3 
ICM 
10 
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Chapter 5 
5.0 DISCUSSION 
 
5.1 ESTABLISHMENT OF MOUSE EMBRYONIC FIBROBLAST AS FEEDER  
      CELLS FOR PRODUCTION OF MURINE EMBRYONIC STEM CELL  
      LINES (EXPERIMENT 1)  
In order to produce murine embryonic stem cells (mESC), source from a large number 
of blastocysts is very important. In this experiment, 3 sub-topics are discussed including 
a) effects of murine pure-strain on superovulation responses, b) effects of murine source 
on the percent cleavage for the production of blastocyst (such as in vivo oviduct or 
uterine flushing; in vitro-derived blastocyst through somatic cell nuclear transfer) and c) 
effects of 3 different pure-strain of murine for mouse embryonic fibroblast (MEF) cell 
lines on murine embryonic stem cell lines performance by looking into freezing of 
mouse embryonic fibroblast (P1 and P2), mouse embryonic fibroblast passages numbers 
(P0, P1, P2 and P3) and culture media (DMEM and αMEM).  
 
5.1.1 Effects of Murine Pure-strain on Superovulation Responses  
Superovulation was required to obtain a large number of blastocysts for embryonic stem 
cell (ESC) culture. Ideal strain of murine should be the one that produces a large 
amount of normal oocytes or embryos after superovulation which will successfully 
develop to the blastocysts stage. Sato et al. (2007) reported that 2 different strains of 
murine (ICR and BDF) were superovulated with large amount gonadotrophins to induce 
maturation of murine oocytes. The impact of exogenous stimulation with increasing 
amounts of gonadotrophins on the number and quality of oocytes per pre-embryos 
recovered from outbred BALB/c murine was investigated by Ozgunen et al. (2001). By 
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selecting the suitable strain of murine, embryonic stem cell lines can be produced more 
efficiently. A poor choice of strain will result in low efficiency and quality of 
embryonic stem cell lines derived, thus wasting resources. Superovulated mature 
females were found to be lower responders than were superovulated prepubescent 
murine (Ozgunen et al., 2001).  
In present study, the performance of superovulation using pregnant mare’s 
serum gonadotrophin (PMSG) and human chorionic gonadotrophin (hCG) treatments in 
3 pure-strains murine (ICR, CBA/ca and C57BL/6J) gave the percentages of successful 
superovulation ranging from 65-77% (P>0.05). This is in agreement with the findings of 
Goh and Abdullah (2008). However, the success rates of superovulation of 3 strains 
were considered low when compared to previous findings in ABEL laboratory (Goh and 
Abdullah, 2008). Superovulation with hormones is widely used to increase the number 
of embryos per female, consequently reduces the number of murine used in experiments. 
However, the efficacy of exogenous stimulation varies with the strain, age, nutritional 
status and health, breeding-housing conditions of a female murine, and the dose of 
administered gonadotrophins (Licht et al., 1979; Hogan et al., 1986). In present study, 
the possible factors that could be explained for the reduction in the superovulation 
response could be due to poor health condition and significant death of the murine that 
might be related to the unavoidable transfer of murine to a new animal house. Other 
factors could be the efficacy of new batch of gonadotrophins used that was often 
resulted in superovulation responses variation and the intraperitoneal gonadotrophin 
injection technique as well as unskillful embryo flushing by the personnel (Ainul 
Bahiyah et al., 2010).  
In addition, oestrous cycle of the murine during which the gonadotrophin 
injection is made may affect the success rate of superovulation. In present study, 
injections of gonadotrophins were done without taking into account the oestrous stage 
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of the murine. Some researchers reported no successful superovulation when pregnant 
mare’s serum gonadotrophin was injected during the dioestrous stage of murine 
(Edwards and Fowler, 1960); while others have reported success but with lower number 
of embryos (Redina et al., 1994). Both findings agree that the oestrous cycle stage of 
the murine has significant influence affecting the success rate of superovulation and 
suggest the optimum time of gonadotrophin injection is during the dioestrous stage. 
Age of the murine also is one of the factors that determine the success of 
superovulation. As reported in the literature, the recommended age for superovulation 
usually falls between 3 and 5 weeks during the prepubescent stage to produce the 
highest number of oocytes (Hogan et al., 1986). At the other end of the spectrum, using 
older murine, especially above 10 weeks of age may produce lower amount of embryos. 
Another factor affecting the performance of superovulation in murine is the 
strain or genetic background of the species. Ozgunen et al. (2001) strongly suggested 
that very high doses of hormone must be avoided in the prepubescent BALB/c murine 
in order to prevent increased numbers of degenerated or parthenogenetic oocytes. 
Therefore, these factors that influence the number and quality of superovulated oocytes 
must be optimised for any given strain of murine. For example, both CBA/ca and 
C57BL/6J murine were classified by Hogan et al. (1986) as high ovulators, while other 
strains such as A/J and BALB/cJ were considered low ovulators. This may due to the 
variations in the different murine strains have different natural gonadotrophin levels and 
number of ovarian luteinising hormone (LH) receptors available for stimulation 
(DeLeon et al., 1990).  
 Although there were no significant differences (P>0.05) between number of 2-
cell embryos and blastocyts per female, the number of 2-cell stage embryos and 
blastocyts embryos obtained per female were highest in CBA/ca, followed by ICR and 
C57BL/6J. This may be attributed to both the quality of the oocytes and also the quality 
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of sperm from the male studs of each murine strain. There were significant differences 
(P<0.05) in number of oocytes for ICR and CBA/ca with C57BL/6J. This may be due to 
the strains or genetic background whereby, for example, BALB/c females were reported 
to be a difficult strain to work with in superovulation (Hogan et al., 1986). The results 
of this study showed that C57BL/6J is less suitable as a source of blastocysts due to the 
lowest rate of superovulation compared to other strains and lowest number of 2-cell 
embryos as well as blastocysts obtained. CBA/ca may provide blastocysts of better 
quality as high number of blastocysts obtained.  
The number superovulated oocytes varies depending on strain among inbred 
murine, however, sufficient numbers of oocytes and embryos for practical and research 
use could be easily obtained. Researchers often encounter difficulty obtaining sufficient 
numbers of oocytes and embryos from laboratory rats due to their limited responses to 
superovulatory treatment. Various methods, such as combination of pregnant mare’s 
serum gonadotrophin-human chorionic gonadotrophin injection regime used in murine 
(Zarrow and Wilson, 1961; Wilson and Zarrow, 1962; Miller and Armstrong, 1981a, 
1981b; Mukumoto et al., 1995; Corbin and McCabe, 2002; Sotomaru et al., 2005; 
Kagabu and Umezu, 2006), continuous infusion of the gonadotrophin (Armstrong and 
Opavsky, 1988) and anti-inhibin in antiserum treatment (Ishigame et al., 2004), have 
been shown to induce superovulation in rats. Among these methods, combination of 
pregnant mare’s serum gonadotrophin-human chorionic gonadotrophin injection regime 
seems to be the most practical and economical method of inducing superovulation of 
cloned animals. Therefore, the combination of pregnant mare’s serum gonadotrophin 
and human chorionic gonadotrophin was used in this study to induce superovulation, as 
recommended by Hogan et al. (1986). 
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5.1.2 Effect of Murine Sources on the Percent Cleavage for the Production of     
          Blastocysts 
 
The sources of murine blastocyst for murine embryonic stem cell lines production could 
be obtained from either in vivo or in vitro-derived blastocysts. In the present study, in 
vivo-derived blastocysts were obtained from in vivo oviduct after flushing embryos at 2-
cell stage or in vivo uterine flushing to obtain blastocysts. As for in vitro-derived 
blastocysts were obtained via somatic cell nuclear transfer (SCNT). There were no 
significant differences (P>0.05) among the 3 different pure-strains of murine. However, 
the blastocyst rate obtained in ICR was the highest followed by CBA/ca and C57BL/6J. 
When comparing the rate of blastocysts formation in both in vivo oviduct and in vivo 
uterine flushing, C57BL/6J showed the lowest rate compared to other strains. One 
possible explanation is that the health of murine has been compromised, which led to 
non-response to gonadotrophin treatment and lower blastocysts formation. This may be 
due to the higher humidity in the animal house at the ISB Mini farm. Also, there were 
times whereby the pellet was out of stock due to failure of the supplier to deliver the 
pellet on time, thus causing minor starvation on murine. Therefore, to overcome this 
problem, pellet feed should be available at all time to ensure the murine are not under 
starvation.  
Although the number of blastocysts obtained from in vivo-derived blastocysts 
were higher than in vitro-derived blastocysts, the C57BL/6J showed the lowest rate of 
blastocysts formation in in vivo oviduct or uterine flushing compare to other murine 
strains; on the contrary, C57BL/6J gave the highest hatched blastocyst rate formation 
through in vitro-derived blastocysts by somatic cell nuclear transfer techniques 
compared to other murine strains. This could be due to an increased incidence of rare 
imprinting disorders associated with assisted reproduction technologies (ARTs) such as 
somatic cell nuclear transfer (Sato et al., 2007). In normal embryo development, 
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genomic imprinting, which describes the allele-specific expression of certain genes, 
accounts for the requirement of both maternal and paternal genomes (Ohlsson et al., 
1998; Reik and Walter, 1998; Surani, 1998; Tilghman, 1999). In the murine, the sex-
specific epigenetic modifications are imposed during gametogenesis and act as markers 
to distinguish the maternal and paternal alleles (Surani, 1998). Allele-specific DNA 
methylation has been observed in the vicinity of most imprinted genes in somatic cells 
(Reik and Walter, 1998; Paulsen and Ferguson-Smith, 2001) when cloning was carried 
out. Thus, in vitro-derived blastocysts rate in C57BL/6J is higher than in vivo-derived 
blastocysts which could be due to imprinting gene and DNA methylation mechanism 
occurred in the former. Besides that, superovulation has been shown to have a negative 
effect on the embryos, causing an increase in incidence of chromosome abnormality in 
blastocyst for different strains of murine (Fujimoto et al., 1974). The ability of the 
donor cell to support development has been shown to be affected by the murine strains 
(Wakayama and Yanagimachi, 2001). 
 For in vitro-derived blastocysts via somatic cell nuclear transfer, the effects of 
pre-intracytoplasmic injection (pre-ICI) duration have been evaluated. There were 
highly significant differences (P<0.05) in pre-intracytoplasmic injection durations 
treatments at 90 minutes, whereby it gave the highest cleavage rate for all 3 different 
pure-strains murine compared to simultaneous injection as well as 30, 60 and 120 
minutes pre- intracytoplasmic injection durations. Whereas, simultaneous injection right 
after enucleation showed the lowest cleavage rates in ICR, CBA/ca and C57BL/6J. 
According to Wakayama et al. (1998), enucleated oocytes were incubated in incubator 
before injection of donor nuclei to restore the oocyte viability due to the sensitivity of 
the oocytes and can easily lyse just after enucleation. Therefore, pre-intracytoplasmic 
injection duration for 90 minutes seemed to be more suitable for somatic cell nuclear 
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transfer in murine which was significantly higher compared to other pre-
intracytoplasmic durations.  
 
5.1.3 Effect of 3 Different Pure-strains of Murine for Mouse Embryonic Fibroblast  
         Cell Lines on Murine Embryonic Stem Cell Lines Performance 
 
Mouse embryonic fiborblasts have been used reliably as feeder cell layer for murine 
embryonic stem cells since the early 1980s when the first murine embryonic stem cell 
lines were being derived and cultivated. Mouse embryonic fiborblast cells are isolated 
from murine embryos at day 14 of gestation as described by Robertson (1987). 
Conventionally, mouse embryonic fibroblast serve as feeder cells in embroynic stem 
cell culture (Evans and Kaufman, 1981; Thomson et al., 1998; Smith, 2001; Turksen, 
2002). The specific role of mouse embryonic fiborblast in prolonging embryonic stem 
cell culture is less clear. It is generally known that mouse embryonic fibroblast that 
provides a befitting environment for the interplay of signaling networks that regulate the 
fate of embryonic stem cells (Xu et al., 2001; Lim and Bodnar, 2002). In this 
experiment, we discussed the suitable strain of murine to be used to derive mouse 
embryonic fibroblast, based on their growth rate. The mouse embryonic fibroblasts 
showed similar growth rates regardless whether they were Passages 1 and 2, fresh or 
frozen-thawed, Dulbecco’s Modified Eagle’s Medium (DMEM) or Alpha Minimum 
Essential Medium Eagle (αMEM). This finding is very important as it shows that there 
were no differences in term of the quality of mouse embryonic fiborblasts. Thus, they 
all could be used for embryonic stem cell culture. However, the mouse embryonic 
fibroblast were not passaged to higher numbers which only up to Passage 2 because 
there will be a significant reduction in quality and increase in senescence at more 
passages number (C. Lorthongpanich, personal communication) which is not good for 
embryonic stem cell culture.  
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 In the present study, there were no significant differences (P>0.05) in the growth 
rate of mouse embryonic fiborblast derived from ICR, CBA/ca and C57BL/6J. 
Therefore, 3 different pure-strains of murine also could be used as feeder cell layers for 
production of murine embryonic stem cell lines. However, CAB/ca gave the lowest 
growth rate for Passage 1 frozen-thawed mouse embryonic fiborblast compared to ICR 
and C57BL/6J.  According to Kawase et al. (1994), different strains is a possible factor 
as it has been shown that the same cell type derived from different strains of murine has 
different degree of sensitivity to trypsinisation. Therefore, this finding suggested that 
mouse embryonic fiborblasts from the CBA/ca strain may be more sensitive to 
trypsinisation compared to ICR and C57BL/6J strains, and thus causing their lower 
growth rate. Thus, CBA/ca may be less suitable as a source to derived mouse embryonic 
fibroblasts.  
 For mouse embryonic fibroblast culture medium, the foetal bovine serum (FBS) 
is commonly used as an essential supplement to cell culture media. Foetal bovine serum 
is a cocktail of most of the factors required for cell attachment, growth, and 
proliferation in vitro (Gstraunthaler, 2003). There were no significant differences 
(P>0.0.5) between DMEM+10%FBS and αMEM+10%FBS culture media for fresh 
mouse embryonic fibroblast cells at Passage 0 and Passage 2 as well as frozen-thawed 
mouse embryonic fiborblast cells at Passages 1 and 2. Therefore, both 
DMEM+10%FBS and αMEM+10%FBS culture media could be used in culturing the 
mouse embryonic fibroblast cell lines. However, the DMEM+10% FBS culture medium 
gave higher growth rate than αMEM+10%FBS culture medium. This could be due to 
Dulbecco’s Modified Eagle’s Medium culture medium contains a 4-fold higher 
concentration of amino acids and vitamins, as well as additional iron (ferric nitrate) 
compared to Alpha Minimum Essential Medium Eagle culture medium. Dulbecco’s 
Modified Eagle’s Medium was developed in 1969 and is a modification of Basal 
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Medium Eagle (BME) that contains 1000 mg/L of glucose and was first reported for 
culturing murine embryonic stem cells. Therefore, apparently DMEM+10% FBS is 
more suitable culture medium for culturing mouse embryonic fibroblasts.                    
              
 
5.2 PRODUCTION OF CAPRINE BLASTOCYSTS AS A SOURCE OF INNER  
      CELL MASS FOR THE ESTABLISHMENT OF CAPRINE EMBRYONIC  
      STEM CELL LINES (EXPERIMENT 2) 
The aims of this experiment were (a) to compare the efficiency and quality of 
embryonic stem cells growth from in vitro or in vivo derived caprine blastocysts, (b) to 
compare the squeezing and laser enucleation techniques in deriving the blasotcysts as 
source for caprine embryonic stem cells production, (c) to compare the grades of 
caprine oocytes in deriving of caprine blastocysts and (c) to compare the pre-
intracytoplasmic injection durations for simultaneous, 30 and 60 minutes in production 
of high caprine blastocysts. In addition, bovine somatic cell nuclear transfer and 
parthenogenesis to produce blastocysts as a comparative study (control) to caprine 
species were included in this experiment.  
 
5.2.1 Production of Bovine Blastocysts through Somatic Cell Nuclear Transfer and  
         Parthenogenesis (Control) 
 
Recent evolutions of somatic cloning by nuclear transfer are reported, especially in the 
bovine species where potential applications are underway for biomedicine in association 
with transgenesis, or for agriculture by improving livestock productivity. The overall 
efficiency of this biotechnology remains low in terms of viable offspring, but significant 
progress has been achieved on the different steps of the technique. In this experiment, 
bovine species was used as a comparative study (control) to caprine species due to lack 
of caprine sample as we need a lot of sample numbers to carry out fundamental 
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experiments for each treatment as well as getting more consistent and accurate results 
before it could be applied into caprine species. In other words, with the more sample 
number from the bovine species, it could be practiced more on the somatic cell nuclear 
transfer techniques such as squeezing and laser enucleation techniques, injection 
technique and modification of culture medium to be applied in the caprine species. 
Bovine species could be used as comparative preliminary studies and learning curve for 
our laboratory to improve the techniques and modified culture conditions and media in 
caprine species.  
Somatic cell nuclear transfer in bovine species has been successfully applied by 
Cibelli et al. (1998). Since 1998 when the first calves derived from somatic cell nuclear 
transfer were born (Cibelli et al., 1998; Kato et al., 1998), many experiments of bovine 
somatic cell nuclear transfer have been performed (Thongphakdee et al., 2008; Yang et 
al., 2008). In nearly all of these experiments, oocytes used for cloning were obtained 
from the ovaries of slaughtered bovine so that genetic background of the oocytes was 
usually unknown.  
 One of the major steps involved in the nuclear transfer procedure is the removal 
of genetic material from the recipient oocyte (enucleation). It is clear that this procedure 
also removes important cytoplasmic components which may reduce cytoplast viability. 
In routine nuclear transfer procedures, one third or more of the ooplasm is frequently 
removed that would presumably result in a corresponding decrease in the total cell 
number of cloned blastocysts (S.Y. Goh, unpublished data). This reduced cell number 
may contribute to the decreased viability of cloned embryos (Zakhartchenko et al., 
1997). Zakhartchenko et al. (1997) reported that the volume of enucleation is critical to 
the development of embryonic cell nuclear transfer. Peura et al. (1998) reported that 
embryos containing 150% of the original oocyte volume would improve the embryonic 
development. However, how much to be removed during nuclear transfer and its 
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removal mechanism are still not clear. Successful enucleation is important for nuclear 
transfer. A less harmful, more productive, fast, and reliable enucleation technology for 
somatic cell nuclear transfer would allow more efficient production of embryos for 
transfer. At present, various enucleation methods have been reported, which include 
blind enucleation (Kubota, 2000), Hoechst 33342 induced enucleation (Tsunoda et al., 
1988), chemical enucleation (Russell et al., 2005) and Demecolcine induced oocyte 
enucleation (Ibanez et al., 2003; Li et al., 2007).  
In this study, we compared 2 different approaches to enucleate oocytes, namely 
squeezing and laser enucleation techniques in order to obtain high production of bovine 
blastocysts. Embryos development at various stages were significantly higher in laser 
enucleation technique compared to squeezing enucleation technique for 2-, 4-, 8-cell, 
morula, blastocyst and hatched blastocyst. Also, no cloned blastocyst was obtained by 
using squeezing techniques. According to Lee et al. (2008), in the squeezing method, 
the zona pellucida was partially dissected and a small amount of cytoplasm containing 
metaphase II (MII) chromosomes and the first polar body (PB) were pushed out, and 
this method took much longer duration compared to laser technique. For laser 
enucleation techniques, the used of laser in enucleation of porcine oocytes was shown to 
be easier to operate (V.T. Nguyen, personal communication). Although expensive, the 
laser technique gave the highest results in somatic cell nuclear transfer in bovine species 
in the present study.  
The cleavage rate of bovine embryos based on oocytes grading regardless of 
enucleation techniques are shown to have the highest maturation (49.77±3.21%), 
enucleation (84.34±3.12%) and injection (86.73±3.03%) rates of Grade A followed by 
Grades B, C, D and E. Similarly, cleavage rates for each developmental stage decreased 
as the grades of oocytes decreased. The present results indicate that good quality 
oocytes surrounded by multi-layers of compact investment with a homogenous ooplasm 
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(Grade A, B) had significantly higher cleavage and development rates up to the hatched 
blastocyst stage compared to those of fair or poor quality oocytes (Grades C,D and E). 
This finding signifies the essential role of cumulus cells in promoting normal 
cytoplasmic maturation of oocyte necessary for fertilisation, cleavage and subsequent 
development of cloned embryos. It has been reported that cumulus cells are a sub-
population of granulosa cells that surround the oocyte by providing nutrients and signals 
that regulate its growth and maturation (Eppig, 1991; Picton et al., 1998; Tanghe et al., 
2002). Furthermore, oocyte quality is determined by various criteria such as the degree 
of expansion, number of cumulus cell layers and texture of the ooplasm, where all these 
criteria were found to have significant effects on the rates of maturation, fertilisation 
and cleavage in vitro (Tanghe et al., 2002). This could be observed in the present study, 
where the oocytes with the most cumulus cell layers with more than 5 layers (Grade A) 
had the highest cleavage rates up to hatched blastocysts. Whereas, embryos derived 
from oocytes with 3 to 4 layers of cumulus cells but with homogenous cytoplasm 
(Grade B) also developed up to hatched blastocyst similar to those with 5 layers of 
cumulus cells (Grade A). However, the percentage of cleaved embryos was 
significantly lower in the latter.   
The present results also indicate that oocytes from Grade C were less competent 
than Grades A and B. This may be due to the fewer layers of cumulus cells may 
possible come from smaller or more atretic follicles than those with more layers 
(Martino et al., 1995). Thus, oocytes derived from smaller follicles may require a longer 
culture time for in vitro maturation (Qian et al., 2001). Oocytes that lacked cumulus 
cells (Grade D) had negatively affected cleavage rates. It has been shown in several 
species that removal of cumulus cells had negatively affected oocyte maturation and 
development (Zhang et al., 1995; Cecconi et al., 1996; Ka et al., 1997; Goud et al., 
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1998). However, clarifications of the physiological mechanism that underline these 
observations require further studies. 
 It is noteworthy that, albeit a limited number in the present study, some embryos 
originating from Grades D and E were able to cleaved and develop to the blastocyst 
stage. This indicated that some oocytes lacking of cumulus cells and showing evidence 
of degeneration may retain developmental capacity.   
There were no significant differences (P>0.05) between squeezing and laser 
enucleation techniques for Grades B, C, D and E, except Grade A where the laser 
percent enucleation was higher than squeezing enucleation. Also, there were 
significant differences (P<0.05) in percent injection between squeezing and laser 
enucleation for Grade A bovine oocytes. The possible reason for this phenomenon 
could not be explained in the present study and needs future research in the future.  
It was clearly evident shown that laser enucleation technique gave the highest 
cleavage rate for all the grades compared to squeezing enucleation technique from 2-
cell stage embryos up to hatched blastocysts. The probable reasons are laser 
enucleation technique is easier and less time consuming compared to squeezing 
technique, where the latter needs to pierce a slit or hole on zona pellucida by cutting 
needle and then pressed out the DNA of oocyte through the piercing hole. By pressing 
the oocytes, it might damage the chromosome of the enucleated oocyte and this would 
affect the oocytes development in future. Therefore, using laser enucleation technique 
was the preferred to prevent the damage of chromosome in the enucleated oocyte 
without pressing through the chromosome of the oocytes. Thus, the laser enucleation 
technique could be applied in caprine species to obtain higher blastocyst formation rate 
for embryonic stem cell lines production.  
In the present study, we compared the embryo developmental rates between 
somatic cell nuclear transfer and parthenogenesis. There were significant differences 
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(P<0.05) between parthenogenesis and somatic stem cell nuclear transfer, where the 
parthenogenesis showed higher cleavage rates than somatic cell nuclear transfer 
technique. Replacement of the somatic cell nuclear transfer with other alternatives is 
important for obtaining more sources of blastocyst for production of embryonic stem 
cells. The establishment of embryonic stem cells by parthenogenesis has not been 
reported, except for one case in primates (Cibelli et al., 2002). The parthenogenetic 
activation of oocytes is important in cloning research, as artificial activation of oocytes 
is an essential component of nucleus transfer protocols. Optimised activation protocols 
could enhance complete reprogramming of reconstructed embryos, which may increase 
success rates in cloning. Furthermore, parthenogenetic activation represents a valid tool 
to mimic the fertilisation Ca
2+
 transients and oscillation in nucleus transplantation 
experiments and to investigate the comparative roles of paternal and maternal genomes 
in controlling early embryonic development.  
Parthenogenesis of bovine oocytes can be induced with an electrical pulse 
(Collas et al., 1993; Prochazka et al., 1993), ethanol (Nagai, 1987; Fukui and Sawai, 
1992; Presicce and Yang, 1994), calcium ionophore A23187 (Ware et al., 1989; Liu et 
al., 1998), cycloheximide (CHX) (Presicce and Yang, 1994; Saeki et al., 1997),  1,4,5-
inositol triphosphate (Ahn et al., 2001), ionomycin (Susko-Parrish et al, 1994; Winger 
et al., 1997), or strontium (Meo et al., 2004). Activation with ethanol and N-6 
dimethylaminopurine (6-DMAP) combined could induce not only a transient 
inactivation of maturation promoting factor (MPF) and a single Ca
2+
 rise but also a 
persistent inhibition of maturation promoting factor (Susko-Parrish et al, 1994; Liu et 
al., 1998). Therefore, in the current study, activation with calcium ionophore (CaI) plus 
N-6 dimethylaminopurine resulted in higher cleavage and blastocyst developmental 
rates in bovine oocytes species. In bovine, depending on the activation method, 
percentages of oocyte activation varies from 29% to 52% (Suttner et al., 2000) and this 
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is similar to the results obtained in this study. The different methods of parthenogenetic 
activation used to date attempt to induce these reactions directly or indirectly. In fact, 
oocytes could be activated by agents that induce a rise in the intracellular concentration 
of calcium (Ca
2+
), either by enabling the entrance of this cation from the external 
medium (Kaufman, 1983; Onodera and Tsunoda, 1989) or by the action of specific 
ionophores that liberate calcium from intracellular stores (Steinhardt et al., 1974; 
Vincent and Johnson, 1992). Embryo reconstitution by nuclear transfer depends upon a 
number of important technical and biological variables such as oocyte quality, 
enucleation and cell transfer procedures, and oocyte activation. Ultimately, the nucleus 
of the donor somatic cell must render itself to be reprogrammed by the oocyte, which in 
turn must be capable to induce all the epigenetic changes to down-regulate somatic 
genes and up-regulate embryonic ones. Therefore, the cleavage rates of parthenogenesis 
were highly significant different (P<0.05) compared to somatic cell nuclear transfer. 
 
5.2.2 Production of Caprine Blastocysts Through Somatic Cell Nuclear Transfer  
         and Parthenogenesis (Control) 
 
In this experiment, we discussed in details on the effects of a) oocyte source, b) oocyte 
quality, c) enucleation technique, d) pre-intracytoplasmic injection duration, e) 
parthenogenesis versus somatic cell nuclear transfer and f) pregnant mare’s serum 
gonadotrophin and human chorionic gonadotrophin treatment on in vivo uterine flushing 
derived blastocysts on percent caprine blastocyst formation as a source for production 
of caprine embryonic stem cell lines. 
 Cleavage rates of caprine embryos through somatic cell nuclear transfer by 3 
different sources of oocytes, namely laparoscopic ovum pick-up (LOPU), ovariectomy 
and abattoir were carried out in present study. There were significant differences 
(P<0.05) in maturation and enucleation rates for these 3 different sources. Even though 
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insignificance in embryo developmental, the embryo development at various stages was 
apparently higher in laparoscopic ovum pick-up, followed by ovariectomy and abattoir. 
However, ovariectomy showed the highest blastocysts and hatched blastocysts rates, 
followed by laparoscopic ovum pick-up and abattoir. 
 In this experiment, ovaries that were surgically ovariectomised consistently 
provided greater follicle surface exposure for oocyte retrieval that could be due to the 
ability of more clearly visualised follicles on the ovaries (Cognie, 1999). Slicing of 
ovary from ovariectomy or abattoir sources was performed as an alternative protocol 
due to unavoidable circumstances such as repeated low response of old donor caprine to 
hyperstimualtion after repeated oocyte retrieval cycles or physically abnormal ovary 
such as adhesion, polycystic ovary syndrome or degenerative ovary or small follicular 
diameter of caprine ovaries. In regards to small follicular (diameter between 2.5 to 3.0 
mm), it was necessary to recover the oocytes by slicing the ovarian surface to yield high 
number of oocytes (Martino et al., 1994). Although caprine showing low reproductive 
capabilities were usually ovariectomised for ovarian slicing as most of them might be 
non-responsive to hormone stimulation, more oocytes will be obtained via ovariectomy 
and chances to develop and blastocyst formation is higher compared to laparoscopic 
ovum pick-up oocyte source.   
In the present study, total number of oocytes retrieved was 641 and 487 from 
slicing and laparoscopic ovum pick-up techniques, respectively. It is generally agreed 
that the ovarian slicing method yields higher number of oocyte. This is agreement with 
Keskintepe (1994) who also obtained higher results of oocytes by surgically removing 
the ovaries of caprine donor. Martino et al. (1994) obtained more oocytes from ovarian 
mincing or slicing than follicular dissection or aspiration in caprine donor.  The reasons 
for higher ooccyte yield may be attributed to the presence of some follicles embedded 
deeply within the ovarian cortex, which could only be released by slicing of the ovary. 
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Additionally, unlike laparoscopic ovum pick-up, the slicing protocol was done under 
visual observation regardless of ovarian follicle size; therefore, ensuring that more 
oocytes were retrieved.  
 However, collections of oocytes after exposure of the ovary by laparotomy or 
ovariectomy has been progressively replaced by laparoscopic techniques in small 
ruminants including caprine (Rahman, 2008). The low time consumption and repeatable 
cycle on the same animal showed that laparoscopic ovum pick-up is relatively a simple 
and efficient technique compared to slicing method (Baldassarre et al., 2002, Koeman 
et al., 2003). Since the embryo development at 2-, 4-, 8-cell and morula stages was 
apparently higher from laparoscopic ovum pick-up as shown in the present study, it was 
suggested that repeated laparoscopic ovum pick-up performed on common caprine 
genotypes in Malaysia either prepubertal or pubertal caprine after hyperstimulation 
treatment is a valuable tool for the synchronisation of follicular growth and retrieval of 
component oocytes. The impact of oocyte retrieval methods on the quantity and quality 
of oocytes retrieved is believed to be of major important. Laparoscopic ovum pick-up 
technique in combination with in vitro-produced of cloned-caprine embryos has the 
potential to improve the number of hatched blastocyst obtained. The laparoscopic ovum 
pick-up can be repeated several times without ovarian damage or decrease in the 
donors’ fertility (McKelvey et al., 1986; Stangl et al., 1999; Alberio et al., 2002; 
Pierson et al., 2004). Additionally, compared with oocytes sourced from abattoir 
ovaries, laparoscopic ovum pick-up allows one to source the oocytes from live animals 
of known health status, which is very important for the production of therapeutic 
proteins for pharmaceutical applications. Laparoscopic ovum pick-up technique already 
allows field application in commercial programmes (Hasler et al., 1995). In addition, 
this method can be applied to prepubertal animals and thereby could contribute to a 
considerable shortening of the generation interval.  However, in vitro developmental 
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competence of these oocytes from various qualitites obtained from different factors 
needs to be evaluated in further study.  
 Regardless the sources of oocyte retrieved, there were no significant differences 
(P>0.05) in percent cleavage at Grades A, B and C for 2-, 4-, 8-cell, morula, blastocyst 
and hatched blastocyst. However, Grades A, B and C showed better cleavage rates than 
Grades D and E for all stages of embryo development. The data obtained in the present 
experiment indicated that Grade A oocytes are highly competent in terms of maturation 
and subsequent embryo development compared with Grades B and C. The Grade D 
oocytes (no layers of cumulus cells (denuded) with evenly granulated cytoplasm) and E 
(pale-coloured or heterogeneous cytoplasm) were least competent. The roles of cumulus 
cells in the acquisition of full developmental competence of the oocytes have been 
investigated earlier (Leibfried-Rutledge and First, 1976; Sato et al., 1977; Xu et al., 
1986). Visual assessment of morphology of cumulus cells investment surrounding an 
oocyte remains the most important criteria for selection of developmentally competent 
oocytes during recovery (Shioya et al., 1988; Madison et al., 1992; Lonergan et al., 
1994). It was suggested that earlier that expanded cumulus cells investment mature and 
good quality oocytes, while compact cumulus cells characterises immature oocytes 
(Veeck, 1988).  
 In regard to enucleation techniques, laser enucleation gave highest maturation, 
enucleation and injection rates for Grades B, D and E, except for Grades A and C in 
overall. Several enucleation methods have been published (Willadsen et al., 1986) and 
most rely on the removal of a karyoplast via micromanipulation in combination with a 
DNA fluorescent stain to confirm positive enucleation (Westhusin, 1992). This 
technique has improved enucleation and development as compared with enucleation by 
blind oocyte biopsy (Willadsen, 1986), but it has limitations associated with the time 
required for the production of large numbers of nuclear transfer embryos through 
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micromanipulation. However, enucleation is a major limiting step in the nuclear transfer 
procedure. The successful and efficient removal or the destruction of genetic material in 
the recipient oocyte is dependent upon the technique used. Staining by places the oocyte 
under stresses associated with exposure to Hoechst 33342 and ultra-violet irradiation 
(Smith, 1993), which may also affect development. In earlier reports, germinal vesicle 
enucleation was performed rather ‘indirectly’ by increasing the pressure inside a 
holding pipette to expel a germinal vesicle karyoplast (nucleus) through a slit made in 
the zona (Sun et al., 1991). The zona pellucida was penetrated by pressing a glass 
micro-needle tangentially into the perivitelline space against the holding pipette also 
known as squeezing enucleation technique.  
Similar as previous findings in bovine species, we compared the squeezing and 
laser enucleation techniques in caprine oocytes. Same results were shown where most 
of the laser enucleation technique gave the highest maturation, enucleation and injection 
rates compared with squeezing enucleation techniques for all grades of oocytes, except 
Grade A.  These most probably due to the laser technique that have been master the 
skills rather than using squeezing enucleation technique in the previous learning curve.  
There were obviously significant differences (P<0.05) of embryos development at the 
later stages cloned embryos (morula, blastocyst and hatched blastocyst) where the laser 
enucleation techniques gave significantly higher percent cleavage rates compared with 
squeezing enucleation technique as shown on Grade A. This could be due to maternal 
zygotic transition occurred where the onset of maternal zygotic transcription is species 
dependent such as murine 1 to 2-cell stage (Bolton et al., 1984); bovine, caprine and 
ovine 8 to 16 (Calarco and McClaren, 1976; Camous et al., 1986) and Xenopus 
approximately 4000 (Newport and Kirschner, 1982).  Therefore, the caprine species at 
later stages were passed over the maternal zygotic transcription and reach the stability 
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on the cleavage rates in order to obtain good quality of blastocysts compared to early 
stage of embryos (2-, 4- and 8-cell).  
In cloned embryos, reprogramming usually occurs aberrantly. Incomplete 
reprogramming may contribute to the low efficiency of cloning. Global epigenetic 
reprogramming of somatic nuclei is mainly in most preimplantation cloned embryos 
(Dean et al., 2001). Therefore, correct epigenetic reprogramming is necessary for 
successful and normal developmental of clones (Dean et al., 2001). The low success 
rate could be caused by an incomplete reprogramming of the epigenetic state of nuclei 
from differentiated donor cells. It is easy to understand that genes permanently switched 
off in the course of cell differentiation may be hard to reactivate efficiently. The 
incomplete reactivation of Oct 4 may account for some failures of nuclear transfer 
embryo development (Boiani et al., 2002; Bortvin et al., 2003). Most of cloning used an 
unfertilised and mature oocyte as recipient, reprogramming occurred within the brief 
interval between the transfer of the donor nucleus into the enucleated oocyte and here 
the start of zygotic transcription. Thus, pre-zygotic modifications (any modifications 
that have occurred before the mature oocyte stage) are expected to be less efficiently 
reprogrammed than post-zygotic modifications.  
For pre-intracytoplasmic injection durations, it was vividly shown that for each 
embryo developmental stages from 2-, 4-, 8-cell, morula, blastocyst and hatched 
blastocyst the cleavage rates were significantly higher (P<0.05) for 60 minutes followed 
by simultaneous injection and 30 minutes pre-intracytoplasmic injection durations. 
Similar as previous findings in murine species, the caprine enucleated oocytes need 
time to restore the oocyte viability due to sensitivity of the oocytes by incubated in 
incubator before injection of donor nuclear. Simultaneous injection right after 
enucleation could cause the lower oocyte viability as it could easily lyse just after 
enucleation. This is agreement with Wakayama et al. (1998) findings. Therefore, pre-
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intracytoplasmic injection duration for 60 minutes seemed to be more suitable for 
somatic cell nuclear transfer in caprine speceis which was significantly higher 
compared to other pre-intracytoplasmic injection durations.  
Although insignificance in comparison between parthenogenesis and somatic 
cell nuclear transfer in present experiment, the percent cleavage of somatic cell nuclear 
transfer were apparently higher than parthenogenesis for all the stages, except 
blastocyst. This could be explained in maternal zygotic transcription occurred in 
parthenogenesis start at 8- to 16-cell stages in caprine species (Calarco and McClaren, 
1976; Camous et al., 1986).   
Besides in vitro-derived caprine blastocysts as source for producing caprine 
embryonic stem cells, in vivo-derived caprine blastocyst also carried out in this 
experiment in order to obtain more number of blastocsyst to produce good quality of 
caprine embryonic stem cell lines. Two different hormones are used in superovulated to 
obtain more number of blastocysts, namely pregnant mare’s serum gonadotrophin and 
follicle stimulating hormone. There were obviously significant differences in number of 
blastocyst obtained between pregnant mare’s serum gonadotrophin and follicle-
stimulating hormone treatments. By using the follicle stimulating hormone, it gave the 
highest number of caprine blastocysts (27) compared with pregnant mare’s serum 
gonadotrophin (0). Superovulation in caprine is frequently restricted by the cost of 
gonadotropin or the handling requirements. In this situation pregnant mare’s serum 
gonadotrophin has the advantage of a lower cost and single dose protocol, but the 
variability of response obtained restricts its use. Partial replacement of follicle-
stimulating hormone with pregnant mare’s serum gonadotrophin at the end of treatment 
also did not compromise the number of embryos collected. This variability is even more 
marked when the gonadotropin used to induce superovulation is pregnant mare’s serum 
gonadotrophin (Dieleman, 1993), rather than follicle stimulating hormone. The same 
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observation has been made in caprine (Armstrong et al., 1983; Pendleton et al., 1992). 
However, pregnant mare’s serum gonadotrophin provides important economical and 
labour advantages over follicle stimulating hormone (Alfuraji et al., 1993), which 
justifies its choice in some circumstances. Use of pregnant mare’s serum gonadotrophin 
substantially reduces the cost of hormones and labour involved (Alfuraji et al., 1993), 
and the administration in a single dose may represent another advantage over follicle 
stimulating hormone, since the stress caused by repeated handling contributes to poor 
reproductive results in some breeds (Fenandez-Arias et al., 1997). However, these 
advantages are eclipsed by reported variable responses to pregnant mare’s serum 
gonadotrophin, with a high number of unfertilised ova, low ovulation rate, high number 
of large follicles, and an apparent increase in the incidence of premature luteal 
regression (Armstrong et al., 1983, Pendleton et al., 1992). Present study showed the 
more ovulated number in follicle stimulating hormone (65) than pregnant mare’s serum 
gonadotrophin (12). Our results also confirm how follicle stimulating hormone provides 
a more constant ovarian response in caprine variations in follicle stimulating hormone 
protocols suggest that dose of follicle stimulating hormone plays a determinant role in 
superovulatory response.  
 
5.2.3 Comparison Between Caprine and Bovine Species on Production of  
          Blastocysts Through Somatic Cell Nuclear Transfer and Parthenogenesis 
 
Among domestic mammals, successful nuclear transfer has also been reported in 
caprine (Yong et al., 1991). In present results, there were significant differences 
(P<0.05) in maturation, enucleation and injection rates between caprine and bovine 
species. Also, percent maturation, enucleation and injection in caprine were apparently 
higher than bovine species for all the grades of oocyte. This might be due to the sources 
of oocyte retrieved where part of the caprine oocytes retrieved from laparoscopic ovum 
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pick-up which provide more high quality of oocytes compared with bovine species 
where the oocytes obtained only from abattoir source with unknown history or 
background.  
There were obviously significant differences (P<0.0.5) between caprine and 
bovine in percent embryos development for 2-, 4-, 8-cell, morula, blastocyst and 
hatched blastocyst where caprine species gave higher cleavage rates compared with 
bovine species. One of the most prominent developments, particularly in bovine embryo 
cloning, has been the use of in vitro matured oocytes to prepare large numbers of 
recipient cytoplasms (Yang et al., 1993). However, the introduction of blastomere 
nuclei into enucleated metaphase II oocytes results in poor development, probably due 
to damage induced by premature chromosome condensation caused by high levels of 
maturation promoting factor activity in such cytoplasts (Szollosi et al., 1988; Collas and 
Robl, 1991) as the genetic background of the bovine species from abattoir source is 
unknown. Therefore, the efficiency of the trials with clones is dependent on the 
heritability of the trait under study. The use of clones is more appropriate if the trait has 
a high degree of heritability and if a high technical expenditure is required per day and 
animal in the trial.  
In the present experiment, there were significant differences (P<0.05) in percent 
enucleation and injection between caprine and bovine at Grades A and C. Thus, the 
quality and cost of recipient oocytes are important in the economics of cloning. The use 
of in vitro matured oocytes has a number of advantages as compared to in vivo derived. 
Firstly, the use of slaughterhouse derived material has an obvious cost advantage 
allowing the collection of large numbers of oocytes. However, more importantly the use 
of in vitro derived oocytes provides greater control over the maturation process 
allowing collection of oocytes at defined stages during maturation. This results in a 
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greater consistency of oocyte quality for animal production and further research of 
oocyte reprogramming activities.  
There were significant differences (P<0.05) between caprine and bovine species 
in percent enucleation for squeezing and laser enucleation techniques where the percent 
enucleation were higher in the former compared to the latter in both enucleation 
techniques. Caprine species always showed higher percent cleavage than bovine species 
for both enucleation techniques. Caprine has emerged as an excellent model system for 
studies involving reproductive physiology, endocrinology, and virology (Marini et al., 
2002). Although, many researchers used bovine species as model in somatic cell nuclear 
transfer research, the unknown genetic background of the bovine oocyte sources caused 
abnormalities in cloned embryos obtained. Therefore, the source and genetic 
background of oocytes are significant important to prevent abnormal embryos 
development. In comparing to caprine species, it is one of the most widely studied 
animal models of human influenza infection (Pearson and Gorham, 1998) and is also an 
ideal choice for modeling genetic lung diseases such as cystic fibrosis (CF) (Li and 
Engelhardt, 2003). In part, this is due to the remarkable similarity between caprine and 
human lung cell biology (Mercer et al., 1994; Choi et al., 2000; Wang et al., 2001). 
Moreover, the caprine has a 42 day gestation period and reaches sexual maturity in 4 to 
5 months (Fox and Bell, 1998), making it one of the more rapidly reproducing species 
for animal modeling by somatic cell nuclear transfer. The successful production of 
viable caprine progeny following somatic cell nuclear transfer provides exciting new 
opportunities for basic research, investigating early embryogenesis and the propagation 
of endangered black-footed caprine and European minks. Given the relatively short total 
reproductive cycle of the caprine, with a gestation period of 42 days and 4 to 5 months 
to sexual maturity (Fox et al., 2002), the caprine represents an attractive animal model 
for genetic manipulation in conjunction with somatic cell nuclear transfer.  
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To be used as cytoplast recipients for somatic cell nuclear transfer, the genetic 
material must be removed from the oocytes. In general, this has been achieved by 
aspiration of the metaphase II spindle using a small glass pipette, so called enucleation 
(Li et al., 2004b). Not only does this technique require significant skill but the process 
also removes a variable portion of the oocyte cytoplasm which may affect subsequent 
development. To simplify the process and reduce the volume of cytoplasm removed 
various modifications to the enucleation technique have been developed. In most 
species, the metaphase plate of metaphase II oocytes is not visible by light microscopy 
due to the presence of cytoplasmic lipid. Enucleation has been achieved by so called 
“blind enucleation” using the first polar body as a marker for the location of the 
metaphase II plate. Generally, the first polar body and a small volume of cytoplasm (10 
to15%) located below first polar body are removed by squeezing them out. The 
disadvantages of squeezing enucleation technique were in many cases the metaphase 
plate is not close to first polar body. The removal of cumulus cells prior to oocyte 
manipulation can further disrupt the relationship between the metaphase II spindle and 
first polar body. These factors could result in a proportion of the oocytes containing 
residual DNA following enucleation (Li et al., 2004c). In fact it has been reported that 
less than 50% of metaphase plates are located beneath first polar body in bovine (Nour 
and Takahashi., 1999). A second problem is that up to one-third of recipient cytoplasm 
just beneath the first polar body is generally squeezed out in order to improve 
enucleation efficiency. The removal of such a large proportion of the oocyte cytoplasm 
may result in the oocyte having a reduced capacity for epigenetic reprogramming of the 
transferred nucleus and subsequent development. Therefore, laser enucleation technique 
without disrupt the relationship between the metaphase II and first polar body and small 
volume of cytoplasm were removed were more advantageous compared with squeezing 
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enucleation technique. Thus, most of the cleavage values were significantly higher in 
laser enucleation technique for both species in the present study. 
 
5.3 EFFECTS OF STRAINS, CULTURE MEDIUM AND MOUSE EMBRYONIC  
      FIBROBLAST FREEZING ON PRODUCTION OF MURINE EMBRYONIC  
      STEM CELL LINES USING WHOLE BLASTOCYST CULTURE  
     TECHNIQUE (EXPERIMENT 3) 
In the present experiment, we discussed about the effects of a) murine strains, b) culture 
medium and c) fresh and frozen-thawed mouse embryonic fibroblast on production of 
murine embryonic stem cell lines performance by using whole blastocyst culture 
technique. Also, 5 different stages of murine blastocyst have been studied, namely 
early-, mid-, expanded-, hatching- and hatched-blastocyst to produce good quality of 
murine embryonic stem cell lines.  
 
5.3.1 Effects of Murine Strains on Production of Murine Embryonic Stem Cells  
           Lines Using Whole Blastocyst Culture Technique 
 
The effects of strain and blastocyst stage on the efficiency of deriving murine 
embryonic stem cell lines were discussed in this experiment. Different success rates of 
embryonic stem cells derived from different strains of murine were reported by Kawase 
et al. (1994) and Bryja et al. (2006). Our results have shown that there were significant 
differences between CBA/ca and ICR with C57BL/6J, whereby murine embryonic stem 
cells derived from CBA/ca strain had higher success rate of passaging up to Passage 3 
compared with ICR and C57BL/6J. Although the difference is not significant, it 
suggests that CBA/ca strain may be more suitable for deriving murine embryonic stem 
cells. 
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Previously, it was found that blastocysts from C57BL/6J and CBA/ca have an 
efficiency of deriving embryonic stem cells of 58% and 66% (Schoonjans et al., 2003) 
which was considerably higher than the findings of this study. However, it should be 
noted that in their study, only 12 blastocysts were used for each strain, whereas in this 
study 124 and 129 blastocysts from C57BL/6J and CBA/ca were used. No data was 
found on the performance of blastocysts derived from ICR strain. The overall low 
efficiency in deriving murine embryonic stem cells compared to other researchers may 
be attributed to the use of 35mm culture dishes instead of multi-well plates which 
provide greater contact between the blastocysts and feeder cells (Williams et al., 1988; 
Bryja et al., 2006). In general, only a few strains of murine have been used in the 
establishment of germ line competent embryonic stem cell lines (McWhir et al., 1996). 
Although refinements in conditions have resulted in improved efficiencies, very few 
lines have been established in inbred strains other than the 129 strain (Schoonjans et al., 
2003; Cheng et al., 2004). In strains that are considered non-permissive, pluripotent 
cells within the inner cell mass may be more susceptible to differentiation signals. 
McWhir and co-workers selectively destroy the differentiating cells to obtain embryonic 
stem cell lines from the CBA/ca mouse strain from which no embryonic stem cell lines 
had previously been established.  
 Comparison among the blastocyst stages were shown in Table 4.56, whereby 
expanded blastocysts showed a significantly higher success rate of reaching Passage 3 
(17.24±3.67%) compared to early (9.18±2.98%) and hatched blastocysts (8.08±2.94%). 
The low success rate of deriving embryonic stem cells from hatched blastocysts is in 
agreement with the findings of Movaassagh-Pour et al. (2003). No reports were found 
comparing the 5 different blastocyst stages. The factors behind the differences in 
efficiency are poorly understood. A possible explanation could be derived by looking 
into the events taking place during the development of blastocysts from early to hatched 
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stage. In early blastocysts, the inner cell mass and trophectoderm have not fully 
separated. Therefore, when cultured on the feeder cell layer, the consecutive outgrowth 
will have a high mixture of both inner cell mass and trophectoderm derived cells. The 
interaction among the cells possibly makes the embryonic stem cells more likely to 
differentiate. Moreover, hatched blastocysts have inner cell mass that were already 
beginning to differentiate into the epiblast. This could be supported by the fact that Oct 
4 expression in blastocysts decreases sharply in at 4.5 days post coitum (Kehler et al., 
2004). Oct 4 expression is crucial in maintaining the the pluripotency and 
undifferentiated state in embryonic stem cells (Masui et al., 2007). Thus, embryonic 
stem cells derived from them may have a higher tendency to differentiate.  
 By comparing each strain and blastocyst stage combination, expanded blastocyst 
stage always showed the highest percent successful attachment of blastocysts and 
consecutive passages up to Passage 3 throughout the 3 different pure-strains of murine 
compared to other blastocyst stages. Meanwhile, the success rate was very low in early 
and hatched blastocysts for all the murine strains in this finding. In summary, 
embryonic stem cells could be successfully derived from different strains of murine and 
blastocyst stages. Blastocysts from the CBA/ca strain, especially expanded blastocysts 
were the most efficient for deriving murine embryonic stem cell lines, whereas early 
and hatched blastocysts were not suitable for deriving murine embryonic stem cell lines.  
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5.3.2 Effect of Culture Media on Production of Murine Embryonic Stem Cell  
             Lines Using Whole Blastocyst Culture Technique  
 
In the present study, there were no significant differences in percent attachment of 
blastocysts and successful consecutive passages of murine embryonic stem cell lines for 
both DMEM+10%FBS and αMEM+10% FBS culture media. However, the 
DMEM+10% FBS culture medium showed higher percent successful attachment of 
blastocysts and consecutive passages of murine embryonic stem cell lines than 
αMEM+10% FBS culture medium. An important element affecting the efficiency of 
deriving embryonic stem cells is the composition of the culture medium. Most of the 
researchers used Dulbecco’s Modified Eagle’s Medium for culturing embryonic stem 
cells rather than Alpha Minimum Essential Medium Eagle. Dulbecco’s Modified 
Eagle’s Medium with 10 to 20% foetal bovine serum has been used since the early days 
of murine embryonic stem cell culture (Evans and Kaufman, 1981; Tesar, 2005). Lately, 
Knockout Serum Replacement (SR) is frequently used to substitute foetal bovine serum 
and have shown significantly better results (Wakayama et al., 2007; Doungpunta et al., 
2009). Another chemical often added is leukaemia inhibitory factor, which helps to 
further maintain the embryonic stem cells in an undifferentiated state. Their addition 
has also increased efficiency (Schoonjans et al., 2003). Some researchers’ findings 
reported that one possible factor is the use of embryonic stem cells culture media 
conditioned with rabbit fibroblast cell lines which may have increased the amount of 
leukaemia inhibitory factor and other support factors in the culture medium, thus 
improving efficiency (Schoonjans et al., 2003). Other modifications to the culture 
medium include pre-conditioning the culture medium on fibroblast (Schoonjans et al., 
2003) and addition of 6-bromoindirubin-3’-oxime (BIO) which activates the Wnt 
signalling pathway involved in the maintenance of pluripotency (Sato et al., 2004; 
Doungpunta et al., 2009). Similar findings also obtained for the combination of 
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different culture media (DMEM and αMEM) with the 5 different blastocyst stages, we 
found that most expanded blastocysts gave the highest percent attachment of blastocysts 
and successful consecutive passages of murine embryonic stem cell lines up to Passage 
3 compared with other blastocyst stages for both culture media used. 
 
5.3.3 Effect of Fresh and Frozen-thawed Mouse Embryonic Fibroblast on  
            Production of Murine Embryonic Stem Cell Lines Using Whole Blastocyst  
            Culture Technique 
 
Furthermore, there were no significant differences (P>0.05) between fresh and frozen-
thawed mouse embryonic fibroblast for percent successful attachment of blastocysts, 
consecutive passages of murine embryonic stem cell up to Passage 3. However, there 
was slightly decreasing in the growth rate of mouse embryonic fibroblasts after frozen-
thawed. Nevertheless, as the difference in small, the reduction in quality of mouse 
embryonic fibroblast should be little as well, thus both can still be used as feeder cells. 
The present results showed that majority of expanded blastocysts gave the highest 
percent attachment of blastocysts and successful consecutive passages in both fresh and 
frozen-thawed mouse embryonic fibroblast. Freezing of mouse embryonic fibroblast 
when they have reached the confluent state in culture have been shown to result in 
higher cell viability after thawing (Buck et al., 1981). The cell density during freezing 
also affects the viability rate (Freshney, 1994). Therefore, the thawing step significantly 
affects the viability and quality of cells, especially in regards to the thawing rate 
(Freshney, 1994). It has been reported that the centrifugation time and speed after 
thawing has an effect on cell viability (Cheng et al., 2004). The rate of dilution 
(addition of culture medium to the cell suspension) also influences the viability.  
In general, cryopreservation is the cooling of samples to low sub-zero 
temperatures for long term storage (Shaw and Jones, 2003). The reasons for the freezing 
of mouse embryonic fibroblast cells were the inevitable senescence of cells, possible 
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contamination after prolonged cultured, discard the need to maintain the cell lines in 
continuous culture and allow the cells to be distributed to other users (Freshney, 1994). 
Cells are typically cooled to a low temperature and finally stored in liquid nitrogen 
(LN2), which has a temperature of -196°C (Freshney, 1994). Despite the inevitable 
cellular damage, thawed and subsequently cultured cells exhibit rapid regeneration 
(Pereira and Marques, 2008). Thus, with the right methods, cells can be stored for later 
use and revived effectively. The period of equilibration usually completes once the 
temperature reaches -80°C, whereby the cells and then transferred to lower temperatures 
for storage (Shaw and Jones, 2003). During this period, water leaves the cells 
(dehydration), thus minimising intracellular ice crystallisation and reducing cryogenic 
damage from the highly concentrated solutes (Freshney, 1994). Low concentrations of 
cryoprotectant are used, thus minimising their chemical toxicity and osmotic shock 
(Pereira and Marques, 2008). Nevertheless, due to their low concentration, they are less 
potent to prevent ice crystallisation compared to techniques using higher cryoprotectant 
concentrations (Pereira and Marques, 2008).  
In regard to the passages number of mouse embryonic fibroblast, we used only 
Passages 1 and 2 for both fresh and frozen-thawed mouse embryonic fibroblast in our 
study for culturing murine embryonic stem cell lines. There were no significant 
differences (P>0.05) in percent successful consecutive passages on murine embryonic 
stem cell lines between Passages 1 and 2 for fresh mouse embryonic fibroblast, whereas 
for Passsages 1 and 2 on frozen-thawed mouse embyonic fibroblast, there were 
significant differences (P<0.05) at Passage 3. Smilar as previous findings, the expanded 
blastocysts always showed the highest percent attachment of blastocysts and 
consecutive passages for both Passages 1 and 2 in fresh and frozen-thawed mouse 
embryonic fibroblasts. Puck et al. (1956) first described a method of increasing the 
growth rate of in vitro cell cultures through the use of feeder cells layer. While some 
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cell lines can grow efficiently on plates containing nutrient medium alone, others grow 
poorly without the use of feeder cells layer (Fisher and Puck, 1956). In general, cells 
survive and expand better layer (Degrassi et al., 1993). In the early days, the use of 
feeder cells layer simply involved using inactivated cells of the same type of the 
primary cell culture (Puck et al., 1956). These cells could no longer multiply 
effectively, but due to their metabolism remaining active, they continue to secrete 
growth factors necessary to support the primary cell culture. However, the use of the 
same cell type as feeder cells layer may not be applicable in every condition. Mature, 
differentiated cells such as neurons rely on other cells for growth factors (Pellitteri et 
al., 2006).  
Feeder cells provide support in a few ways. In an incomplete medium, feeder 
cell layer will provide certain nutrients not found in the medium (Fisher and Puck, 
1956). Feeder cell layer also negate the effects of certain inhibitory substances found in 
the medium, such as those originating from the serum extract (Fisher and Puck, 1956). 
They can also form intercellular junctions such as tight junctions, adherens junctions 
and gap junctions with the cell culture, thus providing physical support to assist in the 
attachment of the cells (Ehmann et al., 1998). Besides that, feeder cells layer also 
secrete factors that support the clonal growth and expansion of the cell culture, such as 
various growth factors called fibroblast growth factors (FGF) (Shimoaka et al., 2002) 
and anti-apoptotic factors (Tseng et al., 1996). Thus, whenever a cell type is to be 
considered as a suitable candidate for use as feeder cells layer, they should exhibit the 
above characteristics. But once the feeder cells layer underwent cryopreservation, it 
might be affected their original properties and thus could not performed well compared 
with fresh mouse embryonic fibroblasts. The present of dimethyl sulfoxide (DMSO) as 
cryoprotectant in cryopreservation the mouse embryonic fibroblasts cells might gave 
toxic to the feeder cells layer if in high concentration. Therefore, it would cause the 
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reduced growth rate as compared with fresh mouse embryonic fibroblasts. In a 
developing murine embryo, mouse embryonic fibroblasts function to assist in tissue 
morphogenesis, remodeling, repair, fibrogenesis and overall embryogenesis via 
connective tissue growth factors (Kennedy et al., 2007). While in in vitro culture, it has 
been observed that growth rate of mouse embryonic fibroblasts was not exponential, but 
declines progressively within and after each passage, beginning from the initial passage 
(Karatza et al., 1984). The reduction in growth potential is not due to the increase in the 
cell cycle duration, but due to reduction in the fraction of dividing cells. 
 
5.4 EFFECTS OF INNER CELL MASS ISOLATION TECHNIQUES, CULTURE  
      MEDIUM AND MOUSE EMBRYONIC FIBROBLAST FREEZING ON  
      PRODUCTION OF MURINE AND CAPRINE EMBRYONIC STEM CELL  
      LINES USING MOUSE EMBRYONIC FIBROBLAST AS FEEDER CELL      
       LAYER (EXPERIMENT 4) 
The objectives of this experiment were a) to determine the effects of inner cell mass 
isolation technique, b) culture medium and c) fresh and frozen-thawed mouse 
embryonic fibroblast on production of murine and caprine embryonic stem cell lines 
using mouse embryonic fibroblasts as feeder cell layer.  
 
5.4.1 Effects of Inner Cell Mass Isolation Techniques, Murine Strains, Culture  
          Medium and Mouse Embryonic Fibroblast Freezing on Production of  
          Murine Embryonic Stem Cell Lines 
 
Inner cell mass isolation technique is an important step to ensure the success of the 
embryonic stem cells establishment. In the present study, the whole blastocyst culture 
gave the lowest inner cell massattachment, primary inner cell mass outgrowth and 
successful passages up to Passage 3 rates compared to manual cut and laser dissection 
inner cell mass isolation techniques. This may be due to in intact embryos where 
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trophoblastic cells induce inner cell mass differentiation to be 3 embryonic germ layers 
by suppressing Oct 4 and Nanog expression level (Roberts, 2004). Therefore, 
completely removed trophoblastic cells provide more benefit to inner cell mass cells 
turn to be embryonic stem cells.  
The inner cell mass could be separated and isolated from the trophectoderm by 5 
ways, namely immunosurgery (Solter and Knowles, 1975), with mechanical processes 
(Bongso et al., 1994), with whole embryo culture of the blastocysts and partial embryo 
culture methods (Kim et al., 2005) or single blastomeres (Chung et al., 2006) and laser 
dissection (Turetsky et al., 2008). In the present study, we only compared among the 
whole blastocyst culture, manual cut and laser dissection inner cell mass isolation 
techniques. In the present experiment, C57BL/6J showed the highest inner cell mass 
attachment, primary inner cell mass outgrowth and consecutive passages of murine 
embryonic stem cells lines rates followed by ICR and CBA/ca by manual cut isolation 
techniques. Therefore, C57BL/6J is the more suitable strain to produce murine 
embryonic stem cell lines. 
Manual cut always gave the highest percent successful consecutive passages of 
murine embryonic stem cell lines in both DMEM+10% FBS and αMEM+10% FBS 
culture media. This could be proved by mechanical isolation of the inner cell mass has 
previously been successfully used in the derivation of 2 cell lines, as reported by 
Mummery (2004) , Genbacev et al. (2005) and van de Stolpe et al. (2010). Manual cut 
inner cell mass isolation technique has been proven to improve results (C. 
Lorthongpanich, personal communication). However, the difficulty of the manual cut 
procedure limits the rate at which blastocysts can be dissected. Furthermore, some inner 
cell mass may become damaged due to the use of needles to pull the inner cell mass 
away from the overlying trophectoderm. The embryo tended to rotate away from the 30 
G needle when it was cut towards one pole. The choice of fully expanded blastocysts 
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enabled trophoblast to be obtained with little risk of inclusion of inner cell mass. 
Ideally, more training and practice should be done to master manual cut inner cell mass 
isolation technique to allow comparisons in terms of efficiency.  
In fresh mouse embryonic fibroblast, there were no significant differences 
(P>0.05) for 3 different inner cell mass isolation techniques. However, there were 
significant differences (P<0.05) in inner cell mass attachment and primary inner cell 
mass outgrowth rates between whole blastocyst culture and manual cut as well as laser 
dissection in frozen-thawed mouse embryonic fibroblast, whereby the laser dissection 
isolation techniques gave higher primary inner cell mass outgrowth rate followed by 
manual cut and whole blastocyst culture techniques in frozen-thawed mouse embryonic 
fibroblasts. Also, laser dissection technique gave the higher passages of murine 
embryonic stem cell lines at Passages 2 and 3 compared with manual cut and whole 
blastocyst culture techniques. Laser dissection method are used in the present study was 
to evaluate a new method of isolation inner cell mass and derivation of embryonic stem 
cell lines in a murine. Usually, laser technology is commonly used for assisted hatching 
with some applications. One of them consists of making the embryonic membrane 
weaker to make the exit of the future blastocyst easier and so favour the derivation 
(Antinori and Steirteghem, 2000). Until now, this new laser dissection method has been 
suggested to derive stem cell lines by Wang et al. (2005), although without presenting 
any conclusive results. A recent paper, Tanaka et al. (2006) reported preliminary results 
for a murine model using this method; subsequent culture of embryonic stem cells in a 
serum or cell-free culture system was achieved. To our knowledge, some notion of 
which of these methods are the most efficient for the isolation of inner cell mass is very 
important for future research in this field. Accordingly, we have compared the inner cell 
mass isolation method using laser dissection in a murine blastocyst with one of the most 
commonly used methods, the whole blastocyst culture (Kim et al., 2005). However, 
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with good quality blastocysts with a large and distinct inner cell mass, we used the laser 
drill (Hamilton, USA).  
In our experiment, the murine blastocyst to be treated with laser shot was 
positioned at the center of the field of view under 40x magnification. The blastocyst 
position was moved when necessary. Blastocysts can be secured by 2 holding pipettes 
with the inner cell mass positioned at ‘9 o’clock’ if desired (Tanaka et al., 2006). After 
focusing on the trophectoderm cells, the object had to be moved so that the part of the 
trophectoderm to be treated was located at the cross-hair position displayed on the 
monitor as the impact location of the laser focus. Thus this new mechanical method 
destroyed the trophectoderm cells by shooting the laser over them carefully without 
damaging the inner cell mass. The length of radiation time of the laser and the number 
of laser shots were controlled by the embryologist. Although some reported that the 
whole blastocyst culture method of the blastocysts is more effective than the laser 
method (70% versus 52.4%) (Polzin et al., 2010), taking into account that we have used 
the laser drill for the good quality blastocysts and that the concealment of the inner cell 
mass by the trophectoderm cells is the only disadvantage of the whole blastocyst culture 
method (Bongso et al., 1994). Therefore, we must continue to improve the laser 
dissection technique so that the trophectoderm cells are destroyed and do not interfere 
with inner cell mass (Tanaka et al., 2006). Curiously, the blastocysts treated with the 
laser at day 1 formed a pseudo-trophectoderm, with a few cells not destroyed by the 
laser because they were near the inner cell mass. Trophectoderm cells disappeared after 
repeated passages (Polzin et al., 2010).  
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5.4.2 Effects of Caprine Inner Cell Mass Isolation Techniques, Culture Medium  
          and Mouse Embryonic Fibroblast Freezing on Production of Caprine  
          Embryonic Stem Cell Lines  
 
A total of 169 caprine blastocysts were used as a source of inner cell mass isolation for 
production of caprine embryonic stem cell lines. Isolation of inner cell mass is a very 
important step in the culture of embryonic stem cells. Although caprine embryonic stem 
cells could be produced from intact whole blastocyst culture, the efficiency was low as 
compared to manual cut and laser dissection techniques. When in vitro produced 
blastocysts were used, they found that intact or whole blastocyst culture was better than 
isolated inner cell mass culture as small or unclear inner cell mass were present in vitro 
produced blastocysts (Li et al., 2003a). Li et al. (2003a) reported that isolated inner cell 
mass is superior to intact blastocyst culture when in vivo produced blastocysts were 
used. More primary colonies were formed from inner cell mass cells than intact or 
whole blstocysts (Li et al., 2003b). It is probably that trophoblasts affects inner cell 
mass growth in the intact or whole blastocysts culture and induced inner cell mass cells 
differentiation in culture at the early stage.  Therefore, manual cut technique shows the 
highest percent attachment of inner cell mass, followed by laser dissection and whole 
blastocyst culture. In percent successful consecutive passages of caprine embryonic 
stem cell lines, manual cut technique always show the highest percent passages 
compared to laser dissection and whole blastocyst culture techniques. The similar 
reasons were discovered, whereby completely removed trophoblastic cells provide more 
benefit to inner cell mass cells turn to be embryonic stem cells.  
A total of 45 replicates were carried out in the present study, where 22 replicates 
for DMEM+10% FBS and 23 replicates for αMEM+10% FBS. 169 total of caprine 
blastocyst were used to determine the quality of caprine embryonic stem cell lines in 2 
different culture media. There were no significant differences (P>0.05) in percent 
attachment of inner cell mass, primary inner cell mass outgrowth, successful 
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consecutive passages of caprine embryonic stem cell lines from Passage 1 up to Passage 
3. However, DMEM+10% FBS culture medium gave higher percent attachment of 
inner cell mass, primary outgrowth of inner cell mass, successful consecutive passages 
than αMEM+10%FBS culture medium. This may be due to DMEM culture medium 
containing a 4-fold higher concentration of amino acids and vitamins, as well as 
additional iron (ferric nitrate) compared to Alpha Minimum Essential Medium Eagle 
culture medium. The Dulbecco’s Modified Eagle’s Medium was developed since 1969 
and is a modification of Basal Medium Eagle (BME) that contains 1000 mg/L of 
glucose and was first reported for culturing murine embryonic stem cells. Therefore, 
DMEM+10% FBS is probably suitable culture medium for culturing caprine embryonic 
stem cells. Furthermore, most of the researchers used Dulbecco’s Modified Eagle’s 
Medium for culturing embryonic stem cells rather than Alpha Minimum Essential 
Medium Eagle, where Dulbecco’s Modified Eagle’s Medium with 10 to 20% foetal 
bovine serum has been used since the early days of murine embryonic stem cell culture 
(Evans and Kaufman, 1981; Tesar, 2005).  
Manual cut technique always show the highest percent attachment of inner cell 
mass, primary inner cell mass outgrowth and successful consecutive passages caprine 
embryonic stem cell lines in both DMEM+10% FBS and αMEM+10% FBS culture 
media compared to whole blastocyst culture and laser dissection techniques. Culture 
conditions currently in use for caprine embryonic stem cells have been mainly 
developed from murine embryonic stem cell culture and it would appear that they are 
not very effective for maintaining caprine embryonic stem cells. Various components 
are usually supplemented to embryonic stem cell culture media. One of the components 
is the cytokine, such as leukaemia inhibitory factors (LIF), basic fibroblast growth 
factor (bFGF) and stem cell factor (SCF). Some researchers used only feeder cell layer 
and did not add any foreign cytokines in the embryonic stem cell medium (Chen et al., 
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1991) while others added leukaemia inhibitory factors, basic fibroblast growth factor 
and stem cell factor to the embryonic stem cell medium and also used feeder cell layer 
(Piedrahita et al., 1990). Although leukaemia inhibitory factors can inhibit 
differentiation of embryonic stem cell, basic fibroblast growth factor can stimulate 
embryonic stem cells proliferation (Schmitt et al., 1991) and feeder cell layer is one of 
the key factors influencing embryonic stem cell culture (Piedrahita et al., 1990), we 
only add to our embryonic stem cell culture medium and used mouse embryonic 
fibroblast as feeder cell layer. Leukaemia inhibitory factor has been proved to leukemia 
inhibitory factors inhibit differentiation of embryonic stem cells (Niwa et al., 1998).  
As discussed in previous findings in murine species, the trophectoderm cells will 
induce the differentiation of inner cell mass. Therefore, completely removal of 
trophectoderm cells from inner cell mass cells is very important in order to obtain high 
quality and efficacy of caprine embryonic stem cell line production. This has been 
proved that mechanical isolation of the inner cell mass has previously been successfully 
used in the derivation of 2 cell lines (Mummery, 2004; Genbacev et al., 2005; van de 
Stolpe et al., 2010). Our results have been improved by manual cut inner cell mass 
isolation technique in caprine species as described in the previous findings in murine 
species.  In previously studied in other laboratories, inner cell mass cells were isolated 
from blastocysts by immunosurgery (Solter and Knowles, 1975; Wianny et al., 1997; 
Chen et al., 1999), but it is not always effective when antiserum is used during 
immunosurgery. In addition, making antiserum is laborious. In this study, an easy 
method to isolate inner cell mass cells from blastocysts was established. We found that 
it is very easy to isolate inner cell mass cells from blastocysts by manual cut as it is not 
costly and obtained healthier inner cell mass cells and better results of consecutive 
embryonic stem cell culture.  
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The present results showed that no significant differences (P>0.05) in percent 
attachment of inner cell mass, primary outgrowth of inner cell mass, successful 
consecutive passages of caprine embryonic stem cell lines for fresh and frozen-thawed 
mouse embryonic fibroblasts. However, fresh mouse embryonic fibroblast gave higher 
percent attachment of inner cell mass, primary inner cell mass outgrowth and successful 
consecutive passages of caprine embryonic stem cell lines up to Passage 3 than frozen-
thawed mouse embryonic fibroblasts. It has been reported that mouse embryonic 
fibroblast secrete some kinds of cytokines (Smith et al., 1988), which may stimulate 
embryonic stem cells growth and inhibit their differentiation. Mouse embryonic 
fibroblast has been shown to produce the factors responsible for maintaining embryonic 
carcinoma cells in undifferentiated state by inhibiting their differentiation as reported by 
Martin and Evans (1975). In addition, mitomycin C treat time also affected the mouse 
embryonic fibroblast activity. If the time was more than 3 hours, the mouse embryonic 
fibroblast could not be used as a feeder cell layer as the cell’s ability to adhere to the 
dishes was decreased significantly. Once the mouse embryonic underwent 
cryopreservation, the above properties of mouse embryonic fibroblast would get 
affected. Thus, the frozen-thawed mouse embryonic fibroblast would gave lower 
percent attachment of inner cell mass, primary outgrowth of inner cell mass and 
successful consecutive passages of caprine embryonic stem cell lines up to Passage 3 
than fresh mouse embryonic fibroblasts.   
There were highly significant differences (P<0.05) between in vivo- and in vitro- 
derived blastocyst sources in percent caprine embryonic stem cell lines in Passages 1 
and 3. Correspondily, the percent attachment of inner cell mass, primary inner cell mass 
outgrowth and consecutive caprine embryonic stem cell lines passages were higher in 
the former. The present study indicates that culture inner cell mass from in vivo-derived 
caprine blastocysts is more effective than in vitro-derived blastocysts. When in vitro 
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produced blastocysts were used, they found that intact or whole blastocyst culture was 
better than isolated inner cell mass culture as small or unclear inner cell mass were 
present in vitro produced blastocysts (Li et al., 2003b). Li et al. (2003b) reported that 
isolated inner cell mass is superior to intact blastocyst culture when in vivo produced 
blastocysts were used.  
 
5.5 CONFIRMATION OF CAPRINE AND MURINE EMBRYONIC STEM  
      CELLS BY IMMUNOFLUORESCENT STAINING PROTEIN MARKERS       
      (EXPERIMENT 5) 
 
5.5.1 Confirmation of Murine Embryonic Stem Cells by Specific Embryonic Stem  
          Cell Markers  
 
In the present study, we used the specific embryonic stem cell markers such as Oct 4, 
SSEA 1, SSEA3, SSEA 4, TRA-1-60 and TRA-1-81 to confirm the presence of 
embryonic stem cell in murine species. Five widely adopted antibody markers (anti-Oct 
4, anti-Sox 2, anti-SSEA 1, 3 and 4, anti-TRA-1-60 and anti-TRA-1-81) are the protein 
markers that usually found on embryonic stem cells. Several transcription factors, 
including Oct 3/4 (Nichols et al., 1998; Niwa et al., 2002), Sox 2 (Avilion et al., 2003) 
and Nanog (Chambers et al., 2003; Mitsui et al., 2003) function in the maintenance of 
pluripotency in both early embryos and embryonic stem cells. Oct 4 and Sox 2 are 
transcription factors highly expressed in undifferentiated embryonic stem cells and 
embryonic germinal carcinoma (Looijenga et al., 2003; Masui and Shinji, 2007; Zhao 
and Daley, 2008).  
Oct 4 marker was found in murine embryonic stem cell in the present results, 
where it showed green colour after underwent embryonic stem cell markers staining. A 
classical marker of embryonic stem cells (cultured cells derived from the pluripotent 
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inner cell mass cells of pre-implantation embryos) and in vivo embryonic blastocyst 
cells is the transcription factor, Oct 4. Oct 4, exclusively expressed by embryonic and 
germ cells, plays a critical role in the establishment and/or maintenance of pluripotency 
(Donovan and Gearhart, 2001; Pesce et al., 1998a, b) The Oct 4 gene transcript is found 
in the totipotent and pluripotent stem cells of the early murine embryo and is down 
regulated when the cells differentiate (Scholer et al., 1990; Palmieri et al., 1994). Oct 4 
is active in the inner cell mass cells and down regulated in the pre-trophectoderm cells, 
or cells of the outer layer of the blastocyst. The Oct 4 transcript levels are maintained in 
the epiblast, but expression soon becomes gradually restricted to cells of the germline as 
gastrulation proceeds (Pesce et al., 1998a; Yeom et al., 1996). Oct 4 is the first 
described protein which appears to be specific for the mammalian totipotent cycle 
(Yeom et al., 1996; Yoshimizu et al., 1999). The Oct 4 protein could either repress or 
activate transcription in particular target genes during embryonic development. These 
varied, initiating molecular events remain uncertain and complex, and deciphering these 
cell differentiation pathways is pivotal to the growth of stem cell technology (Ovitt and 
Scholer, 1998). The Oct 4 gene has been found only in mammals, and the human 
sequence is 87% identical to that of the murine (Ovitt and Scholer, 1998; Brehm et al, 
1998).  
The transcription factor, Oct 4 is regarded as a candidate master regulator for the 
initiation, maintenance, and differentiation of pluripotent cells (Nichols et al., 1998; 
Niwa and Smith, 2000; Boiani et al., 2002; Zhang et al., 2005). An understanding of 
this gene’s expression will provide experimental evidence for clarification of target 
genes controlled by Oct 4 (Zhang et al., 2005). Because the quantitative expression of 
Oct 4 defines differentiation and self-renewal of embryonic stem cells (Niwa and Smith, 
2000), the ability to regulate Oct 4 expression is a vehicle to understanding 
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tumorigenesis, increasing pluripotency of somatic cells, and modeling of the multiple 
layers of transcription and growth factors involved in embryology.  
In murine, Oct 4 expression is crucial to the success of murine preimplantation 
development (Scholer et al., 1989a, 1990; Okamoto et al., 1990; Takeda et al., 1992; 
van Eijk et al., 1999). Maternal Oct 4 mRNA and protein are present in unfertilised 
murine oocytes (Palmieri et al., 1994) and in the nuclei of subsequent cleavage stages 
(Palmieri et al., 1994; Yoem et al., 1996; Kirchhof et al., 2000). During the first 2 
cleavage stages, the levels of Oct 4 mRNA decrease to background and then steadily 
increase thereafter. After activation, in murine hatched blastocysts, Oct 4 mRNA is 
found in the inner cell mass which differentiates into epiblast and hypoblast (second 
extraembryonic lineage) (Pesce et al., 1998b); as the murine blastocyst forms, Oct 4 
expression is downregulated, and with expansion, Oct 4 protein and mRNA are 
primarily found in the inner cell mass (Pesce et al., 1998a; Palmieri et al., 1994). As the 
inner cell mass differentiates into the epiblast (embryonic ectoderm) and the hypoblast 
(embryonic endoderm), and the hypoblast cells migrate along the inner surface of the 
trophectoderm, high levels of Oct 4 protein are found within these tissues (Pesce et al., 
1998a; Scholer et al., 1990; Kirchhof et al., 2000). The pluripotent cells of the murine 
embryo and germ line, and embryonic stem cells in culture are characterised by 
expression of the homeobox gene, Oct 4 (Rathjen et al., 1999). Oct 4 was identified as a 
nucleic acid binding embryonic stem cell-enriched gene (Ramalho-Santos et al., 2002).  
For nuclear transfer murine embryos, less than half of all somatic cell clones 
develop to the blastocyst stage, and of those, less than one-third develop beyond 
implantation. They died shortly after implantation with an inability to form embryonic 
tissues. An absence of Oct 4 results in preimplantation lethality before the murine 
oocyte cylinder forms (Nichols et al., 1998). The murine embryos deficient in Oct 4 
developed to blastocysts that lacked an inner cell mass. Murine Oct 4 is expressed in the 
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murine inner cell mass but not in the pre-trophectodermal cells (Palmieri et al., 1994; 
van Eijk et al., 1999). Expression of the gene is uniform in all cells of the embryo 
through the morula stage, however, as the outer cells differentiate into trophectoderm 
cells, Oct 4 expression becomes restricted to the cells of the inner cell mass in the 
blastocyst (Scholer et al., 1990; Yeom et al., 1996; Ovitt and Shocler, 1998).  
Expression stage-specific embryonic antigen (SSEA) also appeared on murine 
embryonic stem cells. There are several types of stage-specific embryonic antigen that 
found in pluripotent of embryonic stem cells, namely SSEA 1, SSEA 3 and SSEA 4. In 
present study, only SSEA 1 was found in murine embryonic stem cells which gave 
green colour for embryonic stem cell markers staining. SSEA 1 is a globoseries 
carbohydrate antigen present on the surface of murine embryonic stem cells, but not 
human embryonic stem cells (Kohji et al., 2008). It was localised on the stem cells of 
differentiating solid teratocarcinomas and on the surface of core cells of solid embryoid 
bodies. At the embryo cylinder stage, the antigen is restricted to embryonic ectoderm 
and visceral endoderm. During subsequent development, SSEA 1 becomes localised to 
portions of the brain and primordial germ cells. In adult murine, the epithelium of the 
oviduct, the endometrium, and the epididymis are the cells most reactive with the 
monoclonal antibody to SSEA 1; although some areas of the brain and kidney tubules 
are weakly positive. SSEA 3 and SSEA 4 is a globoseries carbohydrate antigen present 
on the surface of human embryonic stem cell, but not murine embryonic stem cell 
(Solter and Knowles, 1978; Przyborski, 2001). Upon differentiation, murine embryonic 
stem cells are characterised by the loss of SSEA 1 expression and may be accompanied, 
in same instances, by the appearance of SSEA 3 and SSEA 4 (Solter et al., 1979).  
Murine embryonic stem cells also express high levels of membrane alkaline 
phosphatase (AP) as found in the present experiment. Alkaline phosphatase is a stem 
cell membrane marker. Elevated expression of alkaline phosphatase is associated with 
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pluripotent status (Thomson et al., 1998). Alkaline phosphatase is an enzyme in the 
blood, intestines, liver, and bone cells and exists as membrane-bound isoforms of 
glycoproteins sharing a common protein structure but differing in carbohydrate content. 
These enzymes are most active at alkaline pH-hence the name (Thomson et al., 1998). 
Undifferentiated human embryonic stem cells, embryonic carcinoma cells and 
embryonic germ cells have been shown to express a very high level of the liver or bone 
or kidney isozyme of alkaline phosphatase (Thomson et al., 1995; Millan and Fishman, 
1996; Shamblott et al., 1998; Draper et al., 2004). Alkaline phosphatase staining was 
carried out to determine the alkaline phosphatase activities that found in the murine 
embryonic stem cell lines. Purplish colour was shown in murine embryonic stem cells 
after underwent alkaline phosphatase staining. Expression levels of alkaline 
phosphatase decrease following stem cell differentiation. It was found that decreasing in 
alkaline phosphatase activities once the stem cell underwent differentiation. It 
confirmed the presence of true murine embryonic stem cells which showed alkaline 
phosphatase activities. There were no colour shown for TRA-1-60 and TRA-1-81 
embryonic stem cell markers in murine species. We used human embryonic stem cell 
specific markers (TRA-1-60 and TRA-1-81) as negative control in the present 
experiment. TRA-1-60 and TRA-1-81 antigens are expressed on the surface of human 
teratocarcinoma stem cells human embryonic germinal carcinoma and human 
embryonic stem cells (Andrews et al., 1984), but no expression in murine embryonic 
stem cells.  
In summary, Oct 4, SSEA 1 and alkaline phosphatase activities were found in 
murine embryonic stem cells which prove the presence of true and pluripotent 
embryonic stem cells in murine species. 
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5.5.2 Confirmation of Caprine Embryonic Stem Cells by Specific Embryonic Stem  
         Cell Markers  
 
Similar as murine species, caprine embryonic stem cells also confirmed the true of 
embryonic stem cells by using embryonic stem cell markers staining. In the present 
study, Oct 4 (red) and SSEA 3 (green)were expressed on caprine embryonic stem cells 
as well as alkaline phopsphatase staining gave positive results by showing purplish 
colour after alkaline phospatase staining.  
Expression of Oct 4 was found caprine (Pawar et al., 2009). To our knowledge, 
Oct 4 is an octamer binding protein stimulates transcription and is found in primary 
germ cells (PGC), unfertilised oocytes and pluripotent embryonic stem cells; when the 
stem cells are induced to differentiate, the amount of the octamer binding factor 
decreases (Scholer et al., 1989a, b). It was suggested by Scholer and co-workers that the 
Oct 4 protein was not only present in oocytes but could be synthesised de novo by 
zygotic expression in the embryo (Scholer et al., 1989b). This mammalian transcription 
factor is exclusively expressed by embryonic and germ cells. Transcription factors are 
DNA binding proteins that could control the rate of transcription of certain genes. 
Understanding how transcription factors are expressed and function is a requirement for 
comprehending developmental processes. Oct 4 plays an important role during the early 
stage of murine embryogenesis and in the germline as an essential component of 
regulation for germline maintenance (Brehm et al., 1998).  
Developmental lineage begins at the end of the cleavage stage of an embryo 
with compaction and leads to the development of the blastocyst. The trophectoderm, or 
outer layer of the blastocyst, generates the trophoblastic components of the placenta, 
while the inner cell mass cells develop into the pluripotent progenitors of all of the 
foetal cell types, including the germ cells and the non-trophoblastic extraembryonic 
tissues (Nichols et al., 1998). Understanding the molecular basis of these pluripotent 
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cells is critical to efforts to propagate stem cells. The explanation of molecular 
interaction that governs the trophoblast and inner cell mass development will provide an 
outline of complex tissue interaction in further development (Nichols et al., 1998). Oct 
4 could either repress or activate transcription in particular target genes and is one of the 
best candidates for an embryonic regulatory factor. These varied embryonic initiating 
molecular events remain uncertain and complex, while Oct 4 has emerged as a critical 
transcription factor that establishes pluripotency (Ovitt and Scholer, 1998). Deciphering 
the cell differentiation pathways is pivotal to growth of stem cell technology.  
Oct 4 action appears to go beyond a simple repression of trophoblastic lineage 
and activation of embryonic stem cells; it activates transcription of genes through 
cooperation of protein “partners.” Thus, Oct 4 regulates expression of multiple genes 
via interactions with other transcription factors such as: Sry-related (Sex determining 
region on the Y), Sox 2 (Nichols et al., 1998; Niwa and Smith, 2000; Du et al., 2001), a 
stem-cell-restricted E1A-like protein (Ovitt and Scholer, 1998; Nichols et al., 1998; 
Niwa and Smith, 2000; Du et al., 2001; Scholer et al., 1991) and the transcription factor 
Rox1 (Niwa and Smith, 2000). Maintaining Oct 4 expression within a certain range 
appears to be crucial for stem-cell renewal, while any increase or decrease triggers 
differentiation to endoderm or mesoderm or trophectoderm, respectively (Niwa and 
Smith, 2000). Oct 4 is a master regulator of pluripotency that determines lineage 
commitment and illustrates the complexity of critical transcriptional regulators with the 
need for quantitative analyses (Niwa and Smith, 2000; Pesce et al., 1999).  
For cloned embryos through somatic cell nuclear transfer, the Oct 4 temporal 
activation in somatic cell clones appeared to be normal, the maintenance of expression 
and cell type-specific Oct 4 regulation in the trophectoderm and inner cell mass were 
not. The abnormalities of Oct 4 expression in clones suggested that pluripotency was 
compromised. Activation of Oct 4 is not due to a general opening of chromatin after 
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nuclear transfer. Thus, gene regulation in later stage clones may involve transcription 
factors available in the oocyte cytoplasm or the chromatin remodeling might become 
dysfunctional (Boiani et al., 2002). Theoretically, totipotency can be restored to the 
nuclei of somatic cells by reprogramming the nucleus with the technique of nuclear 
transfer. A change in gene expression of the somatic cells must accompany this nuclear 
reprogramming. In addition, maintaining Oct 4 expression within a certain level appears 
to be critical for stem cell renewal.  
Alkaline phosphatase is one of the markers to evaluate pluripotent cells and has 
been used to identify stem cells in culture for many years (Wobus et al., 1984; Talbot et 
al., 1993). Our results indicate that the caprine embryonic stem cells obtained in the 
present study are pluripotent, where it gave positive results for alkaline phosphatase 
staining. Alkaline phosphatase and Oct 4 expression has been used characteristically to 
identify pluripotent embryonic stem cells in many animal species such as buffalo 
(Verma et al., 2007), porcine (Li et al., 2003a), equine (Saito et al., 2002) and primate 
(Thomson and Marshall, 1998). Expression stage-specific embryonic antigen SSEA 3 
only appeared on caprine embryonic stem cells (SSEA 1 is not found in caprine species 
as it is only found in murine embryonic stem cells).  
In contrast, human embryonic stem cells and embryonic carcinoma cells 
typically express SSEA 3 and SSEA 4 but not SSEA 1, while their differentiation is 
characterised by down regulation of SSEA 3 and SSEA 4 and an up regulation of SSEA 
1 (Andrews, 1984; Andrews et al., 1987; Fenderson et al., 1987). The differences of 
between murine and caprine embryonic stem cells were summarised in Table 4.74 
based on expression of embryonic stem cells protein markers, morphoplogy and 
characteristics of embryonic stem cells. In summary, the caprine embryonic stem cells 
were successfully identified in the present study. These cells exhibit many important 
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features of pluripotent stem cells, including positive alkaline phosphatase activity, Oct 4 
and SSEA 3 expressions.  
 
5.6 GENERAL DISCUSSION 
In order to obtain good quality and healthy embryonic stem cell lines, good sources of 
blastocyst obtained, suitability of feeder cell layer and culture medium are the main 
consideration to be look into in greater details. Before obtaining the blastocysts, 
superovulation of the female is conventionally necessary to produce large amount of 
oocytes and embryos to be used as a source for production of embryonic stem cells. In 
the present study, among the strains studied, CBA/ca gave the optimise superovulation 
response with regard to blastocyst obtained. Superovulation using gonadotrophins has 
the benefit to synchronise the oestrous cycle of many female donors, whereby it eases 
coordination of experiments as well as facilitates the use of immature female to obtain 
oocytes and collection of oocytes from less fertile animals (Pinkert and Martin, 2005). 
The general method in the traditional superovulation of murine is the injection of 
pregnant mare’s serum gonadotrophin, followed by human chorionic gonadotrophin 48 
hours apart, although the dose may vary among researchers (Ertzeid and Storeng, 1992; 
Van der Auwera and D’Hooghe, 2001). It was thought that successful superovulation in 
murine requires the synergistic effects of both pregnant mare’s serum gonadotrophin 
and human chorionic gonadotrophin injection. Pregnant mare’s serum gonadotrophin 
mimics the effects of follicle stimulating hormone produced by the female murine and 
functions to induce follicular growth and subsequently prepares them for ovulation 
(Christenson and Eleftheriou, 1972). More follicles were induced to mature as a result 
of increased amount of stimulating gonadotrophins, thus producing more embryos. On 
the other hand, human chorionic gonadotrophin also referred to as equine chorionic 
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gonadotrophin (eCG) (Spearow and Barkley, 1999) mimics the luteinising hormone 
(LH) to stimulate the ovulation of mature ova.  
The efficiency of superovulation in females murine depends on several factors. 
The factors include the strains of murine, their physical condition such as age, weight 
and sexual maturity, the type, dose and timing of gonadotrophin administration (Hogan 
et al., 1986) and external factors (Zarrow et al., 1971; 1972). Differences in 
superovulatory response in different strains of murine have been observed (Hogan et al., 
1986; Byers et al., 2006). Hogan et al. (1986) divides different strains of murine 
according to their superovulatory performance. High ovulators are C57BL/6J, 129/SvJ 
and CBA/CaJ strain while low ovulators are such as the A/J, BALB/CJ and DBA/2J 
strains (Hogan et al., 1986). The role of genetics in the variation in superovulatory 
response in murine is confirmed by Spearow and Barkley (1999). According to DeLeon 
et al. (1990), genetic variation among different strains of murine causes variation in the 
oestrous cycle in terms of the hormonal secretory patterns. Different strain differs in the 
timing of peak prolactin and progesterone secretion and the amount of prolactin that 
released is also different. In addition, murine with good reproductive performance have 
higher ovarian luteinising hormone receptors and lower prolactin concentration during 
the pro-oestrous stage compared to those with poor reproductive performance. Thus, 
this explains their better ovulatory response, as high concentration of prolactin will 
inhibit the induction of luteinising hormone receptors. The higher number of 
unoccupied ovarian luteinising hormone receptors allows better response to 
superovulatory treatment. Besides that, high concentration of prolactin would inhibit 
ovarian aromatase, responsible for oestrogen production (Tsai-Morris et al., 1983). 
Lower oestrogen secretion in turn results in the irregular oestrous cycle and reduced 
fertility in murine (DeLeon et al., 1990). Therefore, genetic differences in the various 
strains of murine result in different hormonal levels, which influence the number of 
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unoccupied ovarian luteinising hormone receptors available for superovulation, thus 
resulting in different superovulatory performance.  
Individual murine exhibit varying degree of response to superovulation 
treatment depending on the individual physical condition. Sexually immature females of 
between 3 to 5 weeks old were the most receptive of pregnant mare’s serum 
gonadotrophin treatment (Hogan et al., 1986). This could be due to the high number of 
follicles available for stimulation. Unhealthy and underweight murine produces lower 
amount of embroys after superovulation (Hogan et al., 1986). There was also some 
correlation between body weight and ovulation rate, whereby a healthy body weight 
positively influences the induction of luteinising hormone receptors, thus allowing 
better stimulation by gonadotrophins (Spearow and Bradford, 1983). The efficiency of 
superovulation in murine is also greatly dependent on the dose of gonadotrophins 
administered (Fowler and Edwards, 1957; Wilson and Zarrow, 1962). This also 
demonstrated in other rodent species (Mukumoto et al., 1995). Researchers generally 
use the optimum dose of 5 to10 IU of pregnant mare’s serum gonadotrophin for murine 
(Wilson and Zarrow, 1962; Ertzeid and Storeng, 2001; Van der Auwera and D’Hooghe, 
2001). Excess doses of pregnant mare’s serum gonadotrophin failed to induce 
superovulation in murine due to thickening of the zona granulosa of the follicles, which 
impede the release of the ova (Wilson and Zarrow, 1962). The dose of human chorionic 
gonadotrophin influences superovulation to a lesser extent. Ovulation will occur even if 
small amounts were administered. Excessive dose of human chorionic gonadotrophin 
did not affect the oocytes count (Wilson and Zarrow, 1962).  
Superovulation is also influenced by the time of hormonal administration and 
subsequent time interval between the initial injection of pregnant mare’s serum 
gonadotrophin and subsequent human chorionic gonadotrophin injection (Wilson and 
Zarrow, 1962). The optimal time for the administration of hormones is in turn 
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dependent on the local light-dark cycle, as it influences the endogenous luteinising 
hormone release in response to pregnant mare’s serum gonadotrophin (Hogan et al., 
1986). Human chorionic gonadotrophin is best administered a few hours before 
endogenous luteinising hormone release. The time interval is also important, as 
sufficient time is required for maximum follicular stimulation, while mature follicles 
that are left for too long without release of oocyte will begin to degenerate. The 
optimum time interval reported by Wilson and Zarrow (1962) is between 30 to 50 hours 
apart. Others have found 42 to 48 hours to be optimal (Hogan et al., 1986). The widely 
used time interval is 40 hours (Fowler and Edwards, 1957; Wilson and Zarrow, 1962) 
and 48 hours (Van der Auwera and D’Hooghe, 2001). Superovulation in murine also 
facilitated by external factors, among them pheromones produced by male murine. In 
certain strain of murine such as the C57BL/6J, the presence of males causes a higher 
number of oocytes to be produced. The pheromones released by the male murine 
stimulate the endogenous release of follicles timulating and luteinising hormone, thus 
facilitating superovulation (Zarrow et al., 1971; 1972).   
From this study, it was determined that ICR is the more suitable strain to derive 
mouse embryonic fibroblasts. Thus, future studies involving murine embryonic stem 
cells coulb be carried out using ICR mouse embryonic fibroblast rather than a random 
or inferior strain as used in some previous studies (Brook and Gardner, 1997; Bryja et 
al., 2006). Also, both fresh and frozen-thawed mouse embryonic fibroblast and 
Passages 1 and 2 could be used as feeder cell layer for embryonic stem cells. Besides 
that, both culture media (DMEM and αMEM) also could be used for cultured 
embryonic stem cells. However, Dulbecco’s Modified Eagle’s Medium is more suitable 
and produce high successful attachment of blastocyst, primary inner cell mass 
outgrowth and consecutive passages rate in embryonic stem cells.  
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Also, a significant finding in the present experiment is that expanded blastocysts 
from CBA/ca strain are better sources of embryonic stem cell line. The use of expanded 
blastocysts could be applied in future experiment involving embryonic stem cells to 
improve efficiency, rather than ignoring the blastocyst stage when deriving embryonic 
stem cell lines (Suemori and Nakatsuji, 1987; Kawase et al., 1994; Brook and Gardner, 
1997; Bryja et al., 2006). It is important to increase the quality and efficiency of 
embryonic stem cells experiments because of its potential in regenerative medicine and 
also embryonic stem cells research requires the sacrifice of life in the form of murine 
and blastocysts, hence any form of unnecessary wasting should be minimised. This is 
crucial in embryonic stem cells research of other animals such as caprine which 
produces only a small amount of blastocysts even after superovulation, thus each and 
every blastocyst is very valuable and their use must be maximised. The findings in the 
effects of blastocyst stage on embryonic stem cells derivation is important as future 
studies involving embryonic stem cells could be enhanced by using the appropriate 
blastocyst stage. However, the exact mechanism causing this is still poorly understood, 
thus necessitating further research into factors such as possible differences in the 
expression of Oct 4 and Sox 2 among the blastocyst stages.  
The inner cell mass isolation also is the crucial factor in determine the quality of 
murine embryonic stem cells production. Manual cut inner cell mass isolation technique 
is the most effective technique in producing high quality and undifferentiated murine 
embryonic stem cells. By total removing the trophectoderm cells from the inner cell 
mass cells, the murine embryonic stem cells could maintain in undifferentiated state and 
able to obtaine pure murine embryonic stem cell lines compared with whole blsatocyst 
culture and laser dissection techniques.   
In summary, ICR is the suitable strain as feeder cell layer as well as CBA/ca is 
more suitable strain as a source of blastocyst for embryonic stem cells culture. 
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Meanwhile, the C57BL/6J strain is the least suitable. The present study also found that 
fresh and frozen-thawed mouse embryonic fibroblasts at Passages 1 and 2 have similar 
growth rates and both can be efficiently used for embryonic stem cell culture. Also, 
even though embryonic stem cells could be derived from any strain or blastocyst stage, 
expanded blastocysts from the CBA/ca strain gave the highest efficiency. This finding, 
coupled with the fact that CBA/ca strain gave the best performance in superovulation 
means that this strain is most suitable as a source for deriving murine embroynic stem 
cells. Early and hatched blastocysts are not suitable sources for deriving murine 
embryonic stem cells. The presence of true and pluripotent murine embryonic stem cells 
also confirmed by embryonic stem cells protein markers staining where it gave positive 
expression of Oct 4, SSEA 1 and alkaline phosphatase activities in our present 
experiment.  
 There were several constraints in the present experiment. Firstly, the murine 
should be maintain in the best possible condition and health to ensure high quality and 
quantity of embryos produced. For best performance in mating, a stud male should be 
isolated in a single cage 1 week prior to mating as the testosterone level will be lowered 
in the presence of other males, thus affecting the quantity and quality of sperm (Hogan 
et al., 1986). To do this is barely possible due to insufficient amount of cages and space 
in the animal house. Also, to ensure best performance in superovulation, females should 
be on a high-fat diet so that they could be at the optimal weight once they hit sexual 
maturity, which is the time that they could mate and also have the best response to 
superovulation (Hogan et al., 1986). Thus, to overcome these constrains, extra funds 
should be allocated to the maintenance of quality of murine especially in regard to space 
and feed. 
 The culture of embryonic stem cells is best done on multi-well plates as each 
blastocyst or inner cell mass should be separate from another during culture (Bryja et 
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al., 2006; Wakayama et al., 2007). This will ensure that each embryonic stem cell line 
will contain the same genetic material originating from the same blastocyst and not 
mixed with embryonic stem cells from another blastocyst. The use of multi-well plates 
also provides a higher surface area for attachment (Williams et al., 1988). The correct 
method of establishing an embryonic stem cell line is to firstly culture the blastocysts on 
separate wells on a 96-well plate, and once an outgrowth forms, they are transferred to a 
48-well plate, and subsequently to larger wells according to the size of the colony 
(Bryja et al., 2006). The use of different multi-well plates is much more costly 
compared to using 35 mm culture dishes. Therefore, this method could be used when 
there are extra research fundings. For now, the best way to improve efficiency is by 
improving the technique of the personnel.  
 The latest studies in embryonic stem cell used Knockout DMEM supplemented 
with serum replacment (SR) as the culture medium as it gives the best efficiency (Bryja 
et al., 2006; Wakayama et al., 2007). This medium selectively favours the proliferation 
of embryonic stem cells while inhibiting other cell types of the blastocyst (Bryja et al., 
2006). However, this medium is more costly. Thus, when there are enough research 
fundings, this medium can be used to replace the current use of DMEM supplemented 
with foetal bovine serum as the culture medium for embryonic stem cells.  
In caprine species, laser enucleation technique seems to be more suitable 
compared to squeezing enucleation technique. However, the laser facility is costly and 
need practice to obtain optimal outcome in cloning. Also, pre-intracytoplasmic 
injection duration at 60 minutes seems to produce better cleavage rates in somatic cell 
nuclear transfer technique. These findings are believed to be first to be studied since 
there is no report regarding this in the literature. Furthermore, modification and method 
on preparation the in vitro maturation culture medium, where it supplemented with 
bFSH help in improve the maturation rates (Gupta, personnel communication).  
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General factors known to affect the production caprine embryonic stem cell 
lines were those such as types of feeder cell layer, embryonic stem cells culture 
medium, in vivo- or in vitro-derived blastocyst sources, inner cell mass isolation 
techniques and blastocyst stages used in producing caprine embryonic stem cell lines. In 
the present study, we used mouse embryonic fibroblast as feeder cell layer and mouse 
embryonic stem cell culture medium for culturing the caprine embryonic stem cells 
since it was working by culturing the murine embryonic stem cell lines. Although we 
manage to obtain caprine embryonic stem cells by applying the techniques and culture 
media from murine species, the caprine embryonic stem cells tends to differentiate 
when reach Passage 3. To our knowledge, different species required different growth 
factors such as cytokines to give nutrients to produce embryonic stem cell lines. This 
could be due to the type of feeder cell layer and embryonic stem cell culture medium 
used in this experiment. For future studies, we suggested that used goat foetal fibroblast 
as feeder cell layer as it may secrets some known and unkown factors which are closer 
to caprine species needed compared with mouse embryonic fibroblast (Pawar et al., 
2009) as well as modified the murine embryonic stem cell culture medium by increased 
the leukaemia inhibitory factors concentration for obtaining higher and more 
undifferentiated caprine embryonic stem cell lines.  
Also, sources of blastocyst derived are lysignificant important to obtain high 
efficacy of caprine embryonic stem cells production. In the present findings, we noticed 
that in vivo-derived blastocysts produce high percent of caprine inner cell mass 
outgrowth and successful consecutive passages of caprine embryonic stem cells up to 
Passage 3 compared with in vitro-derived blastocysts. The main reasons of these were 
in vivo-derived blatocysts are more stable which already developed as embryos in the 
body condition where it provides more suitable condition for embryos development, 
whereas the in vitro-derived blastocysts were culture in vitro which outside the body 
  
 
367 
 
would less stablised compared to in vivo-derived blastocysts. In vitro-derived 
blastocysts such as embryos from nuclear transfer will produce less effective quality of 
embryos compared with in vivo-derived blastocysts. This is because the low frequency 
of successful development has been attributed to incomplete or inappropriate 
reprogramming of the transferred nuclear genome. Many studies have demonstrated that 
such reprogramming occurs by epigenetic mechanisms not involving alterations in 
DNA sequence, however, at present the molecular mechanisms underlying 
reprogramming are poorly defined. The first visible manifestation of the reprogramming 
of a somatic nucleus is the formation of a blastocyst, characterised by the differentiation 
of the trophectoderm and its separation with the inner cell mass. However, careful 
examination of these blastocysts reveals that they are, in fact, abnormal in several ways. 
For example, most caprine somatic cell nuclear transfer blastocysts exhibit an abnormal 
pattern of expression and methylation of imprinted genes, even those that are 
morphologically perfect (Mannen et al., 2003). The aberrant expression pattern of Oct 4 
and related genes was also thought to account for the high mortality of somatic cell 
nuclear transfer embryos because of the inability to maintain pluripotent inner cell mass 
cells (Boiani et al., 2002; Bortvin et al., 2003). In blastocyst cell nuclei, an asymmetric 
methylation pattern begins to appear in fertilised embryos, with the extraembryonic 
lineages-trophectoderm, and later primitive endoderm-derived lineages being hypo-
methylated compared to the epiblast (Santos et al., 2002; Monk et al., 1987). In nuclear 
transfer blastocysts, this process is apparently disrupted, with the trophectoderm being 
hyper-methylated (Dean et al., 2001; Bourc’his et al., 2001; Kang et al., 2002). 
Nuclear transfer of murine embryonic stem cells (ntES) has always been 
relatively simple, provided the embryonic stem cell lines sources are available. Single 
murine embryonic stem cells survive well and predictably have high cloning efficiency, 
ranging up to 50%. This is not the case for caprine embryonic stem cells, which seem to 
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be exquisitely sensitive to dissociation and typically clone with efficiencies of less than 
1%. Methods to improve cloning efficiencies are in active development, and include 
combinations of growth factors, co-cultures and optimising other medium components. 
The development of the reconstructed embryo is thought to be controlled by interactions 
between the recipient cytoplasm and the donor chromatin. The role of cytoplasm from 
the donor cell is undefined; however, our studies using nuclear donors with different 
volumes of cytoplasm provided evidence that a high karyoplast-cytoplast volume ratio 
may interfere with development of caprine nuclear transfer embryos (Zakhartchenko et 
al., 1997). Basic studies on nuclear transfer will continue to increase our understanding 
how genomic activation and cell cycle synchrony affect nuclear reprogramming and 
cloning efficiencies. Previous study shows that epigenetic reprogramming occurs 
aberrantly in most cloned embryos; incomplete reprogramming may contribute to the 
low efficiency of cloning. Global epigenetic reprogramming of somatic nuclei is 
aberrant in most preimplantation cloned embryos (Dean et al., 2001). Correct epigenetic 
reprogramming is necessary for successful and normal developmental of clones (Dean 
et al., 2001) The transplantation of somatic cell nuclei to enucleated oocytes has shown 
that genes can be reprogrammed to an embryonic pattern of expression, thereby 
indicating a reversal of their epigenetic state.  In normal embryonic development, cells 
lose their pluripotent status and become restricted to a particular differentiation pathway 
by receiving signals from other cells. Once on the pathway to one kind of 
differentiation, cells do not redifferentiate in other directions and their commitment to 
differentiation is very stable. However, this does not mean that their nuclei have stably 
lost their earlier developmental plasticity. In addition, successful cloning involves 
efficient DNA replication, appropriate DNA methylation or demethylation, chromatin 
remodeling and X chromosome reactivation (Reik et al., 2001; Rideout et al., 2001; Shi 
et al., 2003), the low success rate could be caused by an incomplete reprogramming of 
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the epigenetic state of nuclei from differentiated donor cells. These considerations led 
us to explore further the nature of the constraints that limit the efficiency with which 
somatic cell nuclei can be reprogrammed by oocyte cytoplasm. It is easy to understand 
that genes permanently switched off in the course of cell differentiation may be hard to 
reactivate efficiently. An example of such a gene is Oct 4, whose product is required for 
embryonic development and the maintenance of stem cell status (Nichols et al., 1998). 
The incomplete reactivation of Oct 4 may account for some failures of nuclear transfer 
embryo development (Boiani et al., 2002; Bortvin et al., 2003).  
 Besides that, the inner cell mass isolation techniques also are crucial factor that 
affected the production of caprine embryonic stem cell lines where the manual cut 
technique produce more healthy and good quality of caprine embroyinc stem cell lines 
as similar to our previous findings in murine species. Totally removed the trophoblastic 
cells is very important to prevent the trophectoderm cells induced the differentiation of 
caprine inner cell mass. This is the new finding where no researchers have been 
reported by using this method before.  Also, by looking into the caprine blastocyst 
stages as source for production caprine embryonic stem cells is very important. In the 
present study, we did not considering the blastocyst stages in caprine species due to the 
lack of caprine blastocysts source. More caprine sample is needed in order to obtain 
more consistent and accurate results for future study.  
In summary, in vivo-derived caprine blastocysts, Dulbecco’s Modified Eagle’s 
Medium embryonic stem cell medium, fresh mouse embryonic fibroblast and manual 
cut technique provide the high efficacy and quality of caprine embryonic stem cell lines 
in our study. This could prove the pluripotent of caprine embryonic stem cells by 
confirmation with embryonic stem cells protein markers staining where it gave positive 
expression of Oct 4, SSEA 3 and alkaline phosphatase activities.  
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Several further studies could be carried out to investigate a few parameters that 
affect the efficiency and also as an extension to the current study. For murine species, it 
was previously reported that the murine strains used to derive mouse embryonic 
fibroblast feeder cell layer may have an effect on the efficiency of deriving embryonic 
stem cells (Suemori and Nakatsjui, 1987; Kawase et al., 1994). In this study, the direct 
effect of mouse embryonic fibroblast from different strains on the embryonic stem cell 
culture was not investigated. Thus, further studies investigating the efficiency of mouse 
embryonic fibroblast derived from ICR, C57BL/6J, CBA/ca and other strains of murine 
in supporting the growth of embroynic stem cells could be carried out. This could lead 
to the finding of the mouse embryonic fibroblast and embroyinc stem cells strain 
combination that gives the best efficiency. Also, a study which compares the efficiency 
of embroyic stem cells derivation from different strains of murine in terms of 
expression of Oct 4 gene could also be carried out. Oct 4 is expressed in pluripotent 
embroyinc stem cells and the degree of expression determines the pluripotency and 
hence quality of the embryonic stem cell lines (Masui et al., 2007). In the present study, 
efficiency is determined based on the success rate of reaching a higher passage and 
embryonic stem cells protein markers staining. Thus, gene expression and visualisation 
using fluorescence microscopy is a more accurate method. Similar experiments could 
also be carried out using Sox 2 expression.  
An extension of the current experiment that could be done is a possible 
modification of the experiment that could be done to improve the results is by using 
microdissection of the inner cell mass of blastocyst or using mechanical isolation in 
murine and caprine species. Microdissesction of the inner cell mass has been proven to 
improve results (Wakayama et al., 2007) while mechanical isolation has the same 
potential. Ideally, more training and practice should be done to master both the 
microdissection and mechanical isolation technique to allow comparisons in terms of 
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efficiency. A study which compares the efficiency of caprine embryonic stem cells 
derivation from different stages of blastocyst could be carried out. Using embryonic 
stem cell-like, it was shown that stage of blastocysts at inner cell mass isolation to be a 
significant factor in establishment of caprine embryonic stem-like cells colonies (Pawar 
et al., 2009). The authors showed that the inner cell mass isolated from hatched 
blastocyst enhanced primary colony formation (66.6%) as compared with 23.3% 
primary colony formation in inner cell mass obtained from early and expanded 
blastocysts. The mechanical isolation in caprine was found comparatively easier for 
hatched blastocyst than the early and expanded blastocyst (Pawar et al., 2009). This 
phenomenon could be studied in detail using caprine embryonic stem cell lines in the 
future. In addition, the further research is required to maintain and enhance the 
efficiency of embryonic stem cell culture in the caprine.  
In order to confirm the pluripotency of the caprine embroyinc stem cells, 
differentiation of caprine embryonic stem cells could be carried out in future. To our 
knowledge, by culturing the caprine embryonic stem cells without feeder cell layer and 
leukaemia inhibitory factors, it would differentiate into specific type of cells such as 
muscle cell, heart cells and neuron cells by specific culture medium. By this way, we 
could prove the pluripotent characters in caprine embryonic stem cells. Furthermore, it 
could be applied into patient to cure some degenerative diseases such as cardiovascular, 
diabetes, Parkinson’s and Alzhemier’s diseases.  
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Chapter 6 
6.0 CONCLUSIONS 
 
This study presents the use of mouse embryonic fibroblasts (MEF) as feeder cells for  
following production of embryonic stem cell (ESC) lines in murine and caprine. The 
can be concluded from the findings of the present study: 
 
1) For murine species 
a) Superovulation was successfully carried out in ICR, CBA/ca and C57BL/6J strains 
of murine. There were no significant differences in terms of success rate. However, 
the CBA/ca (77.00±3.81%) strain showed the highest percent successful 
superovulation followed by ICR (75.34±3.66%) and C57BL/6J (65.71±4.12%). 
b) Pre-intracytoplasmic injection durations treatments at 90 minutes gave the highest 
cleavage rate in 3 different pure-strains murine compared to simultaneous injection 
as well as 30, 60 and 120 minutes pre-intracytoplasmic injection durations. 
c) Protocol for the derivation of mouse embryonic fibroblast cell lines and 
establishment of murine embryonic stem cell lines were successfully developed 
that may serve as the basic for further research in ABEL laboratory. 
d) No murine strain differences in the growth rate of mouse embryonic fibroblasts. 
However, ICR is the suitable strain for use to derive mouse embryonic fibroblast 
cell lines used as feeder cell layer for murine embryonic stem cells whereby it gave 
highest growth rate of mouse embryonic fibroblast compared with CBA/ca and 
C57BL/6J. 
e) Fresh and frozen-thawed mouse embryonic fibroblast as well as DMEM+10% FBS 
and αMEM+10% FBS culture media for mouse embryonic fibroblast at Passages 1 
and 2 have similar growth rates. However, culture medium for DMEM+10% FBS 
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gave the highest growth rates (P1: 94.44±5.56%; P2: 97.22±2.78%) compared to 
αMEM+10% FBS culture medium (P1: 88.89±6.46%; P2: 91.67±6.06%).  
f) There were no significant differences among the 3 different pure-strains of murine 
in establishment of murine embryonic stem cell lines. However, CBA/ca gave the 
highest percent attachment of blastocysts and successful consecutive passages 
murine embryonic stem cell lines compared with ICR and C57BL/6J. Thus, 
CBA/ca is the most suitable strain to produce high quality of murine embryonic 
stem cell lines. 
g) Murine embryonic stem cell lines could be successfully derived from any strain or 
blastocyst stage. However, expanded blastocysts from the CBA/ca strain gave the 
highest efficiency, whereas early and hatched blastocysts are not suitable sources 
for deriving murine embryonic stem cell lines due to their poor efficiency.  
h) Both DMEM+10% FBS and αMEM+10% FBS could be used for culture murine 
embryonic stem cells. However, DMEM+10% FBS culture medium is most 
suitable use for culture murine embryonic stem cells where it showed higher 
percent successful attachment of blastocysts and consecutive passages than 
αMEM+10% FBS culture medium.  
i) Majority of expanded blastocysts gave the highest percent attachment of 
blastocysts and successful consecutive passages in both fresh and frozen-thawed 
mouse embryonic fibroblasts for Passages 1 and 2. 
j) Murine embryonic stem cell lines could be successfully derived from any inner cell 
mass isolation techniques. However, manual cut inner cell mass isolation technique 
in C57BL/6J gave the highest percent primary outgrowth of inner cell mass with 
the values of 78.35±1.24%, followed by laser dissection (75.67±0.85%) and whole 
blastocyst culture (75.32±1.73%). Also, this technique in general gave higher 
percent inner cell mass attachment, primary outgrowth of inner cell mass and 
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consecutive passages of murine embroyinc stem cell lines for both DMEM+10% 
FBS and αMEM+10% FBS as well as fresh and frozen mouse embryonic fibroblast 
at Passages 1 and 2. 
k) Oct 4 and SSEA 1 expression and alkaline phosphatase (AP) activites were found 
in murine embryonic stem cell lines.   
 
2) For caprine species (bovine as comparative study) 
a) Majority laser enucleation technique apparently gave higher maturation, 
enucleation, injection and cleavage rates in caprine and bovine species 
compared with squeezing enucleation technique.  
b) Grade A, B and C oocytes showed the best performance in maturation, 
enucleation, injection and better cleavage rates than Grades D and E for all the 
stages in both caprine and bovine species. 
c) Even though insignificance, the caprine embryo development at various stages 
was apparently higher in LOPU, followed by ovariectomy and abattoir. 
However, ovariectomy showed better results at blastocyst and hatched 
blastocysts compared to LOPU and abattoir. 
d) Pre-intracytoplasmic injection durations at 60 minutes gave the highest cleavage 
rates compared with simultaneous injection and 30 minutes pre-intracytoplasmic 
injection durations in caprine species. 
e) Caprine always showed higher percent maturation, enucleation, injection and 
cleavage rates for all the stages (2-cell to hatched blastocysts) as well as all the 
grades, except Grade A than bovine species. 
f) Most of the cleavage values were significantly higher in laser enucleation 
technique for both species. However, caprine species always showed higher 
percent cleavage than bovine species for both enucleation techniques.  
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g) Average number of blastocysts obtained in FSH treatment showed higher than 
that of PMSG treatment in in vivo caprine uterine flushing. 
h) Manual cut inner cell mass isolation technique shows the highest percent 
attachment of caprine inner cell mass, successful passages of caprine embryonic 
stem cell lines followed by laser dissection and whole blastocyst culture.  
i) There were no significant differences in percent attachment of caprine inner cell 
mass, primary outgrowth of inner cell mass, successful consecutive passages 
caprine embryonic stem cell lines from Passage 1 up to Passage 3 for both 
DMEM+10% FBS and αMEM+10% FBS as well as fresh and frozen-thawed 
mouse embryonic fibroblast at Passages 1, 2 and 3. However, DMEM+10% 
FBS culture medium and fresh mouse embryonic fibroblast gave higher percent 
inner cell mass attachment, primary outgrowth of inner cell mass, successful 
consecutive passages caprine embryonic stem cell lines than αMEM+10% FBS 
culture medium and frozen-thawed mouse embryonic fibroblast.  
j) In vivo-derived caprine blastocyst gave the highest percent inner cell mass 
attachment, primary outgrowth of inner cell mass and successful passages of 
caprine embryonic stem cell lines than in vitro-derived caprine blastocyst 
sources.  
k) Expression of Oct 4 and SSEA 3 as well as alkaline phosphatase (AP) activities 
were found in caprine embryonic stem cell lines. 
 
In summary, the results of this study show that murine and caprine embryonic stem cell 
lines could be established using mouse embryonic fibroblast as feeder layers. Murine 
strains, blastocyst stages and inner cell mass isolation techniques are factors that affect 
the production of embryonic stem cell lines. In murine, ICR is the best strain for 
deriving mouse embryonic fibroblast, expanded blastocyst from CBA/ca is the optimal 
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strain for deriving murine embryonic stem cell lines, while manual cut inner cell mass 
isolation technique is the most suitable technique in isolating inner cell masses. For 
caprine species, in vivo-derived blatocysts is the best source to produce high efficiency 
of caprine embryonic stem cell lines as well as manual cut inner cell mass isolation 
technique is the best technique in producing undifferentiated caprine embryonic stem 
cell lines. 
 
3) Originality 
There are several original findings obtained from caprine embryonic stem cell 
research. Firstly, mouse embryonic stem cells from 3 different strains of murine to 
be used as feeder cell layer for caprine embryonic stem cell culture. Second, laser 
enucleation technique in caprine species is a new approach to obtain good and high 
quality of blastocyst formation from cloned embryos to be used as source for 
producing caprine embryonic stem cell lines. Thirdly, manual cut and laser 
dissection techniques are the new techniques that can be used to isolated the inner 
cell mass from murine and caprine blastocysts to produce more healthy and 
undifferentiated murine and caprine embryonic stem cell lines. Lastly, blastocyst 
stages in murine species can be used to derive a good quality of embryonic stem cell 
lines.  
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APPENDICES 
APPENDIX 1: LIST OF MATERIALS 
 
Appendix Table 1.1: List of facilities and equipment 
No. Item/Product Model/Catalogue 
no. 
Manufacturer Local agent 
1. Stereomicroscope SZH10 Olympus Matrix Optics 
(M) Sdn Bhd 
2. Compound microscope CH-2 Olympus - 
3. Inverted microscope IMT-2 Olympus Optical 
Co., Japan 
- 
4. Laminar flow CMF series ERLA, Malaysia Trade Knight 
(M) Sdn Bhd 
5. Waterbath 870354 Memmert, 
Germany 
Interscience 
(M) Sdn Bhd 
6. Oven 40050-IP20 Memmert GmbH, 
Schwabach 
Germany 
Interscience 
(M) Sdn Bhd 
7. Autoclave ‘Hiclave’ Model 
HA-300M 2 
Hirayama, 
Manufacturing 
Corp Tokyo, Japan 
Aliran Sains 
Sdn Bhd 
8. CO2 incubator Model 3165 Forma Scientific 
Inc. 
Aliran Sains 
Sdn Bhd 
9. Ultra-pure water system 
(Mili-Q UF Plus) 
- Millipore, Bedford, 
MA, USA 
- 
10. Digital analytical balance AB104 Mettlet, Toleda, 
Switzerland 
- 
11.  pH meter HI 8417 HANNA 
Instrument, 
Singapore 
- 
12. Osmometer Vapro 5520 WESCOR Inc. 
USA 
- 
13. Liquid nitrogen tank - - MVE, USA 
14.  Dissecting set - Aesculap, 
Germany 
Chemolab 
Supplies 
15. Beaker (Pyrex) - - - 
16. Micropipettor (10 µl, 100 
µl, 1000 µl) 
- Eppendorf, 
Germany 
- 
17. Flushing needle 30 G B. Braun, 
Melsungen, 
Germany 
 
18. Haemacytometer - - - 
19. Centrifuge  D37520 Heraeus, Kendro 
Laboratory 
Products, 
Germany 
- 
20. Digital camera - MicroLamba, - 
(Continued) 
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Kuala Lumpur, 
Malayasia 
21. Fluorescent microscope Axiovert 135 M Carl-Zeiss, Inc., 
Germany  
- 
22. Flushing and aspiration 
system consists of the 
following: 
a) Aspriation system 
b) Flushing system 
c) Test tube heater 
 
 
 
K-MAR-5100 
K-MAR-4000 
K-FTH-1012 
Cook Australia, 
Brisbance 
Technology Park, 
Eight Mile Plains, 
Queeland, 
Australia 
- 
23. Flushing and aspiration 
pedals 
6210-72535-OB Hega Electric 
Limited, Suffolk, 
UK 
- 
24. Impulse sealer KF-300H Khind, Taiwan - 
25.  Inverted microscope 
fitted with 
micromanipulators (for 
cloning) 
IX71 Olympus Optical 
Co., Ltd, Tokyo, 
Japan 
- 
26. La banana (hand-
controlled pipette for 
handling oocytes or 
embryos) 
- Self-assembled -  
 
 
 
28.  Micropipette puller P-97 SSutter Instrument 
CO., Novato, CA, 
USA 
- 
29. Microforge - Technical 
Products 
International, St. 
Louis, MO, USA 
- 
30. Microgrinder EG-4 Narishige Co., 
Ltd., Tokyo, Japan 
- 
31. Micropipette dispenser 
(2-20 µl, 10-100 µl, 200-
1000 µl) 
- Eppendorf, 
Humburg, 
Germany 
- 
32. Narishige hydraulic 
micromanipulators 
ON3-99D Narishige Co., 
Ltd., Tokyo, Japan 
- 
 
33. Ovum pick-up needle 
(FAS Set C2) 
- Gynetics Medical 
Product, Hamont-
Achel, Belgium 
- 
 
34. Laparoscopic system 
consists of the following: 
a) Aesculap 
endoscopic 
camera system 
b) Autraumatic 
grasping forceps 
(pediatric 
grasper) 
c) CCD camera 
(David 3) 
d) Pediatric Storz 
 
 
PV431 
 
 
PO951R 
 
 
 
PV430 
 
PE 688A 
Aesculap A.G. 
and Company, 
Tuttlingen, 
Germany 
- 
(Continued) 
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laparoscope (7.0 
mm) 
e) Electronic CO2 
gas insufflators 
unit 
f) Light probe with 
fibre optic cable 
g) Light system 
(Light source 300 
W) 
h) Small trocar with 
canula (5.5 mm) 
for grasper 
i) Trocar and canula 
(7.0 mm) for the 
pediatric Storz 
laparoscope 
j) Verrus needle 
attached to a 
plastic tubing 
 
 
PG001 
 
 
OP913 
 
OP927 
 
 
EJ456 
 
 
EJ457 
 
 
 
PG3 
34. Refrigerator (Cooltech) SR-21NME Samsung 
Electronics, Seoul, 
Korea 
- 
35. Spirit Burner (150 ml) - Shanghai 
Machinery Import 
and Export 
Company, 
Shanghai, China 
- 
36. Surgical cradle (table) - Syarikat Copens 
Enterprise, Kuala 
Lumpur, Malaysia 
- 
 
37. Laser machine XYclone Halmiton, USA - 
38. Surgical tray - Syarikat Copens 
Enterprise, Kuala 
Lumpur, Malaysia 
- 
39. Surgical trolley - Syarikat Copens 
Enterprise, Kuala 
Lumpur, Malaysia 
- 
40.  ThermoPlate (Stage 
warmer for cloning or 
inverted microscope) 
HATS-U55R30 Tokai Hit 
Company Ltd., 
Tokyo, Japan 
- 
 
41. Vortex mixer (Mixer 
UZUSIO) 
VTX-3000L LMS Co., Tokyo, 
Japan 
- 
42. Water purification 
system (Milli-RO 10 
Plus) 
- Millipore, 
Bedford, MA, 
USA 
- 
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Appendix Table 1.2: List of labwares and disposables 
No. Item/Product Model/Catalogue 
no. 
Manufacturer Local agent 
1. Hypodermic needle  18 G, 20 G, 21 G, 
23 G, 25 G, 26 G, 
30 G 
Terumo Corporation, 
Tokyo, Japan 
- 
2. Micropipette tips Yellow and blue - Megalab 
Supplies 
3. Plastic culture dish 351008 (35 x 10 
mm) 
Becton Dickinson 
Labware, USA 
FC- Bios Sdn 
Bhd 
4. Plastic culture dish 351007 (60 x 15 
mm) 
Becton Dickinson 
Labware, USA 
Biomarketing  
(M) Sdn Bhd 
5. Tissue culture dish 35 mm Nunc Megalab 
Supplies 
6. Tissue culture dish 60 mm Nunc Megalab 
Supplies 
7. Aluminum foil Diamond Reynolds Consumer 
Product, Virginia, 
USA 
Megalab 
Supplies 
8. Nylon  - - - 
9. Disposable glove - Cross Protection (M) 
Sdn Bhd 
Megalab 
Supplies 
10.  Autocalvable disposal bag - Megalab supplies, 
Subang Jaya, 
Selnagor, Malaysia 
Megalab 
Supplies 
11. Beaker  50 ml, 100 ml, 250 
ml, 500 ml 
Pyrex®, Iwaki Glass, 
Japan 
- 
12. Blades (Super Nacet) - Gillette, USA - 
13. Borosilicate glass tubing  Microcaps® Drummond 
Scienctific Company, 
Broomall, PA, USA 
- 
14. CIDR applicator - Pharmacia and 
Upjohn Limited 
Company, Mt. 
Wellington, 
Auckland, New 
Zealand 
- 
15. Conical centrifuge tube  15 ml, 50 ml; 
Falcon 
Becton Dickinson 
Labware, Franklin 
Lakes, NJ, USA 
Megalab 
supplies 
 
16. Cover slips - Hirschmann® 
Laborgerate, 
Germnay 
-  
 
 
17.  Disposable glass Pasteur 
pipettes 
- John Poulten Ltd., 
Essex, England 
Megalab 
supplies 
18. Haematocrit capillary tube  75 mm Hirschmann® 
Laborgerate, 
Germany 
Megalab 
supplies 
19. Holding pipettes - Self-made - 
(Continued) 
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20. Injection needle - Self-made - 
21. Cutting needle - Self-made - 
22. Biopsy needle - Self-made - 
23. Lens cleaning tissue  Kimswipe®EX-L Kimberly-Clark, 
Roswell, GA, USA 
- 
24. Measuring cyclinder 50 ml, 100 ml Pyrex®. Iwaki Glass, 
Japan 
- 
25. Microcentrifuge tubes 0.2 ml, 0.5 ml, 1.5 
ml 
Eppemdorf GmbH, 
Hambrug, Germany 
- 
26. Millex®-GS syringe driven 
filter unit 
0.22 µm Millipore, 
Carringtwohill, Co. 
Cork, Ireland 
- 
27. 4-well dish Nunc Nunc, Roskilde, 
Denmark 
- 
28. Parafilm - Pechiney Plastic 
Packaging, Chicago, 
IL, USA 
- 
29. Schott bottle 50 ml, 100 ml, 250 
ml, 500 ml, 1 litre 
Duran, Germany - 
30. Sterile gloves - Ansell International, 
Malaysia 
- 
31. Syringes 1 ml, 5 ml, 10 ml, 
20 ml, 50 ml 
Terumo Corporation, 
Tokyo, Japan 
- 
(Continued) 
  
 
440 
 
Appendix Table 1.3: List of chemicals 
 
No. Item/Product Chemical 
name/Content/
Description 
Model/ 
Catalogue 
no. 
Manufacturer Local 
agent 
1. PMSG 
(Folligon) 
1000 IU - Intervet International BV., 
Boxmeer, Holland 
Lazuli 
Sdn Bhd 
2 hCG 
(Chorulon) 
5000 IU - Intervet International BV., 
Boxmeer, Holland 
Lazuli 
Sdn Bhd 
3. Silicone oil - SI-380-00 Aldrich Chem. Co., USA - 
4. PBS tablet - BR0014G Oxoid Ltd, Hampshire, 
England 
- 
5. DMSO - D-5879 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
6. BSA - A-9418 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
7. NaCl - S-5886 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
8. KCl - P-8014 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
9. KH2PO4 - P-5655 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
10. MgSO4.7H2O Anhydrous M-8150 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
11. NaHCO3 - S-5761 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
12. CaCl2.2H2O Dehydrate C-7902 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
13. Glucose Anhydrous G-7021 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
14. Calcium 
lactate 
- 2376 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
15. Lactic acid - L-4263 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
16. Natrium 
pyruvate 
- P-3662 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
17. L-glutamine - G8540 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
18. Taurine Synthetic T-7146 SIGMA Chem. Co., USA - 
19. HEPES, 
sodium salt 
- H7006 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
20. Natrium 
EDTA 
- E-5143 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
21. Penicillin - - Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
28. Trypsin - - - - 
22. Streptomycin - S-9137 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
23. Phenol red - P-3532 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
24. Sucrose - S-1888 Sigma-Aldrich Co., St. - 
(Continued) 
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Louis, MO, USA 
25. HCL - - HmbG Chemicals, Germnay - 
26. Alcohol 70% - Prepared from absolute 
ethanol 
- 
27. DMEM - D5796 - 1L Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
28. Trypsin - - - - 
29. Pronase - - - - 
30. 7X
TM
 (non-
toxic) 
detergent 
- - FlowLab
TM
, Sydney, 
Australia 
- 
 
31.  Absolute 
ethanol 
100% 1322219 HmbG Chemicals, Germnay - 
32. Hoechst 33342 - B2261 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
33. Calcium 
ionophore 
- I0634 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
34. Cloprostenol 
(Estrumate®) 
- - Schering-Plough Animal 
Health, Baulkham Hills, 
NSW, Australia 
- 
35. Cysteamine  - M9768 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
36. FSH Ovagen
TM
 Ofsh ICPbio Limited, Auckland, 
New Zealand 
- 
 
37. Gigasept®FF 
(disinfectant) 
- - Schulke and Mary GmbH, 
Nonderstedt, Germnay 
- 
38. Heparin, 
sodium salt 
- H0777 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
39.  Hibiscrub 
cleanser 
Hibiscrub - ZENECA Limited, 
Macclesfield, UK 
- 
40. Hyaluronidase 
(bovine testes) 
Type IV-S H4272 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
41. HFl - 1301030 HmbG Chemicals, Germnay - 
42. Ketamine 
hydrochloride 
Ketamil L10077 Troy Laboratories Pty Ltd., 
NSW, Australia 
- 
43. K-Y Jelly - - Pharmedica Lb (Pty) Ltd., 
East London, South Africa  
- 
44. Liquid 
nitrogen 
- - Mox Gases Berhad, PJ, 
Selangor, Malaysia 
- 
45. MgCl2.6H2O - M2393 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
46. Medium 199 
(with Ealre’s 
salt, L-
glutamine and 
NaHCO3) 
- M4530 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
47. Mineral oil - M8410 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
(Continued) 
(Continued) 
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48. Minimum 
Essential 
Media (MEM) 
non essential 
amino acid 
solution, 100x 
- M7145 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
49. Oestradiol-17β - E4389 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
50. Oestrus goat 
serum 
- - Prepared ‘in-house’ - 
51. PVP medium - 10890001 Medicult. Jyllinge, 
Denmark 
- 
52. Pyruvic acid, 
sodium salt 
- P3662 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
53. Sodium DL-
lactate (60% 
w/w syrup) 
- L4263 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
54. NaH2PO4.H2O - S5011 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
55. Xylazine 
hydrochloride 
Ilium 
Xylazine-20 
L10600 Tryo Laboratories Pty Ltd., 
NSW, Australia 
- 
56. Triton®X-100 - 93420 Fluka Chemie GmbH, 
Buchs, Germany 
- 
57. Iodine solution - - ICN Biomedicals, USA - 
58. Mitomycin C - M4287 Sigma-Aldrich Co., St. 
Louis, MO, USA 
- 
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Embryonic  stem  (ES)  cells  have  limitless  potential  in  the  ﬁeld  of  biological  sciences  and
regenerative  medicine  due  to  their  pluripotency  and  ability  for indeﬁnite  self-renewal.  The
aims  of  this  study  were:  (i)  to  isolate  goat  ES cell  lines  from  both  in  vivo  and  in  vitro  derived
blastocysts  and  (ii)  to  characterize  the  growth  characteristics  and  expression  of markers
indicative  of  pluripotency  in goat  ES  cells.  The  goat  inner  cell  mass  (ICM)  of  in  vitro  and  in vivo
derived whole  blastocysts  was  isolated  by  manually  cutting  or laser  dissection,  with  in  vitro
cultured mouse  embryonic  ﬁbroblasts  (MEF’s)  as  a feeder  layer  to obtain  the  ES  cells.  The
in vivo derived  blastocysts  recorded  a signiﬁcant  difference  in  producing  goat  ES cell lines
at Passage  3,  compared  with  in  vitro  derived  blastocysts  (91.7%  vs.  20.8%  respectively).  The
manually  cut  ICM  (inner  cell  mass)  isolation  technique  consistently  recorded  the  highest
success rate  in  goat  ES cells  for  Passages  1 and  3, compared  with  the  whole  blastocyst  culture
(control)  and  those  from  the  laser  dissection  technique  (71.3%  vs. 39.6%  and  43.9%;  35.0%
vs. 12.5%  and  23.3%  respectively).  Alkaline  phosphatase  (AP),  Oct-4 and  SSEA-3  staining
gave  positive  results  in  identifying  the  goat  ES  cells.  In  conclusion,  goat  ES  cells could  be
produced  by isolation  of  the  ICM  by  using  both  manual  and  laser  dissection  of  blastocysts,
as characterized  by AP,  Oct-4 and  SSEA-3  staining.
Crown Copyright ©  2012 Published by Elsevier B.V. All rights reserved.. Introduction
Embryonic stem (ES) cells are used as a therapeutic tool
n humans. It is important to develop an animal model by
sing domestic animals which are immunologically and
hysiologically more closely related to humans than mice
nd rats (Gjorret and Maddox-Hyttel, 2005). ES cells can be
sed to study cell differentiation, embryonic development,
ene regulation as well as be incorporated into biomedi-
al research (Wheeler, 1994; Thomson and Odorico, 2000).
S cells were ﬁrst successfully obtained in mice (EvansPlease cite this article in press as: Goh, S.Y., et al., Characterizatio
from the inner cell mass isolation. Small Ruminant Res. (2012), 
nd Kaufman, 1981), sheep (Notarianni et al., 1991), pri-
ates (Thomson and Marshal, 1998), horses (Saito et al.,
002), pigs (Li et al., 2003), humans (Hovatta et al., 2003;
∗ Corresponding author. Tel.: +60 3 79674366; fax: +60 3 79674374.
E-mail address: ramli@um.edu.my (R.B. Abdullah).
921-4488/$ – see front matter. Crown Copyright ©  2012 Published by Elsevier B
ttp://dx.doi.org/10.1016/j.smallrumres.2012.03.020Mitalipova et al., 2003), cattle (Yadav et al., 2005) and goats
(Pawar et al., 2009). However, the methods of derivation,
propagation and differentiation of ES cells for domestic ani-
mals have not been fully established.
Under appropriate culture conditions, isolated ICM
(inner cell mass) will form ES cells and be maintained in
an undifferentiated state in the culture. The ES cells sub-
sequently have the potential to differentiate into various
types of cells.
Proper characterization of ES cell lines were based on
the expression of pluripotency markers such as Oct-4, SOX
2, Nanog, SSEA-1, 3 and 4. Oct-4 is a homeodomain tran-
scription factor of the POU family. This protein is essentially
involved in the self-renewal of the undifferentiated embry-n of caprine embryonic stem cell-like outgrowths derived
http://dx.doi.org/10.1016/j.smallrumres.2012.03.020
onic stem cells. Too much Oct-4 expression will induce
differentiation of the cells (Niwa et al., 2000). SSEA-3 is a
“globo-series” carbohydrate antigen present on both the
glycolipid and glycopeptide cell surfaces. It is also found
.V. All rights reserved.
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on the surface of human teratocarcinoma cells (EC), embry-
onic germ cells (EG) and ES cells (Takeda et al., 1992; Niwa
et al., 2000).
Due to limited information on the ICM isolation and
establishment of goat ES cell lines, the present study was
designed to explore new techniques to isolate the ICM from
goat blastocysts and to characterize the embryonic stem
cell-like outgrowths.
2. Materials and methods
2.1. Reagents and media
All chemicals and reagents were purchased from Sigma Chemical Co.
(St. Louis, Mo,  USA), unless otherwise stated. Plastic dishes were obtained
from Nunc (Roskilde, Denmark). All media were obtained from Chemicon
(Millipore, USA).
2.2. Feeder cells
Mouse embryonic ﬁbroblasts (MEF’s) were prepared from 13.5 to 14.0
d.p.c. mouse foetuses and cultured in Dulbecco’s modiﬁed Eagle’s medium
(DMEM; Sigma–Aldrich Co., St. Louis, MO,  USA), supplemented with 10%
foetal bovine serum (FBS; Invitrogen, Singapore), 200 mM l-glutamine
and 3× penicillin/streptomycin. The fetuses were washed in phosphate
buffer saline without calcium and magnesium [PBS(−)]. Then, the head
limbs and internal organs were removed and minced into small pieces
and  the minced tissue placed in a beaker. A volume of trypsin (0.25%)
and  EDTA (0.05%) was  added into the beaker and stirred with a magnetic
stirrer for 30 min. Subsequently, it was ﬁltered and centrifuged twice at
3000 × g for 5 min. The supernatant was removed. The pellet were re-
suspended with culture media and immediately seeded in a 60 mm tissue
culture dish. The primary MEF’s were cultured at 37 ◦C in a 5% CO2 incuba-
tor, until the cells reached 80–90% conﬂuency. At 80–90% conﬂuency the
MEF’s were sub-cultured to expand and frozen for the feeder cell bank, for
future use. In order to be used as feeder cells, the feeder layers were pre-
pared by expanding the MEF  cultures on gelatinized Petri dishes, before
seeding the cells. Culture dishes were coated with 0.1% gelatin prior to the
culturing of the MEF’s. The source of MEF’s was either freshly passaged
or thawed from frozen stock. The MEF’s were seeded at a rate of 3.0 × 105
viable cells per dish, to allow conﬂuency to be reached within 2–3 days.
The  conﬂuent MEF  was ﬁlled with DMEM + 10% FBS, supplemented with
10  g/ml mitomycin C and incubated for 3 h to inactivate the propagation
of  MEF’s. The feeder cells were prepared 1 day before and incubated with
an  ES cell culture media at least 3 h before being used.
2.3. Flushing of embryos
Goat blastocysts were derived in vitro or in vivo (Fig. 1). For in vivo
derived goat blastocyts, uterine ﬂushings were carried out. The doe was
superovulated with 160 mg  of a follicle stimulating hormone (FSH) for 4
consecutive days. The goat donor being treated with a control internal
drug release (CIDR) device inserted for 17 days. This was  removed on Day
18. Estrous detection was  carried out and the doe in estrus was mated
with a fertile buck 3 times per day. This process was carried out for 2–3
days, until the end of estrus. The blastocyst recovery was  performed on
Day  7 through uterine ﬂushing. All the collected blastocysts were cultured
in a k-simplex optimization medium (KSOM), prior to ICM isolation.
2.4.  In vitro embryo production
For in vitro derived blastocysts, goat blastocysts were derived by a
somatic cell nuclear transfer (SCNT) to produce goat ES cell lines. Differ-
ent goat oocytes retrieval techniques were used to produce blastocysts,
namely laparoscopic ovum pick-up (LOPU), ovariectomy (via laparotomy)
and ovary slicing from local abattoir material. Estrous synchronization
was  conducted to facilitate the time and date for retrieval of the oocytesPlease cite this article in press as: Goh, S.Y., et al., Characterizatio
from the inner cell mass isolation. Small Ruminant Res. (2012),
for  LOPU.
The goat ovaries were obtained from local abattoirs and transported to
the  laboratory within 2 h in a warm saline medium at 35–38 ◦C. In the lab-
oratory, the ovaries were washed thoroughly with saline medium (37 ◦C)
and the oocytes recovered by slicing. All retrieved oocytes were washed PRESS
search xxx (2012) xxx– xxx
with the TL-hepes working solution, followed by placment in an in vitro
maturation medium, prior to the oocytes being graded for the subsequent
experiment. Cumulus oocyte complexes (COC’s) were classiﬁed according
to the cumulus cell characteristics and cytoplasm morphologies under a
stereomicroscope and cultured in 50 l drops of a maturation medium
under mineral oil at 38.5 ◦C, in a 5% CO2 incubator and humidiﬁed atmo-
sphere. All the retrieved oocytes from the above sources were further
processed by SCNT and parthenogenetic activation (PA) to obtain goat
blastocysts as a source of the goat ES cell lines.
2.5. Isolation of inner cell mass (ICM’s)
The zona pellucida of the blastocysts were removed using pronase
(0.5%). ICM’s were isolated by using manual cut (30 gauge needle), laser
dissection or whole blastocyst cultures (control).
For the manual cut technique, a cut was performed between ICM and
trophectoderm (TE), by using two 30 gauge needles. Then, the ICM was
transferred carefully onto an inactivated feeder in a cell layer with a sufﬁ-
cient gap. A single dish contained 10–15 ICM’s. The culture was observed
on Day 2. Media were changed every other day.
For the laser isolation technique, the ICM isolation was  carried out on
the micromanipulator system where the holding pipette (left side) and
biopsy needle (right side) were used in the manipulation of the blastocyst.
The ICM was located at the 9 o’clock position and the laser shot between
the ICM and the TE cells. The biopsy needle was sucked on the other side
of  the blastocyst to remove the zona pellucida and TE from the ICM. The
isolated ICM was  placed and cultured onto the inactivated feeder layer
in a 5% CO2 incubator, at 37 ◦C. After 5–12 days, the growing colonies
were individually dissociated into clumps after treating with a mixture of
trypsin (0.05%) and EDTA (0.01%). The resultant small clumps containing
approximately 20–50 cells were transferred to a new well with a fresh
feeder layer and medium. The new colonies were inspected daily and sub-
cultured at an interval of 6–10 days, according to their size and growth
rate. Culture medium was  changed every other day.
2.6. Culture of outgrowth colonies (OC’s) and passages
The primary goat ICM outgrowths were sub-cultured by using
trypsinization or mechanical dissection procedures with trypsin (0.05%)
and EDTA (0.01%). After 6 to 10 days, the primary ICM outgrowths with
undifferentiated cells characterized by slightly dark-pigmented clumps of
cells, were selected (Fig. 2). The ICM with a ﬂattened shaped colony sur-
rounded with primitive endoderm, homogeneous and a higher nuclear to
cytoplasm ratio (bigger nucleus) was selected.
For trypsinization, the ICM outgrowths were lifted from the feeder
cells and transferred to trypsin (0.05%) and EDTA (0.01%) for 3 min  at 37 ◦C.
Then, it was gently pipetted up and down several times to break the ICM
outgrowth into small pieces, which contained 20 to 30 cells/piece and
spread onto a new feeder layer. The cell colonies grew 4–6 days after
trypsinization (Passage 1) and were subsequently sub-cultured.
For  the mechanical dissection, a pulled Pasteur pipette connected
with mouth piece was used to cut the colony into smaller pieces. The
ICM outgrowths were detached and transferred to 30 l trypsin (0.05%)
and EDTA (0.01%); and gently disaggregated into smaller aggregates. The
clumps that did not disaggregate into single cells were transferred into a
4-well dish and incubated at 37 ◦C in 5% CO2. The cells with goat ES cell
characteristics were checked daily and selected for sub-culture.
2.7. Alkaline phosphatase (AP), SSEA and Oct-4 staining
In  order to conﬁrm the pluripotency of the goat ES cells in the present
study, AP staining was performed. The cell was ﬁxed in paraformaldehyde
(4%) for 30 min, after which the ES cells were washed with PBS(−), 5 times.
After the AP was added into the substrate and incubated for 30 min in a
dark  environment, the ES cells were washed again with PBS(−) twice and
PBS(−)  was  again added to the ES cells. The goat ES cells showed a pur-
plish colour, while the differentiated cells were colourless after staining,
as  shown in Fig. 3.
The goat ES cells could also be conﬁrmed by using an ES cell markern of caprine embryonic stem cell-like outgrowths derived
 http://dx.doi.org/10.1016/j.smallrumres.2012.03.020
staining kit, from Chemicon (Millipore, USA and Canada). The ES cells
were ﬁxed in paraformaldehyde (4%) for 30 min. Then, the cells were
washed with PBS(−) 5 times, followed by addition of a blocking solution
[10% FBS + PBS(−)] and left for 2 h at room temperature (25 ◦C). The pri-
mary antibodies (Oct-4, SSEA-1, SSEA-3, SSEA-4) were prepared at the
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0ig. 1. (a and b) In vitro-derived caprine blastocysts from somatic cell nu
ptimal concentration in the ratio of 1:250. After 2 h of immersion in
he blocking solution, the blocking solution was removed and the speciﬁc
iluted individual primary antibody added. Then, the mixture was incu-
ated overnight at 4 ◦C. After that, the primary antibody was removed andPlease cite this article in press as: Goh, S.Y., et al., Characterizatio
from the inner cell mass isolation. Small Ruminant Res. (2012), 
ashed 5 times with PBS(−). After washing with PBS(−), a secondary anti-
ody (diluted in ratio 1:1000) was added and incubated for 2 h in a dark
nvironment. After a 2 h period, the secondary antibody was removed
nd washed 5 times with PBS(−). Lastly, Hoechst 33342 (5 g/ml) was
dded to immerse the cells and incubated for 5 min  in a dark environment.
ig. 2. Morphology of primary outgrowths of caprine ICM development after (D
.05%  trypsin 0.01% EDTA but the later passages were performed by manual dissoNT. (c and d) In vivo-derived caprine blastocyst from uterine ﬂushings.
The cell staining was  recorded. The cell staining being observed using a
ﬂuorescent microscope with the expression of glow exhibited from the
secondary antibody and the nucleus (Hoechst 33342), as shown in Fig. 3.n of caprine embryonic stem cell-like outgrowths derived
http://dx.doi.org/10.1016/j.smallrumres.2012.03.020
2.8. Experimental design
Two experiments were conducted to develop an isolation method
of  homogenous embryonal outgrowths of the ES cells from the in vivo
or  in vitro derived goat blastocysts; and to characterize the growth
ays 0–12). On Day 12, the primary ICM outgrowth was  sub-cultured by
ciation. Arrow: ICM outgrowths.
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Fig. 3. Caprine embryonic stem cells conﬁrmed by the expression of caprine speciﬁc embryonic stem cell markers Oct-4 (red) and SSEA-3 (green). The
urplish 
b versioalkaline  phosphatase activities in caprine embryonic stem cells gave a p
references to colour in this ﬁgure legend, the reader is referred to the we
characteristics and expression of markers indicating the pluripotency in
ES  cells. Experiment 1 used a manual cut, laser dissection and a whole blas-
tocyst culture (control) to isolate the ICM from both in vivo and in vitro
derived goat blastocysts. Experiment 2 used AP staining to determine the
AP activities in the ES cell lines. A purplish colour conﬁrmed the pluripo-
tency of the ES cells. Speciﬁc colours were shown for speciﬁc protein
markers (Oct-4: red and SSEA-3: green) to indicate the pluripotency of
ES  cells.
2.9. Statistical analysis
The effects of the inner cell mass isolation techniques and blastocyst
sources on the percentage of ICM attachment, primary ICM outgrowth and
successful ES cell passages were analyzed using the Statistical Package
for  Social Science (SPSS 16.0 version). Means were obtained and ana-
lyzed by one-way analysis of variance (ANOVA). The differences between
the  means were determined by using the Duncan’s Multiple Range Test
(DMRT). The data were presented as mean ± standard error of the means
(SEM).
3. Results
3.1. Experiment 1: embryo culture and goat ES cell
derivation
A comparison between the in vivo and in vitro derived
goat blastocysts as a source for ES cell production is set out
in Table 1. A total of 13 and 156 blastocysts were derived
in vivo and in vitro, respectively. There were signiﬁcant dif-
ferences between in vivo and in vitro derived blastocysts
regarding the percentage successful cell lines in Passage 1Please cite this article in press as: Goh, S.Y., et al., Characterizatio
from the inner cell mass isolation. Small Ruminant Res. (2012),
(95.0% vs. 52.8% respectively) and Passage 3 (91.7% vs. 20.8%
respectively). Even though insigniﬁcant in most cases, the
means of parameters in vivo were consistently higher than
those in vitro.colour for alkaline phosphatase (AP) staining. (For interpretation of the
n of the article.)
3.2. Experiment 2: ICM isolation techniques to produce
ES cell lines
The percentage attachment of goat ICM, primary ICM
outgrowths and successful ES cell passage on the whole
blastocyst culture, manually cut or by laser dissection tech-
niques are summarized in Table 2. There were no signiﬁcant
differences (P > 0.05) in the percentage attachment of ICM
and primary ICM outgrowths for the ICM isolation tech-
niques, with values of 62.9%, 74.4% and 74.0%, as well as
83.3%, 71.6 and 80.4%, respectively. Except for Passage 2,
manual cutting showed a consistently higher percentage of
ICM attachment and primary ICM outgrowths in Passage 1
and Passage 3.
3.3. Experiment 3: characterization of ES cells: PA, Oct4
and SSEA-3 staining
The goat ICM outgrowths expressed positive AP activity
after AP staining, which then exhibited a purplish colour.
Speciﬁc ES cell markers were expressed in the goat ES cells
as Oct-4 (red) and SSEA-3 (green) in the goat species. The
expressions of ES cell protein markers are summarized in
Table 3.
4. Discussion
Embryonic stem (ES) cells may  be produced from then of caprine embryonic stem cell-like outgrowths derived
 http://dx.doi.org/10.1016/j.smallrumres.2012.03.020
ICM of intact blastocysts (Evans and Kaufman, 1981;
Robertson, 1987), by immunosurgery (Solter and Knowles,
1975; Martin, 1981), and by other methods to isolate
pluripotent cells constituting the ICM (Brook and Gardner,
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Table 1
Mean (±SE) percentage attachment of blastocysts, primary ICM outgrowths and consecutive passages of goat ES-like cell lines.
Source No. of replicates No. of blastocysts % Blastocyst attachments (n) % Primary ICM outgrowths (n) % Successful ES cell passages (n)
P1 P2 P3
In vivo 4 13 100.0 ± 0.0a,x (13/13) 87.5 ± 8.0a,x (11/13) 95.0 ± 5.0a,y (10/11) 81.3 ± 12.0a,x (8/11) 79.2 ± 12.5a,y (7/11)
In  vitro* 41 156 69.5 ± 4.7c,x (124/156) 75.6 ± 5.1c,x (104/124) 52.8 ± 6.1b,x (74/104) 41.8 ± 6.7b,x (51/104) 20.8 ± 5.5a,x (24/104)
Total  45 169 72.2 ± 4.5 76.6 ± 4.7 56.5 ± 5.9 45.3 ± 6.4 34.7 ± 2.4
abc Means with different superscripts in a row within a group were signiﬁcantly different (P < 0.05).
xy Means with different superscripts in a column within a group were signiﬁcantly different (P < 0.05).
* In vitro included SCNT and PA treatments.
Table 2
Mean (±SE) percentage attachment of ICM, primary ICM outgrowths and consecutive passages of goat ES-like cell lines.
Isolation technique No. of
replicates
No. of
blastocysts
% ICM attachments
(n)
% Primary ICM
outgrowths (n)
% Successful ES cell passages (n)
P1 P2 P3
Whole blastocyst culture
(control)
8 26 62.9 ± 6.7bc,x (16/26) 83.3 ± 8.3c,x (13/16) 39.6 ± 13.0ab,x (6/13) 22.9 ± 13.0ab,x (3/13) 12.5 ± 12.5a,x (1/13)
Manual  cut 22 90 74.4 ± 7.5b,x (79/90) 71.6 ± 7.5b,x (68/79) 71.3 ± 9.0b,y (59/68) 46.4 ± 9.2a,x (43/68) 35.0 ± 9.1a,x (25/68)
Laser  dissection 15 53 74.0 ± 7.3cd,x (42/53) 80.4 ± 7.7d,x (34/42) 44.0 ± 7.4ab,xy (19/34) 30.0 ± 6.1bc,x (13/34) 12.2 ± 4.9a,x (5/34)
Total  45 169 72.2 ± 4.5 76.6 ± 4.7 56.5 ± 5.9 45.3 ± 6.4 27.1 ± 5.9
abcd Means with different superscripts in a row within a group were signiﬁcantly different (P < 0.05).
xy Means with different superscripts in a column within a group were signiﬁcantly different (P < 0.05).
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Table 3
Summarization of ESC protein marker expressions on goat ES cells.
Pluripotent markers Goat ES cells
AP +
SSEA-1 −
SSEA-3 +
SSEA-4 −
TRA-1-60 −
TRA-1-81 −
Oct-4 +
1997) or single blastomeres (Sills et al., 2005; Chung et al.,
2006).
The current culture conditions used for mammalian ES
cells have been mainly developed for mouse ES cell cul-
ture, and it appears that these culture conditions were not
very effective for maintaining ES cells in domestic animals.
In the present study, ICM from goat blastocysts were suc-
cessfully isolated by using whole blastocyst cultures, using
manual cutting or laser dissection to produce ES cells, as
characterized by AP, SSEA-3 and Oct-4 staining. The ICM’s
were cultured on a MEF  feeder layer to produce the goat
ES cells. The ICM from in vivo derived blastocysts gave a
higher percentage of successful ES cell passages, compared
to in vitro derived blastocysts. The pig ES cells obtained
were reported to be lower for blastocysts, produced from
in vitro produced blastocysts, compared to in vivo produced
embryos (Vassiliev et al., 2010), and similar to those in the
present study.
Attempts in the primary culture of the ICM of the feeder
cell layer (MEF), in the presence of leukaemia inhibitory
factors (LIF), have seldom been successful. The feeder layer
was shown to be one of the key factors inﬂuencing ES cell
culture (Piedrahita et al., 1990). Various components have
been used as supplements in the ES cell culture media. One
of the components being cytokine e.g. LIF, a basic ﬁbroblast
growth factor (bFGF) and the stem cell factor (SCF). Some
researchers used feeder cell layers only, without adding
any foreign cytokines to the ES cell medium (Chen et al.,
1991). Others again added LIF, bFGF and SCF into the ES
cell (Piedrahita et al., 1990). Although LIF could inhibit the
differentiation of ES cells, bFGF may  stimulate ES cell prolif-
eration (Schmitt et al., 1991). LIF has been shown to inhibit
the differentiation of ES cells (Niwa et al., 1998). In this
study, LIF was added to the ES cell culture medium and MEF
was used as the feeder cell layer. It has been reported that
MEF’s secrete some kind of cytokines (Smith et al., 1988),
which may  stimulate ES cell growth and inhibit their dif-
ferentiation. MEF’s had been shown to produce the factors
responsible for maintaining embryonic carcinoma cells in
an undifferentiated state, by inhibiting their differentia-
tion (Martin and Evans, 1975). In addition, mitomycin C
treatment time also affected the MEF  activity. If the incu-
bation period exceeded 3 h, the MEF  could not be used as
a feeder layer, due to the decrease in cell adhesion to the
dishes.
ICM cells were isolated from the blastocysts by usingPlease cite this article in press as: Goh, S.Y., et al., Characterizatio
from the inner cell mass isolation. Small Ruminant Res. (2012),
an immuno-surgery technique (Solter and Knowles, 1975;
Wianny et al., 1997; Chen et al., 1999). However, the
retrieval of ICM cells was not always successful, as anti-
serum was used during immuno-surgery. It has been PRESS
search xxx (2012) xxx– xxx
shown earlier that mechanical ICM isolation was success-
ful in producing cat ES cells (Yu et al., 2008). Subsequently,
Wolf et al. (2011) showed that cat ICM’s could be obtained
by using manual isolation, immunosurgery, immuno-
surgery with manual cleaning or whole blastocyst culture.
Although all isolation methods resulted in ES-like cell
outgrowth colonies (OC’s), immunosurgery with manual
cleaning yielded signiﬁcantly higher rates of ICM attach-
ment and subsequent ES-like morphology. An alternative
method to isolate ICM cells from blastocysts was suggested
and it was found that it was easier to isolate ICM cells from
blastocysts by manually cutting (Wolf et al., 2011).
Alkaline phosphotase (AP) (Wobus et al., 1984; Talbot
et al., 1993), Oct-4 (Pawar et al., 2009) and SSEA-3 (Yang
et al., 2010) have been the most common markers used
to evaluate pluripotent cells and to identify stem cells. As
shown in Table 2, the ES cells obtained from ICM conﬁrmed
their pluripotency by using the mentioned staining, which
was  similar for the buffalo (Verma et al., 2007), pig (Li et al.,
2003), horse (Saito et al., 2002) and primates (Thomson
and Marshal, 1998). Expression stage-speciﬁc embryonic
antigen SSEA-3 only appeared on goat ES cells.
5. Conclusions
In summary, the understanding of culture conditions
such as by using MEF  as a feeder layer in the presence of
LIF in this study is important to develop an efﬁcient deriva-
tion of ES cells in goats. In addition, appropriate isolation
techniques of the ICM of blastocysts such as e.g. the whole
culture of blastocysts, manually cut and laser dissection
should be given due consideration in order to establish a
routine and practical protocol for the production of ES cells.
The goat ES cells were positively characterized by AP, Oct-4
and SSEA-3 staining.
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ABSTRACT The aim of this study was to compare the effects of murine strain, blastocyst stage and 
inner cell mass (ICM) isolation technique on the efficiency of deriving murine embryonic stem cell 
(mESC) lines. Foetal mouse embryonic fibroblasts (MEFs) were cultured to Passage 2, cryopreserved and 
thawed at each passage to be used as feeder layer for mESC culture. Five blastocyst stages from in vivo and 
in vitro produced blastocysts were cultured on the MEFs by using 3 different ICM isolation techniques. 
ICM outgrowths were disaggregated by trypsin/EDTA (0.05%) and manual dissociation, cultured on new 
inactivated MEFs in CO2 (5%) incubator, 37ºC. The attachment, primary ICM outgrowth and successful 
consecutive passages rates up to P3 were compared among the murine strains, blastocyst stages and ICM 
isolation techniques. There were significant differences (P<0.05) in successful passage rate at P3 between 
CBA/ca with ICR and C57BL/6J (19.81% vs. 9.00% and 8.50%), respectively, also mESC at P1 for mid-, 
expanded- and hatching blastocyst stages versus early- and hatched blastocyst (45.35%, 52.79% and 
43.01% vs. 27.88% and 24.53%), respectively. Manual cut ICM isolation technique consistently gave the 
highest attachment, primary ICM outgrowth and successful mESC P2 and P3 rates compared with whole 
blastocyst culture and laser dissection techniques (78.03% vs. 66.52% and 71.06%; 78.35% vs. 75.32% and 
75.67%; 52.06% vs. 41.62% and 45.06%; 36.52% vs. 25.77% and 30.49%), respectively. In conclusions, 
the CBA/ca strain, expanded blastocyst stage and manual cut ICM isolation techniques showed the highest 
results obtained in production of mESC lines.  
 
ABSTRAK Kajian ini adalah untuk membandingkan strain mencit, peringkat blastosis dan teknik-
teknik mengasingkan jisim sel dalaman (ICM) terhadap kecekapan dalam memperolehi titisan sel batang 
embrionik mencit (mESC). Fibroblas embronik mencit (MEF) dikultur sehingga pasaj 2, dikrioawet dan 
dinyahsejukbeku pada setiap pasaj untuk digunakan sebagai lapisan sel pembantu bagi pengkulturan 
mESC. Lima peringkat blastosis diperolehi daripada in vivo dan in vitro telah dikultur atas MEF dengan 3 
teknik pengasingan ICM. Pertumbuhan ICM telah dipisahkan dengan cara trypsin/EDTA (0.05%) dan 
penceraian secara manual, dikultur di atas MEF baru tak teraktif dalam inkubator CO2 (5%) pada 37ºC 
Pelekapan, pertumbuhan ICM primer dan kadar pasaj turutan yang berjaya sehingga ke P3 telah dibanding 
antara strain mencit, peringkat blastosis dan teknik pengasingan ICM. Terdapat perbezaan signifikan 
(P<0.05) dalam kadar pasaj yang berjaya pada P3 antara CBA/ca dengan ICR dan C57BL/6J (19.81% vs. 
9.00% dan 8.50%), masing-masing, juga mESC pada P1 bagi peringkat blastosis pertengahan, 
pengembangan dan penetasan berlawan dengan peringkat blastosis awal- dan menetas (45.35%, 52.79% 
dan 43.01% vs. 27.88% dan 24.53%), masing-masing. Teknik penceraian ICM secara pemotongan manual 
adalah dengan konsisten memberi kadar-kadar dalam pelekapan, pertumbuhan ICM primer serta P2 dan P3 
bagi mESC yang berjaya yang paling tinggi berbanding dengan kultur seluruh blastosis dan teknik 
pembedahan laser (78.03% vs. 66.52% dan 71.06%; 78.35% vs. 75.32% dan 75.67%; 52.06% vs. 41.62% 
dan 45.06%; 36.52% vs. 25.77% dan 30.49%), masing-masing. Secara ringkasnya, strain CBA/ca, 
peringkat pengembagan blastosis dan teknik pemotongan secara manual bagi teknik pengasingan ICM 
menunjukkan hasilan optimal diperolehi dalam menghasilkan titisan-titisan mESC.  
 
(Keywords: Blastocyst stage, ICM isolation technique, mESC, murine strain)  
 
INTRODUCTION 
 
Murine serves as a preferred human therapeutic 
model for embryonic stem cell (ESC) research as 
this species has close similarities in terms of 
molecular biology, physiology and 
developmental process. Since murine species has 
relatively short generation interval and prolific, 
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easy to handle, bred and managed as well as 
capable of reproducing in large numbers, it is 
suitable to establish a large number of both MEF 
stock and to obtain the blastocysts needed for 
stem cell culture. ESC could differentiate into 
any cell type in the body, including gametes [1, 
2]. It is defined functionally as cells that have the 
capacity to self-renew and the ability to generate 
differentiated cells [3, 4]. Isolation and culture of 
embryo-derived cell lines have been reported in 
many mammals such as murine [2, 4], ovine [6, 
7], hamster [8, 9], porcine [10, 11, 12, 13], mink 
[14], rabbit [15, 16], bovine [17, 18], including 
primates [19] and humans [20].  
 
mESC isolated from both whole embryos [21] 
and isolated ICM [2, 22], have similar 
morphological and biochemical properties to 
cells from the early murine embryos [23]. mESC 
have generate chimeric murine showing 
pluripotency in nature [24] and cultured ICM on 
MEF in the presence of leukaemia inhibitory 
factor (LIF) [25]. Blastocysts are either plated 
intact of feeder layer [26, 27] where they hatch 
and attach to feeder cell layer or the ICM is 
isolated from blastocysts either by 
immunosurgery [27, 28], enzymatic digestion 
using trypsin [26, 27] or mechanical isolation 
[26].   
 
Feeder cell is one of the important factors 
affecting ESC culture [29]. Feeder cell of various 
types have been used for ESC culturing; STO 
fibroblasts in murine [2], bovine foetal 
fibroblasts, bovine uterus epithelial cells, MEF, 
human lung fibroblasts for ESC culturing in 
bovines [28, 30, 31] and buffalo foetal 
fibroblasts in buffalo [26]. It has been reported 
that feeder layer could secrete some kinds of 
cytokines, such as LIF [32], which may stimulate 
ESC growth and inhibit their differentiation. 
Without a suitable culture medium or feeder 
layer, ESC would spontaneously differentiate. 
The original protocol for deriving mESC by 
Evans and Kaufman [2] is highly inefficient. 
Even though improvements have been made 
[33], an efficient protocol is still needed to be 
developed. 
 
The production of blastocysts as s source for 
mESC production involves either natural mating 
or superovulation of murine females to produce a 
large amount of fertilisable eggs, followed by 
timed-mating. The desirable blastocysts could 
also be obtained directly via uterine flushing or 
indirectly by culturing early stages oviduct-
flushed embryos up to blastocyst stage. Many 
regard the 129 strain as the most favourable and 
efficient strain [33]. Experiments using other 
strains showed varying success rates [34, 33]. It 
has been established that strain difference has an 
effect on the efficiency of establishing mESC 
lines [35]. The reason behind this is still poorly 
understood. Although the 129 and C57BL/6J 
strains are commonly used, relatively few 
researchers used the ICR or CBA/ca strain to 
develop ESC lines.  
 
Most studies ignore the blastocyst stage as a 
factor when deriving ESC [35, 33]. Movassagh-
Pour et al. [36] found that the efficient of 
deriving ESC from hatched blastocysts were 
low. This study indicates that blastocyst stage 
may be a crucial factor affecting ESCs 
derivation.  
 
mESC could be obtained by culturing the whole 
blastocyst, manual cut or laser dissection 
technique on a suitable culture medium with 
MEF as feeder cell layer. Besides that, other 
methods of deriving ESC include 
microdissection of blastocysts [34], isolation of 
the ICM through micromanipulation and 
culturing of single blastomeres [37]. The cells 
could then be used for subsequent steps in 
research, or cryopreserved for future usage.  
 
Culture of ICM of murine blastocysts was 
carried out for production of mESC lines and 
characterised with marker expressed as alkaline 
phosphatase, Oct 4, SSEA 1, SSES 3, TRA-1-60 
and TRA-1-81.    
 
In the present study, we evaluated the effects of 
murine strain (ICR, CBA/ca and C57BL/6J), 
blastocyst stage (early-, mid-, expanded-, 
hatching- and hatched blastocyst) and ICM 
isolation technique (whole blastocyst culture, 
manual cut, laser dissection) on efficiency of 
mESC culture.  
 
MATERIALS AND METHODS 
 
Preparation of feeder cell  
 
The feeder cells (MEF) were prepared from 
13.5-14.0 d.p.c. murine foetuses. The pups were 
processed by removing the head, tail, limbs and 
internal organs, then transferred to a fresh PBS(-) 
solution for washing and minced it by using a 
sterile blade in small amount of trypsin/EDTA 
(0.25%) solution. Mincing was done for a few 
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more minutes to further reduce the size of the 
pieces. The large pieces were filtered out through 
a sheet of sterilised nylon and then centrifuged at 
2000 rpm for 5 min. After centrifugation, the 
supernatant was removed and the pellet was re-
suspended in around 2 to 4 ml of 3x MEF culture 
media. The cells were then seeded into the 
culture dishes coated with 0.1% gelatine with 
culture medium DMEM (Invitrogen) 
supplemented with 10% foetal bovine serum 
(FBS; Hyclone), 200mM L-glutamine 
(Invitrogen) and 1x penicillin/streptomycin (PS) 
(Invitrogen). The MFF were inactivated with 5 
μg/ml mitomycin C (Sigma) for 2-3 hr followed 
by a thorough wash before plating.  
 
When the cells from the explants reached 80% 
confluence, they were harvested using 
trypsin/EDTA (0.25%) and then sub-cultured to 
P1 or P2. The MEF at P1 or P2 were 
cryopreserved using DMSO (20%) mixed in the 
tissue culture medium and stored in liquid 
nitrogen. The frozen cells were thawed and 
cultured up to 80% confluence to use ready used 
as feeder cells for mESC cultured.   
 
Embryo collection 
 
Three pure-strains of murine (ICR, CBA/ca and 
C57BL/6J) blastocysts were collected by in vivo 
oviduct (2-cell stage embryos) or uterine 
(blastocysts) flushing. Murine females (6-8 
weeks old) were superovulated with an 
intraperitoneal (i.p.) injection of pregnant mare’s 
serum gonadotrophin (PMSG; 10 IU) followed 
by an intraperitoneal injection of human 
chorionic gonadotrophin (hCG; 10 IU) at 46-48 
hr later. Each female murine was then placed in a 
cage with a stud male and copulation plug was 
checked on the next morning (day 1 pregnancy). 
 
For recovery 2-cell stage murine embryos, 
oviducts of superovulated murine females were 
flushed with Hepes Whitten’s medium (HWM) 
using a flushing needle (32 G) connected to a 
syringe (1 ml). Collected embryos were washed 
3 times in equilibrated Whitten’s medium (WM) 
and cultured under mineral oil at 37.5ºC in CO2 
(5%) in humidified air for in vitro development 
until blastocyst stage prior to use for producing 
mESC. Murine blastocyst stage will be located in 
the uterus. By using a method described by 
Hogan et al. [38], blastocysts were flushed from 
the uterus between days 3.5-4.5 d.p.c.  
  
 
Isolation of inner cell masses from blastocysts 
 
Three different ICM isolation techniques were 
used in present study, namely whole blastocyst 
culture, mechanical dissection or manual cut (30 
G needle) and laser dissection, and the cells 
consecutively cultured to obtain primary ICM 
outgrowths (Figure 2). In whole blastocyst 
culture, the efficiency of early-, mid-, expanded-, 
hatching- and hatched-blastocysts for deriving 
mESC were compared. The zona pellucida of 
each blastocyst stage was removed by using 
pronase (0.5%). Then, the whole blastocysts 
were plating on inactivated MEF in a humidified 
atmosphere of CO2 (5%) in air at 37˚C for 
culturing. After 6-8 days later, the growing 
colonies were individually dissociated into 
clumps after treating with trypsin/EDTA 
(0.05%). The resultant small clumps containing 
approximately 20-50 cells were transferred to a 
new well with a fresh feeder cell and medium. 
The new colonies were inspected daily and sub-
cultured at an interval of approximately 6-10 
days according to their size and growth rate, and 
medium were changed on every other day.  
 
For manual cut ICM isolation technique, the 
zona pellucida of blastocyst was removed similar 
as previously described. A single murine 
blastocyst was transferred onto a droplet of ESCs 
culture medium. A cut was performed between 
the ICM and trophectoderm (TE) on blastocyst 
by using 2 needles (30 G). The murine ICM was 
isolated after the cutting and transferred onto an 
inactivated feeder cell and finally was placed 
onto the feeder cell with sufficient gap in 
between them.  
 
In laser dissection techniques, the zona pellucida 
of blastocyst was not removed. This technique 
was carried out on the micromanipulator system 
where the holding pipette (left side) and biopsy 
needle (right side) were used in manipulated 
blastocyst. The ICM was located at the 9 o’clock 
position. The blastocyst was held by holding 
pipette and the laser was shot along the way 
between the ICM cells and TE cells. After 
shooting, the biopsy needle was sucked on the 
other side of the blastocyst to remove the zona 
pellucida and TE from the ICM. The isolated 
murine ICM was cultured onto the inactivated 
feeder cells and the primary outgrowth of the 
culture was observed. 
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Isolation and passages of embryo-derived cell 
lines 
 
The primary ICM outgrowths were sub-cultured 
using trypsinisation or mechanical dissection 
procedures by trypsin/EDTA (0.05%). After 
around 4-6 days of culture, the primary ICM 
outgrowths were picked and sub-cultured into 
new feeder cells. The ICM that were selected had 
characteristics included dome shape colony 
surrounded with primitive endoderm, 
homogeneous and higher nuclear to cytoplasm 
ratio (bigger nucleus). They had a slightly 
refracted and were located directly next to the 
outgrowths (Fig. 1). The suitable outgrowths 
were picked before differentiation occurred.  
 
Alkaline phosphatase (AP) staining 
 
For alkaline phosphatise (AP) staining, the 
mESC was fixed with paraformaldehyde (4%) 
for 30 min. After 30 min, they were washed with 
PBS(-) for 5 times. The AP was added to the 
substrate just to cover the cell and incubated for 
15-30 min in dark environment. After 15-30 min, 
it was washed again with PBS(-) for 2 times. AP 
staining was carried out to determine the AP 
activities that found in mESC lines. The mESC 
were purplish and differentiated cells were 
colourless after staining (Figure 4). 
 
Characterisation mESC by ESC protein 
markers 
 
The mESC can be confirmed by 
immunofluorescent staining. They were fixed 
with paraformaldehyde (4%) for 30 min and the 
cell was washed with PBS(-) for 5 times and 
blocking solution (10% FBS+PBS(-)) was added 
and leave it for 2 hr at room temperature. The 
primary antibody (such as Oct 4, SSEA 1, SSEA 
3, SSEA 4, TRA-1-80 and TRA-1-60) was 
prepared at the optimal concentration with the 
ratio (1:250). After 2 hr of blocking solution, the 
blocking solution was removed and the diluted 
primary antibody was added and incubated 
overnight at 4°C. After that, the primary 
antibody was removed out and washed 5 times 
with PBS(-). The washing step took 10-15 
min/time. Next, secondary antibody (diluted in 
ratio 1:1000) was added just to cover the cell and 
incubated 2 hr in dark environment. After 2 hr, 
the secondary antibody was discarded out and 
washed again 5 times with PBS(-). Lastly, 
Hoechst 33342 (5 μg/ml) was added and 
incubated 5 min in dark condition. The staining 
cell was observed under fluorescent microscope.  
 
 
Statistical analysis 
 
Data were analysed by analysis of variance 
(ANOVA) and Duncan’s multiple range tests (D-
MRT), using the SPSS statistical software 
package version 16. A probability of P<0.05 was 
considered significant for all statistical tests. 
Values were presented as mean±SEM. 
 
 
RESULTS AND DISCUSSION 
 
A total of 864 and 212 murine were used in vivo 
oviduct flushing and in vivo uterine flushing with 
representative numbers of 297 and 121 (ICR), 
278 and 37 (CBA/ca), 289 and 54 (C57BL/6J), 
respectively. After in vitro culture, a total of 
6324 (84.36%) murine blastocysts were obtained 
from 7544 two-cell stage murine embryos 
through in vivo oviduct flushing.  Out of 6324 
blastocysts obtained, 2589 (86.39%), 1988 
(84.26%) and 1747 (81.84%) blastocysts were 
obtained from the ICR, CBA/ca and C57BL/6J 
murine pure-strains, respectively.  
 
The percent successful attachment of blastocysts 
and consecutive passages of mESC lines up to 
P3 derived from 3 pure-strains of murine (ICR, 
CBA/ca and C57BL/6J) are summarised in 
Table 1 and Figure 1. There were no significant 
differences (P>0.05) among the 3 pure-strains of 
murine in percent successful consecutive 
passages mESC lines up to P3. However, 
CBA/ca gave the highest percent attachment of 
blastocysts and successful consecutive passages 
mESC lines with the values of 62.68% 
(attachment rate), 41.32% (P1), 31.00% (P2) and 
19.81% (P3), respectively. ESC derived from 
different strains of murine generally have 
different success rates [35, 33]. Our results have 
shown that there were significant differences 
between CBA/ca and ICR with C57BL/6J, 
whereby mESC derived from CBA/ca strain 
have higher success rate of passaging up to P3 
compared to ICR and C57BL/6J. Therefore, it is 
suggested that CBA/ca strain may be more 
suitable for deriving mESC.  
 
Previously, it was found that blastocysts from 
C57BL/6J and CBA/ca have an efficiency of 
deriving ESC of 58% and 66% [39], which was 
considerably higher than the findings of this 
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study. One possible factor is the use of ESC 
medium conditioned with rabbit fibroblast cell 
line which may have increased the amount of 
LIF and other support factors in the culture 
medium, thus improving efficiency [39] in their 
studies. However, it is noteworthy to mention 
that only 12 blastocysts were used for each strain 
in their reports; whereas in the present study 758 
and 709 blastocysts from CBA/ca and C57BL/6J 
were used. No data were found on the 
performance of blastocysts derived from ICR 
strain. The overall low efficiency in deriving 
mESC (11.62%) compared to other researchers 
may be attributed to the use of 35 mm culture 
dishes instead of multi-well plates which provide 
greater contact between the blastocysts and 
feeder cells [40, 33]. 
 
Percent successful attachment of blastocysts and 
consecutive passages of mESC lines up to P3 
from 5 blastocyst stages (early-, mid-, expanded-
, hatching- and hatched blastocyst) are 
summarised in Table 2. There were no 
significant differences (P>0.05) in percent 
attachment for early-, mid-, expanded-, hatching- 
and hatched blastocyst with the values of 
65.17%, 48.08%, 68.78%, 57.01% and 37.45%, 
respectively. Although each blastocyst stage 
could passage up to P3 in producing mESC lines, 
expanded blastocyst stage showed the highest 
percent successful attachment of blastocysts and 
successful consecutive passages compared to 
other blastocyst stages with the values of 68.78% 
(attachment rate), 52.79% (P1), 37.55% (P2) and 
17.24% (P3), respectively. The low success rate 
of deriving mESC from hatched blastocysts is in 
agreement with the findings of Movaassagh-Pour 
et al. [36]. Up to now, no reports were found 
comparing the 5 different blastocyst stages in 
murine species on the mESC culture. The reason 
for this phenomenon is not known as this time. A 
possible explanation could be the biochemical 
and morphological events taking place during the 
development of blastocysts from early to hatched 
stage. In early blastocysts, the ICM and TE have 
not fully separated. Thus, when cultured on the 
feeder cell, the consecutive outgrowth would 
have a high mixture of both ICM and TE derived 
cells. The interaction among the cells possibly 
makes the mESC more likely to differentiate. 
Meanwhile, hatched blastocysts have ICM that 
were already beginning to differentiate into the 
epiblast. This is supported by the fact that Oct4 
expression in blastocysts decreases sharply at 4.5 
d.p.c. [41]. Oct 4 expression is crucial in 
maintaining the pluripotency and 
undifferentiated state in ESC [42]. Thus, ESC 
derived from them may have a higher tendency 
to differentiate. Therefore, hatched blastocysts 
were not suitable for deriving mESC.  
 
A significant finding in this experiment is that 
expanded blastocysts are better sources of mESC 
lines. The use of expanded blastocysts could be 
applied in future experiment involving ESC to 
improve efficiency, rather than ignoring the 
blastocyst stages when deriving ESC lines [33, 
34, 35, 43]. 
 
A total of 6831 murine blastocysts were used in 
this experiment consisting of 2438, 2062 and 
2331 for whole blastocyst culture, manual cut 
and laser dissection techniques, respectively. 
There were significant differences (P<0.05) in 
percent attachment of blastocysts for 3 different 
ICM isolation techniques with the values of 
66.52%, 78.03% and 71.06% for whole 
blastocyst culture, manual cut and laser 
dissection techniques, respectively (Table 3; 
Figure 2). Manual cut ICM isolation technique 
gave the highest percent primary ICM outgrowth 
with the values of 78.35%, followed by laser 
dissection (75.67%) and whole blastocyst culture 
(75.32%). There was a significant decrease in 
percent successful consecutive passages from P1, 
P1, P2 and P3 for 3 different ICM isolation 
techniques.  
 
ICM isolation technique is an important step to 
ensure the success of the ESC establishment. In 
present study, the whole blastocyst culture gave 
the lowest attachment, primary ICM outgrowth 
and successful passages up to P3 rates compared 
to manual cut and laser dissection ICM isolation 
techniques. This may be due to intact embryos, 
where trophoblastic cells induce ICM 
differentiation to be 3 embryonic germ layers by 
suppressing Oct 4 and Nanog expression level 
[44]. Therefore, completely removed 
trophoblastic cells provide more benefit to ICM 
cells turn to be ESC. The ICM could be 
separated and isolated from the TE by 5 ways, 
namely immunosurgery [45], with mechanical 
processes [46], with whole embryo culture of the 
blastocysts and partial embryo culture methods 
[47] or single blastomeres [48] and laser 
dissection [49]. 
 
Mechanical isolation of the ICM has previously 
been successfully used in the derivation of 2 cell 
lines, as reported by Genbacev et al. [50], 
Mummery [51] and van de Stolpe et al. [52]. 
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Manual cut ICM isolation technique has been 
proven to improve results (Chanchao 
Lorthongpanich, personal communication). 
However, the difficulty of the manual cut 
procedure limits the rate at which blastocysts can 
be dissected. Furthermore, some ICM may 
become damaged due to the use of needles to 
pull the inner cell mass away from the overlying 
trophectoderm. The embryo tended to rotate 
away from the 30 G needle when it was cut 
towards one pole. The choice of well expanded 
blastocysts enabled trophoblast to be obtained 
with little risk of inclusion of ICM. Ideally, more 
training and practice should be done to master 
manual cut ICM isolation technique to allow 
comparisons in terms of efficiency. 
 
Laser dissection method are used in the present 
study was to evaluate a new method of isolation 
ICM and derivation of ESC lines in a murine. 
Laser technology is commonly used for assisted 
hatching with some applications. One of them 
consists of making the embryonic membrane 
weaker to make the exit of the future blastocyst 
easier and so favour the derivation [53]. Until 
now, this new laser dissection method has been 
suggested to derive stem cell lines by Wang et 
al. [54], although without presenting any 
conclusive results. A recent paper, Tanaka et al. 
[55] reported preliminary results for a murine 
model using this method; subsequent culture of 
ESC in a serum/cell-free culture system was 
achieved. We have compared the ICM isolation 
method using laser dissection in a murine 
blastocyst with one of the most commonly used 
methods, the whole blastocyst culture [47]. 
However, with good quality blastocysts with a 
large and distinct ICM, we used the laser drill 
(Hamilton, USA). In our experiment, the murine 
blastocyst to be treated with laser shot was 
positioned at the centre of the field of view under 
40x magnification. Blastocysts can be secured by 
2 holding pipettes with the ICM positioned at ‘9 
o’clock’ if desired [55]. After focusing on the TE 
cells, the object had to be moved so that the part 
of the TE to be treated was located at the cross-
hair position displayed on the monitor as the 
impact location of the laser focus. Thus, this new 
mechanical method destroyed the TE cells by 
shooting the laser over them carefully without 
damaging the ICM. Although some reported that 
the whole blastocyst culture method of the 
blastocysts is more effective than the laser 
method (70% versus 52.4%) [56], we have used 
the laser drill for the good quality blastocysts and 
that the concealment of the ICM by the TE cells 
is the only disadvantage of the whole blastocyst 
culture method [46]. Therefore, we must 
continue to improve the laser dissection 
technique so that the TE cells are destroyed and 
do not interfere with ICM [55].  
 
ESC protein markers were used in determining 
the ESCs formation. Specific ESC markers were 
found in mESC such as Oct 4 (green) and SSEA 
1(green) in this experiment (Figure 4). There 
were no colours shown for TRA-1-60 and TRA-
1-81 ESC markers in murine species. Therefore, 
it indicates the presence of ESC in murine 
species. Also, purplish colour was shown in 
mESC after underwent AP staining. It could be 
confirmed that the presence of true mESC and 
pluripotent of mESC have been found. Five 
widely adopted antibody markers (anti-Oct 4, 
anti-Sox 2, anti-SSEA 1, 3 and 4, anti-TRA-1-60 
and anti-TRA-1-81) are the protein markers that 
usually found on ESC. Transcription factors 
(such as Oct 3/4 [57, 58], Sox 2 [59] and Nanog 
[60, 61]) function to identify pluripotency in 
both early embryos and ESC. Oct 4 and Sox 2 
are transcription factors that are highly expressed 
in undifferentiated ESC and EGC [62, 63, 64]. In 
our study, mESC express high levels of 
membrane alkaline phosphatase (AP) and Oct 4, 
a transcriptional factor critical to ICM and 
germline formation. Expression stage-specific 
embryonic antigen (SSEA 1) only appeared on 
mESC. 
 
For future studies, ESC could be directed 
towards differentiation pathways by changing 
growth conditions, leading to development of 
specialised cells such as heart muscle cells, 
neurons or insulin-secreting cells, opening the 
way to the development of new therapies in 
human regeneration medicine.  
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Table 1:  Percent successful attachment of blastocysts and consecutive passages of mESC (%,    
               mean±SEM) up to P3 from 3 pure-strains of murine. 
 
Strain No. of 
females 
No. of 
blastocysts 
Percent 
attachment    
(n) 
Percent successful consecutive passages         
(n) 
 P1 
(n) 
P2 
(n) 
P3 
(n) 
ICR 63 971     56.74±3.18
d,x  
(n=777) 
35.20±2.61
c,x  
(n=443) 
23.77±2.48
b,x  
(n=207) 
 9.00±1.65
a,x  
(n=71) 
CBA/ca 34 758 62.68±20.90
b,x  
(n=429) 
41.32±3.49
ab,x  
(n=237) 
31.00±3.56
ab,x
  
(n=109) 
19.81±3.51
a,y
  
(n=38) 
C57BL/6J 39 709     44.68±2.53
c,x
  
(n=359) 
40.71±4.49
c,x
  
(n=160) 
 22.10±3.75
a,x
  
(n=64) 
  8.50±2.59
a,x
  
(n=22) 
Total 136 2438     55.18±5.55  38.15±1.93  25.18±1.80   11.62±1.39 
xy
Mean values within a column within a group with different superscripts was not significantly different 
(P>0.05). 
abcd
Mean values within a row within a group with different superscripts were significantly different 
(P<0.05). 
 
 
 
 
 
Table 2:  Percent successful attachment of blastocysts and consecutive passages of mESC lines up to  
               P3 (mean±SEM) from 5 blastocyst stages. 
 
Blastocyst 
stage 
No. of 
females 
No. of 
blastocysts 
Percent 
attachment    
(n) 
Percent successful consecutive passages         
(n) 
 P1 P2 P3 
Early 82 256 65.17±24.88
b,x
  
(n=198) 
 27.88±3.79
ab,x
  
(n=105) 
      20.28±3.70
a,xy
  
(n=46) 
 9.18±2.98
a,x 
 (n=14) 
Mid 115 488   48.08±4.00
c,x
  
(n=278) 
45.35±5.60
c,y
  
(n=164) 
      28.11±4.29
b,yz 
     (n=81) 
15.16±3.47
a,x
  
(n=30) 
Expanded 129 666   68.78±3.38
d,x
  
(n=465) 
     52.79±3.92
c,y
  
(n=262) 
      37.55±4.36
b,z
  
(n=138) 
17.24±3.67
a,x
  
(n=55) 
Hatching 122 682   57.01±3.65
d,x
  
(n=418) 
     43.01±3.67
c,y
 
(n=224) 
      28.02±3.81
b,yz
  
(n=89) 
11.60±2.95
a,x
  
(n=25) 
Hatched 97 346   37.45±4.58
c,x
  
(n=206) 
     24.53±3.53
b,x 
 (n=85) 
      11.92±3.26
a,x
  
(n=26) 
 8.08±2.94
a,x
  
(n=7) 
Total 545 2438     5.44±5.48      38.71±1.94       25.18±1.80   2.27±1.44 
 xyz
Mean values within a column within a group with different superscripts were significantly different 
(P<0.05). 
 abcd
Mean values within a row within a group with different superscripts were significantly different 
(P<0.05). 
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Table 3: Percent attachment of blastocysts, primary outgrowth inner cell mass and successful  
                consecutive passages of mESC lines (%, mean±SEM) on 3 different inner cell mass   
                isolation techniques 
                          
Isolation 
techniques 
No. of 
females 
No. of 
blastocysts 
Percent 
attachment  
(n) 
Percent 
primary 
outgrowth  
(n) 
Percent successful consecutive passages  
(n) 
     P1 
(n) 
P2 
(n) 
P3 
(n) 
Whole 
blastocyst 
culture 
241 2438 66.52±2.18
c,x 
(n=1565) 
75.32±1.73
d,xy 
(n=1167) 
72.51±2.25
cd,y 
(n=841) 
41.62±3.23
b,x 
(n=380) 
25.77±3.34
a,x 
(n=131) 
Manual cut 
 
494 2062 78.03±0.94
d,z 
(n=1624) 
78.35±1.24
d,y 
(n=1295) 
67.84±1.60
c,y 
(n=906) 
52.06±1.94
b,y 
(n=545) 
36.52±2.45
a,y 
(n=255) 
Laser 
dissection 
357 2331 71.06±1.11
d,y 
(n=1690) 
75.67±0.85
d,x 
(n=1275) 
58.75±2.25
c,x 
(n=843) 
45.06±2.35
b,x 
(n=457) 
30.49±2.52
a,xy 
(n=194) 
Total 1092 6831 72.97±0.79 75.67±0.85    65.70±1.19  47.23±1.39        31.96±1.57 
xyz 
Mean values within a column within a group with different superscripts were significantly different 
(P<0.05). 
abcd 
Mean values within a row within a group with different superscripts were significantly different 
(P<0.05). 
 
 
       Figure 1: a) Blastocyst without the zona pellucida. b) Attachment and primary ICM outgrowth   
                      ICM at day3. c) Primary ICM outgrowth was sub-cultured by 0.05% trypsin/EDTA (P1).  
                      d) P2 of mESC was sub-cultured by manual dissociation before differentiation occurred.  
                      e) Undiffernetiated mESC at P3 with the sharp and clear edge as well as dome-shape. f)  
                      ESC colonies obtained. Arrow: ICM.                      
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Figure 2: A) Whole blastocyst culture, B) manual cut ICM and C) laser dissection ICM isolation 
               techniques with theirs ICM outgrowth shown by arrow. 
 
A 
B 
C 
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Figure 3: mESC were confirmed by the expression of murine specific ESC markers (Oct4,           
                  SSEA1) and human ESC specific markers (TRA-1-60 and TRA-1-81) as negative  
                  control. Transmission light images and Hoechst DNA staining were showed in the first  
                  and second column. The AP activities were positive and showed in the bottom line of  
                  the picture.  
 
 
CONCLUSION 
 
In conclusion, protocols for the derivation of 
MEF cell culture and establishment of mESC 
lines were successfully developed that may serve 
as the platform for future scientific research in 
ESC. Three murine strains could produce mESC 
lines. However, the CBA/ca strain shows  
 
satisfactory rate of consecutive passages mESC 
lines than ICR and C57BL/6J strains. With the 
establishment of ESC lines in murine by 
different stages of blastocyst and ICM isolation 
techniques, expanded blastocysts gave better 
growth rate of mESC lines then other stages. 
Manual cut gave highly significant successful 
rate in producing mESC lines compared the 
100 µm 50 µm 
50 µm 
100 µm 
Hoechst 3342 
 Hoechst 3342 
 
Hoechst 3342 
Oct 4 
SSEA1 
TRA-1-81 
Hoechst 3342 TRA-1-60 
AP 
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other 2 techniques. mESC lines were confirmed 
where it was found that Oct 4 and SSEA 1 
protein markers as well as gave positive results 
in AP staining. 
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Abstract: It has been successed since the first cloned mammals were generated from 10 
somatic cells using nuclear transfer, but the success rate for producing live offspring 11 
by cloning still remains low which less than 5%. The aims of this investigation were 12 
to compare the effects of a) oocytes sources, b) oocyte grading, c) pre - 13 
intracytoplasmic injection durations and d) enucleation techniques on somatic cell 14 
nuclear trasnfer performance. Source of caprine oocytes were obtained from 15 
laparoscopic ovum pick - up, ovariectomy and abattoir. The collected oocytes were in 16 
vitro matured and characterized by cumulus expansion as well as the extrusion of the 17 
first polar body. Cumulus cells were denuded off and oocytes that had extruded the 18 
first polar body as well as with evenly granulated cytoplasm were selected and 19 
grouped by Grades A, B, C, D and E for enucleation, which were placed into TCM 20 
199 Hepes containing cytochalasin B (5.0 µg/mL). The first polar body and 21 
approximately 10 - 15% of the oocyte cytoplasm was squeezed out by 2 different 22 
techniques, namely laser or squeezing techniques. Fresh cumulus cells obtained from 23 
the matured oocytes could be used directly for nuclear transfer using whole cell 24 
intracytoplasmic injection technique. The reconstructed oocytes were activated by 25 
calcium ionophore (5 min) and 6 - dimethylaminopurine for 4 h and cultured in vitro 1 
in KSOM at CO2 (5%) incubator at 38.5
o
C in humidified atmosphere for 8 - 9 days. 2 
The medium was changed every 2 days of in vitro culture.  There were significant 3 
differences (P < 0.05) in maturation and enucleation rates for these 3 different sources 4 
with the values of 61.99 ± 3.12% and 66.16 ± 5.21% versus 51.23 ± 3.37% as well as 5 
97.85 ± 1.23% and 98.32 ± 1.16% versus 90.27 ± 2.72% for laparoscopic ovum pick - 6 
up, ovariectomy and abattoir sources, respectively. Even though insignificance, the 7 
embryo development at 2 -, 4 -, 8 - cell and morula was higher in laparoscopic ovum 8 
pick - up, followed by ovariectomy and abattoir. However, ovariectomy showed the 9 
highest blastocysts and hatched blastocysts rates (24.52 ± 8.53% and 18.42 ± 6.79%), 10 
followed by laparoscopic ovum pick-up (13.33 ± 3.68% and 8.12 ± 2.29%) and 11 
abattoir (10.06 ± 5.83% and 5.01 ± 3.19%), respectively. There were significant 12 
differences (P < 0.05) in percent cleavage between Grades A, B and C with Grades D 13 
and E for all stages of embryo development. The 60 min pre – intracytoplasmic 14 
injection duration gave highly significant differences (P < 0.05) for all the cleavage 15 
rates followed by simultaneous injection and 30 min pre – intracytoplasmic injection 16 
duration. The results from this study showed that laser enucleation technique gives 17 
better cleavage rate compared to squeezing enucleation technique for all the stage 18 
embryos development. It is concluded that ovariectomy oocyte source, Grade A, B 19 
and C, 60 min pre – intracytoplasmic injection duration and laser enucleation were 20 
sucessfully develop in caprine species in our laboratory. It is hoped that the findings 21 
obtained from this research will provide the fundamental information for future 22 
studies and could be potentially applied to overcome issues in livestock production 23 
and wildlife conservation. 24 
 25 
Key words: Oocyte sources, oocyte grading, enucleation techniques, pre - 1 
intracytoplasmic injection durations, caprine, somatic cell nuclear transfer 2 
 3 
 4 
Introduction 5 
 6 
The basic biology underlying nuclear transfer in cloning still remains unclear 7 
although it began more than 20 years ago. The birth of Dolly the sheep by Wilmut et 8 
al. (1), the first cloned mammal using somatic cell nuclear transfer (SCNT), success in 9 
cloning using adult somatic cells has been reported. The other mammalian species 10 
also reported including murine by Wakayama and Yanagimachi (2); Wakayama et al. 11 
(3); Wakayama et al. (4), bovine by Kato et al. (5); Galli et al. (6); Renard et al. (7); 12 
Wells et al. (8); Zakhaxtchenko et al. (9); Hill et al. (10); Kubota et al. (11), caprine 13 
by Baguisi et al. (12), porcine by Polejaeva et al. (13), and Bos gaurus (gaur) by 14 
Lanza et al. (14). A clone could be defined as a set of genetically identical animals 15 
was reported by Smith (15). Besides that, it also very useful in animal selection for 16 
the determination of the genetic traits or in research to reduce the number of 17 
experimental animals used as reported by Lamberson (16). The advantages of SCNT 18 
are valuable research animals may alleviate a limited availability of highly 19 
informative genotypes while to obtain optimum results by reducing the number of 20 
animals used. Today, cloning and transgenics are now available for producing 21 
phenotypes in large animals to study devastating disease and plays a relatively small 22 
role in research. Cloned animals could also replace more genetically dissimilar 23 
animals in the studies when the trait being investigated is highly heritable.  24 
In the early 1990 s, Genzyme (17) was first attempt on cloning to produce 1 
therapeutic proteins in the milk of transgenic caprine. They inserted a genetic 2 
construct into the nucleus of embryo at one-cell stage by using microinjection 3 
technique. Furthermore, Yong and Yuqiang (18) from the Northwest University of 4 
Science and Technology for Agriculture and Forestry from China have successfully 5 
produced the first cloned caprine from ear fibroblast cells. The first success in cloning 6 
Asian Yellow Goat by nuclear transfer had recently been achieved in east China by 7 
Chen et al. (19).  The improvement of the cloning technique may provide new 8 
approaches for conserving and saving endangered animal species. Successfu1 nuclear 9 
transfer has also been reported in caprine by Yong et al.  (20). Cloning by nuclear 10 
transfer has great potential application in pharmaceutical protein production, 11 
xenotransplanation, and therapeutic cloning. The success rate of cloning is quite low 12 
due to many technical factors such as donor cell cycle, oocyte activation, 13 
reprogramming of donor nucleus and recipient cytoplast and chemical agents. 14 
The cloned Dolly in 1997 showed us the way to physiologically differentiate 15 
already committed somatic cells as reported by Cibelli et al. (21). After Dolly, nuclear 16 
transfer enabled the cloning of murine, bovine, caprine and porcine where the era of 17 
livestock cloning had arrived. Cloning could be used as a great biochemical tool in 18 
providing invaluable advances in pharmacology and medicine. Thus, the objectives of 19 
this study were to investigate the effects of oocytes retrieval source, oocyte grading, 20 
pre – intracytoplasmic injection (pre – ICI) durations and enucleation techniques on 21 
caprine SCNT performance. 22 
 23 
 24 
 25 
Materials and methods 1 
 2 
Preparation of donor cells: The fresh caprine cumulus cells were obtained 3 
from in vitro matured oocytes harvested either from laparoscopic ovum pick - up, 4 
ovariectomy or abattoir ovaries. After 18 - 24 h of in vitro maturation, the cumulus 5 
cells were isolated by pipetting in hyaluronidase (0.2%) within 5 min at 37
o
C. All 6 
fresh cumulus cells were collected and washed in holding medium (TL - hepes 7 
working solution) and centrifuged for 5 min. Cumulus cell pellet was formed and the 8 
supernatant was removed. TL - hepes working solution (100 µL) was added into the 9 
pellet and sucked up and down to make the fresh cumulus cells became a single cell 10 
(7 - 8 µm) and were ready for use as donor cells. 11 
 12 
Oocyte retrieval and in vitro maturation: The caprine ovaries were obtained 13 
from LOPU (aspiration-flushing system), ovariectomy (ovaries were surgically 14 
removed) and abattoir [transported ovaries back to the laboratory in sterile NaCl 15 
(0.9%) supplemented with penicillin - G (60 µg/mL) and streptomycin (50 µg/mL) at 16 
30 - 35
o
C] sources. For ovariectomy and abattoir, the cumulus - oocyte complexes 17 
(COCs) were retrieved by checkerboard slicing the entire surface of the ovary inside 18 
the culture dish containing TL-hepes medium (holding medium) by using the razor 19 
blade. The retrieved oocytes group into Grades A, B, C, D and E based on the number 20 
layer of cumulus cells (Figure 1 a, b, c and d) and cultured in in vitro maturation 21 
(IVM) medium (TCM 199 supplemented with 10 µg/mL FSH, 1 µg/mL 17 - β 22 
estradiol, 100 µM/mL cysteamine, 0.2 mM sodium pyruvate, 10% FBS) overlaid with 23 
mineral oil in CO2 incubator (5%) at 38.5
o
C for 18 - 24 h.   24 
 25 
Enucleation of matured caprine oocyte: After maturation, the COCs were 1 
denuded in hyaluronidase (0.2%) and subsequently washed 5 times in TL - hepes 2 
medium. All selected matured oocytes with the extrusion of first polar body were 3 
transferred to the microdroplet containing TL - hepes medium supplemented with 4 
cytochalasin B (5 µg/mL) for 10 min prior to enucleation. Two enucleation 5 
techniques, namely squeezing and laser enucleation technique were used. Briefly, a 6 
cut or small hole was made on the zona pellucida above the first polar body by using 7 
cutting needle or laser and 10 - 15% of the cytoplasm beneath the first polar body 8 
(containing metaphase II (MII) chromosomes) was gently squeezed out or pushed out, 9 
respectively. The enucleated oocytes were then washed 3 times in TL - hepes medium 10 
(without cytochalasin B) and simultaneous injection with donor cell or allowed to 11 
recover at 38.5
o
C in KSOM medium in CO2 incubator for 30 and 60 min (pre - 12 
incubated) prior to nuclear transfer. 13 
 14 
Nuclear transfer: For whole cell intracytoplasmic injection, a single fresh 15 
cumulus cell (7 - 8 µm) was pipetted in and out few times in polyvinylpyrrolidone 16 
(PVP; 10%) medium using a blunt mouth injection needle (ID: 8 - 9 µm; OD: 9 - 10 17 
µm) to break the plasma membrane prior to injection. Briefly, before injection, a 18 
small amount of cytoplasm of an oocyte was gently aspirated into the injection needle 19 
until a sudden flux of cytoplasm went into the needle observed. This was to confirm 20 
the breakage of the cytoplasm’s membrane, thereby facilitating donor cell injection. A 21 
single cumulus cell was then gently deposited into the cytoplasm. All the injected 22 
oocytes were washed 3 times in TL - hepes medium, 3 times in KSOM medium and 23 
incubated in the final microdroplet of KSOM medium at least 60 min prior to 24 
activation. 25 
 1 
Activation: All the injected caprine oocytes were subjected to activation with 2 
calcium ionophore (5 µM) for 5 min and followed with 6 - dimethylaminopurine (6 - 3 
DMAP; 1.9 µM) for 4 h at 38.5
o
C under CO2 (5%).  4 
 5 
In vitro culture: Following activation, the reconstructed caprine oocytes were 6 
washed 5 times and then cultured in KSOM medium under CO2 incubator (5%) at 7 
38.5
o
C. The developmental of cloned - caprine embryos were observed every 2 days 8 
and recorded. At the same time, the refreshment of culture medium was also made 9 
every 2 days culture.  10 
 11 
Statistical analyses: All data were subjected to Analysis of Variance 12 
(ANOVA) followed by comparison of means using Duncan Multiple Range Test 13 
(DMRT). All statistical analysis was performed using SPSS (Statistical Package for 14 
Social Sciences) for windows Version 16.0. The data was presented as (mean ± 15 
SEM).  16 
 17 
 18 
Results  19 
 20 
Cleavage rates of caprine embryos through SCNT by 3 different sources of 21 
oocytes, namely LOPU, ovariectomy and abattoir were carried out in present study. 22 
There were significant differences (P < 0.05) in maturation and enucleation rates for 23 
these 3 different sources with the values of 61.99 ± 3.12% and 66.16 ± 5.21% versus 24 
51.23 ± 3.37% as well as 97.85 ± 1.23% and 98.32 ± 1.16% versus 90.27 ± 2.72% for 25 
laparoscopic ovum pick - up, ovariectomy and abattoir sources, respectively. Even 1 
though insignificance, the embryo development at 2 -, 4 -, 8 - cell and morula was 2 
higher in laparoscopic ovum pick - up, followed by ovariectomy and abattoir with 3 
values of 74.12 ± 5.30% versus 65.86 ± 7.87% versus 66.61 ± 6.64%; 63.40 ± 5.48% 4 
versus 56.83 ± 6.51% versus 51.46 ± 7.33%; 53.30 ± 5.84% versus 50.18 ± 9.05% 5 
versus 43.48 ± 8.14%; 48.56 ± 5.38% versus 44.68 ± 8.94% versus 26.28 ± 8.19%, 6 
respectively. However, ovariectomy showed the highest blastocyst and hatched 7 
blastocyst rates (24.52 ± 8.53% and 18.42 ± 6.79%), followed by laparoscopic ovum 8 
pick - up (13.33 ± 3.68% and 8.12 ± 2.29%) and abattoir (10.06 ± 5.83% and 5.01 ± 9 
3.19%) respectively as shown in Table 1 (Figures 2 (a, b) and 3 (a, b)).  10 
 For caprine oocytes grading, there were no significant differences (P > 0.05) 11 
in percent cleavage at Grades A, B and C with values of 46.40 ± 5.26%, 42.89 ± 12 
5.11%, 34.63 ± 4.91%; 31.06 ± 4.76%, 13.91 ± 3.56% and 6.88 ± 1.90%; 48.34 ± 13 
5.08%, 40.43 ± 4.85%, 33.57 ± 4.70%; 29.79 ± 4.48% and 9.86 ± 2.95%, 5.99 ± 14 
1.92%; 40.15 ± 5.17%, 32.78 ± 5.01%, 30.25 ± 5.00%, 26.62 ± 4.76%, 8.21 ± 2.80% 15 
and 5.38 ± 2.01% for 2 -, 4 -, 8 - cell, morula, blastocyst and hatched blastocyst, 16 
respectively. However, Grades A, B and C showed better cleavage rates than Grades 17 
D and E for all stages of embryo development (Table 2). For pre - ICI durations, it 18 
was vividly shown that for each embryo developmental stages from 2 -, 4 -, 8 - cell, 19 
morula, blastocyst and hatched blastocyst the cleavage rates were significantly higher 20 
(P < 0.05) for 60 minutes followed by simultaneous injection and 30 minutes pre - ICI 21 
durations (Table 3).  22 
In regard to enucleation techniques, there were no significant differences (P > 23 
0.05) in enucleation rates between squeezing and laser enucleation techniques. 24 
However, embryos development at various stages were significantly higher in laser 25 
enucleation technique compared to squeezing enucleation technique with values of 1 
82.07 ± 3.45% versus 58.15 ± 6.76%, 74.14 ± 3.62% versus 42.04 ± 6.53%, 70.93 ± 2 
3.87% versus 25.73 ± 6.05%, 64.08 ± 3.91% versus 16.36 ± 5.22%; 25.33 ± 4.66% 3 
versus 0.00 ± 0.00% and 15.68 ± 2.99% versus 0.00 ± 0.00% for 2 -, 4 -, 8 - cell, 4 
morula, blastocyst and hatched blastocyst respectively (Table 4). For both enucleation 5 
techniques, the cleavage rates were decreasing as the stages of development 6 
progressing. No blastocysts were obtained for squeezing enucleation technique.  7 
 8 
 9 
Discussion 10 
 11 
Production of cloned-caprine embryos through SCNT is influence by many 12 
factors including oocytes retrieval source, oocyte grading, pre - ICI durations and 13 
enucleation techniques.  The findings from this studies showed that ovariectomy 14 
showed the highest blastocyst and hatched blastocyst rates followed by laparoscopic 15 
ovum pick-up and abattoir. It could be due to the caprine ovaries that were surgically 16 
ovariectomized consistently provided greater follicle surface exposure for oocyte 17 
retrieval and the ability of more clearly visualized follicles on the ovaries as reported 18 
by Cognie (22). For small follicles, it was necessary to recover the oocytes by slicing 19 
the ovarian surface to obtain high number of oocytes as suggested by Martino et al.  20 
(23). Although caprine shows low reproductive capabilities are usually 21 
ovariectomized for ovarian slicing as most of them might be non - responsive to 22 
hormone stimulation during superovulation, more oocytes will be obtained via 23 
ovariectomy and chances to develop and blastocyst formation is higher compared to 24 
laparoscopic ovum pick - up oocyte source. It is generally agreed that the ovarian 25 
slicing method gains higher number of oocyte. Martino et al. (23) obtained more 1 
oocytes from ovarian mincing or slicing than follicular dissection or aspiration.  The 2 
reasons for higher oocyte obtain may be due to the presence of some follicles 3 
embedded deeply within the ovarian cortex, which could only be released by slicing 4 
of the ovary. Unlike laparoscopic ovum pick - up, the ovariectomy ovary by slicing 5 
protocol was done under visual observation regardless of ovarian follicle size; 6 
therefore, more oocytes were retrieved. Keskintepe et al. (24) who also obtained 7 
higher results of oocytes by surgically removing the ovaries of the does. 8 
The data obtained in this study indicated that Grade A oocytes are highly 9 
competent in terms of maturation and subsequent embryo development compared 10 
with Grades B and C. The Grade D oocytes (no layers of cumulus cells with evenly 11 
granulated cytoplasm and E (pale - coloured or heterogeneous cytoplasm) were least 12 
competent. The roles of cumulus cells in the acquisition of full developmental 13 
competence of the oocytes have been investigated earlier by Leibfried-Rutledge and 14 
First (25), Sato et al. (26) and Xu et al. (27). It is important that visual assessment of 15 
morphology of cumulus cells that surrounding an oocyte remains the most important 16 
criterion for selection of developmentally competent oocytes during recovery as 17 
reported by Shioya et al. (28), Madison et al. (29) and Lonergan et al. (30). Veeck (31) 18 
suggested that earlier that expanded cumulus cells characterizes mature and good 19 
quality oocytes, while compact cumulus cells characterize immature oocytes.  20 
The 60 min pre - ICI duration showed the highest cleavage rates followed by 21 
simultaneous injection and 30 min pre - ICI duration. This might be due to the 22 
enucleated caprine oocytes need time to restore the oocyte viability due to sensitivity 23 
of the oocytes after placing in CO2 incubator before injection of donor nuclear. 24 
Simultaneous injection right after enucleation could cause the lower oocyte viability 25 
as it could easily lyse just after enucleation. Therefore, pre - ICI duration for 60 1 
minutes seemed to be more suitable for SCNT in caprine species which was 2 
significantly higher compared to other pre - ICI injection durations.  3 
Our results demonstrate that using laser enucleation techniques have the 4 
ability to produce cloned - caprine hatched blastocyst stage. There is a scarce report 5 
on the caprine SCNT research using laser enucleation technique. Laser is a new and 6 
advance technique that has been used to enucleate recipient oocytes (cytoplast). In 7 
comparison with squeezing technique, laser enucleation technique is easier, less time 8 
consuming in enucleating the caprine oocytes. Low efficiency of cloned-caprine 9 
embryo development in the squeezing method might be due to the time consumption, 10 
where the squeezing method took much more longer duration compared to aspiration 11 
technique to remove the DNA (metaphase II) from caprine oocyte as reported by Lee 12 
et al. (32), whereas for laser enucleation techniques, the used of laser in enucleation of 13 
porcine oocytes was shown to be easier to operate. Although expensive, the laser 14 
enucleation technique gave the highest results in SCNT in caprine species in the 15 
present study.  16 
In cloned embryos, reprogramming usually occurs. Low efficiency of cloning 17 
may be due to imcomplete reprogramming. Therefore, correct epigenetic 18 
reprogramming is necessary for successful and normal developmental of clones by 19 
Dean et al. (33). The incomplete reactivation of Oct - 4 may account for some failures 20 
of NT embryo development as reported by Boiani et al. (34) and Bortvin et al. (35). 21 
Reprogramming usually occurred within the brief interval between the transfer of the 22 
donor nucleus into the enucleated oocyte and here the start of zygotic transcription. 23 
Also, due to maternal zygotic transition occurred where the onset of maternal zygotic 24 
transcription is species dependent such as murine 1 to 2 - cell stage; bovine, caprine 25 
and ovine 8 - 16 and Xenopus approximately 4000 as reported by Newport and 1 
Kirschner (36). Thus, a better understanding of the processes involved in nuclear 2 
reprogramming of in cloned embryos would enable to apply this knowledge to 3 
improving the overall efficiencies of NT. 4 
 In conclusions, cloned - caprine embryos were successfully produced in vitro 5 
from LOPU, ovariectomy and abattoir sources. The ovariectomy oocyte - retrieved 6 
seems to be more suitable source to produce cloned - caprine embryos through SCNT. 7 
Also, Grades A, B and C oocytes were more suitable to be used as karyoplast for 8 
SCNT compared with Grades D and E. The 60 min pre - ICI duration gave the highest 9 
cleavage rates in producing cloned - caprine embryos. The laser enucleation method 10 
shows higher cleavage rates up to hatched blastocyst than squeezing methods. With 11 
incorporation laser enucleation technology, the efficiency of SCNT will be enhanced 12 
for the production of cloned - caprine embryos.  13 
 14 
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Table 1. Cleavage rates of caprine embryos (%, mean ± SEM) from in vitro culture through somatic cell nuclear transfer by 3 different sources 1 
of oocytes           2 
abcde
 Means with different superscripts in a row within a group were significantly different (P < 0.05). 3 
 4 
 
xy
 Means with different superscripts in a column within a group were significantly different (P < 0.05). 5 
 6 
Source of 
oocytes 
No. of 
ovaries 
No. of 
oocytes 
Maturation 
rate  
(n) 
Enucleation 
rate  
(n) 
Injection rate 
(n) 
Percent cleavage  
(n)  
      2 - cell  
(n) 
4 - cell  
(n) 
8 - cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst  
(n) 
LOPU 91 487 61.99 ± 3.12
xy 
(297) 
97.85 ± 1.23
y 
(292) 
98.26 ± 0.92
x 
(287) 
74.12 ± 5.30
d,x 
(227) 
63.40 ± 5.48
cd,x 
(207) 
53.30 ± 5.84
bc,x 
(184) 
48.56 ± 5.38
b,x 
(169) 
13.33 ± 3.68
a,x 
(66) 
8.12 ± 2.29
a,xy 
(43) 
Ovariectomy 19 168 66.16 ± 5.21
y 
(115) 
98.32 ± 1.16
y 
(111) 
97.78 ± 2.22
x 
(110) 
65.86 ± 7.87
c,x 
(75) 
56.83 ± 6.51
c,x 
(65) 
50.18 ± 9.05
c,x 
(54) 
44.68 ± 8.94
bc,x 
(45) 
24.52 ± 8.53
ab,x 
(29) 
18.42 ± 6.79
a,y 
(21) 
Abattoir     99 641 51.23 ± 3.37
x 
(355) 
90.27 ± 2.72
x 
(312) 
94.61 ± 2.25
x 
(289) 
66.61 ± 6.64
e,x 
(226) 
51.46 ± 7.33
de,x 
(190) 
43.48 ± 8.14
cd,x 
(166) 
26.28 ± 8.19
bc,x 
(136) 
10.06 ± 5.83
ab,x 
(75) 
 5.01 ± 3.19
a,x 
(35) 
Total 209 1296 59.76 ± 2.28 95.99 ± 1.10 97.28 ± 0.86 71.23 ± 3.83 59.59 ± 3.99 50.43 ± 4.32 42.45 ± 4.20 13.85 ± 2.93  8.57 ± 1.86 
Table 2. Percent cleavage of caprine embryos (%, mean ± SEM) based on oocyte grading  1 
abcd
 Means with different superscripts in a row within a group were significantly different (P < 0.05). 2 
 3 
 
xy
 Means with different superscripts in a column within a group were significantly different (P < 0.05). 4 
Oocyte 
Grades 
No. of 
oocytes 
Maturation rate 
(n) 
Enucleation rate 
(n) 
Injection rate 
(n) 
Percent cleavage (n)  
     2 - cell  
(n) 
4 - cell  
(n) 
8 - cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst 
 (n) 
A 366 51.73 ± 4.83
y 
(253) 
64.09 ± 5.47
y 
(246) 
63.53 ± 5.45
y 
(240) 
46.40 ± 5.26
d,y 
(185) 
42.89 ± 5.11
bc,y 
(171) 
34.63 ± 4.91
bc,y 
(149) 
31.06 ± 4.76
b,y 
(133) 
13.91 ± 3.56
a,y 
(67) 
6.88 ± 1.90
a,y 
(39) 
B 362 46.94 ± 4.48
y 
(202) 
63.22 ± 5.43
y 
(190) 
63.31 ± 5.54
y 
(185) 
48.34 ± 5.08
c,y 
(144) 
40.43 ± 4.85
bc,y 
(129) 
33.57 ± 4.70
b,y 
(114) 
29.79 ± 4.48
b,y 
(99) 
  9.86 ± 2.95
a,y 
(48) 
5.99 ± 1.92
a,y 
(28) 
C 306 44.71 ± 5.07
y 
(180) 
54.73 ± 5.67
y 
(166) 
54.74 ± 5.70
y 
(154) 
40.15 ± 5.17
c,y 
(116) 
32.78 ± 5.01
bc,y 
(101) 
30.25 ± 5.00
bc,y 
(87) 
26.62 ± 4.76
b,y 
(74) 
  8.21 ± 2.80
a,xy 
(39) 
5.38 ± 2.01
a,y 
(21) 
D 111 12.40 ± 3.30
x 
(67) 
15.14 ± 4.06
x 
(60) 
16.00 ± 4.26
x 
(60) 
12.33 ± 3.46
c,x 
(47) 
 7.67 ± 2.71
bc,x 
(38) 
 7.67 ± 2.71
bc,x 
(38) 
 3.96 ± 2.06
ab,x 
(28) 
  2.33 ± 1.64
ab,x 
(14) 
1.83 ± 1.29
a,xy 
(11) 
E 151 14.21 ± 3.34
x 
(65) 
19.67 ± 4.47
x 
(53) 
19.13 ± 4.39
x 
(47) 
  9.44 ± 3.00
b,x 
(26) 
8.33 ± 2.83
b,x 
(23) 
 6.67 ± 2.63
ab,x 
(18) 
 5.33 ± 2.15
ab,x 
(16) 
 1.33 ± 0.94
a,x 
(2) 
0.00 ± 0.00
a,x 
(0) 
Total 1296    34.00 ± 2.09 43.37 ± 2.51 43.34 ± 2.52 31.33 ± 2.18 26.42 ± 2.05 22.56 ± 1.95 19.35 ± 1.82   7.13 ± 1.16 3.65 ± 0.69 
Table 3. Percent cleaved caprine embryos (%, mean ± SEM) based on different pre-intracytoplasmic injection (pre - ICI) durations 1 
*n = number of embryos (2 -, 4 -, 8 - cell, morula blastocyst and hatched blastocyst)/number of injected oocytes. 2 
 
abcd
 Means with different superscripts in a row were significantly different (P < 0.05). 3 
 
xy
 Means with different superscripts in a column were significantly different (P < 0.05). 4 
 5 
Pre-ICI 
durations 
No. of 
ovaries 
No. of 
oocytes 
 Percent cleavage 
 (n) 
   2 - cell 
(n) 
4 - cell 
(n) 
8 - cell 
(n) 
Morula 
(n) 
Blastocyst 
(n) 
Hatched 
blastocyst  
(n) 
 
Simultaneous   68   322   61.17 ± 10.65
d,x 
(96/125)* 
42.42 ± 8.77
cd,x 
(76/125) 
37.12 ± 8.97
c,x 
(69/125) 
29.39 ± 7.74
bc,x 
(59/125) 
7.68 ± 5.93
ab,xy 
(30/125) 
 4.29 ± 3.41
a,xy 
(17/125) 
 
30 min   31   194 45.39 ± 9.03
c,x 
(49/89) 
33.82 ± 7.47
bc,x 
(36/89) 
28.93 ± 7.11
bc,x 
(26/89) 
24.83 ± 7.37
b,x 
(18/89) 
 0.45 ± 0.45
a,x 
(1/89) 
0.00 ± 0.00
a,x 
(0/89) 
 
60 min 110   780 83.33 ± 3.10
d,y 
(383/472) 
74.42 ± 4.20
cd,y 
(350/472) 
62.42 ± 5.47
bc,y 
(309/472) 
53.10 ± 5.61
b,y 
(273/472) 
20.49 ± 4.16
a,y 
(139/472) 
12.95 ± 2.71
a,y 
(82/472) 
 
Total 209 1296   71.23 ± 3.83 59.59 ± 3.99 50.43 ± 4.32 42.45 ± 4.20 13.85 ± 2.93   8.57 ± 1.86  
Table 4. Cleavage rates of caprine embryos (%, mean ± SEM) from in vitro culture through different enucleation techniques                  1 
abcd
 Means with different superscripts in a row were significantly different (P < 0.05). 2 
 3 
xy
 Means with different superscripts in a column within a group were significantly different (P < 0.05). 4 
 5 
 6 
 7 
Enucleation 
techniques 
No. of 
ovaries 
No. of 
oocytes 
Maturation 
rate  
(n) 
Enucleation 
rate 
 (n) 
Injection rate 
(n) 
Percent cleavage  
(n)  
      2 - cell  
(n) 
4 - cell  
(n) 
8 - cell  
(n) 
Morula  
(n) 
Blastocyst  
(n) 
Hatched 
blastocyst  
(n) 
Squeezing  89   516 51.74 ± 3.19
x 
(509) 
95.23 ± 1.73
x 
(375) 
94.71 ± 1.76
x 
(320) 
58.15 ± 6.76
d,x 
(94) 
42.04 ± 6.53
c,x 
(71) 
25.73 ± 6.05
b,x 
(45) 
16.36 ± 5.22
b,x 
(16) 
 0.00 ± 0.00
a,x 
(0) 
 0.00 ± 0.00
a,x 
(0) 
Laser 120   780 66.42 ± 2.87
y 
(806) 
96.61 ± 1.42
x 
(699) 
99.41 ± 0.38
y 
(644) 
82.07 ± 3.45
c,y 
(412) 
74.14 ± 3.62
bc,y 
(327) 
70.93 ± 3.87
b,y 
(257) 
64.08 ± 3.91
b,y 
(195) 
25.33 ± 4.66
a,y 
(70) 
15.68 ± 2.99
a,y 
(33) 
Total 209 1296 59.76 ± 2.28 95.99 ± 1.10 97.28 ± 0.86  71.23 ± 3.83 59.59 ± 3.99 50.43 ± 4.32  42.45 ± 4.20  13.85 ± 2.93   8.57 ± 1.86 
 1 
Figure 1. a) Grade A, b) Grade B, c) Grade C, d) Grade D and d) Grade E of caprine oocytes. 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
  1 
Figure 2. (a - b) Development of caprine - cloned embryos at day 3 (4 - to 8 - cells) and day 5  2 
               (blastocysts).  3 
 4 
 5 
 6 
 7 
 Figure 3. a) Hatching cloned caprine - blastocyst. b) hatching cloned - caprine blastocyst  8 
                staining with Hoechst 3342 and observed under fluorescent microscope (20 ×  9 
                magnification). 10 
 11 
 12 
 13 
 14 
a b 
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   Although it has been 10 years since the first cloned mammals were generated from somatic cells 
using nuclear transfer (NT), the success rate for producing live offspring by cloning remains less than 5%. 
Cloning by somatic stem cell nuclear transfer (SCNT) involves the transfer of genetic material from a 
donor cell (karyoplast) to the cytoplasm of an oocyte or zygote from which the genetic material has been 
removed (cytoplast). The objectives of this study were to compare the different species oocytes and 
determine the effect of oocytes quality through the whole cell intracytoplasmic injection (WCICI) 
technique in ABEL laboratory. Goat oocytes were collected by laparoscopic ovum pick-up (LOPU) 
technique after superovulation with PMSG (1500 IU) and ovidrel (250 IU), whereas bovine ovaries were 
collected from abattoir and brought to the laboratory in normal saline at 30-35°C within 4 h for slicing to 
obtain oocytes. Both collected oocytes were matured by in vitro and assessed by cumulus expansion and 
the extrusion of the first polar body. Cumulus cells were removed through use of finely drawn glass 
pipettes with 0.1% hyaluronidase. Oocytes that had extruded the first polar body and with evenly 
granulated cytoplasm which were grouped by Grades A, B, C, D and E were selected for enucleation 
which were placed into TCM 199 HEPES containing 5.0 µg/ml cytochalasin B. The first polar body and 
approximately 10% of the oocyte cytoplasm was squeezed out. Fresh cumulus cells obtained from the 
matured oocytes can be used directly for nuclear transfer, that is by transferring into enucleated oocytes 
using WICI technique. The reconstructed oocytes were activated by calcium ionophore (5 min) and 6-
DMAP for 4 hours and cultured in vitro in KSOM. The cleaved embryos cell stages were observed and 
recorded daily. A total of 90 out of 192 (46.9%) matured oocytes were obtained from caprine while 271 
out of 982 (27.6%) from bovine. There were no significant differences in maturation rate, successful 
enucleation and injection rates among caprine and bovine (P>0.05). Bovine showed the higher successful 
enucleation and injection rates (40.2±4.4; 37.4±4.3) than caprine (35.0±4.3; 35.1±4.3). The results from 
this study showed that bovine gives better cleavage rate at 2-cell (15.5±2.9) and 4-cell (11.3±2.5) but 
lower at 8-cell (5.5±1.9) and morula (0.7±0.7) compare to caprine. However, no significant differences 
were observed between caprine and bovine in regard to cleavage rate (P>0.05). Grade A (36.0±9.5; 
43.4±8.1) oocyte give the highest cleavage rate followed by Grade B (18.0±7.0; 29.2±8.1), Grade C 
(8.0±4.7; 4.2±4.2), Grade D (0.0±0.0; 0.8±0.8) and Grade E (0.0±0.0; 0.0±0.0) for both caprine and 
bovine oocytes. Grade A (43.4±8.1) and B (29.2±8.1) bovine oocytes showed highest cleavage rate 
compare to caprine (36.0±9.5; 18.0±7.0) but Grade C (4.2±4.2) bovine oocytes is lower than Grade C 
(8.0±4.7) caprine oocytes. In conclusion, we successfully develop the WCICI technique in caprine and 
bovine species at ABEL laboratory. Improvement and standardization is still necessary for the more 
general use of this technique and its broader application to the study of livestock genetics.   
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and Grade C (8.0±4.7; 4.2±4.2) for both caprine and
bovine oocytes. Grade A (43.4±8.1) and B (29.2±8.1)
bovine oocytes showed highest cleavage rate compare to
caprine (36.0±9.5; 18.0±7.0) but Grade C (4.2±4.2) bovine
ve o spr ng y c on ng rema ns ess an . on ng
by somatic stem cell nuclear transfer (SCNT) involves
the transfer of genetic material from a donor cell
(karyoplast) to the cytoplasm of an oocyte or zygote
from which the genetic material has been removed
(cytoplast).
Table 2 (A-D): Effect of oocyte quality between caprine and bovine 
species through WCICI technique  
a) To compare the different species oocytes
between bovine and caprine through whole cell
intracytoplasmic injection (WCICI) technique.
b) To determine the effect of oocytes quality
Species No. of 
oocyte
Maturation
rate
Successful 
enucleated 
rate
Successful 
injected 
rate
Cleavage rate
2-cell 4-cell 8-cell Morula
Caprine 192 46.9 35.0 35.1 20.7±
4.4a,z
18.0±
5.2a,yz
9.7±
3.2a,xy
4.0±
2.8a,x
Bovine 982 27.6 40.2 37.4 25.6±
4.5 a,z
18.6±
3.9a,yz
8.9±
3.0a,x
1.8±
1.8 a,xy
a Means with same superscript in a column were not significantly different (P>0.05).
xyz Means with different superscript in a row were significantly different (P<0.05).
a
Figure 5: Development stage of  cloned-bovine embryos. (a) 2-cell, 
(b) 8- cell and (c) morula.
b c
OBJECTIVES
oocytes is lower than Grade C (8.0±4.7) caprine oocytes.
Goat oocytes were collected by laparoscopic oocyte
pick-up (LOPU) technique after superovulation with
PMSG (1500 IU) and ovidrel (250 IU), whereas bovine
ovaries were collected from abattoir and do slicing to
obtain oocytes. Both collected oocytes were matured
by in vitro and assessed by cumulus expansion and the
extrusion of the first polar body. Cumulus cells were
removed with 0 1% hyaluronidase Oocytes that had
through whole cell intracytoplasmic injection
(WCICI) technique in ABEL laboratory.
MATERIALS AND METHODS
Species
Grades Caprine (%) Bovine (%)
A 36.0±9.5yz 43.4±8.1z
B 18.0±7.0xy 29.2±8.1yz
C 8.0±4.7x 4.2±4.2x
Total 20.7±4.4 25.6±4.5 Figure 6: Development stage of  cloned-caprine embryos. (a) 2-cell, (b) 8-cell and (c) morula.
A) 2-cell stage
b ca
xyz Means with different superscript in a row were significantly different (P<0.05).
* Grade D and Grade E are not include because not cleavage. DISCUSSION
. .
extruded first polar body and with evenly granulated
cytoplasm which were grouped by Grades A, B, C, D
and E were selected for enucleation which were placed
into TCM 199 HEPES containing 5.0 µg/ml
cytochalasin B. The first polar body and approximately
10% of the oocyte cytoplasm was squeezed out. Fresh
cumulus cells were used for transferring into
enucleated oocytes using WCICI technique. The
reconstructed oocytes were activated by calcium
ionophore (5 min) and 6-DMAP for 4 h and cultured in
vitro in KSOM.
CONCLUSIONSA) O C ll i
Species
Grades Caprine Bovine
A 28.0±8.9yz 38.3±7.9z
B 8.0±4.7x 17.6±6.6xy
C 4.0±2.8x 0.0±0.0x
Total 18.0±5.2 18.6±3.9
B) 4-cell stage
xyz Means with different superscript in a row were significantly different (P<0.05).
* Grade D and Grade E are not include because not cleavage.
The quality of the oocyte is the key factor determining the
proportion of oocytes to develop or cleave to embryo (1). To
simplify the manipulation procedure and increase the
efficiency of SCNT, WCICI technique is used in obtained
Asian yellow goat cloned embryos (2). WCICI technique is
simple and efficient methods (3). However, one of the most
important things to be concerned in WCICI for NT is that the
plasma membrane of the donor cell may persist in the
oocytes resulting in failure to release the nucleus. WCICI is
also useful for the generation of ntESCs for preservation of
valuable and infertile species.
1) Lonergen, P., Rizos, D., Gutierrez-Adan, A., Fair, T.
and Boland, M.P. 2003. Oocyte and embryo quality:
REFERENCES
We successfully develop the WCICI technique in caprine
and bovine species at ABEL laboratory. Improvement and
standardization is still necessary for the more general use
of this technique and its broader application to the study
of livestock genetics.
Laparoscopic oocyte pick-up (LOPU) Ovary slicing
 ocyte o ect on
B) Searching Oocytes Under Microscope
Species
Grades Caprine Bovine
A 19.2±7.9xy 22.7±8.0y
B 8.0±4.7xy 3.9±2.8x
C 2.0±2.0x 0.0±0.0x
Total 9.7±3.2 8.9±3.0
C) 8-cell stage 
xyz Means with different superscript in a row were significantly different (P<0.05).
* Grade D and Grade E are not include because not cleavage.
effect of origin, culture conditions and gene
expression patterns. Reproduction in Domestic
Animals. 38 (4): 259-267.
2) Chen, D.Y., Jiang, M.X., Zhao, Z.J., Wang, H.L., Sun,
Q.Y., Zhang, L.S., Li, R.C., Cao, H.H., Zhang, Q.J.
and Ma, D.L. 2007. Cloning of Asian Yellow Goat (C.
hircus) by somatic cell nuclear transfer: telophase
enucleation combined with whole cell intracytoplasmic
injection. Molecular Reproduction and Development.
74: 28–34.
3) Lee, J.W., Wu, S.C., Tian X.C., Barber, M., Hoagland,
T., Riesen, J., Lee, K.H., Tu, C.F., Cheng, W.T.K. and
Yang X Z 2003 Production of cloned pigs by whole
   
Species
Grades Caprine Bovine
A 4.0±4.0x 3.6±3.6x
B 4.0±4.0x 0.0±0.0x
Total 4.0±2.8 1.8±1.8
Figure 1: Ooocytes were categorized according to a) Grade A, b) Grade B, 
c) GradeC,  d) Grade D and  e) Grade E.
a b c d e
C) Enucleation and Injection of Donor Cell (SCNT)
D) Morula
x Means with same superscript in a row were not significantly different (P>0.05).
* Grade C, Grade D and Grade E are not include because not cleavage.
, . . .
cell intracytoplasmic microinjection. Biology of
Reproduction. 69: 995-1001.
The authors wish to thank ABEL members and staff of
Mini Farm Institute of Biological Sciences, University of
Malaya, for their advices and assistance throughout this
project. This project was funded was PPP Research
Grant PS287/2010A (UM).
ACKNOWLEDGEMENTSFigure 2: Matured oocyte 
was obtained 
after IVM.
Figure 3: Matured oocyte 
was enucleated 
by using squeezing 
technique.
Figure 4: WCICI into    
enucleated 
oocyte.
D) Activation E) In vitro culture (IVC)
Calcium ionophore 
(5 min)
6-DMAP (4 h)
It is interesting to note that 46.9% (90/192) matured oocytes
were obtained from caprine which was higher than bovine
which was 27.6% (271/982). Bovine showed the higher
successful enucleation and injection rates (40.2±4.4;
37.4±4.3) than caprine (35.0±4.3; 35.1±4.3). The results from
this study showed that bovine gives better cleavage rate at
2-cell (25.6±4.5) and 4-cell (18.6±3.9) but lower at 8-cell
(8.9±3.0) and morula (1.8±1.8) compare to caprine.
However, no significant differences were observed between
caprine and bovine in regard to cleavage rate (P>0.05).
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 Although it has been 10 years since the first cloned mammals were generated from 
somatic cells using nuclear transfer (NT), the success rate for producing live offspring by 
cloning remains less than 5%. Cloning by somatic stem cell nuclear transfer (SCNT) 
involves the transfer of genetic material from a donor cell (karyoplast) to the cytoplasm of 
an oocyte or zygote from which the genetic material has been removed (cytoplast). The 
objectives of this study were to determine the effect of murine strains and the pre-
intracytoplasmic injection (pre-ICI) duration of donor cells through the cloning procedure 
in ABEL laboratory.  
 The mature female mice from 3 different strains (ICR, CBA/ca and C57BL/6J) 
aged 6-8 weeks old were superovulated using pregnant mare serum gonadotrophin 
(PMSG) (10 IU) via intraperitoneal (i.p.) injections on Day-1 at 1800 hours and followed 
by injection of human chorionic gonadotrophin (hCG) (10 IU), 48 hours apart. After 13-15 
hours post-hCG injections, the female mice were killed by cervical dislocation for oocyte 
recovery. The COCs were collected and denuded in 0.1% hyaluronidase to remove the 
cumulus cells. The matured oocytes with polar bodies were selected for enucleation to 
remove the spindle. Fresh cumulus cells (donor cells) were transferred into enucleated 
oocytes using whole cell intracytoplasmic injection (WCICI) technique with pre-
intracytoplasmic injection (pre-ICI) duration of 30 min, 1 hr, 1 hr 30 min or 2 hr. After 
nuclear transfer, the reconstructed oocytes were activated by strontium chloride for 6 hr 
and cultured in in vitro culture medium (Whitten medium). The cleaved embryos cell 
stages were observed and recorded daily.  
A total of 389 out of 658 (57.3±2.4) matured oocytes were obtained from mice. 
There were 358, 149 and 151 oocytes from the respective female of the superovulated ICR, 
CBA/ca and C57BL/6J strains. There were no significant differences in maturation rate 
among 3 different strains of mice where 60.0±3.5 (ICR), 59.3±4.4 (C57BL/6J) followed by 
51.7±4.8 (CBA/ca) (P<0.05). C57BL/6J showed the highest successful enucleation and 
injection rates (67.6±6.4; 75.7±9.3), followed by CBA/ca (62.4±8.5; 65.0±9.1) and ICR 
(54.2±1.6; 59.7±5.6). There were no significant differences in successful enucleation and 
injection rates among the 3 different strains of mice (P<0.05). In this study, 1 hr 30 min 
(44.1±6.3) gave the optimised pre-ICI duration for nuclear transfer compared to 30 min 
(0.0%), 1 hr (6.7%) and 2 hr (25.0%). The results from this study showed that ICR gives 
better cleavage rate which were 34.2±3.9, 21.7±10.5, 3.2±3.2, 2.6±2.6 and 1.9±1.9 for 2-, 
4-, 8-cell, morula and blastocyst, respectively, whereas C57BL/6J strain showed the lowest 
cleavage rates which were 6.3±4.4 (2-cell), 12.5±12.5 (4- and 8-cell) and 0.0% (morula 
and blastocyst) (P<0.05) by using the optimised pre-ICI injection duration (1 hr 30 min).  
 In conclusion, we successfully developed the standard somatic stem cell nuclear 
transfer (SCNT) protocol in murine species at ABEL laboratory. Improvement and 
standardisation is still necessary for the more general use of this technique and its broader 
application to the study of murine genetics.   
 
 
Figure 1: Cloned-murine embryos at (a) 2-cell, (b) 4-cell, (c) morula and (d-f) blastocyst stage.  
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throughout this project. This project was funded was PPP Research Grant PS197/2009A 
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Advances in mammalian cloning is very rapid worldwide.
However, there are many factors affecting the success of
cloning sing n clear transfer Mice is an e cellent model
INTRODUCTION
u u . x
animal to study cloning. However, there are different
approaches of somatic stem cell nuclear transfer (SCNT)
to produce cloned embryos which involves the whole cell
intracytoplasmic injection (WCICI) and electrofusion
techniques.
Objectives of this study:
a) To determine the effect of murine strains through the
cloning procedure in ABEL laboratory.
b) To determine the pre-intracytoplasmic injection (pre-
ICI) duration of donor cells through the cloning
procedure in ABEL laboratory.
Figure 3: Oviduct was collected by Figure 4: Oviduct with swollen part
Figure 1: Mouse was superovulated by 
intrapenitoneal injection.
Figure 2: Mouse was sacrificed  by 
cervical dislocation. a b
spindle
MATERIALS AND METHODS
      
excision.
        
of ampulla.
Figure 5: Cumulus oocyte     
complexes (COCs).
Figure 6: Matured murine 
oocytes with PB1.
dc
Superovulation in mice
Day 1: PMSG
Day 3: hCG
Flow of Experiment
Pre-ICI duration for 90 min seemed to be more suitable for
somatic stem cell nuclear transfer in murine which was significantly
higher compared to other pre-ICI duration. The chromosome-
spindle complex, visible as a translucent region in mouse oocyte’s
cytoplasm (1). Enucleated oocytes were incubated 90 min in
incubator before injection of donor nuclei to restore the oocyte
viability due to the sensitivity of the oocytes and can easily lyse just
DISCUSSION
Figure 7: Enucleated spindle of 
oocyte by squeezing technique.
Figure 8: Enucleated oocyte             
was confirmed by 
Hoerchst 33324 staining.
Figure 12: Development stages of  cloned-murine embryos. (a) 2-cell, (b) 
4-cell, (c) morula, (d) blastocyst and (e) hatching blastocyst.
e
In vivo matured oocytes (post-
hCG injection 13-15 hr)
Denuding of cumulus 
oocyte complexes (COCs)
after enucleation. Fresh donor cumulus cells were gently aspirated
in and out of the injection pipette until their nuclei were largely
devoid of visible cytoplasmic material (2). The ability of the donor
cell to support development has been shown to be affected by the
mouse strains (3). It is believed that ICR strains gave highest
cleavage rate than CBA/ca and C57BL/6J. Finally, SCNT is useful
for the generation of NT-ESCs for preservation of valuable and
infertile strains.
Figure 9: Injection of fresh donor 
cumulus cell (WCICI) into 
enucleated murine oocyte.
Figure 10: Nuclear transfer oocytes 
were activated with Sr2+.
We successfully produced cloned-murine embryos and applied
WCICI technique in ABEL laboratory Pre ICI duration and strains of
CONCLUSIONS
 
Matured oocyte Fresh cumulus cell
Oocytes enucleation
WCICI (NT)
Pre-ICI duration No. of replicate Cleavage rate
30 min 5 0.0±0.0a
60 min 5 6.7±6.7a,b
90 min 5 44.1±6.3c
120 min 5 25.0±8.3c
T t l 20 19 0±4 9
Table 1: Cleavage rate of murine by different pre-ICI duration of donor 
cells through SCNT technique
RESULTS
The authors wish to thank ABEL members and staff of Institute of
Biological Sciences (ISB) Animal House, University of Malaya
(UM), for their advices and assistance throughout this project. This
project was funded was PPP Research Grant PS287/2010A (UM).
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Figure 11: Nuclear transfer oocytes were 
cultured in vitro.
. -
mice are important consideration in SCNT. Improvement and
standardisation is still necessary for the more general use of this
technique and its broader application to the study of murine
genetics.
REFERENCES
Activation
(Sr2+, 6 hr)
In Vitro Culture (IVC)
Table 2: Percentage of maturation, successful enucleated, successful 
injected and cleavage rate of murine through SCNT 
technique
ab Means with different superscript in a column were significantly different (P<0.05).
xy Means with different superscript in a row  within a group were significantly different (P<0.05).
Strains No. of 
oocyte
Maturation
rate
Successful 
enucleated 
rate
Successfu
l injected 
rate
Cleavage rate
2-cell 4-cell 8-cell Morula Blastocyst
ICR 358 60.0±3.5a 54.2±1.6a 65.0±5.6a 34.2±3.9b,y 21.7±10.5a,y 3.2±3.2a,x 2.6±2.6a,x 1.9±1.9a,x
CBA/ca 149 51.7±4.8a 62.4±8.5a 60.0±9.1a 9.3±6.3 a,x 6.3±6.3a,x 6.3±6.3a,x 6.3±6.3a,x 6.3±6.3a,x
C57BL/6J 151 59.3±4.4a 67.6±6.4a 75.7±9.3a 6.3±4.4 a,x 12.5±12.5a,x 12.5±12.5a,x 0.0±0.0a,x 0.0±0.0a,x
Total 658 57.3±2.4 60.2±3.2 66.2±4.4 19.2±3.6 14.9±6.0 6.6±4.0 2.9±2.0 2.6±1.9
o a . .
abc Means with different superscript in a column were significantly different (P<0.05).
1) Wakayama, S. 2005. Mice cloned by nuclear transfer from
somatic and ntES cells derived from the same individuals.
Journal of Reproduction and Development. 51:765–772.
2) Wakayama, T., A.C.F. Perry, M. Zuccotti, K.R. Johnson and R.
Yanagimachi. 1998. Full term development of mice from
enucleated oocytes injected with cumulus cell nuclei. Nature.
394: 369-374.
3) Wakayama, T. and R. Yanagimachi. 2001. Mouse cloning with
nucleus donor cells of different age and type. Molecular
Reproduction and Development. 58: 376-383.
This cloning research involved the enucleation of oocytes
from mice and injection of fresh donor cumulus cell into
enucleated oocytes. The protocol is depicted in Figure 1 to
11.
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School of Biotechnology, Suranaree University of Technology 
  
Venue: Suranaree University of Technology, Nakhon Ratchasima, Thailand 
Lecture session: Suranaree Room, Surasammanakarn  
Hands-on workshop session: Embryo Technology and Stem Cell Research Center, 
Equipment 1 (F1) Bldg. 
 
Date 
Lecture session: 24-25 July 2010 
Hands-on workshop session: 26-30 July 2010 
 
Registration Fee  
Lecture session: 1000 Baht includes printed handouts together with banquets and  
 refreshments (120 seats available) 
Hands-on workshop session (20 seats available): 14,000 Baht  
                                   
Application Deadline: 20 June 2010  
 
Lecture Programme: Suranaree Room, Surasammanakarn   
24 July 2010 
8.00-8.30  Registration 
8.30-8.45  Opening remarks 
8.45-9.30  Embryonic Stem Cells: Past, Present and Future  
Prof. Davor Solter, Ph.D., Mammalian Development Laboratory,  
Institute of Medical Biology, A*STAR, Singapore      
9.30-10.15  The Biology of Human Embryonic Stem Cells  
Prof. Peter W. Andrews, D.Phil., Centre for Stem Cell Biology,  
The University of  Sheffield, UK 
10.15-10.45 Refreshment 
10.45-11.15 TGFb Family Signaling in the Regulation of Human ESC Self-Renewal 
and Early Stem Cell Fate 
Dr. Stuart Avery, Ph.D.,  Mammalian Development Laboratory,  
Institute of Medical Biology, A*STAR, Singapore 
11.15-11.45  The Role of Elabela in Human ESCs 
Dr. Katie Avery, Ph.D., Mammalian Development Laboratory,  
Institute of Medical Biology, A*STAR, Singapore      
11.45-13.00 Luncheon talk 
“Usefulness of Xeno-Free System in Stem Cells Banking and Therapy 
13.00-13.45 Reprogramming as a Biological Process 
Prof. Barbara Knowles, Ph.D., Mammalian Development Laboratory,  
Institute of Medical Biology, A*STAR, Singapore  
13.45-14.15 Nuclear Reprogramming in One Cell Stage Embryo 
Dr. Chanchao Lorthongpanich, Ph.D., Mammalian Development 
Laboratory, Institute of Medical Biology, A*STAR, Singapore      
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14.15-15.00 
 
 
15.00-15.30 
To Be, or Not to Be, Monoclonal  
Dr. Bruno Revesade, Ph.D., Human Embryology Laboratory,  
Institute of Medical Biology, A*STAR, Singapore 
Refreshment 
15.30-16.00 
 
 
16.00-17.00 
Buffalo Embryonic Stem Cells and their Differentiation Potential 
Prof. Yindee Kitiyanant, DVM,  Department of Anatomy, Faculty of Science, 
Mahidol University, Thailand 
Short communications (15 minutes each) will be selected from abstracts 
for poster presentation. 
18.00-20.30 Welcome dinner 
 
 
25 July 2010 
   
8.30-9.00 
 
Building Up the Network for International Stem Cell Research: the  
Lessons from the ISCI and the ESTOOLS 
Prof.  Peter W. Andrews, D.Phil., Centre for Stem Cell Biology,  
The University of Sheffield, UK      
9.00-9.30 Asia Pacific Stem Cell Network and Thai Society for Stem Cell Research 
Prof. Surapol Issaragrisil, M.D., Department of Medicine, Faculty of 
Medicine Siriraj Hospital, Mahidol University, Thailand 
9.30-10.00 Shedding New Life on Stem Cells Using SR-FTIR Microspectroscopy  
Dr. Kanjna Thumanu, Ph.D., Synchrotron Light Research Institute (Public 
Organization), Thailand  
10.00-12.00 Poster presentation together with refreshment 
12.00-13.15 Luncheon talk  
Induce Pluripotent Stem Cells: Is it Really New Hope for Patients? 
13.15-14.00 The Birth of iPSC Mice from Tetraploid Complementation 
Prof. Qi Zhou, Ph.D., State Key Laboratory of Reproductive Biology, 
Institute of Zoology, Chinese Academy of Sciences, Beijing, China 
14.00-14.30 Epigenetic Therapy in Cancer: a Perspective from Human Pluripotent 
and Nullipotent Stem Cells 
Mr. Patompon Wongtrakoongate, PhD candidate, Centre for Stem Cell 
Biology, The University of Sheffield, UK 
14.30-15.00 Neural Differentiation of Human Embryonic Stem Cells: a Tool to 
Reveal Neurodevelopment 
Dr. Parinya Noisa, Ph.D., Embryo Technology and Stem Cell Research 
Center, School of Biotechnology, Suranaree University of Technology, 
Thailand 
15.00-15.15 Refreshment 
15.15-15.45 Survival and Differentiation of hESC-derived Otic Neural Progenitor 
Cells (ONPs) Transplanted into the Gerbil Cochlea 
Dr. Nopporn Jongkamonwiwat, Ph.D., Faculty of Health Science, 
Srinakharinwirot University, Thailand 
 
 
 
15.45-16.15 
 
 
 
Nuclear Transfer for Producing Human ESCs  
Asst. Prof. Rangsun Parnpai, Ph.D., Embryo Technology and Stem Cell 
Research Center, School of Biotechnology, Suranaree University of 
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Technology, Thailand 
16.15-16.30 Poster presentation prize awarding 
16.30-17.00 Final discussion by all speakers and closing remarks  
 
Hands-on Workshop Programme: Embryo Technology and Stem Cell Research Center, 
Equipment 1 (F1) Bldg.  
26-30 July 2010 
Group I: Embryonic Stem Cells (Available for 10 participants) 
1. Establishment of mouse ES cells  
  1.1. Preparation of mouse spleenocytes for raising antibody 
     1.2. Primary mouse embryonic fibroblast preparation 
    1.3. Feeder cell preparation 
     1.4. Collection of mouse embryos at blastocyst stage  
  1.5. Isolation of inner cell mass cell by immunosurgery  
     1.6. Culture and passage of mouse ES cells 
  1.7. Characterization of mouse ES cells 
  1.8. Freezing of mouse ES cells 
 2. Culture and characterization of human ES cells 
 3. Differentiation of human ES cells into neural progenitor cells 
 
Group II: Adult Stem Cells (Available for 10 participants) 
 1. Isolation, culture and characterization of rat bone marrow derived mesenchymal 
stem cells (MSCs).  
2. Isolation, culture and characterization of rat adipose tissue derived MSCs.  
3. Isolation, culture and characterization of rat amniotic epithelial cells. 
4. Differentiation of rBM-MSCs into pre-adipocytes, osteoblasts and chondrocytes.
  
 
 
 
 
